A	O
recent	O
movement	O
suggests	O
minimizing	O
screen	O
time	O
for	O
youth	O
because	O
television	O
,	O
computers	O
,	O
and	O
video	O
games	O
contribute	B
to	O
sedentary	O
behavior	O
.	O

Handwashing	O
with	O
soap	O
was	O
more	O
frequently	O
observed	O
among	O
intervention	O
mothers	O
than	O
controls	O
before	O
breastfeeding	O
(	O
RD	O
0	O
.	O
65	O
,	O
95	O
%	O
CI	O
0	O
.	O
03	O
–	O
0	O
.	O
99	O
)	O
and	O
after	O
fecal	O
contact	O
(	O
RD	O
0	O
.	O
10	O
,	O
95	O
%	O
CI	O
0	O
.	O
04	O
–	O
0	O
.	O
17	O
)	O
(	O
Table	O
3	O
).	O

Men	O
consuming	O
the	O
most	O
folate	O
(>	O
75thpercentile	O
)	O
had	O
a	O
lower	O
frequency	O
of	O
disomy	O
21	O
,	O
X	O
,	O
sex	O
nullisomy	O
,	O
and	O
lower	O
overall	O
sperm	O
aneuploidy	O
[	O
11	O
].	O

)	O
45	O
.	O
02	O
±	O
13	O
.	O
32LF	O
/	O
HF	O
Ratio1	O
.	O
37	O
±	O
0	O
.	O
87	O
Values	O
expressed	O
as	O
percentage	O
or	O
mean	O
±	O
SD	O
.	O

The	O
Remaining	O
169	O
participants	O
were	O
assigned	O
to	O
the	O
control	O
or	O
vitamin	O
D	O
groups	O
with	O
a	O
block	O
randomization	O
design	O
,	O
and	O
they	O
were	O
referred	O
to	O
the	O
laboratory	O
to	O
provide	O
blood	O
sample	O
.	O

We	O
conducted	O
stratified	O
analyses	O
by	O
parity	O
status	O
to	O
assess	O
whether	O
the	O
trend	O
of	O
effectiveness	O
is	O
different	O
among	O
the	O
two	O
nulliparous	O
and	O
multiparous	O
subgroups	O
.	O

Results	O
Among	O
women	O
with	O
a	O
live	O
,	O
singleton	O
birth	O
and	O
at	O
least	O
one	O
25	O
(	O
OH	O
)	O
D	O
test	O
during	O
pregnancy	O
(	O
N	O
=	O
1	O
,	O
064	O
),	O
the	O
overall	O
PTB	O
rate	O
was	O
13	O
%.	O

Guidelines	O
for	O
evaluation	O
and	O
treatment	O
of	O
thyroid	O
cancer	O
must	O
consider	O
the	O
gestational	O
age	O
but	O
also	O
the	O
patients	O
'	O
desires	O
.	O

A	O
detailed	O
description	O
of	O
the	O
study	O
methods	O
(	O
14	O
)	O
and	O
primary	O
findings	O
have	O
been	O
published	O
previously	O
(	O
7	O
).	O

Introduction	O
In	O
2013	O
,	O
an	O
estimated	O
2	O
.	O
8	O
million	O
deaths	O
occurred	O
in	O
the	O
neonatal	O
period	O
globally	O
[	O
1	O
].	O

Compared	O
to	O
women	O
with	O
a	O
large	O
increase	O
in	O
25OHD	O
(≥	O
30	O
nmol	O
/	O
L	O
),	O
women	O
with	O
a	O
decrease	O
in	O
25OHD	O
had	O
significantly	O
higher	O
OR	O
of	O
having	O
a	O
child	O
born	O
SGA	O
(	O
OR	O
=	O
3	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
002	O
),	O
with	O
LBW	O
(	O
OR	O
=	O
4	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
014	O
)	O
as	O
well	O
as	O
a	O
trend	O
toward	O
higher	O
odds	O
of	O
preterm	O
delivery	O
(	O
OR	O
=	O
2	O
.	O
9	O
,	O
p	O
=	O
0	O
.	O
061	O
).	O

A	O
significant	O
correlation	B
was	O
observed	O
between	O
the	O
first	O
and	O
second	O
trimesters	O
visfatin	O
level	O
with	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
,	O
such	O
that	O
this	O
relationship	B
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

Such	O
a	O
relation	B
has	O
been	O
attributed	B
to	O
special	O
receptors	O
for	O
vitamin	O
D	O
in	O
pancreatic	O
betacells	O
.	O
9Moreover	O
,	O
vitamin	O
D	O
was	O
shown	O
to	O
have	O
positive	O
effects	B
on	O
insulin	O
sensitivity	O
,	O
and	O
its	O
deficiency	O
to	O
have	O
negative	O
effects	B
on	O
the	O
function	O
of	O
betacells	O
.	O
11In	O
agreement	O
with	O
this	O
,	O
cohort	O
studies	O
revealed	O
that	O
vitamin	O
D	O
had	O
a	O
protective	B
effect	B
against	O
diabetes	O
type	O
II	O
.	O
8	O
,	O
11Also	O
,	O
serum	O
concentration	O
of	O
vitamin	O
D	O
during	O
24	O
-	O
29thweek	O
of	O
pregnancy	O
in	O
women	O
suffering	O
from	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
was	O
lower	O
than	O
that	O
in	O
women	O
without	O
the	O
disease	O
.	O
12	O
The	O
study	O
of	O
vitamin	O
D	O
status	O
and	O
improving	O
it	O
in	O
the	O
lactating	O
mothers	O
with	O
previous	O
GDM	O
is	O
of	O
conspicuous	O
value	O
.	O
4	O
,	O
13	O
Due	O
to	O
the	O
limited	O
exposure	O
to	O
sunshine	O
and	O
inadequate	O
intake	O
,	O
the	O
level	O
of	O
vitamin	O
D	O
is	O
reduced	O
in	O
the	O
milk	O
of	O
lactating	O
mothers	O
.	O

It	O
was	O
a	O
review	O
that	O
covered	O
the	O
evidence	O
supporting	O
the	O
idea	O
that	O
prenatal	O
infection	O
on	O
the	O
central	O
nervous	O
system	O
may	O
increase	O
the	O
incidence	O
of	O
autism	O
spectrum	O
disorders	O
[	O
63	O
].	O

However	O
,	O
this	O
sample	O
may	O
have	O
decreased	O
the	O
representativeness	O
of	O
our	O
study	O
;	O
mothers	O
with	O
a	O
newborn	O
who	O
also	O
have	O
infants	O
or	O
older	O
children	O
to	O
care	O
for	O
may	O
be	O
less	O
likely	O
to	O
change	O
handwashing	O
behavior	O
because	O
of	O
time	O
constraints	O
,	O
or	O
because	O
their	O
current	O
pregnancy	O
does	O
not	O
lead	O
to	O
a	O
dramatic	O
alteration	O
of	O
their	O
self	O
-	O
definition	O
or	O
role	O
in	O
the	O
family	O
and	O
society	O
since	O
they	O
already	O
have	O
children	O
.	O

Subsequent	O
identification	O
of	O
human	O
relevant	O
mechanisms	O
of	O
epigenetic	O
toxicity	O
can	O
then	O
be	O
further	O
validated	O
as	O
appropriate	O
in	O
smaller	O
more	O
focused	O
studies	O
.	O

Similarly	O
,	O
a	O
pooled	O
analysis	O
from	O
Pakistan	O
on	O
8512	O
live	O
births	O
reported	O
maternal	O
antenatal	O
IFA	O
supplements	O
significantly	O
reduced	O
the	O
adjusted	O
risk	O
of	O
death	O
on	O
day	O
0	O
by	O
33	O
%	O
and	O
during	O
the	O
neonatal	O
period	O
by	O
29	O
%.	O

Ensuring	O
adequate	O
nutrition	O
during	O
pregnancy	O
is	O
one	O
of	O
the	O
key	O
actions	O
endorsed	O
by	O
the	O
South	O
African	O
Government	O
to	O
promote	O
optimal	O
early	O
childhood	O
development	O
in	O
an	O
effort	O
to	O
eradicate	O
poverty	O
[	O
25	O
].	O

Analysis	O
of	O
Samples	O
Approximately	O
5	O
ml	O
whole	O
blood	O
was	O
collected	O
by	O
venipuncture	O
in	O
a	O
non	O
-	O
heparinized	O
tube	O
.	O

The	O
challenge	O
now	O
is	O
to	O
fully	O
identify	O
and	O
investigate	O
the	O
specific	O
functional	O
epigenetic	O
mechanisms	O
and	O
biological	O
pathways	O
relevant	B
to	I
humans	O
so	O
that	O
the	O
risk	O
(	O
s	O
)	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
to	O
public	O
health	O
can	O
be	O
properly	O
assessed	O
and	O
addressed	O
.	O

She	O
clarified	O
the	O
study	O
’	O
s	O
goals	O
and	O
if	O
the	O
mothers	O
were	O
willing	O
to	O
participation	O
a	O
written	O
informed	O
consent	O
was	O
obtained	O
from	O
them	O
.	O

Maternal	O
and	O
cord	O
blood	O
were	O
collected	O
for	O
determining	O
the	O
25	O
(	O
OH	O
)	O
D	O
level	O
.	O

Reactive	O
oxygen	O
species	O
are	O
also	O
proposed	O
to	O
stimulate	O
the	O
production	O
of	O
alpha	O
-	O
ketoglutarate	O
,	O
a	O
co	O
-	O
substrate	O
for	O
TETs	O
and	O
one	O
of	O
the	O
two	O
main	O
classes	O
of	O
histone	O
demethylases	O
(	O
Chervona	O
&	O
Costa2012	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

Such	O
results	O
may	O
be	O
considered	O
in	O
context	O
with	O
exposure	O
to	O
psychotropic	O
drugs	O
.	O

Different	O
approaches	O
were	O
used	O
to	O
delineate	O
the	O
impact	B
of	O
UCP1	O
on	O
insulin	O
sensitivity	O
.	O

2	O
.	O

Reducing	O
anaemia	O
rates	O
by	O
18	O
.	O
2	O
%	O
for	O
women	O
of	O
reproductive	O
age	O
therefore	O
constitutes	O
a	O
6	O
.	O
7	O
%	O
reduction	O
in	O
anaemia	O
on	O
average	O
in	O
the	O
labour	O
force	O
(	O
using	O
the	O
proportion	O
of	O
women	O
of	O
reproductive	O
age	O
in	O
the	O
overall	O
labour	O
force	O
in	O
Vietnam	O
:	O
women	O
'	O
s	O
labour	O
force	O
participation	O
rate	O
is	O
similar	O
to	O
men	O
'	O
s	O
).	O

At	O
6	O
months	O
,	O
the	O
strongest	O
predictors	O
of	O
higher	O
WFA	O
z	O
-	O
scores	O
were	O
greater	O
percentage	O
of	O
calories	O
from	O
sweets	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
30	O
;	O
t	O
=	O
3	O
.	O
2	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
also	O
greater	O
increases	O
in	O
percentage	O
of	O
calories	O
from	O
protein	O
during	O
pregnancy	O
beta	O
=	O
0	O
.	O
20	O
;	O
Table	O
3	O
).	O

During	O
resistance	O
measurements	O
,	O
which	O
include	O
intra	O
,	O
extrathoracic	O
,	O
and	O
pulmonary	O
resistance	O
,	O
the	O
extrathoracic	O
airway	O
resistance	O
dominates	O
in	O
obligatory	O
nasal	O
breathing	O
infants	O
[	O
42	O
].	O

Compared	O
with	O
lean	O
women	O
non	O
-	O
snorers	O
,	O
those	O
women	O
who	O
were	O
both	O
overweight	O
and	O
who	O
snored	O
had	O
a	O
statistically	O
significant	O
6	O
.	O
91	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
RR	O
=	O
6	O
.	O
91	O
;	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
)	O
(	O
Table3	O
).	O

Nearly	O
half	O
of	O
the	O
participants	O
(	O
47	O
.	O
8	O
%,	O
451	O
/	O
943	O
)	O
reported	O
having	O
had	O
a	O
prior	O
live	O
birth	O
.	O

The	O
degree	O
of	O
risk	O
seems	O
to	O
be	O
directly	O
related	B
to	O
the	O
family	O
history	O
of	O
allergy	O
and	O
especially	O
to	O
maternal	O
atopy	O
,[	O
53	O
]	O
particularly	O
when	O
the	O
mother	O
has	O
diagnosed	O
atopic	O
eczema	O
and	O
has	O
elevated	O
IgE	O
levels	O
.	O

Low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
,	O
low	O
household	O
income	O
,	O
and	O
poorer	O
ratings	O
of	O
the	O
child	O
’	O
s	O
general	O
health	O
were	O
significantly	O
associated	B
with	O
S	O
-	O
ECC	O
on	O
logistic	O
regression	O
.	O

Miscarriages	O
or	O
premature	O
birth	O
have	O
raised	O
concern	O
about	O
the	O
use	O
of	O
radioactive	O
iodine	O
in	O
a	O
childbearing	O
age	O
due	O
to	O
the	O
known	O
mutagenic	O
effect	B
of	O
radiation	O
and	O
the	O
theoretical	O
possibility	O
that	O
it	O
may	O
affect	B
germ	O
cells	O
,	O
thereby	O
causing	O
genetic	O
damage	O
,	O
congenital	O
abnormalities	O
and	O
malignancy	O
in	O
offspring	O
.	O

Ninety	O
-	O
nine	O
percent	O
(	O
99	O
%)	O
of	O
the	O
respondents	O
affirmed	O
that	O
ANC	O
was	O
important	O
not	O
only	O
for	O
the	O
mother	O
but	O
for	O
the	O
foetus	O
as	O
well	O
.	O

The	O
filter	O
paper	O
cards	O
are	O
allowed	O
to	O
dry	O
at	O
room	O
temperature	O
for	O
24	O
h	O
,	O
placed	O
in	O
ziplock	O
bags	O
with	O
desiccants	O
,	O
and	O
stored	O
at	O
−	O
20	O
°	O
C	O
until	O
analysis	O
.	O

Primary	O
outcome	O
The	O
primary	O
outcome	O
was	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infant	O
age	O
and	O
sex	O
at	O
follow	O
-	O
up	O
[	O
27	O
].	O

Concerning	O
to	O
total	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
in	O
adolescence	O
(	O
Figure3C	O
),	O
we	O
detected	O
a	O
main	O
effect	B
of	O
time	O
[	O
F	O
(	O
3	O
,	O
65	O
)=	O
272	O
.	O
872	O
;	O
P	O
<	O
0	O
.	O
001	O
],	O
sex	O
[	O
F	O
(	O
1	O
,	O
67	O
)=	O
25	O
.	O
663	O
;	O
P	O
<	O
0	O
.	O
001	O
],	O
and	O
interaction	B
between	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
65	O
)=	O
22	O
.	O
908	O
;	O
P	O
<	O
0	O
.	O
001	O
].	O

Microbiome	O
profiling	O
To	O
identify	O
microbial	O
population	O
structure	O
profiles	O
,	O
we	O
used	O
full	O
-	O
length	O
amplicon	O
sequences	O
for	O
the	O
rRNA	O
gene	O
V4	O
-	O
V5	O
hypervariable	O
regions	O
.	O

All	O
calves	O
were	O
then	O
fed	O
the	O
same	O
diet	O
for	O
22	O
months	O
,	O
and	O
muscle	O
tissues	O
were	O
collected	O
by	O
biopsy	O
.	O

We	O
have	O
chosen	O
the	O
current	O
usual	O
programs	O
as	O
our	O
comparator	O
.	O

The	O
LASSO	O
results	O
are	O
given	O
in	O
Additional	O
file1	O
:	O
Figure	O
S3	O
.	O

Negative	O
maternal	O
energy	O
status	O
at	O
mid	O
-	O
gestation	O
(	O
80	O
%	O
of	O
the	O
energy	O
requirements	O
for	O
maintenance	O
of	O
body	O
weight	O
)	O
did	O
not	O
affect	O
MS	O
,	O
intramuscular	O
fat	O
percentage	O
,	O
and	O
HCW	O
,	O
but	O
increased	O
the	O
ratio	O
of	O
MS	O
to	O
12th	O
rib	O
fat	O
thickness	O
and	O
the	O
ratio	O
of	O
percent	O
intramuscular	O
fat	O
to	O
12th	O
rib	O
fat	O
thickness	O
in	O
offspring	O
compared	O
with	O
positive	O
energy	O
status	O
[	O
154	O
].	O

Results	O
Seventy	O
-	O
six	O
women	O
were	O
evaluated	O
,	O
53	O
(	O
69	O
.	O
7	O
%)	O
had	O
10	O
yrs	O
.	O

In	O
contrast	O
,	O
in	O
the	O
previous	O
studies	O
2000	O
IU	O
vitamin	O
D	O
supplementation	O
was	O
more	O
sufficient	O
to	O
increase	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
up	O
to	O
the	O
adequate	O
amount	O
(≥	O
32	O
ng	O
/	O
mL	O
)	O
[	O
18	O
,	O
57	O
,	O
58	O
].	O

They	O
had	O
free	O
access	O
to	O
standard	O
diets	O
formulated	O
for	O
post	O
-	O
weaning	O
(	O
d	O
29	O
to	O
d	O
76	O
),	O
growing	O
(	O
d	O
77	O
to	O
d	O
105	O
)	O
and	O
finishing	O
periods	O
[	O
64	O
].	O

We	O
would	O
like	O
to	O
propose	O
a	O
potential	O
model	O
where	O
,	O
during	O
preterm	O
birth	O
,	O
GR	O
α	O
is	O
the	O
predominant	O
receptor	O
since	O
there	O
is	O
a	O
decrease	O
in	O
negative	O
regulators	B
such	O
as	O
GR	O
β	O
,	O
GR	O
γ	O
,	O
and	O
the	O
“	O
pseudo	O
-	O
GRE	O
”	O
GAS5	O
.	O

(	O
2015	O
)	O
and	O
Leseva	O
et	O
al	O
.	O

PubMed	O
Central	O
:	O

β	O
:	O
Parameter	O
estimate	O
indicating	O
the	O
alteration	O
in	O
HRV	O
components	O
caused	O
by	O
one	O
unit	O
of	O
change	O
in	O
the	O
independent	O
variable	O
;	O
SE	O
:	O
Standard	O
error	O
;	O
CI	O
:	O
Confidence	O
interval	O
;	O
BMI	O
—	O
Body	O
Mass	O
Index	O
;	O
RMSSD	O
—	O
Root	O
Mean	O
Square	O
of	O
Successive	O
Differences	O
;	O
pNN50	O
—	O
Percentage	O
of	O
Differences	O
Between	O
Adjacent	O
Normal	O
-	O
to	O
-	O
Normal	O
Intervals	O
that	O
is	O
Greater	O
than	O
50	O
Milliseconds	O
;	O
HF	O
(	O
n	O
.	O
u	O
.	O

Furthermore	O
,	O
the	O
nature	O
of	O
the	O
precise	O
catalyst	O
of	O
autism	O
has	O
not	O
been	O
revealed	O
as	O
of	O
yet	O
.	O

Further	O
,	O
several	O
studies	O
examined	O
head	O
circumference	O
and	O
height	O
abnormalities	O
in	O
autism	O
patients	O
.	O

Participants	O
were	O
considered	O
to	O
have	O
quit	O
the	O
study	O
if	O
they	O
were	O
unreachable	O
after	O
7	O
recontact	O
attempts	O
,	O
and	O
no	O
further	O
follow	O
-	O
up	O
attempts	O
were	O
made	O
.	O

The	O
other	O
newborn	O
was	O
a	O
female	O
with	O
a	O
birthweight	O
of	O
2180	O
grams	O
.	O

As	O
a	O
result	O
of	O
these	O
findings	O
,	O
it	O
may	O
be	O
advantageous	O
for	O
primary	O
care	O
providers	O
(	O
including	O
dentists	O
and	O
physicians	O
)	O
to	O
consider	O
serum	O
25	O
(	O
OH	O
)	O
D	O
status	O
when	O
assessing	O
the	O
child	O
’	O
s	O
overall	O
health	O
.	O

Based	O
on	O
the	O
distribution	O
of	O
messages	O
,	O
investigators	O
examined	O
estimated	O
dosage	O
levels	O
,	O
dichotomized	O
on	O
whether	O
a	O
participant	O
received	O
lower	O
or	O
higher	O
than	O
median	O
message	O
exposure	O
to	O
messaging	O
.	O

Estimates	O
of	O
BAT	O
mass	O
and	O
activity	O
from	O
FDG	O
-	O
PET	O
studies	O
suggest	O
that	O
humans	O
have	O
,	O
on	O
average	O
,	O
50	O
–	O
80	O
g	O
of	O
BAT	O
(	O
Peirce	O
et	O
al	O
.,	O
2014	O
).	O

We	O
highlight	O
evidence	O
-	O
based	O
interventions	B
along	O
the	O
continuum	O
of	O
care	O
,	O
noting	O
gaps	O
in	O
coverage	O
,	O
quality	O
,	O
equity	O
and	O
implications	O
for	O
integration	O
and	O
scale	O
up	O
.	O

Parity	O
was	O
categorised	O
into	O
nullipara	O
,	O
secundipara	O
and	O
multipara	O
(>	O
two	O
deliveries	O
).	O

Rats	O
receiving	O
daily	O
doses	O
of	O
arsenic	O
equivalent	O
to	O
the	O
levels	O
in	O
groundwater	O
from	O
heavily	O
arsenic	O
-	O
contaminated	O
areas	O
of	O
the	O
Bengal	O
Basin	O
retained	O
significantly	O
less	O
of	O
the	O
element	O
in	O
blood	O
and	O
liver	O
and	O
excreted	O
significantly	O
more	O
in	O
urine	O
when	O
fed	O
2	O
mg	O
/	O
mL	O
AGE	O
.	O

More	O
recently	O
,	O
the	O
effects	B
of	O
relative	O
‘	O
overnutrition	O
’	O
have	O
come	O
into	O
question	O
.	O

Hughes	O
et	O
al	O
.	O

This	O
vitamin	O
is	O
photosynthesized	O
by	O
ultraviolet	O
-	O
B	O
radiation	O
in	O
the	O
epidermis	O
.	O

Simultaneous	O
with	O
the	O
above	O
two	O
Acta	O
Paediatrica	O
publications	O
,	O
a	O
paper	O
elsewhere	O
reported	O
that	O
among	O
117	O
adult	O
psychiatric	O
outpatients	O
is	O
Sweden	O
with	O
various	O
diagnoses	O
,	O
the	O
10	O
patients	O
with	O
autism	O
had	O
the	O
lowest	O
vitamin	O
D	O
levels	O
of	O
any	O
of	O
the	O
groups	O
studied	O
,	O
a	O
mean	O
of	O
12	O
ng	O
/	O
mL	O
(	O
31	O
nM	O
),	O
approaching	O
the	O
osteomalacic	O
range	O
for	O
adults	O
and	O
the	O
rachitic	O
range	O
for	O
children	O
(	O
6	O
).	O

It	O
is	O
also	O
worth	O
noting	O
that	O
some	O
of	O
these	O
RNA	O
-	O
mediated	O
phenotypes	O
have	O
been	O
shown	O
to	O
be	O
dependent	B
upon	O
the	O
remaining	O
member	O
of	O
the	O
DNMT	O
family	O
,	O
DNMT2	O
(	O
Kiani	O
et	O
al	O
.	O
2013	O
).	O

Introduction	O
Mobile	O
health	O
(	O
mHealth	O
),	O
the	O
use	O
of	O
mobile	O
phones	O
as	O
a	O
tool	O
for	O
health	O
care	O
treatment	O
and	O
public	O
health	O
behavior	O
change	O
,	O
is	O
a	O
rapidly	O
expanding	O
field	O
that	O
has	O
significant	O
promise	O
to	O
improve	O
public	O
health	O
and	O
increase	O
the	O
effectiveness	B
of	O
disease	O
prevention	O
and	O
health	O
promotion	O
programs	O
[	O
1	O
-	O
3	O
].	O

Women	O
interested	O
to	O
partake	O
in	O
the	O
study	O
are	O
screened	O
according	O
to	O
inclusion	O
and	O
exclusion	O
criteria	O
,	O
and	O
referred	O
to	O
RMMCH	O
ANC	O
clinic	O
for	O
signing	O
informed	O
consent	O
and	O
data	O
collection	O
if	O
eligible	O
.	O

Note	O
that	O
values	O
in	O
ng	O
/	O
mL	O
can	O
be	O
converted	O
to	O
nmol	O
/	O
L	O
by	O
multiplying	O
by	O
2	O
.	O
5	O
.	O

We	O
also	O
found	O
a	O
sex	O
effect	B
on	O
the	O
gene	O
expression	O
of	O
Chrebp	O
,	O
Acaca	O
,	O
Acox1	O
,	O
Srebf1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
and	O
Hmgcr	O
in	O
liver	O
,	O
and	O
Scd1	O
,	O
Cpt1b	O
,	O
and	O
Cox4i1	O
in	O
PAT	O
.	O

This	O
variable	O
had	O
a	O
median	O
value	O
of	O
11	O
.	O
20	O
and	O
mode	O
value	O
of	O
4	O
.	O

We	O
found	O
similar	B
ionized	O
calcium	O
levels	O
in	O
Hispanic	O
and	O
Caucasians	O
at	O
birth	O
.	O

To	O
correct	O
for	O
potential	O
loss	O
to	O
follow	O
-	O
up	O
bias	O
,	O
we	O
used	O
inverse	O
probability	O
weighting	O
and	O
assigned	O
to	O
each	O
woman	O
a	O
weight	O
that	O
was	O
the	O
inverse	O
of	O
the	O
probability	O
of	O
her	O
selection	O
for	O
given	O
values	O
of	O
covariates	O
(	O
see	O
further	O
details	O
in	O
the	O
supplementary	O
material	O
)	O
[	O
35	O
].	O

However	O
,	O
there	O
may	O
have	O
been	O
some	O
recall	O
bias	O
and	O
head	O
circumference	O
could	O
only	O
be	O
measured	O
on	O
the	O
first	O
year	O
of	O
life	O
all	O
within	O
a	O
modest	O
sample	O
size	O
,	O
indicating	O
a	O
need	O
for	O
replicating	O
the	O
study	O
in	O
a	O
larger	O
cohort	O
[	O
45	O
].	O

Fructose	O
consumption	O
,	O
in	O
the	O
form	O
of	O
high	O
fructose	O
corn	O
syrup	O
(	O
ratio	O
of	O
fructose	O
/	O
glucose	O
60	O
/	O
40	O
%),	O
increased	O
from	O
near	O
0	O
%	O
to	O
near	O
30	O
%	O
of	O
per	O
capita	O
consumption	O
of	O
refined	O
sugars	O
in	O
the	O
USA	O
between	O
1970	O
and	O
2000	O
,	O
whereas	O
the	O
consumption	O
of	O
sucrose	O
and	O
glucose	O
declined	O
or	O
remained	O
constant	O
[	O
3	O
].	O

However	O
,	O
little	O
seasonal	O
variation	O
exists	O
in	O
the	O
light	O
/	O
dark	O
cycle	O
in	O
the	O
area	O
where	O
the	O
majority	O
of	O
study	O
participants	O
were	O
born	O
[	O
208	O
].	O

In	O
Romania	O
,	O
a	O
study	O
conducted	O
by	O
the	O
Alfred	O
Rusescu	O
Institute	O
of	O
Mother	O
’	O
s	O
and	O
Child	O
’	O
s	O
Care	O
(	O
IOMC	O
),	O
found	O
that	O
the	O
use	O
of	O
iron	O
supplements	O
during	O
pregnancy	O
in	O
Romania	O
only	O
reduced	O
the	O
incidence	O
of	O
anaemia	O
at	O
birth	O
by	O
5	O
%	O
even	O
when	O
iron	O
supplements	O
were	O
provided	O
free	O
of	O
charge	O
under	O
reimbursement	O
arrangements	O
from	O
16	O
weeks	O
of	O
gestation	O
,	O
and	O
treatment	O
was	O
supervised	O
by	O
primary	O
care	O
physicians	O
[	O
14	O
].	O

Meanwhile	O
,	O
diastolic	O
BP	O
(	O
r	O
=	O
-	O
0	O
.	O
182	O
;	O
P	O
=	O
0	O
.	O
070	O
)	O
was	O
not	O
influenced	O
by	O
BW	O
in	O
these	O
children	O
(	O
Fig	O
1B	O
).	O

Most	O
subject	O
characteristics	O
and	O
maternal	O
dietary	O
factors	O
were	O
not	O
different	O
between	O
delivery	O
mode	O
groups	O
(	O
Table	O
1	O
).	O

Also	O
,	O
intervention	O
exposure	O
,	O
as	O
measured	O
by	O
estimated	O
number	O
of	O
antepartum	O
messages	O
delivered	O
and	O
number	O
of	O
antepartum	O
days	O
enrolled	O
in	O
the	O
messaging	O
campaign	O
,	O
were	O
assessed	O
for	O
all	O
study	O
participants	O
in	O
the	O
intervention	O
group	O
.	O

Vitamin	O
D	O
status	O
(	O
measured	O
as	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25OHD	O
))	O
of	O
pregnant	O
women	O
has	O
been	O
inversely	O
associated	B
with	O
adverse	O
gestational	O
outcomes	O
and	O
associated	B
with	O
uteroplacental	O
dysfunction	O
[	O
2	O
].	O

In	O
LGA	O
infants	O
,	O
hyperinsulinemia	O
in	O
fetal	O
period	O
leads	O
to	O
fetal	O
macrosomia	O
(	O
14	O
).	O

Of	O
the	O
patients	O
,	O
79	O
.	O
2	O
%	O
of	O
IG	O
and	O
81	O
.	O
9	O
%	O
of	O
CG	O
suffered	O
to	O
some	O
degree	O
from	O
vitamin	O
D	O
deficiency	O
.	O

showing	O
a	O
negative	O
correlation	B
between	O
dietary	O
PUFA	O
intake	O
and	O
the	O
severity	O
of	O
psychotic	O
symptoms	O
[	O
15	O
],	O
as	O
well	O
as	O
studies	O
showing	O
that	O
patients	O
with	O
schizophrenia	O
or	O
depression	O
have	O
lower	O
levels	O
of	O
PUFAs	O
in	O
brain	O
tissue	O
,	O
red	O
blood	O
cells	O
and	O
skin	O
fibroblasts	O
and	O
with	O
a	O
low	O
intake	O
of	O
fish	O
and	O
PUFAs	O
[	O
16	O
,	O
29	O
-	O
31	O
].	O

Mechanisms	O
and	O
model	O
systems	O
The	O
nature	O
of	O
the	O
research	O
means	O
that	O
studies	O
in	O
humans	O
are	O
mainly	O
restricted	O
to	O
epidemiological	O
cohorts	O
.	O

A	O
recent	O
meta	O
-	O
analysis	O
found	O
a	O
latitude	O
related	B
increase	O
in	O
schizophrenia	O
prevalence	O
that	O
was	O
greater	O
for	O
groups	O
with	O
low	O
fish	O
consumption	O
[	O
12	O
].	O

BMI	O
:	O
body	O
mass	O
index	O
.#:	O
n	O
=	O
8956	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Madigan	O
text4baby	O
CONSORT	O
flow	O
diagram	O
.	O

b	O
.	O

Methods	O
Study	O
Design	O
and	O
Participants	O
We	O
examined	O
baseline	O
data	O
(	O
N	O
=	O
123	O
)	O
from	O
a	O
randomized	O
controlled	O
trial	O
,	O
Madre	O
Sana	O
,	O
Bebé	O
Sano	O
(	O
Healthy	O
Mother	O
,	O
Healthy	O
Baby	O
),	O
designed	O
to	O
prevent	O
excessive	O
GWG	O
.	O

In	O
the	O
treatment	O
group	O
,	O
the	O
aim	O
was	O
to	O
maintain	O
a	O
fasting	O
glucose	O
level	O
of	O
<	O
5	O
.	O
5	O
mmol	O
/	O
L	O
,	O
and	O
2	O
hour	O
post	O
-	O
prandial	O
reading	O
<	O
7	O
.	O
0	O
mmol	O
/	O
L	O
.	O

Immediate	O
-	O
phase	O
type	O
I	O
allergic	O
symptoms	O
usually	O
occur	O
within	O
several	O
minutes	O
after	O
allergen	O
contact	O
.	O

Significantly	O
dysregulated	O
proteins	O
were	O
examined	O
in	O
bioinformatic	O
pathways	O
analysis	O
(	O
Ingenuity	O
Pathway	O
Analysis	O
[	O
IPA	O
];	O
Ingenuity	O
Systems	O
,	O
Mountain	O
View	O
,	O
CA	O
).	O

1	O
.	O

Results	O
3	O
.	O
1	O
.	O

We	O
drew	O
a	O
random	O
sample	O
of	O
all	O
women	O
meeting	O
criteria	O
at	O
the	O
Madigan	O
Obstetrics	O
and	O
Gynecology	O
Clinic	O
between	O
December	O
2011	O
and	O
January	O
2013	O
.	O

Follow	O
-	O
up	O
Follow	O
-	O
up	O
is	O
planned	O
according	O
to	O
the	O
stage	O
of	O
the	O
disease	O
and	O
to	O
the	O
extent	O
of	O
the	O
surgery	O
performed	O
.	O

Furthermore	O
,	O
the	O
placenta	O
responses	O
to	O
maternal	O
diet	O
in	O
a	O
sex	O
-	O
specific	O
manner	O
(	O
Tarrade	O
et	O
al	O
.,	O
2015	O
),	O
suggesting	O
that	O
the	O
sexual	O
dimorphism	O
in	O
adiposity	O
-	O
relevant	O
parameters	O
could	O
be	O
present	O
at	O
very	O
early	O
stages	O
.	O

Vitamin	O
D	O
posters	O
and	O
brochures	O
were	O
available	O
for	O
all	O
patients	O
at	O
MUSC	O
clinics	O
and	O
educational	O
materials	O
were	O
included	O
in	O
the	O
prenatal	O
packet	O
received	O
by	O
all	O
first	O
time	O
OB	O
patients	O
.	O

Statistical	O
methods	O
Among	O
the	O
34	O
415	O
women	O
included	O
in	O
the	O
study	O
,	O
we	O
had	O
information	O
on	O
dietary	O
intake	O
(	O
parent	O
study	O
)	O
and	O
psychotic	O
-	O
like	O
symptoms	O
for	O
34	O
310	O
women	O
(	O
follow	O
-	O
up	O
study	O
).	O

Limitations	O
This	O
study	O
is	O
based	B
on	I
retrospectively	O
self	O
-	O
reported	O
data	O
,	O
which	O
could	O
have	O
led	O
to	O
an	O
underestimation	O
of	O
the	O
use	O
of	O
supplements	O
,	O
especially	O
folic	O
acid	O
[	O
27	O
].	O

The	O
researchers	O
studied	O
858	O
mother	O
–	O
infant	O
pairs	O
between	O
1978	O
and	O
1982	O
.	O

If	O
these	O
findings	O
are	O
replicated	O
we	O
would	O
design	O
an	O
appropriate	O
intervention	O
study	O
in	O
pregnancy	O
to	O
establish	O
or	O
refute	O
causality	O
.	O

Out	O
of	O
which	O
,	O
79	O
women	O
(	O
42	O
.	O
9	O
%)	O
scored	O
<	O
9	O
,	O
90	O
women	O
(	O
57	O
.	O
1	O
%)	O
scored	O
9	O
–	O
13	O
and	O
15	O
women	O
(	O
8	O
.	O
2	O
%)	O
scored	O
>	O
13	O
.	O

Differences	O
in	O
the	O
definition	O
of	O
atopy	O
,	O
a	O
lack	O
of	O
objective	O
measures	O
of	O
atopy	O
,	O
residual	O
confounding	O
,	O
and	O
bias	O
(	O
e	O
.	O
g	O
.,	O
detection	O
,	O
selection	O
,	O
interview	O
,	O
recall	O
)	O
are	O
important	O
to	O
consider	O
when	O
interpreting	O
the	O
above	O
studies	O
[	O
92	O
,	O
121	O
].	O

In	O
a	O
previous	O
genome	O
-	O
wide	O
association	O
study	O
(	O
GWAS	O
),	O
we	O
demonstrated	O
that	O
a	O
number	O
of	O
single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
or	O
near	O
to	O
genes	O
encoding	O
key	O
components	O
of	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
are	O
associated	B
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
(	O
8	O
).	O

This	O
study	O
is	O
registered	O
withClinicalTrials	O
.	O
gov	O
,	O
numberNCT00548379	O
.	O

Baseline	O
characteristics	O
between	O
the	O
low	O
and	O
the	O
high	O
level	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
were	O
compared	O
using	O
a	O
two	O
-	O
sided	O
t	O
-	O
test	O
for	O
equal	O
means	O
for	O
continuous	O
,	O
normally	O
distributed	O
variables	O
and	O
and	O
χ2	O
-	O
test	O
for	O
categorical	O
variables	O
.	O

Vitamin	O
D3	O
can	O
be	O
synthesized	O
de	O
novo	O
.	O

We	O
were	O
able	O
to	O
adjust	O
for	O
smoking	O
,	O
BMI	O
,	O
migration	O
,	O
education	O
and	O
alcohol	O
that	O
could	O
confound	O
our	O
associations	B
between	O
diet	O
and	O
psychotic	O
-	O
like	O
symptoms	O
.	O

The	O
IG	O
was	O
given	O
intramuscular	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
,	O
while	O
the	O
CG	O
was	O
not	O
.	O

The	O
diagnosis	O
is	O
made	O
with	O
an	O
oral	O
glucose	O
tolerance	O
test	O
,	O
though	O
the	O
criteria	O
vary	O
around	O
the	O
world	O
(	O
Table	O
1	O
).	O

The	O
appropriate	O
age	O
for	O
,	O
and	O
duration	O
of	O
,	O
vitamin	O
A	O
deple	O
tion	O
or	O
supplementation	O
have	O
been	O
suggested	O
as	O
important	O
factors	O
that	O
affect	B
MS	O
.	O
Oka	O
et	O
al	O
[	O
134	O
]	O
reported	O
that	O
restricting	O
vitamin	O
A	O
in	O
15	O
-	O
month	O
-	O
old	O
cattle	O
until	O
the	O
final	O
finishing	O
phase	O
(	O
29	O
months	O
of	O
age	O
)	O
increased	O
MS	O
,	O
but	O
not	O
in	O
23	O
-	O
month	O
-	O
old	O
cattle	O
prior	O
to	O
finishing	O
.	O

Nodes	O
in	O
the	O
jugular	O
chains	O
should	O
also	O
be	O
carefully	O
examined	O
with	O
US	O
before	O
surgery	O
and	O
,	O
when	O
suspicious	O
,	O
FNAB	O
should	O
be	O
obtained	O
.	O

Thus	O
,	O
once	O
individual	O
exposures	O
have	O
been	O
characterized	O
,	O
it	O
may	O
also	O
be	O
relevant	B
to	I
assess	O
the	O
effect	B
of	O
(	O
1	O
)	O
mixtures	O
of	O
environmental	O
exposures	O
,	O
(	O
2	O
)	O
multiple	O
lifetime	O
exposures	O
of	O
single	O
environmental	O
exposures	O
,	O
and	O
(	O
3	O
)	O
multiple	O
lifetime	O
exposures	O
of	O
mixtures	O
of	O
environmental	O
exposures	O
.	O

Although	O
our	O
study	O
included	O
only	O
women	O
of	O
white	O
ethnicity	O
,	O
the	O
G	O
allele	O
was	O
associated	B
with	O
lower	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
.	O
The	O
greater	O
prevalence	O
of	O
the	O
G	O
allele	O
at	O
rs12785878	O
with	O
a	O
resulting	O
increase	O
in	O
7	O
-	O
DHC	O
reductase	O
activity	O
(	O
either	O
due	O
to	O
a	O
functional	O
modification	O
or	O
increased	O
synthesis	O
)	O
leading	O
to	O
reduced	O
availability	O
of	O
7	O
-	O
DHC	O
for	O
conversion	O
to	O
previtamin	O
D	O
might	O
contribute	B
to	O
lower	O
25	O
(	O
OH	O
)	O
D	O
in	O
individuals	O
with	O
darker	O
skin	O
pigmentation	O
.	O

Mice	O
fed	O
with	O
a	O
folate	O
deficient	O
diet	O
were	O
less	O
fertile	O
(	O
52	O
%	O
vs	O
.	O
85	O
%)	O
and	O
experienced	O
a	O
greater	O
post	O
-	O
implantation	O
loss	O
than	O
mice	O
fathered	O
by	O
mice	O
with	O
a	O
folate	O
sufficient	O
diet	O
.	O

A	O
national	O
survey	O
in	O
2000	O
found	O
anaemia	O
rates	O
were	O
24	O
.	O
3	O
%	O
for	O
non	O
-	O
pregnant	O
women	O
nationally	O
(	O
26	O
.	O
3	O
%	O
in	O
rural	O
areas	O
),	O
and	O
32	O
.	O
2	O
%	O
in	O
pregnant	O
women	O
(	O
33	O
.	O
8	O
%	O
in	O
rural	O
areas	O
)[	O
10	O
].	O

After	O
electrophoresis	O
,	O
the	O
proteins	O
were	O
electroblotted	O
on	O
to	O
PVDF	O
transfer	O
membranes	O
(	O
Hybond	O
-	O
P	O
;	O
Amersham	O
Biosciences	O
).	O

Multiple	O
epidemiologic	O
studies	O
have	O
found	O
an	O
association	B
between	O
higher	O
maternal	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentration	O
,	O
the	O
physiological	O
measure	O
of	O
vitamin	O
D	O
status	O
,	O
and	O
lower	O
PTB	O
risk	O
[	O
4	O
–	O
10	O
].	O

Similarly	O
to	O
what	O
was	O
proposed	O
for	O
skeletal	O
muscle	O
(	O
Dulloo	O
et	O
al	O
.,	O
2004	O
),	O
this	O
may	O
contribute	O
to	O
dissipate	O
excess	O
lipids	O
as	O
occurs	O
during	O
prolonged	O
stimulation	O
of	O
lipolysis	O
(	O
e	O
.	O
g	O
.,	O
chronic	O
β3	O
adrenoreceptor	O
treatment	O
).	O

The	O
PBDE	O
μβestimate	O
was	O
-	O
4	O
g	O
,	O
95	O
%	O
CI	O
(-	O
31	O
,	O
22	O
).	O

However	O
,	O
the	O
relationship	B
between	O
vitamin	O
D	O
levels	O
and	O
lung	O
function	O
in	O
infancy	O
has	O
not	O
been	O
investigated	O
.	O

Adjusted	O
mean	O
±	O
SEM	O
values	O
of	O
birth	O
weight	O
,	O
length	O
,	O
head	O
circumference	O
SD	O
-	O
scores	O
and	O
ponderal	O
index	O
z	O
-	O
score	O
between	O
(	O
a	O
)	O
maternal	O
prepregnancy	O
BMI	O
groups	O
of	O
underweight	O
,	O
normal	O
weight	O
,	O
overweight	O
and	O
obese	O
;	O
(	O
b	O
)	O
mothers	O
’	O
inadequate	O
GWG	O
,	O
adequate	O
GWG	O
and	O
excessive	O
GWG	O
;	O
(	O
c	O
)	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
;	O
(	O
d	O
)	O
suboptimal	O
and	O
optimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
;	O
and	O
(	O
e	O
)	O
suboptimal	O
and	O
optimal	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
.	O
Statistical	O
significance	O
is	O
denoted	O
by	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
and	O
***	O
P	O
<	O
0	O
.	O
001	O
.	O

The	O
mean	O
number	O
of	O
glomeruli	O
varied	O
from	O
10897	O
±	O
614	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
14064	O
±	O
308	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
30	O
%	O
difference	O
;	O
P	O
<	O
0	O
.	O
0001	O
,	O
t	O
-	O
test	O
)	O
and	O
from	O
10466	O
±	O
867	O
for	O
the	O
F2	O
-	O
SC	O
mice	O
to	O
12015	O
±	O
785	O
for	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

Skm1	O
mice	O
also	O
exhibited	O
arachnodactyly	O
characterized	O
by	O
elongated	O
phalanges	O
(	O
Figure	O
5	O
,	O
B	O
and	O
D	O
),	O
compared	O
to	O
wild	O
-	O
type	O
littermates	O
(	O
Figure	O
5	O
,	O
A	O
and	O
C	O
),	O
and	O
kinked	O
tail	O
(	O
Figure	O
5B	O
),	O
attributable	O
to	O
either	O
the	O
presence	O
of	O
hemivertebrae	O
or	O
fused	O
vertebrae	O
in	O
the	O
tail	O
region	O
(	O
Figure	O
5E	O
).	O

Weekly	O
supplements	O
for	O
women	O
of	O
reproductive	O
age	O
in	O
the	O
program	O
reported	O
here	O
are	O
accessed	O
at	O
village	O
level	O
.	O

Strengths	O
of	O
this	O
study	O
are	O
that	O
the	O
GraviD	O
cohort	O
is	O
representative	O
of	O
the	O
general	O
pregnant	O
population	O
in	O
terms	O
of	O
origin	O
,	O
education	O
,	O
parity	O
,	O
BMI	O
and	O
tobacco	O
use	O
[	O
25	O
],	O
which	O
increases	O
the	O
external	O
validity	O
of	O
the	O
findings	O
.	O

2007	O
).	O

It	O
also	O
sought	O
to	O
establish	O
reasons	O
that	O
determined	O
these	O
women	O
'	O
s	O
choice	O
of	O
ANC	O
site	O
as	O
well	O
as	O
explore	O
the	O
geographic	O
distribution	O
of	O
the	O
women	O
with	O
respect	O
to	O
their	O
residence	O
and	O
their	O
attending	O
health	O
centre	O
.	O

Also	O
at	O
increased	O
risk	O
for	O
vitamin	O
D	O
insufficiency	O
are	O
young	O
Thai	O
people	O
living	O
in	O
urban	O
areas	O
in	O
Thailand	O
who	O
have	O
less	O
leisure	O
time	O
and	O
spend	O
less	O
time	O
in	O
the	O
sunlight	O
.	O

The	O
relatively	O
greater	O
calcium	O
and	O
phosphorus	O
concentration	O
in	O
US	O
infant	O
formulas	O
compared	O
to	O
human	O
milk	O
may	O
also	O
be	O
protective	B
against	O
rickets	O
in	O
some	O
infants	O
.	O

Foetal	O
crown	O
-	O
rump	O
length	O
is	O
used	O
to	O
determine	O
gestational	O
age	O
of	O
participants	O
in	O
their	O
first	O
trimester	O
[	O
55	O
].	O

It	O
can	O
provide	O
information	O
on	O
genetic	O
and	O
physiological	O
diseases	O
,	O
improper	O
lifestyle	O
(	O
including	O
dietary	O
habits	O
),	O
and	O
a	O
variety	O
of	O
pathological	O
conditions	O
.	O

Increases	O
in	O
stress	O
were	O
related	B
to	O
lower	O
offspring	O
weight	O
status	O
in	O
normal	O
weight	O
mothers	O
(	O
adjusted	O
analyses	O
)	O
and	O
overweight	O
/	O
obese	O
mothers	O
(	O
unadjusted	O
analyses	O
),	O
which	O
is	O
consistent	O
with	O
earlier	O
research	O
on	O
stress	O
in	O
relation	B
to	O
inadequate	O
GWG	O
[	O
45	O
]	O
and	O
long	O
-	O
term	O
offspring	O
health	O
[	O
46	O
].	O

Vitamin	O
C	O
increased	O
preadipocyte	O
growth	O
of	O
3T3	O
L1	O
cells	O
[	O
148	O
]	O
and	O
also	O
had	O
a	O
positive	O
effect	B
on	O
differentiation	O
of	O
sheep	O
preadipocytes	O
in	O
primary	O
culture	O
[	O
149	O
].	O

Some	O
ncRNAs	O
can	O
also	O
promote	O
changes	O
in	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
,	O
and	O
/	O
or	O
the	O
expression	O
of	O
other	O
ncRNAs	O
.	O

Lewis	O
and	O
colleagues	O
surveyed	O
1	O
,	O
304	O
residents	O
,	O
obtaining	O
basic	O
demographic	O
information	O
,	O
mapping	O
the	O
locations	O
of	O
their	O
homes	O
,	O
and	O
taking	O
samples	O
from	O
the	O
wells	O
where	O
they	O
obtained	O
their	O
drinking	O
water	O
.	O

Records	O
included	O
ethnicity	O
,	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
socioeconomic	O
index	O
(	O
SEI	O
)	O
and	O
multivitamin	O
use	O
[	O
29	O
].	O

Furthermore	O
,	O
it	O
is	O
worth	O
noticing	O
that	O
the	O
increased	O
airway	O
resistance	O
may	O
result	O
in	O
a	O
higher	O
risk	O
of	O
wheezing	O
in	O
early	O
childhood	O
.	O

Similarly	O
,	O
a	O
greater	O
proportion	O
of	O
offspring	O
from	O
overweight	O
/	O
obese	O
mothers	O
were	O
classified	O
as	O
macrosomic	O
(>	O
4000	O
grams	O
;	O
17	O
.	O
2	O
%	O
versus	O
4	O
.	O
8	O
%,	O
resp	O
.	O

Economic	O
situation	O
was	O
assessed	O
by	O
ownership	O
of	O
radio	O
and	O
/	O
or	O
bicycle	O
and	O
information	O
on	O
perceived	O
economic	O
status	O
.	O

There	O
was	O
no	O
significant	O
effect	O
of	O
birth	O
hospital	O
on	O
the	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
when	O
ethnicity	O
was	O
accounted	O
for	O
by	O
covariate	O
analysis	O
(	O
p	O
=	O
0	O
.	O
37	O
).	O

The	O
normality	O
of	O
the	O
data	O
was	O
evaluated	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
.	O

While	O
there	O
is	O
still	O
room	O
for	O
much	O
further	O
research	O
,	O
current	O
understanding	O
suggests	O
that	O
length	O
of	O
labor	O
is	O
possibly	O
associated	B
with	O
autism	O
.	O

However	O
,	O
only	O
four	O
out	O
of	O
nineteen	O
participants	O
with	O
supplement	O
use	O
who	O
was	O
also	O
positive	O
for	O
Vitamin	O
D2	O
received	O
Vitamin	O
D2	O
-	O
containing	O
supplements	O
.	O

We	O
used	O
FGDs	O
to	O
understand	O
both	O
perceptions	O
regarding	O
the	O
need	O
for	O
IFA	O
tablets	O
during	O
pregnancy	O
and	O
the	O
state	O
of	O
IFA	O
supplementation	O
programmes	O
.	O

Although	O
,	O
laboratories	O
at	O
the	O
health	O
facilities	O
in	O
developing	O
countries	O
usually	O
lack	O
the	O
capacity	O
to	O
conduct	O
quality	O
blood	O
test	O
,	O
they	O
could	O
be	O
strengthened	O
to	O
provide	O
reliable	O
estimations	O
of	O
red	O
blood	O
cell	O
indices	O
such	O
as	O
haemoglobin	O
,	O
haematocrit	O
,	O
mean	O
cell	O
volume	O
,	O
mean	O
cell	O
haemoglobin	O
,	O
and	O
mean	O
cell	O
haemoglobin	O
concentration	O
.	O

PubMed	O
Central	O
:	O

Thus	O
,	O
the	O
continuous	O
cycling	O
of	O
triglyceride	O
hydrolysis	O
coupled	O
to	O
resynthesis	O
,	O
which	O
requires	O
large	O
amounts	O
of	O
ATP	O
,	O
could	O
be	O
another	O
important	O
mechanism	O
to	O
increase	O
thermogenesis	O
in	O
BAT	O
,	O
in	O
addition	O
to	O
the	O
role	B
of	O
UCP1	O
activation	O
in	O
this	O
process	O
(	O
Mottillo	O
et	O
al	O
.,	O
2014	O
).	O

Interestingly	O
,	O
our	O
results	O
show	O
that	O
increasing	O
maternal	O
BMI	O
had	O
a	O
mild	O
protective	B
effect	B
on	O
risk	O
of	O
SGA	O
.	O

In	O
total	O
,	O
18	O
of	O
the	O
40	O
studies	O
shown	O
inTable	O
2validated	O
loss	O
of	O
both	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
effect	B
(	O
s	O
)	O
following	O
appropriate	O
inhibition	O
,	O
treatment	O
or	O
knock	O
out	O
/	O
down	O
;	O
thereby	O
demonstrating	O
a	O
definitive	O
causal	O
link	B
between	O
exposure	O
(	O
largely	O
high	O
dose	O
)	O
to	O
BPA	O
,	O
formaldehyde	O
,	O
cadmium	O
,	O
methylmercury	O
,	O
2	O
,	O
3	O
,	O
7	O
,	O
8	O
-	O
tetra	O
-	O
chloro	O
-	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
TCDD	O
),	O
urethane	O
,	O
vinyl	O
carbamate	O
,	O
alcohol	O
,	O
caffeine	O
,	O
overnutrition	O
,	O
cigarette	O
smoke	O
,	O
nicotine	O
or	O
4	O
-(	O
methyl	O
-	O
nitrosamino	O
)-	O
1	O
-(	O
3	O
-	O
pyridyl	O
)-	O
1	O
-	O
butanone	O
(	O
NNK	O
),	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
.	O

These	O
data	O
have	O
a	O
few	O
girls	O
whose	O
mothers	O
have	O
a	O
very	O
high	O
BMI	O
and	O
these	O
values	O
appear	O
to	O
dilute	O
the	O
correlation	B
between	O
girls	O
and	O
mother	O
.	O

We	O
will	O
only	O
share	O
datasets	O
with	O
all	O
personally	O
identifiable	O
information	O
removed	O
,	O
and	O
every	O
reasonable	O
effort	O
to	O
keep	O
the	O
identification	O
of	O
study	O
subjects	O
in	O
the	O
strictest	O
confidence	O
.	O

Our	O
goal	O
was	O
to	O
identify	O
specific	O
high	O
-	O
risk	O
subsets	O
of	O
pregnant	O
women	O
who	O
may	O
benefit	O
from	O
vitamin	O
D	O
supplementation	O
in	O
order	O
to	O
mitigate	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
SGA	O
.	O

We	O
also	O
lacked	O
data	O
on	O
vitamin	O
D	O
binding	O
protein	O
which	O
may	O
differ	O
by	O
race	O
/	O
ethnicity	O
and	O
could	O
affect	B
the	O
association	B
between	O
PNV	O
use	O
and	O
25	O
(	O
OH	O
)	O
D	O
measured	O
in	O
the	O
plasma	O
.	O

Macrosomia	O
was	O
defined	O
as	O
weight	O
>	O
4000	O
grams	O
[	O
21	O
].	O

We	O
thus	O
propose	O
a	O
large	O
-	O
scale	O
prospective	O
trial	O
to	O
measure	O
the	O
impact	B
of	O
the	O
early	O
introduction	O
of	O
antenatal	O
iron	O
/	O
folic	O
acid	O
supplementation	O
in	O
pregnancy	O
on	O
neonatal	O
outcomes	O
in	O
rural	O
Bangladesh	O
.	O

Further	O
,	O
a	O
cause	O
-	O
and	O
-	O
effect	O
relationship	B
can	O
not	O
be	O
concluded	O
from	O
this	O
study	O
.	O

PubMed	O
Central	O
:	O

The	O
newly	O
synthesized	O
cytokines	O
and	O
chemokines	O
lead	O
to	O
the	O
late	O
-	O
phase	O
reaction	O
associated	B
with	O
tissue	O
edema	O
by	O
recruitment	O
and	O
activation	O
of	O
additional	O
inflammatory	O
cells	O
,	O
including	O
basophils	O
,	O
eosinophils	O
,	O
and	O
T	O
helper	O
type	O
2	O
(	O
Th2	O
)	O
lymphocytes	O
[	O
6	O
].	O

Anaemia	O
during	O
pregnancy	O
is	O
a	O
public	O
health	O
problem	O
that	O
affects	B
both	O
developed	O
and	O
developing	O
countries	O
and	O
has	O
an	O
impact	B
not	O
only	O
on	O
health	O
providers	O
,	O
but	O
also	O
on	O
the	O
socio	O
-	O
economic	O
environment	O
[	O
12	O
].	O

Mean	O
birth	O
weights	O
of	O
LP	O
newborn	O
piglets	O
used	O
for	O
microarray	O
analyses	O
were	O
numerically	O
lower	O
than	O
birth	O
weights	O
of	O
AP	O
offspring	O
(	O
LP	O
:	O
1	O
.	O
21	O
±	O
0	O
.	O
30	O
kg	O
,	O
AP	O
:	O
1	O
.	O
36	O
±	O
0	O
.	O
31	O
kg	O
,	O
P	O
=	O
0	O
.	O
08	O
,	O
n	O
=	O
32	O
).	O

In	O
the	O
current	O
study	O
the	O
birth	O
weight	O
explained	O
15	O
%	O
of	O
the	O
variance	O
in	O
RMSSD	O
index	O
(	O
R2	O
=	O
0	O
.	O
15	O
)	O
(	O
Table	O
2	O
).	O

Statistical	O
analysis	O
The	O
normality	O
of	O
the	O
variables	O
was	O
visually	O
inspected	O
.	O

Established	O
as	O
the	O
chorioallantoic	O
placenta	O
at	O
the	O
end	O
of	O
the	O
first	O
trimester	O
,	O
villous	O
tissues	O
secrete	O
multiple	O
hormones	O
that	O
maintain	O
pregnancy	O
and	O
regulate	O
placental	O
physiology	O
.	O

Differences	O
in	O
mean	O
calcium	O
,	O
albumin	O
,	O
and	O
PTH	O
concentrations	O
between	O
the	O
groups	O
are	O
also	O
reported	O
in	O
Table	O
2	O
.	O

Infant	O
immune	O
response	O
The	O
infant	O
’	O
s	O
IgG	O
response	O
to	O
measles	O
immunisation	O
is	O
assessed	O
at	O
phase	O
7	O
,	O
which	O
is	O
6	O
weeks	O
after	O
measles	O
immunisation	O
was	O
administered	O
at	O
the	O
study	O
site	O
.	O

Modern	O
techniques	O
for	O
genetic	O
analysis	O
create	O
opportunities	O
for	O
understanding	O
the	O
heritability	O
of	O
complex	O
traits	O
and	O
risk	O
for	O
chronic	O
diseases	O
.	O
2732Height	O
is	O
one	O
of	O
the	O
more	O
complex	O
genetically	O
inherited	O
traits	O
because	O
as	O
many	O
as	O
20	O
genes	O
—	O
if	O
not	O
more	O
—	O
interact	B
to	O
determine	O
a	O
child	O
’	O
s	O
height	O
.	O

A	O
randomized	O
controlled	O
trial	O
of	O
vitamin	O
D	O
supplementation	O
on	O
perinatal	O
depression	O
:	O
in	O
Iranian	O
pregnant	O
mothers	O
Abstract	O
Background	O
Mood	O
disorders	O
in	O
pregnancy	O
and	O
post	O
-	O
partum	O
period	O
are	O
common	O
and	O
considered	O
as	O
a	O
public	O
health	O
issue	O
.	O

Manipulating	O
IMF	O
deposition	O
through	O
developmental	O
programming	O
via	O
metabolic	O
imprinting	O
is	O
a	O
recently	O
proposed	O
nutritional	O
method	O
to	O
change	O
potential	O
IMF	O
deposition	O
during	O
the	O
fetal	O
and	O
neonatal	O
periods	O
in	O
rodents	O
and	O
domestic	O
animals	O
.	O

Prevention	O
strategies	O
for	O
iron	O
deficiency	O
and	O
maternal	O
anaemia	O
include	O
nutritional	O
education	O
,	O
promoting	O
the	O
intake	O
of	O
iron	O
and	O
folic	O
acid	O
supplements	O
,	O
and	O
food	O
fortification	O
[	O
13	O
].	O

There	O
were	O
no	O
differences	O
in	O
neonatal	O
outcomes	O
.	O

All	O
participants	O
gave	O
informed	O
consent	O
to	O
participate	O
in	O
the	O
study	O
and	O
ethical	O
approval	O
was	O
granted	O
by	O
the	O
local	O
ethics	O
committee	O
of	O
the	O
hospital	O
.	O

While	O
vitamin	O
A	O
restriction	O
improves	O
marbling	O
,	O
but	O
vitamin	O
D	O
restriction	O
did	O
not	O
significantly	O
affect	B
marbling	O
in	O
Angus	O
crossbred	O
steers	O
[	O
133	O
].	O

On	O
the	O
one	O
hand	O
,	O
this	O
matter	O
may	O
be	O
related	B
to	O
mitochondrial	O
impairments	O
which	O
may	O
happen	O
due	O
to	O
the	O
LP	O
diet	O
,	O
as	O
has	O
been	O
suggested	O
previously	O
[	O
57	O
,	O
58	O
].	O

Results	O
.	O

A	O
brief	O
wash	O
in	O
1x	O
PBS	O
solution	O
was	O
performed	O
after	O
this	O
.	O

Previous	O
evidence	O
on	O
the	O
longer	O
-	O
term	O
effects	O
of	O
antenatal	O
dietary	O
and	O
lifestyle	O
interventions	O
is	O
limited	O
.	O

However	O
,	O
some	O
sources	O
did	O
cite	O
other	O
factors	O
that	O
could	O
potentially	O
be	O
associated	B
with	O
the	O
delivery	O
room	O
itself	O
.	O

vitamins	O
C	O
,	O
D	O
and	O
E	O
)	O
protect	O
against	O
AM	O
.	O

In	O
addition	O
,	O
Japanese	O
farmers	O
generally	O
restrict	O
vitamin	O
A	O
levels	O
in	O
the	O
diet	O
during	O
the	O
mid	O
-	O
fattening	O
stage	O
to	O
produce	O
highly	O
marbled	O
Japanese	O
Black	O
cattle	O
beef	O
.	O

The	O
association	B
of	O
vitamin	O
D	O
status	O
with	O
BMI	O
has	O
been	O
attributed	B
to	O
an	O
excessive	O
storage	O
of	O
vitamin	O
D	O
in	O
fat	O
tissue	O
decreasing	O
thereby	O
serum	O
concentrations	O
[	O
47	O
].	O

The	O
size	O
of	O
the	O
glomeruli	O
was	O
determined	O
with	O
the	O
same	O
method	O
used	O
to	O
estimate	O
their	O
number	O
,	O
the	O
fractionator	O
/	O
dissector	O
method	O
.	O

Many	O
hundreds	O
of	O
studies	O
have	O
investigated	O
such	O
toxicity	O
,	O
yet	O
relatively	O
few	O
have	O
demonstrated	O
a	O
mechanistic	O
association	B
among	O
specific	O
environmental	O
exposures	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
health	O
outcomes	O
in	O
human	O
epidemiological	O
cohorts	O
and	O
/	O
or	O
rodent	O
models	O
.	O

Results	O
Figure	O
1outlines	O
the	O
flow	O
of	O
participants	O
.	O

For	O
example	O
,	O
research	O
has	O
suggested	O
that	O
Alu	O
sequences	O
often	O
flank	O
CGIs	O
(	O
Graff	O
et	O
al	O
.	O

Far	O
fewer	O
studies	O
have	O
examined	O
the	O
relationship	B
between	O
cord	O
blood	O
vitamin	O
D	O
levels	O
,	O
which	O
may	O
more	O
accurately	O
reflect	B
fetal	O
levels	O
of	O
vitamin	O
D	O
,	O
and	O
neonatal	O
outcomes	O
.	O
14	O
,	O
24Given	O
the	O
racial	O
disparities	O
seen	O
in	O
both	O
vitamin	O
D	O
deficiency	O
and	O
perinatal	O
outcomes	O
,	O
vitamin	O
D	O
has	O
been	O
proposed	O
as	O
part	O
of	O
the	O
explanation	O
for	O
this	O
disparity	O
,	O
particularly	O
with	O
regard	O
to	O
fetal	O
growth	O
and	O
SGA	O
.	O
8	O
Increased	O
awareness	O
of	O
the	O
growing	O
prevalence	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
has	O
led	B
to	I
an	O
urgent	O
need	O
for	O
consideration	O
of	O
supplementation	O
during	O
pregnancy	O
.	O

Access	O
to	O
data	O
All	O
collected	O
data	O
will	O
be	O
accessible	O
by	O
the	O
study	O
investigators	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
food	O
preference	O
in	O
adolescent	O
and	O
adult	O
offspring	O
Compulsive	O
feeding	O
test	O
(	O
chocolate	O
preference	O
and	O
total	O
caloric	O
intake	O
)	O
was	O
evaluated	O
in	O
adolescent	O
and	O
adult	O
offspring	O
at	O
postnatal	O
weeks	O
8	O
–	O
9	O
and	O
12	O
–	O
13	O
,	O
respectively	O
(	O
Figures3A	O
–	O
D	O
).	O

Instead	O
,	O
like	O
older	O
children	O
,	O
they	O
were	O
more	O
likely	O
to	O
eat	O
fatty	O
foods	O
such	O
as	O
french	O
fries	O
,	O
salty	O
snacks	O
,	O
and	O
sweet	O
beverages	O
and	O
less	O
likely	O
to	O
eat	O
bitter	O
-	O
tasting	O
vegetables	O
(	O
36	O
,	O
37	O
).	O

Mean	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
levels	O
were	O
also	O
found	O
to	O
be	O
weakly	O
to	O
moderately	O
correlated	B
,	O
with	O
a	O
Pearson	O
correlation	O
of	O
0	O
.	O
29	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
0	O
.	O
20	O
,	O
0	O
.	O
38	O
].	O

Expression	O
of	O
podocin	O
was	O
45	O
%	O
weaker	O
at	O
weaning	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
70	O
%	O
weaker	O
at	O
6	O
months	O
of	O
age	O
in	O
the	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
SC	O
mice	O
(	O
P	O
=	O
0	O
.	O
0004	O
).	O

This	O
includes	O
information	O
regarding	O
GDM	O
,	O
self	O
-	O
monitoring	O
of	O
blood	O
glucose	O
,	O
dietary	O
counseling	O
,	O
and	O
advice	O
regarding	O
healthy	O
lifestyle	O
measures	O
post	O
-	O
partum	O
.	O

If	O
an	O
association	B
exists	O
the	O
effect	B
probably	O
represents	O
the	O
interplay	O
between	O
various	O
environmental	O
,	O
genetic	O
,	O
lifestyle	O
,	O
and	O
socioeconomic	O
factors	O
,	O
operating	O
on	O
mother	O
and	O
child	O
within	O
a	O
precise	O
window	O
of	O
vulnerability	O
.	O

Significant	O
higher	O
levels	O
of	O
DHA	O
have	O
been	O
found	O
in	O
red	O
cell	O
membranes	O
of	O
un	O
-	O
medicated	O
schizophrenic	O
patients	O
compared	O
to	O
healthy	O
control	O
subjects	O
[	O
42	O
].	O

c	O
Linear	O
model	O
associations	B
between	O
maternal	O
aMED	O
score	O
and	O
relative	O
abundance	O
of	O
infant	O
stool	O
OTUs	O
.	O

The	O
central	O
team	O
will	O
comprise	O
of	O
three	O
research	O
fellows	O
,	O
one	O
medical	O
officer	O
and	O
one	O
research	O
investigator	O
and	O
one	O
BRAC	O
national	O
manager	O
.	O

Associations	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
We	O
separately	O
assessed	O
the	O
relation	B
of	O
maternal	O
diet	O
with	O
the	O
infant	O
gut	O
microbiome	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
n	O
=	O
48	O
).	O

Actually	O
,	O
this	O
is	O
not	O
a	O
new	O
finding	O
.	O

At	O
baseline	O
and	O
during	O
postnatal	O
days	O
4	O
-	O
5	O
,	O
10	O
–	O
12	O
,	O
13	O
–	O
15	O
,	O
and	O
20	O
–	O
22	O
,	O
the	O
data	O
collector	O
identified	O
the	O
presence	O
and	O
location	O
of	O
a	O
designated	O
handwashing	O
station	O
(	O
s	O
),	O
and	O
the	O
presence	O
of	O
water	O
and	O
soap	O
at	O
the	O
handwashing	O
station	O
(	O
s	O
)	O
(	O
Figure	O
1	O
).	O

Early	O
weaning	O
(	O
141	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
high	O
-	O
starch	O
diet	O
improved	O
MS	O
compared	O
with	O
normal	O
weaning	O
(	O
222	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
starch	O
creep	O
-	O
feed	O
diet	O
.	O

In	O
mothers	O
,	O
sensitisation	O
to	O
a	O
house	O
dust	O
mite	O
mixture	O
including	O
Dermatophagoides	O
farinae	O
,	O
as	O
well	O
as	O
German	O
cockroach	O
,	O
mould	O
mixture	O
,	O
cat	O
and	O
dog	O
dander	O
,	O
maize	O
pollen	O
,	O
Bermuda	O
grass	O
and	O
Quercus	O
robur	O
(	O
English	O
oak	O
),	O
Eucalyptus	O
,	O
Cypressus	O
arizonica	O
(	O
Arizona	O
cypress	O
),	O
Platanus	O
hybrida	O
(	O
London	O
plane	O
)	O
and	O
Acacia	O
trees	O
are	O
measured	O
.	O

Conclusions	O
:	O
The	O
single	O
300	O
,	O
000	O
IM	O
dose	O
of	O
vitamin	O
D	O
is	O
regarded	O
as	O
an	O
effective	B
and	O
safe	O
to	O
promptly	O
improve	O
vitamin	O
D	O
status	O
in	O
GDM	O
.	O

Conclusion	O
The	O
obesogenic	O
phenotype	O
in	O
offspring	O
from	O
HV	O
fed	O
dams	O
is	O
prevented	O
by	O
feeding	O
HV	O
or	O
HFol	O
pup	O
diets	O
,	O
possibly	O
due	O
to	O
post	O
-	O
weaning	O
modulation	O
of	O
food	O
intake	O
regulatory	O
mechanisms	O
.	O

No	O
earlier	O
studies	O
that	O
we	O
are	O
aware	O
of	O
have	O
evaluated	O
the	O
relationship	B
between	O
adult	O
vitamin	O
D	O
levels	O
and	O
psychotic	O
symptoms	O
.	O

(	O
2015	O
)*/†	O
Takeda	O
et	O
al	O
.	O

Delivery	O
research	O
Delivery	O
or	O
implementation	O
research	O
addresses	O
how	O
interventions	O
can	O
be	O
best	O
implemented	O
,	O
especially	O
in	O
resource	O
-	O
constrained	O
settings	O
where	O
coverage	O
inequalities	O
are	O
more	O
pronounced	O
so	O
that	O
all	O
families	O
are	O
reached	O
with	O
effective	O
care	O
.	O

DMP	O
exposure	O
was	O
associated	B
with	O
a	O
57	O
g	O
reduction	O
in	O
birth	O
weight	O
(	O
95	O
%	O
CI	O
(-	O
123	O
,	O
10	O
),	O
50	O
%	O
CI	O
(-	O
79	O
,	O
-	O
34	O
)).	O

The	O
main	O
finding	O
was	O
a	O
significant	O
effect	B
of	O
high	O
exposure	O
to	O
text4baby	O
on	O
self	O
-	O
reported	O
alcohol	O
consumption	O
postpartum	O
(	O
OR	O
0	O
.	O
212	O
,	O
95	O
%	O
CI	O
0	O
.	O
046	O
-	O
0	O
.	O
973	O
,	O
P	O
=.	O
046	O
),	O
as	O
measured	O
by	O
the	O
question	O
“	O
Since	O
you	O
found	O
out	O
about	O
your	O
pregnancy	O
,	O
have	O
you	O
consumed	O
alcoholic	O
beverages	O
?”	O
The	O
text4baby	O
participants	O
also	O
reported	O
lower	O
quantities	O
of	O
alcohol	O
consumed	O
postpartum	O
.	O

Infant	O
medical	O
assessments	O
A	O
medical	O
doctor	O
performs	O
a	O
general	O
and	O
physical	O
medical	O
assessment	O
of	O
infants	O
at	O
each	O
postnatal	O
visit	O
.	O

There	O
were	O
no	O
correlations	O
between	O
BMI	O
of	O
the	O
child	O
of	O
either	O
sex	O
at	O
ages	O
0	O
and	O
5	O
with	O
maternal	O
or	O
PGFs	O
,	O
so	O
this	O
evidence	O
suggests	O
that	O
transmission	O
of	O
BMI	O
is	O
not	O
primarily	O
genetic	O
.	O

Contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
:	O
CCM	O
KW	O
SP	O
EM	O
.	O

injection	O
of	O
1	O
.	O
25	O
mg	O
propionyl	O
-	O
promazine	O
(	O
0	O
.	O
2	O
ml	O
Combelen	O
,	O
Bayer	O
AG	O
,	O
Leverkusen	O
,	O
Germany	O
)	O
and	O
50	O
mg	O
ketamine	O
(	O
Ursotamin	O
,	O
Serumwerk	O
Bernburg	O
AG	O
,	O
Germany	O
).	O

The	O
mean	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
levels	O
in	O
case	O
and	O
control	O
groups	O
were	O
compared	O
with	O
independent	O
t	O
test	O
.	O

These	O
functional	O
and	O
behavioral	O
changes	O
may	O
contribute	B
to	O
the	O
signs	O
and	O
symptoms	O
of	O
autism	O
[	O
27	O
].	O

Vitamin	O
D	O
Effect	B
on	O
In	O
Vitro	O
Fertilization	O
VD	O
insufficiency	O
has	O
been	O
in	O
the	O
spotlight	O
of	O
in	O
vitro	O
fertilization	O
(	O
IVF	O
)	O
researchers	O
for	O
many	O
years	O
.	O

However	O
,	O
due	O
to	O
recent	O
changes	O
in	O
national	O
health	O
policies	O
,	O
intake	O
of	O
vitamin	O
D	O
has	O
increased	O
resulting	B
in	I
decreasing	O
rates	O
of	O
vitamin	O
D	O
deficiency	O
[	O
2	O
–	O
5	O
].	O

Methods	O
Study	O
population	O
and	O
setting	O
This	O
preliminary	O
(	O
pilot	O
)	O
study	O
is	O
based	O
on	O
data	O
collected	O
from	O
a	O
cohort	O
of	O
women	O
attending	O
prenatal	O
care	O
clinics	O
affiliated	O
with	O
Swedish	O
Medical	O
Center	O
in	O
Seattle	O
,	O
Washington	O
.	O

There	O
was	O
a	O
systematic	O
and	O
statistically	O
significant	O
difference	O
in	O
the	O
height	O
of	O
the	O
two	O
groups	O
of	O
fathers	O
—	O
those	O
measured	O
were	O
175	O
.	O
8	O
cm	O
tall	O
on	O
average	O
and	O
those	O
reported	O
were	O
significantly	O
taller	O
at	O
178	O
.	O
7	O
cm	O
.	O

In	O
another	O
study	O
,	O
15administration	O
of	O
600	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
was	O
associated	B
with	O
a	O
significant	O
increase	O
in	O
serum	O
vitamin	O
D	O
,	O
a	O
significant	O
decrease	O
in	O
serum	O
PTH	O
,	O
and	O
hypercalcemia	O
occurring	O
in	O
4	O
%	O
of	O
the	O
subjects	O
during	O
4	O
and	O
12	O
months	O
of	O
intervention	O
.	O

Therefore	O
,	O
it	O
has	O
not	O
been	O
possible	O
to	O
ascertain	O
whether	O
the	O
associations	B
at	O
implantation	O
in	O
early	O
pregnancy	O
differ	O
from	O
those	O
during	O
the	O
fetal	O
growth	O
spurt	O
in	O
late	O
pregnancy	O
.	O

Global	O
DNA	O
methylation	O
was	O
similar	O
among	O
the	O
diet	O
groups	O
.	O

2	O
.	O
9	O
.	O

An	O
association	B
between	O
thyroid	O
cancer	O
and	O
parity	O
or	O
full	O
-	O
term	O
pregnancy	O
has	O
been	O
assessed	O
in	O
many	O
studies	O
without	O
significant	O
or	O
conclusive	O
results6	O
.	O

Mothers	O
also	O
took	O
individual	O
micronutrient	O
supplements	O
(	O
e	O
.	O
g	O
.,	O
vitamin	O
C	O
tablets	O
),	O
but	O
most	O
mothers	O
who	O
took	O
these	O
also	O
took	O
multivitamins	O
,	O
making	O
it	O
impossible	O
to	O
determine	O
potential	O
independent	O
effects	B
of	O
these	O
micronutrients	O
.	O

Study	O
population	O
The	O
study	O
population	O
is	O
urban	O
pregnant	O
women	O
attending	O
ANC	O
at	O
either	O
one	O
of	O
four	O
selected	O
primary	O
health	O
care	O
clinics	O
or	O
at	O
the	O
ANC	O
clinic	O
of	O
the	O
hospital	O
.	O

The	O
peptide	O
mixture	O
was	O
then	O
bound	O
and	O
aspirated	O
5	O
times	O
through	O
the	O
column	O
and	O
bound	O
peptides	O
washed	O
with	O
5	O
×	O
10	O
µl	O
of	O
1	O
%	O
formic	O
acid	O
.	O

In	O
subsets	O
of	O
the	O
cohort	O
with	O
complete	O
data	O
for	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
,	O
no	O
association	O
was	O
found	O
between	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
and	O
childhood	O
atopy	O
or	O
atopic	O
asthma	O
.	O

2008	O
;	O
Lu	O
et	O
al	O
.	O

Then	O
,	O
the	O
hypothalamus	O
was	O
dissected	O
out	O
from	O
the	O
base	O
of	O
the	O
brain	O
according	O
the	O
rat	O
brain	O
atlas	O
of	O
Paxinos	O
and	O
Watson	O
(	O
2007	O
).	O

The	O
plasma	O
samples	O
were	O
analyzed	O
for	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
using	O
chemiluminescence	O
,	O
an	O
automated	O
radioimmunoassay21in	O
the	O
Weiss	O
laboratory	O
at	O
the	O
Channing	O
Laboratory	O
,	O
Boston	O
,	O
MA	O
.	O

In	O
this	O
study	O
,	O
VD	O
levels	O
were	O
estimated	O
in	O
donor	O
’	O
s	O
serum	O
before	O
the	O
embryo	O
transfer	O
.	O

Results	O
:	O
The	O
infants	O
were	O
followed	O
up	O
for	O
a	O
mean	O
duration	O
of	O
10	O
.	O
19	O
±	O
2	O
.	O
83	O
months	O
.	O

However	O
these	O
socio	O
-	O
demographic	O
factors	O
were	O
not	O
independent	O
determinants	B
of	O
the	O
use	O
of	O
iron	O
supplements	O
.	O

Authors	O
state	O
that	O
the	O
proliferation	O
of	O
spermatogenic	O
cells	O
was	O
decreased	O
with	O
calcium	O
-	O
dependent	O
down	O
regulation	B
of	O
cyclin	O
E	O
and	O
CDK2	O
,	O
and	O
up	O
regulation	B
of	O
p53	O
and	O
p21	O
expression	O
,	O
which	O
is	O
not	O
a	O
direct	O
effect	B
of	O
active	O
vitamin	O
D	O
deficiency	O
.	O

Women	O
who	O
don	O
’	O
t	O
take	O
vitamins	O
will	O
serve	O
as	O
the	O
control	O
group	O
.	O

In	O
second	O
trimester	O
,	O
development	O
of	O
muscles	O
,	O
organs	O
occurs	O
,	O
so	O
the	O
diet	O
rich	O
in	O
proteins	O
is	O
advised	O
.	O

Ethics	O
statement	O
The	O
Institutional	O
Review	O
Board	O
at	O
the	O
Nicaraguan	O
Ministry	O
of	O
Health	O
reviewed	O
and	O
approved	O
the	O
protocol	O
.	O

Adjunctive	O
treatment	O
of	O
rhinitis	O
,	O
which	O
is	O
permitted	O
in	O
pregnancy	O
,	O
includes	O
oxymetazoline	O
drops	O
or	O
spray	O
for	O
nasal	O
congestion	O
,	O
pseudoephedrine	O
(	O
after	O
the	O
first	O
trimester	O
)	O
for	O
persistent	O
nasal	O
congestion	O
,	O
and	O
buffered	O
saline	O
sprays	O
for	O
nasal	O
dryness	O
,	O
nasal	O
bleeding	O
,	O
and	O
vascular	O
congestion	O
associated	O
with	O
pregnancy	O
.	O

such	O
values	O
for	O
the	O
control	O
group	O
were	O
33	O
.	O
3	O
%	O
and	O
14	O
.	O
3	O
%,	O
respectively	O
.	O

Shown	O
as	O
β	O
and	O
95	O
%	O
CI	O
.	O

Additionally	O
,	O
Pb	O
was	O
associated	B
with	O
a	O
58	O
g	O
decrease	O
in	O
birth	O
weight	O
in	O
the	O
LASSO	O
analysis	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
)	O
and	O
a	O
53	O
g	O
decrease	O
in	O
the	O
Elastic	O
Net	O
analysis	O
(	O
Additional	O
file1	O
:	O
Figure	O
S4	O
).	O

These	O
associations	B
were	O
strongest	O
in	O
nonsmokers	O
.	O
16	O
Caption	O
(	O
FIG	O
)	O
Lactation	O
support	O
includes	O
teaching	O
women	O
techniques	O
to	O
breastfeed	O
and	O
build	O
their	O
milk	O
supply	O
,	O
as	O
well	O
as	O
reassuring	O
them	O
of	O
their	O
ability	O
to	O
nourish	O
their	O
infants	O
.	O

Physical	O
activity	O
,	O
smoking	O
and	O
educational	O
attainment	O
were	O
also	O
self	O
-	O
reported	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

PubMed	O
Central	O
:	O

After	O
intervention	O
,	O
the	O
two	O
groups	O
were	O
different	O
significantly	O
.	O

Furthermore	O
,	O
we	O
did	O
not	O
record	O
when	O
during	O
the	O
pregnancy	O
the	O
supplements	O
were	O
taken	O
,	O
which	O
is	O
of	O
particular	O
importance	O
for	O
folic	O
acid	O
.	O

The	O
predominance	O
of	O
papillary	O
cancer	O
may	O
be	O
an	O
important	O
factor	B
favouring	O
localized	O
disease	O
,	O
as	O
these	O
cancers	O
metastasize	O
slowly	O
,	O
and	O
mostly	O
in	O
the	O
lymphatic	O
system	O
,	O
whereas	O
less	O
common	O
follicular	O
cancers	O
tend	B
to	O
spread	O
via	O
angio	O
-	O
invasion	O
with	O
a	O
higher	O
frequency	O
of	O
distant	O
metastasis	O
.	O

Formative	O
research	O
Before	O
the	O
intervention	O
started	O
,	O
we	O
conducted	O
a	O
formative	O
study	O
using	O
qualitative	O
methods	O
.	O

In	O
addition	O
,	O
researchers	O
find	O
dairy	O
products	O
in	O
China	O
are	O
mainly	O
fortified	O
with	O
Vitamin	O
D3	O
,	O
which	O
will	O
not	O
translate	O
into	O
higher	O
Vitamin	O
D2	O
detection	O
rate	O
among	O
participants	O
.	O

In	O
Cameroon	O
,	O
there	O
are	O
few	O
reported	O
studies	O
on	O
the	O
quality	O
of	O
ANC	O
services	O
rendered	O
;	O
meanwhile	O
the	O
study	O
of	O
consumer	O
perceptions	O
in	O
relation	B
to	O
behavioral	O
outcomes	O
has	O
been	O
on	O
the	O
rise	O
in	O
other	O
countries	O
[	O
8	O
].	O

Increasing	O
propionate	O
production	O
for	O
glucose	O
synthesis	O
is	O
also	O
important	O
for	O
IMF	O
deposition	O
,	O
especially	O
during	O
the	O
fattening	O
period	O
.	O

Preeclampsia	O
occurred	O
less	O
frequently	O
in	O
the	O
intervention	O
group	O
(	O
12	O
%	O
vs	O
18	O
%,	O
adjusted	O
risk	O
reduction	O
0	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
02	O
).	O

Vitamin	O
D	O
requirement	O
during	O
pregnancy	O
Thyroidectomised	O
patients	O
often	O
need	O
calcium	O
and	O
D	O
vitamin	O
supplementation	O
,	O
and	O
the	O
treatment	O
needs	O
frequent	O
adjustment	O
during	O
the	O
pregnancy	O
to	O
prevent	O
maternal	O
and	O
neonatal	O
hypocalcemia	O
.	O

Multivariable	O
logistic	O
regression	O
analyses	O
of	O
the	O
outcome	O
variables	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
were	O
performed	O
with	O
25OHD	O
at	O
T1	O
,	O
T3	O
and	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
as	O
the	O
independent	O
variables	O
.	O

The	O
detection	O
limit	O
of	O
the	O
human	O
cathelicidin	O
ELISA	O
was	O
0	O
.	O
14	O
ng	O
/	O
mL	O
.	O

Conclusions	O
The	O
present	O
trial	O
showed	O
that	O
consuming	O
2000	O
IU	O
vitamin	O
D3daily	O
during	O
late	O
pregnancy	O
was	O
effective	O
in	O
decreasing	O
perinatal	O
depression	O
levels	O
.	O

Correlations	O
between	O
continuous	O
.	O

Whether	O
women	O
treated	O
for	O
thyroid	O
cancer	O
should	O
become	O
pregnant	O
was	O
once	O
a	O
matter	O
of	O
concern	O
,	O
but	O
current	O
evidence	O
suggests	O
that	O
DTC	O
should	O
not	O
discourage	O
intended	O
pregnancy	O
,	O
with	O
the	O
usual	O
recommendation	O
to	O
postpone	O
it	O
to	O
at	O
least	O
6	O
months	O
after	O
radioiodine	O
therapy	O
.	O

The	O
complex	O
interaction	B
of	O
nature	O
and	O
nurture	O
in	O
the	O
regulation	B
of	O
appetite	O
(	O
45	O
)	O
is	O
exemplified	O
by	O
a	O
behavior	O
known	O
as	O
eating	O
in	O
the	O
absence	O
of	O
hunger	O
(	O
EAH	O
),	O
a	O
behavioral	O
marker	B
of	O
impaired	O
satiety	O
(	O
46	O
-	O
49	O
).	O

A	O
larger	O
sample	O
size	O
also	O
enabled	O
subgroup	O
analysis	O
by	O
PTB	O
subtype	O
,	O
race	O
/	O
ethnicity	O
,	O
and	O
among	O
women	O
with	O
a	O
previous	O
PTB	O
.	O

2	O
.	O
4	O
.	O

Solid	O
gray	O
circles	O
and	O
solid	O
black	O
line	O
represent	O
MUSC	O
cohort	O
(	O
N	O
=	O
1064	O
)	O
and	O
open	O
circles	O
and	O
dashed	O
line	O
represent	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Assessment	O
of	O
Other	O
Variables	O
For	O
the	O
infants	O
,	O
birth	O
date	O
,	O
gestational	O
age	O
,	O
and	O
anthropometric	O
measurements	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
were	O
recorded	O
at	O
birth	O
.	O

Eligibility	O
criteria	O
included	O
nonsmoking	O
,	O
adults	O
(	O
age	O
>	O
18	O
years	O
),	O
fluency	O
in	O
English	O
,	O
access	O
to	O
telephone	O
,	O
gestational	O
age	O
between	O
10	O
and	O
16	O
weeks	O
,	O
singleton	O
pregnancy	O
,	O
no	O
current	O
or	O
history	O
of	O
eating	O
disorders	O
,	O
and	O
without	O
major	O
psychiatric	O
illness	O
(	O
i	O
.	O
e	O
.,	O
schizophrenia	O
,	O
bipolar	O
disorder	O
,	O
and	O
panic	O
/	O
anxiety	O
disorder	O
)	O
or	O
major	O
medical	O
problems	O
,	O
including	O
diabetes	O
,	O
stroke	O
,	O
and	O
cancer	O
.	O

Strengths	O
and	O
limitations	O
A	O
potential	O
limitation	O
of	O
our	O
work	O
is	O
the	O
dichotomised	O
seasonal	O
divisions	O
.	O

This	O
finding	O
was	O
not	O
explained	O
solely	O
by	O
social	O
ties	O
between	O
people	O
who	O
were	O
already	O
obese	O
.	O

It	O
also	O
secretes	O
several	O
batokines	O
,	O
allowing	O
for	O
inter	O
-	O
organ	O
communication	O
.	O

However	O
,	O
the	O
majority	O
of	O
vitamin	O
D	O
supplementation	O
intervention	O
trials	O
in	O
pregnancy	O
have	O
not	O
had	O
a	O
significant	O
impact	O
on	O
maternal	O
and	O
offspring	O
health	O
[	O
10	O
].	O

Joo	O
and	O
colleagues	O
[	O
17	O
]	O
found	O
that	O
weekly	O
text	O
messages	O
about	O
diet	O
and	O
PA	O
behavior	O
promoted	O
weight	O
loss	O
.	O

We	O
acknowledge	O
the	O
limitation	O
that	O
the	O
scale	O
have	O
not	O
been	O
used	O
earlier	O
in	O
Sweden	O
and	O
validated	O
in	O
the	O
Swedish	O
population	O
.	O

(	O
p	O
=	O
0	O
.	O
002	O
)	O
[	O
5	O
].	O

Subject	O
scanning	O
does	O
not	O
take	O
place	O
unless	O
all	O
quality	O
control	O
results	O
fall	O
within	O
acceptable	O
limits	O
.	O

Sustained	O
advocacy	O
in	O
tackling	O
micronutrient	O
deficiencies	O
at	O
national	O
and	O
international	O
policy	O
levels	O
is	O
also	O
a	O
prerequisite	O
to	O
the	O
attainment	O
of	O
Millennium	O
Development	O
Goals	O
4	O
and	O
5	O
.	O

Our	O
results	O
are	O
consistent	O
with	O
other	O
data	O
showing	O
that	O
early	O
nutrition	O
alters	O
the	O
central	O
appetite	O
regulatory	O
network	O
.	O
22Effects	B
of	O
the	O
maternal	O
diet	O
on	O
the	O
hypothalamic	O
expression	O
of	O
food	O
intake	O
regulatory	O
pathways	O
were	O
found	O
in	O
lambs	O
of	O
ewes	O
fed	O
a	O
diet	O
that	O
exceeded	O
their	O
energy	O
requirement	O
.	O

A	O
diagnosis	O
of	O
1	O
)	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
2	O
)	O
sensitised	O
and	O
clinically	O
tolerant	O
,	O
3	O
)	O
sensitised	O
and	O
unknown	O
clinical	O
reactivity	O
,	O
4	O
)	O
not	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
5	O
)	O
unknown	O
sensitization	O
with	O
clinical	O
symptoms	O
or	O
6	O
)	O
not	O
sensitized	O
with	O
no	O
clinical	O
symptoms	O
is	O
made	O
.	O

For	O
example	O
,	O
after	O
multivariate	O
adjustment	O
,	O
the	O
risk	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
was	O
53	O
%	O
(	O
95	O
%	O
CI	O
,	O
30	O
-	O
69	O
%)	O
lower	O
for	O
women	O
who	O
ate	O
all	O
types	O
of	O
fish	O
and	O
seafood	O
3	O
-	O
4	O
times	O
per	O
week	O
,	O
and	O
55	O
%	O
(	O
95	O
%	O
CI	O
,	O
46	O
-	O
68	O
%)	O
lower	O
for	O
women	O
who	O
ate	O
white	O
fish	O
two	O
times	O
per	O
week	O
,	O
compared	O
to	O
women	O
who	O
never	O
ate	O
fish	O
and	O
seafood	O
or	O
white	O
fish	O
(	O
Figure1	O
).	O

The	O
GEE	O
models	O
to	O
estimate	O
treatment	O
effects	B
on	O
measured	O
outcomes	O
did	O
not	O
demonstrate	O
any	O
significant	O
postpartum	O
text4baby	O
participation	O
effects	O
on	O
health	O
-	O
promoting	O
behaviors	O
.	O

Women	O
who	O
reported	O
a	O
preference	O
for	O
shadow	O
had	O
a	O
higher	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
in	O
our	O
study	O
.	O

Of	O
note	O
,	O
brain	O
tumors	O
are	O
known	O
to	O
contain	O
sex	O
steroid	O
receptors	O
(	O
e	O
.	O
g	O
.,	O
estrogen	O
,	O
androgen	O
,	O
progestin	O
)	O
[	O
198	O
],	O
and	O
sex	O
hormones	O
have	O
been	O
shown	O
to	O
promote	O
brain	O
tumors	O
in	O
animal	O
studies	O
[	O
199	O
,	O
200	O
].	O

There	O
are	O
few	O
trials	O
examining	O
the	O
efficacy	O
of	O
dietary	O
therapy	O
for	O
GDM	O
,	O
However	O
,	O
a	O
cluster	O
randomized	O
controlled	O
study	O
has	O
provided	O
support	O
for	O
Medical	O
Nutrition	O
Therapy	O
(	O
MNT	O
)	O
for	O
GDM	O
,	O
as	O
recommended	O
by	O
the	O
American	O
Diabetes	O
Association	O
(	O
ADA	O
)	O
(	O
2004	O
).	O

Initial	O
mean	O
25	O
-	O
hydroxyvitamin	O
D	O
level	O
was	O
9	O
.	O
35	O
±	O
6	O
.	O
33	O
ng	O
/	O
mL	O
in	O
the	O
control	O
group	O
and	O
was	O
10	O
.	O
05	O
±	O
7	O
.	O
38	O
ng	O
/	O
mL	O
in	O
the	O
intervention	O
group	O
.	O

Use	O
of	O
vitamin	O
supplements	O
was	O
not	O
significantly	O
linked	O
to	O
leukemia	O
risk	O
.	O

This	O
has	O
been	O
elegantly	O
demonstrated	O
by	O
the	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
the	O
offspring	O
of	O
Pima	O
Indian	O
mothers	O
.	O
16	O
,	O
17Offspring	O
who	O
were	O
born	O
to	O
mothers	O
who	O
were	O
already	O
diabetic	O
when	O
pregnant	O
had	O
a	O
45	O
%	O
likelihood	O
of	O
type	O
2	O
diabetes	O
by	O
the	O
age	O
of	O
20	O
–	O
24	O
,	O
whereas	O
it	O
was	O
8	O
.	O
6	O
%	O
amongst	O
those	O
with	O
mothers	O
who	O
only	O
developed	O
diabetes	O
after	O
pregnancy	O
(	O
ie	O
,	O
were	O
prediabetic	O
).	O

Intravenous	O
magnesium	O
sulfate	O
may	O
be	O
beneficial	O
in	O
acute	O
severe	O
asthma	O
as	O
an	O
adjunct	O
to	O
inhaled	O
β2agonists	O
and	O
corticosteroids	O
.	O

[	O
16	O
]	O
evaluated	O
vitamin	O
D	O
status	O
in	O
healthy	O
young	O
Thai	O
men	O
and	O
women	O
(	O
age	O
25	O
–	O
54	O
years	O
)	O
and	O
found	O
that	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
was	O
three	O
-	O
fold	O
higher	O
in	O
females	O
than	O
in	O
males	O
(	O
43	O
.	O
1	O
%	O
in	O
females	O
compared	O
to	O
13	O
.	O
9	O
%	O
in	O
males	O
).	O

For	O
this	O
reason	O
,	O
in	O
addition	O
to	O
calcitonin	O
-	O
gene	O
products	O
,	O
such	O
as	O
calcitonin	O
CGRP	O
(	O
calcitonin	O
-	O
generelated	O
-	O
peptide	O
)	O
and	O
C	O
-	O
CAP	O
(	O
katacalcin	O
),	O
MTC	O
cells	O
express	O
several	O
other	O
biochemical	O
markers	O
that	O
reflect	B
the	O
features	O
of	O
diffuse	O
neuroendocrine	O
system	O
,	O
implicated	B
in	O
the	O
pathogenesis	O
of	O
the	O
symptoms	O
(	O
flushing	O
,	O
diarrhoea	O
,	O
carcinoid	O
syndrome	O
or	O
Cushing	O
'	O
s	O
syndrome	O
)	O
that	O
may	O
occur	O
in	O
patients	O
with	O
advanced	O
disease	O
.	O

Also	O
,	O
maternal	O
25OHD	O
<	O
28	O
nmol	O
/	O
L	O
in	O
late	O
,	O
but	O
not	O
early	O
,	O
pregnancy	O
have	O
been	O
associated	B
with	O
lower	O
infant	O
birth	O
size	O
and	O
shorter	O
gestational	O
length	O
in	O
a	O
smaller	O
longitudinal	O
study	O
[	O
8	O
].	O

Smith	O
et	O
al	O
[	O
145	O
]	O
suggested	O
a	O
possible	O
connection	B
between	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3and	O
calcium	O
homeostasis	O
in	O
the	O
regulation	O
of	O
marbling	O
.	O

In	O
each	O
clinic	O
all	O
gynaecologist	O
-	O
obstetricians	O
were	O
invited	O
to	O
participate	O
in	O
order	O
to	O
level	O
out	O
a	O
possible	O
gynaecologist	O
effect	B
.	O

Patients	O
with	O
high	O
initial	O
VD	O
levels	O
(	O
267	O
.	O
8	O
±	O
66	O
.	O
4	O
nmol	O
/	O
L	O
)	O
had	O
a	O
four	O
time	O
better	O
chance	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
for	O
successful	O
IVF	O
procedure	O
compared	O
to	O
the	O
group	O
with	O
low	O
VD	O
levels	O
(	O
104	O
.	O
3	O
±	O
21	O
nmol	O
/	O
L	O
)	O
[	O
54	O
].	O

Vitamin	O
D	O
is	O
associated	B
with	O
the	O
two	O
main	O
oral	O
diseases	O
,	O
caries	O
and	O
periodontal	O
disease	O
[	O
14	O
,	O
18	O
-	O
23	O
].	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

Food	O
consumption	O
frequency	O
of	O
food	O
rich	O
in	O
Vitamin	O
D	O
Participants	O
filled	O
dietary	O
records	O
for	O
7	O
–	O
232	O
days	O
,	O
with	O
an	O
average	O
of	O
31	O
.	O
7	O
days	O
.	O

These	O
studies	O
do	O
not	O
necessarily	O
rule	O
out	O
an	O
epigenetic	O
mechanism	O
of	O
toxicity	O
per	O
se	O
,	O
but	O
they	O
do	O
exclude	O
a	O
link	B
between	O
the	O
specific	O
epigenetic	O
,	O
exposure	O
and	O
/	O
or	O
adverse	O
endpoints	O
/	O
markers	O
investigated	O
.	O

Approximately	O
25	O
-	O
30	O
g	O
of	O
calcium	O
are	O
transferred	O
to	O
the	O
fetal	O
skeleton	O
by	O
the	O
end	O
of	O
pregnancy	O
,	O
most	O
of	O
which	O
is	O
transferred	O
during	O
the	O
last	O
trimester	O
.	O

Mean	O
glucose	O
concentrations	O
1	O
-	O
hour	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
were	O
16	O
.	O
3	O
mg	O
/	O
dl	O
higher	O
in	O
women	O
who	O
reported	O
sleeping	O
≤	O
4	O
hours	O
(	O
95	O
%	O
CI	O
1	O
.	O
1	O
-	O
31	O
.	O
6	O
,	O
p	O
=	O
0	O
.	O
04	O
),	O
2	O
.	O
3	O
mg	O
/	O
dl	O
higher	O
for	O
women	O
who	O
reported	O
sleeping	O
5	O
-	O
8	O
hours	O
(	O
95	O
%	O
CI	O
-	O
1	O
.	O
8	O
-	O
6	O
.	O
3	O
,	O
p	O
=	O
0	O
.	O
27	O
),	O
and	O
6	O
.	O
3	O
mg	O
/	O
dl	O
higher	O
for	O
women	O
who	O
reported	O
sleeping	O
≥	O
10	O
hours	O
(	O
95	O
%	O
CI	O
-	O
0	O
.	O
5	O
-	O
13	O
.	O
2	O
,	O
p	O
=	O
0	O
.	O
07	O
)	O
compared	O
with	O
those	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
.	O

The	O
dose	O
-	O
response	O
effects	B
observed	O
here	O
suggest	O
the	O
need	O
to	O
study	O
methods	O
to	O
evaluate	O
exposure	O
and	O
achieve	O
optimal	O
dosage	O
effects	B
in	O
future	O
research	O
.	O

Abstract	O
Background	O
Pet	O
keeping	O
has	O
been	O
linked	B
with	O
decreased	O
risk	O
of	O
allergic	O
sensitization	O
,	O
which	O
has	O
been	O
associated	B
with	O
the	O
Hygiene	O
Hypothesis	O
;	O
and	O
more	O
recently	O
,	O
by	O
ourselves	O
and	O
others	O
,	O
to	O
particular	O
home	O
microbiome	O
patterns	O
.	O

Background	O
Globally	O
,	O
2	O
.	O
6	O
million	O
children	O
died	O
in	O
the	O
neonatal	O
period	O
,	O
the	O
first	O
28	O
days	O
of	O
life	O
in	O
2016	O
[	O
1	O
].	O

(	O
2012a	O
)*	O
PeanutMouseOral	O
(	O
gavage	O
)	O
(	O
5	O
or	O
10	O
mg	O
peanut	O
+	O
10	O
or	O
20	O
µg	O
CT	O
/	O
mouse	O
/	O
d	O
+	O
200	O
mg	O
/	O
mouse	O
challenge	O
)	O
Pre	O
-	O
conception	O
(	O
maternal	O
)	O
±	O
childhoodChildhood	O
to	O
adolescence	O
F1offspring	O
↑	O
peanut	O
-	O
specific	O
allergy	O
and	O
anaphylaxisDNA	O
methylationSong	O
et	O
al	O
.	O

The	O
costing	O
reported	O
here	O
includes	O
distribution	O
of	O
supplements	O
,	O
health	O
staff	O
training	O
,	O
production	O
and	O
distribution	O
of	O
educational	O
materials	O
and	O
regular	O
monitoring	O
.	O

However	O
,	O
the	O
scores	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
were	O
lower	O
than	O
the	O
baseline	O
depression	O
scores	O
((	O
p	O
=	O
0	O
.	O
048	O
and	O
p	O
=	O
0	O
.	O
014	O
,	O
respectively	O
).	O

When	O
analyzing	O
maternal	O
GWG	O
as	O
a	O
continuous	O
measure	O
,	O
no	O
significant	O
effects	O
were	O
observed	O
.	O

However	O
,	O
studies	O
show	O
that	O
the	O
majority	O
of	O
South	O
African	O
women	O
only	O
seek	O
or	O
get	O
access	O
to	O
public	O
antenatal	O
care	O
in	O
their	O
second	O
trimester	O
of	O
pregnancy	O
[	O
27	O
–	O
30	O
],	O
which	O
might	O
be	O
too	O
late	O
for	O
the	O
routine	O
supplementation	O
programme	O
or	O
other	O
interventions	O
to	O
be	O
effective	O
.	O

1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
regulates	O
insulin	O
secretion	O
by	O
pancreatic	O
β	O
-	O
cells	O
and	O
thereby	O
affects	B
circulating	O
glucose	O
levels	O
.	O

The	O
NAD	O
+	O
dependent	O
deacetylase	O
SIRT1	O
is	O
implicated	B
in	O
energy	O
balance	O
regulation	O
by	O
its	O
effect	B
on	O
pro	O
-	O
opiomelanocortin	O
and	O
agouti	O
-	O
related	O
peptide	O
(	O
AgRP	O
)	O
neurons	O
in	O
the	O
arcuate	O
nucleus	O
of	O
the	O
hypothalamusthis	O
(	O
20	O
).	O

In	O
addition	O
,	O
the	O
urine	O
urea	O
(+	O
433	O
%,	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
creatinine	O
(+	O
175	O
%,	O
P	O
<	O
0	O
.	O
0001	O
)	O
values	O
were	O
significantly	O
higher	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1	O
-	O
SC	O
mice	O
.	O

Adjusted	O
mean	O
±	O
SEM	O
values	O
of	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
(	O
a	O
)	O
and	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
nmol	O
/	O
L	O
)	O
(	O
b	O
)	O
in	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
.	O

The	O
results	O
of	O
the	O
Behavioural	O
Risk	O
Factor	O
Surveillance	O
System	O
(	O
BRFSS	O
)	O
also	O
emphasize	O
the	O
role	B
of	O
income	O
and	O
marital	O
status	O
in	O
the	O
use	O
of	O
vitamin	O
and	O
mineral	O
supplements	O
[	O
40	O
].	O

A	O
moderate	O
maternal	O
caloric	O
restriction	O
produces	O
sex	O
-	O
dimorphic	O
effects	B
in	O
feeding	O
and	O
body	O
weight	O
gain	O
only	O
after	O
weaning	O
The	O
dams	O
exposed	O
to	O
undernutrition	O
during	O
prenatal	O
stages	O
exhibited	O
a	O
reduction	O
in	O
their	O
body	O
weight	O
gain	O
and	O
caloric	O
intake	O
during	O
gestation	O
that	O
contrasts	O
with	O
the	O
increase	O
in	O
their	O
body	O
weight	O
during	O
lactation	O
with	O
normal	O
nutrition	O
.	O

People	O
residing	O
near	O
the	O
equator	O
should	O
have	O
lower	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
compared	O
to	O
people	O
living	O
at	O
high	O
latitudes	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
N	O
-	O
ethyl	O
-	O
N	O
-	O
nitrosourea	O
(	O
ENU	O
)	O
breeding	O
scheme	O
and	O
visible	O
morphology	O
of	O
skeletal	O
morphology	O
mutants	O
(	O
Skm	O
).	O

Knowledge	O
of	O
ANC	O
activities	O
done	O
at	O
the	O
ANC	O
The	O
responses	O
by	O
participants	O
concerning	O
routine	O
activities	O
at	O
antenatal	O
clinics	O
revealed	O
that	O
physical	O
examination	O
was	O
the	O
most	O
frequent	O
activity	O
and	O
the	O
least	O
was	O
vaccination	O
.	O

Thirty	O
-	O
six	O
hours	O
after	O
birth	O
,	O
the	O
lightest	O
and	O
the	O
heaviest	O
piglet	O
within	O
one	O
litter	O
were	O
killed	O
by	O
i	O
.	O
m	O
.	O

The	O
pellet	O
was	O
air	O
dried	O
for	O
5	O
min	O
and	O
resuspended	O
in	O
Buffer	O
2	O
(	O
7M	O
urea	O
,	O
2M	O
thiourea	O
,	O
1	O
%	O
C7bZO	O
).	O

As	O
few	O
food	O
items	O
contain	O
or	O
are	O
fortified	O
with	O
vitamin	O
D	O
(	O
such	O
as	O
liver	O
,	O
fatty	O
fish	O
,	O
eggs	O
,	O
milk	O
and	O
dairy	O
products	O
,	O
soy	O
milk	O
,	O
butter	O
,	O
margarines	O
),	O
the	O
skin	O
synthesis	O
of	O
vitamin	O
D	O
induced	O
by	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
)	O
is	O
the	O
main	O
determinant	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
population	O
[	O
23	O
].	O

Tobacco	O
smoke	O
exposure	O
also	O
predicted	B
lower	O
birth	O
weight	O
with	O
a	O
210	O
g	O
reduction	O
among	O
smoking	O
mothers	O
(>	O
3	O
ng	O
/	O
ml	O
serum	O
cotinine	O
)	O
compared	O
with	O
non	O
-	O
smoking	O
mothers	O
(<	O
3	O
ng	O
/	O
ml	O
serum	O
cotinine	O
).	O

Reports	O
by	O
Mischoulon	O
et	O
al	O
.	O

N	O
—	O
sample	O
size7421	O
mother	O
-	O
child	O
pairs	O
.	O
135	O
mother	O
-	O
child	O
pairs5449	O
children	O
assessed	O
.	O
217	O
mother	O
-	O
child	O
pairs	O
.	O
MethodMeasured	O
fish	O
intake	O
during	O
at	O
32	O
weeks	O
gestation	O
by	O
Food	O
Frequency	O
Questionnaire	O
(	O
FFQ	O
)	O
during	O
.	O

Satiety	O
responsiveness	O
,	O
a	O
separate	O
dimension	O
of	O
child	O
intake	O
regulation	B
,	O
has	O
recently	O
been	O
linked	B
to	O
variations	O
in	O
the	O
FTO	O
gene	O
(	O
69	O
),	O
which	O
confers	O
obesity	O
risk	O
and	O
is	O
highly	O
expressed	O
in	O
the	O
hypothalamus	O
,	O
a	O
center	O
of	O
appetite	O
regulation	B
in	O
the	O
brain	O
.	O

*/***	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
control	O
dams	O
.	O

1999	O
).	O

In	O
addition	O
,	O
microarray	O
analyses	O
demonstrated	O
that	O
many	O
transcripts	O
were	O
differentially	O
expressed	O
between	O
JEG	O
-	O
3	O
and	O
BeWo	O
cells	O
[	O
25	O
].	O

Pregnant	O
women	O
were	O
advised	O
to	O
use	O
the	O
daily	O
supplements	O
provided	O
through	O
Government	O
antenatal	O
clinics	O
,	O
or	O
if	O
these	O
were	O
not	O
available	O
,	O
to	O
use	O
a	O
double	O
dose	O
of	O
the	O
weekly	O
supplements	O
.	O

There	O
are	O
an	O
estimated	O
22	O
.	O
2	O
m	O
women	O
of	O
reproductive	O
age	O
(	O
15	O
–	O
44	O
)	O
in	O
Viet	O
Nam	O
out	O
of	O
a	O
working	O
-	O
age	O
population	O
(	O
15	O
–	O
64	O
)	O
of	O
60	O
.	O
6	O
m	O
(	O
and	O
total	O
population	O
89	O
m	O
)[	O
17	O
].	O

On	O
the	O
aetiology	O
of	O
autism	O
I	O
have	O
suggested	O
that	O
the	O
primary	O
environmental	O
trigger	B
for	O
autism	O
is	O
not	O
vaccinations	O
,	O
toxins	O
or	O
infections	O
,	O
but	O
gestational	O
and	O
early	O
childhood	O
vitamin	O
D	O
deficiency	O
(	O
1	O
,	O
2	O
).	O

These	O
actions	O
would	O
reduce	O
disability	O
and	O
chronic	O
disease	O
,	O
improve	O
reproductive	O
and	O
maternal	O
health	O
,	O
and	O
build	O
sustainable	O
health	O
systems	O
.	O

Data	O
collection	O
At	O
the	O
first	O
antenatal	O
consultation	O
,	O
participants	O
were	O
weighed	O
in	O
light	O
clothing	O
using	O
a	O
SECA	O
weighing	O
scales	O
(	O
SECA	O
GmbH	O
&	O
Co	O
.	O
Kg	O
.	O

When	O
considering	O
temporal	O
aspects	O
to	O
reproductive	O
,	O
developmental	O
and	O
endocrine	O
disrupting	O
effects	B
,	O
the	O
TGs	O
currently	O
in	O
use	O
may	O
not	O
incorporate	O
either	O
the	O
most	O
relevant	O
life	O
stage	O
(	O
s	O
),	O
the	O
most	O
sensitive	O
endpoints	O
for	O
epigenetic	O
perturbation	O
and	O
/	O
or	O
sufficient	O
duration	O
of	O
observation	O
to	O
detect	O
later	O
-	O
onset	O
effects	B
.	O

For	O
the	O
purposes	O
of	O
analysis	O
we	O
combined	O
the	O
last	O
three	O
categories	O
to	O
create	O
a	O
binary	O
maternal	O
“	O
diabetes	O
”	O
variable	O
(	O
see	O
supplementary	O
material	O
for	O
further	O
details	O
).	O

In	O
the	O
present	O
study	O
,	O
offspring	O
of	O
nutritionally	O
challenged	O
dams	O
develop	O
obesity	O
;	O
thus	O
a	O
perpetuation	O
and	O
possibly	O
a	O
compounding	O
of	O
accelerated	O
pubertal	O
onset	O
may	O
ensue	O
in	O
the	O
next	O
generation	O
as	O
these	O
offspring	O
will	O
themselves	O
be	O
fatter	O
at	O
an	O
earlier	O
reproductive	O
age	O
.	O

Categorical	O
variables	O
were	O
expressed	O
as	O
percentage	O
.	O

This	O
study	O
is	O
novel	O
due	O
to	O
the	O
comprehensive	O
set	O
of	O
nutrition	O
related	B
data	O
and	O
indicators	O
of	O
maternal	O
and	O
infant	O
health	O
being	O
obtained	O
in	O
a	O
South	O
African	O
setting	O
.	O

Ethical	O
clearance	O
was	O
obtained	O
from	O
the	O
Faculty	O
of	O
Health	O
Sciences	O
’	O
Institutional	O
Review	O
Board	O
(	O
IRB	O
)	O
of	O
the	O
University	O
of	O
Buea	O
,	O
administrative	O
Clearance	O
from	O
the	O
Regional	O
Delegation	O
of	O
Public	O
Health	O
of	O
the	O
South	O
West	O
Region	O
in	O
Buea	O
and	O
from	O
the	O
heads	O
of	O
the	O
different	O
health	O
centres	O
involved	O
in	O
the	O
study	O
.	O

These	O
women	O
had	O
significantly	O
higher	O
pre	O
-	O
pregnancy	O
weight	O
,	O
experienced	O
more	O
associated	O
comorbidities	O
and	O
instrumental	O
deliveries	O
,	O
and	O
delivered	O
a	O
greater	O
proportion	O
of	O
large	O
for	O
gestational	O
age	O
neonates	O
.	O

An	O
increase	O
in	O
this	O
hormone	O
can	O
lead	O
to	O
brain	O
dysfunctions	O
[	O
70	O
,	O
71	O
].	O

Despite	O
these	O
limitations	O
,	O
this	O
is	O
the	O
first	O
study	O
to	O
demonstrate	O
a	O
gene	O
-	O
maternal	O
environment	O
synergism	O
in	O
relation	B
to	O
infant	O
birth	O
weight	O
,	O
using	O
a	O
very	O
brief	O
assessment	O
of	O
maternal	O
attitudes	O
to	O
pregnancy	O
.	O

However	O
,	O
no	O
differences	O
were	O
found	O
between	O
the	O
groups	O
in	O
the	O
F2	O
generation	O
:	O
8	O
.	O
7	O
±	O
0	O
.	O
4	O
mg	O
(	O
F2	O
-	O
SC	O
)	O
vs	O
.	O
9	O
.	O
0	O
±	O
0	O
.	O
9	O
mg	O
(	O
F2	O
-	O
VitD	O
-)	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

One	O
option	O
would	O
be	O
a	O
national	O
or	O
multinational	O
study	O
based	O
on	O
randomization	O
of	O
school	O
districts	O
or	O
other	O
suitable	O
units	O
in	O
regions	O
of	O
low	O
sunlight	O
intensity	O
,	O
perhaps	O
including	O
multiple	O
outcomes	O
that	O
might	O
be	O
affected	B
by	O
vitamin	O
D	O
,	O
such	O
as	O
diabetes	O
,	O
obesity	O
,	O
respiratory	O
infections	O
,	O
and	O
asthma	O
.	O
4546Alternatively	O
,	O
high	O
-	O
risk	O
first	O
-	O
degree	O
relatives	O
of	O
individu	O
-	O
als	O
with	O
MS	O
could	O
be	O
targeted	O
in	O
a	O
smaller	O
trial	O
,	O
47although	O
randomization	O
and	O
compliance	O
could	O
be	O
more	O
challenging	O
.	O

Just	O
about	O
a	O
mile	O
and	O
a	O
half	O
from	O
Bell	O
-	O
Jefferson	O
’	O
s	O
home	O
,	O
a	O
dam	O
broke	O
at	O
the	O
United	O
Nuclear	O
Corporation	O
mill	O
,	O
where	O
workers	O
processed	O
ore	O
from	O
the	O
nearby	O
Northeast	O
Church	O
Rock	O
uranium	O
mine	O
.	O

(	O
2010	O
)	O
*	O
Ostrow	O
et	O
al	O
.	O

Four	O
weeks	O
later	O
,	O
once	O
she	O
was	O
well	O
into	O
the	O
second	O
trimester	O
of	O
her	O
pregnancy	O
,	O
a	O
shave	O
removal	O
with	O
electrodessication	O
of	O
the	O
base	O
was	O
performed	O
after	O
reflecting	O
the	O
nail	O
plate	O
proximally	O
to	O
expose	O
the	O
lesion	O
.	O

•	O
Increase	O
reach	O
of	O
existing	O
preventive	B
interventions	B
in	O
the	O
preconception	O
period	O
,	O
especially	O
family	O
planning	O
,	O
and	O
including	O
adolescent	O
-	O
friendly	O
services	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
6	O
month	O
infant	O
general	O
health	O
and	O
health	O
utilisation	O
outcomes	O
by	O
treatment	O
groupOutcomeLifestyle	O
Advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
Care	O
(	O
N	O
=	O
1065	O
)	O
Unadjusted	O
Treatment	O
Effect	O
(	O
95	O
%	O
CI	O
)	O
Unadjusted	O
P	O
-	O
valueAdjusted	O
Treatment	O
Effect	O
(	O
95	O
%	O
CI	O
)	O
Adjusted	O
P	O
-	O
valueWell	O
Since	O
Discharge491	O
(	O
83	O
.	O
50	O
)	O
548	O
(	O
87	O
.	O
82	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
91	O
,	O
1	O
.	O
00	O
)	O
0	O
.	O
0330	O
.	O
96	O
(	O
0	O
.	O
92	O
,	O
1	O
.	O
01	O
)	O
0	O
.	O
131Visited	O
Doctor	O
/	O
Hospital	O
Since	O
Discharge251	O
(	O
42	O
.	O
83	O
)	O
267	O
(	O
42	O
.	O
86	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
88	O
,	O
1	O
.	O
14	O
)	O
0	O
.	O
9930	O
.	O
97	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
11	O
)	O
0	O
.	O
690Admitted	O
to	O
Hospital36	O
(	O
14	O
.	O
34	O
)	O
33	O
(	O
12	O
.	O
36	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
75	O
,	O
1	O
.	O
80	O
)	O
0	O
.	O
5071	O
.	O
08	O
(	O
0	O
.	O
68	O
,	O
1	O
.	O
71	O
)	O
0	O
.	O
740	O
Values	O
are	O
number	O
and	O
percentage	O
,	O
and	O
treatment	O
effects	O
are	O
relative	O
risks	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Everyone	O
has	O
a	O
role	O
to	O
play	O
:	O
actions	O
for	O
the	O
six	O
key	O
constituency	O
groups	O
involved	O
in	O
Every	O
Women	O
Every	O
ChildGovernments	O
and	O
policy	O
-	O
makers	O
at	O
local	O
,	O
national	O
,	O
regional	O
and	O
global	O
levels	O
:	O
Invest	O
•	O
Set	O
national	O
targets	O
for	O
improved	O
survival	O
of	O
premature	O
babies	O
and	O
increase	O
funding	O
to	O
ensuring	O
equitable	O
access	O
to	O
quality	O
care	O
to	O
meet	O
these	O
targets	O
by	O
2025	O
.	O

Women	O
who	O
were	O
exposed	O
to	O
teratogenic	O
medications	O
unrelated	O
to	O
their	O
psychiatric	O
disorder	O
treatment	O
,	O
such	O
as	O
acutane	O
,	O
or	O
who	O
abused	O
substances	O
(	O
eg	O
,	O
alcohol	O
,	O
marijuana	O
,	O
cocaine	O
,	O
heroin	O
,	O
etc	O
)	O
were	O
excluded	O
from	O
the	O
study	O
cohort	O
.	O

In	O
a	O
study	O
by	O
Mozafari	O
-	O
Khosravi	O
et	O
al	O
.,	O
300	O
,	O
000	O
and	O
150	O
,	O
000	O
IU	O
vitamin	O
D	O
were	O
administered	O
by	O
injection	O
to	O
the	O
two	O
groups	O
who	O
suffered	O
depression	O
and	O
the	O
third	O
group	O
did	O
not	O
receive	O
vitamin	O
D	O
.	O
High	O
doses	O
of	O
vitamin	O
D	O
were	O
effective	B
in	O
decreasing	O
depression	O
levels	O
after	O
3	O
months	O
[	O
30	O
].	O

Abbreviations	O
:	O
25	O
(	O
OH	O
)	O
D	O
,	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
;	O
UCB	O
,	O
umbilical	O
cord	O
blood	O
;	O
GDM	O
,	O
gestational	O
diabetes	O
mellitus	O
We	O
further	O
tested	O
for	O
possible	O
associations	B
between	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
OGTT	O
results	O
with	O
a	O
univariate	O
regression	O
model	O
.	O

In	O
order	O
not	O
to	O
deprive	O
the	O
participants	O
from	O
antenatal	O
supplements	O
all	O
participating	O
mothers	O
were	O
allowed	O
to	O
use	O
prescribed	O
supplementation	O
outside	O
this	O
study	O
’	O
s	O
protocol	O
.	O

This	O
was	O
similar	B
for	O
boys	O
and	O
girls	O
(	O
table	O
5	O
).	O

This	O
was	O
done	O
using	O
a	O
sequential	O
list	O
prepared	O
based	O
on	O
tables	O
of	O
random	O
numbers	O
.	O

This	O
may	O
be	O
an	O
early	O
indicator	O
of	O
placental	O
insufficiency	O
.	O

Fetuses	O
of	O
LP	O
-	O
fed	O
dams	O
showed	O
a	O
numerically	O
lowered	O
weight	O
compared	O
to	O
AP	O
fetuses	O
at	O
94	O
dpc	O
(	O
LP	O
:	O
661	O
±	O
115	O
g	O
,	O
and	O
AP	O
:	O
711	O
±	O
118	O
g	O
,	O
respectively	O
;	O
P	O
=	O
0	O
.	O
12	O
;	O
n	O
=	O
32	O
).	O

Bonferroni	O
analysis	O
showed	O
that	O
RC	O
adolescent	O
females	O
exhibited	O
a	O
decrease	O
in	O
chocolate	O
preference	O
at	O
the	O
second	O
day	O
of	O
the	O
test	O
.	O

25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
assessed	O
by	O
chemiluminescence	O
immunoassay	O
(	O
Liaison	O
automated	O
platform	O
;	O
Diasorin	O
,	O
Dartford	O
,	O
UK	O
).	O

PubMed	O
Central	O
:	O

This	O
might	O
suggest	O
the	O
existence	O
of	O
social	O
inequities	O
and	O
the	O
influence	B
of	O
economic	O
factors	O
in	O
making	O
health	O
-	O
related	O
decisions	O
,	O
as	O
in	O
our	O
country	O
,	O
women	O
in	O
the	O
urban	O
area	O
,	O
more	O
educated	O
and	O
with	O
less	O
children	O
are	O
usually	O
having	O
a	O
better	O
financial	O
status	O
.	O

Schizophrenia	O
is	O
a	O
multifactorial	O
disorder	O
with	O
strong	O
genetic	O
vulnerability	O
and	O
the	O
vulnerability	O
might	O
include	O
metabolic	O
aberrations	O
.	O

Data	O
relating	B
to	O
pre	O
-	O
pregnancy	O
lifestyle	O
behaviours	O
were	O
not	O
collected	O
.	O

Key	O
components	O
in	O
terms	O
of	O
cell	O
cycle	O
regulation	O
are	O
cyclins	O
.	O

Some	O
of	O
this	O
damage	O
done	O
by	O
maternal	O
Vitamin	O
D	O
deficiency	O
gets	O
evident	O
after	O
many	O
years	O
.	O

It	O
is	O
likely	O
that	O
visfatin	O
can	O
be	O
used	O
in	O
the	O
future	O
as	O
a	O
biomarker	B
predicting	B
fetal	O
and	O
neonatal	O
growth	O
.	O

Persistence	O
and	O
clinical	O
relevant	O
impairment	O
may	O
be	O
related	B
to	O
a	O
family	O
history	O
of	O
schizophrenia	O
and	O
environmental	O
risk	B
factors	I
that	O
might	O
interact	B
with	O
the	O
genetic	O
risk	O
.	O

We	O
recruited	O
from	O
49	O
villages	O
in	O
the	O
study	O
area	O
,	O
which	O
were	O
not	O
receiving	O
any	O
active	O
maternal	O
and	O
child	O
health	O
or	O
nutrition	O
interventions	O
.	O

Nutritional	O
fetal	O
programming	O
becomes	O
apparent	O
as	O
an	O
altered	O
hepatic	O
expression	O
of	O
genes	O
related	O
to	O
cell	O
cycle	O
and	O
cell	O
maintenance	O
,	O
and	O
lipid	O
,	O
ketone	O
body	O
,	O
and	O
amino	O
acid	O
metabolism	O
,	O
indicating	O
different	O
functional	O
demands	O
and	O
replies	O
of	O
the	O
liver	O
in	O
both	O
experimental	O
groups	O
under	O
identical	O
nutritional	O
conditions	O
post	O
natum	O
.	O

Even	O
more	O
intriguing	O
,	O
both	O
papers	O
report	O
that	O
the	O
mental	O
condition	O
in	O
rickets	O
improved	B
with	O
vitamin	O
D	O
.	O
Another	O
of	O
the	O
mysteries	O
of	O
autism	O
is	O
the	O
apparent	O
increased	O
incidence	O
of	O
autism	O
in	O
the	O
children	O
of	O
richer	O
college	O
-	O
educated	O
parents	O
,	O
especially	O
women	O
,	O
a	O
finding	O
announced	O
a	O
few	O
months	O
ago	O
(	O
12	O
).	O

Familial	O
cases	O
account	O
for	O
about	O
30	O
%	O
of	O
MTCs	O
.	O

(	O
2015	O
)*/†	O
CaffeineMouseInjection	O
(	O
ip	O
)	O
(	O
20	O
mg	O
/	O
kg	O
)	O
In	O
utero	O
Early	O
adulthood	O
F1offspringCardiac	O
abnormalitiesDNA	O
methylationBuscariollo	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Selected	O
characteristics	O
of	O
participant	O
pregnant	O
women	O
(	O
n	O
=	O
3268	O
),	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
Province	O
,	O
Nicaragua	O
.	O
AllVaccinatedUnvaccinatedp	O
-	O
value	O
†	O
n	O
=	O
3268n	O
=	O
1789n	O
=	O
1479n	O
(%)	O
n	O
(%)	O
n	O
(%)	O
Age	O
<	O
18	O
years415	O
(	O
13	O
)	O
232	O
(	O
13	O
)	O
183	O
(	O
12	O
)	O
0	O
.	O
80	O
18	O
–	O
34	O
years2620	O
(	O
80	O
)	O
1433	O
(	O
80	O
)	O
1187	O
(	O
80	O
)	O
≥	O
35	O
years233	O
(	O
7	O
)	O
124	O
(	O
7	O
)	O
109	O
(	O
7	O
)	O
Number	O
of	O
persons	O
in	O
household	O
2	O
–	O
4898	O
(	O
27	O
)	O
528	O
(	O
30	O
)	O
370	O
(	O
25	O
)	O
0	O
.	O
02	O
5	O
–	O
61070	O
(	O
33	O
)	O
580	O
(	O
32	O
)	O
490	O
(	O
33	O
)	O
7	O
–	O
8707	O
(	O
22	O
)	O
381	O
(	O
21	O
)	O
326	O
(	O
22	O
)	O
>	O
8593	O
(	O
18	O
)	O
300	O
(	O
17	O
)	O
293	O
(	O
20	O
)	O
Delivered	O
at	O
reference	O
*	O
obstetric	O
hospital1722	O
(	O
53	O
)	O
1083	O
(	O
61	O
)	O
639	O
(	O
43	O
)<	O
0	O
.	O
01Education	O
level	O
No	O
education	O
/	O
primary	O
school	O
incomplete421	O
(	O
13	O
)	O
231	O
(	O
13	O
)	O
190	O
(	O
13	O
)	O
0	O
.	O
01	O
Primary	O
school	O
complete337	O
(	O
10	O
)	O
195	O
(	O
11	O
)	O
142	O
(	O
10	O
)	O
Secondary	O
school	O
incomplete1372	O
(	O
42	O
)	O
771	O
(	O
43	O
)	O
601	O
(	O
41	O
)	O
Secondary	O
school	O
complete637	O
(	O
19	O
)	O
353	O
(	O
20	O
)	O
284	O
(	O
19	O
)	O
Technical	O
/	O
university	O
studies501	O
(	O
15	O
)	O
239	O
(	O
13	O
)	O
262	O
(	O
18	O
)	O
Received	O
at	O
least	O
one	O
dose	O
of	O
tetanus	O
vaccine2984	O
(	O
91	O
)	O
1759	O
(	O
98	O
)	O
1225	O
(	O
83	O
)<	O
0	O
.	O
01At	O
least	O
one	O
antenatal	O
visits3172	O
(	O
97	O
)	O
1786	O
(	O
100	O
)	O
1386	O
(	O
94	O
)<	O
0	O
.	O
01Four	O
or	O
more	O
antenatal	O
visits2549	O
(	O
78	O
)	O
1542	O
(	O
86	O
)	O
1007	O
(	O
68	O
)<	O
0	O
.	O
01Gestational	O
age	O
at	O
first	O
antenatal	O
visit	O
(	O
median	O
,	O
quantiles	O
in	O
weeks	O
)	O
12	O
(	O
9	O
,	O
19	O
)	O
12	O
(	O
9	O
,	O
17	O
)	O
13	O
(	O
9	O
,	O
22	O
)<	O
0	O
.	O
01	O
‡	O
Consumption	O
of	O
iron	O
and	O
folic	O
acid1485	O
(	O
45	O
)	O
805	O
(	O
45	O
)	O
680	O
(	O
46	O
)	O
0	O
.	O
59Consumption	O
of	O
albendazol703	O
(	O
22	O
)	O
482	O
(	O
27	O
)	O
221	O
(	O
15	O
)<	O
0	O
.	O
01Consumption	O
of	O
calcium1243	O
(	O
38	O
)	O
722	O
(	O
40	O
)	O
521	O
(	O
35	O
)<	O
0	O
.	O
01Consumption	O
of	O
aspirin938	O
(	O
29	O
)	O
600	O
(	O
34	O
)	O
338	O
(	O
23	O
)<	O
0	O
.	O
01	O
BMI	O
(	O
height	O
and	O
weight	O
measured	O
at	O
1st	O
antenatal	O
visit	O
)	O
Underweight	O
(<	O
18	O
.	O
5	O
)	O
315	O
(	O
10	O
)	O
116	O
(	O
6	O
)	O
199	O
(	O
13	O
)<	O
0	O
.	O
01	O
Normal	O
weight	O
(	O
18	O
.	O
5	O
–	O
24	O
.	O
9	O
)	O
1338	O
(	O
41	O
)	O
808	O
(	O
45	O
)	O
530	O
(	O
36	O
)	O
Overweight	O
(	O
25	O
–	O
29	O
.	O
9	O
)	O
928	O
(	O
28	O
)	O
510	O
(	O
29	O
)	O
418	O
(	O
28	O
)	O
Obesity	O
I	O
(	O
30	O
–	O
34	O
.	O
9	O
)	O
408	O
(	O
12	O
)	O
224	O
(	O
13	O
)	O
184	O
(	O
12	O
)	O
Obesity	O
II	O
(	O
35	O
–	O
39	O
.	O
9	O
)	O
163	O
(	O
5	O
)	O
87	O
(	O
5	O
)	O
76	O
(	O
5	O
)	O
Extreme	O
obesity	O
(>	O
40	O
)	O
88	O
(	O
3	O
)	O
41	O
(	O
2	O
)	O
47	O
(	O
3	O
)	O
Alcohol	O
consumption	O
before	O
pregnancy441	O
(	O
13	O
)	O
220	O
(	O
12	O
)	O
221	O
(	O
15	O
)	O
0	O
.	O
05Renal	O
Disease1266	O
(	O
39	O
)	O
734	O
(	O
41	O
)	O
532	O
(	O
36	O
)<	O
0	O
.	O
01Blood	O
Disease743	O
(	O
23	O
)	O
445	O
(	O
25	O
)	O
298	O
(	O
20	O
)<	O
0	O
.	O
01At	O
least	O
one	O
chronic	O
condition	O
**	O
1855	O
(	O
57	O
)	O
1069	O
(	O
60	O
)	O
786	O
(	O
53	O
)<	O
0	O
.	O
01	O
Number	O
of	O
parturitions	O
11519	O
(	O
46	O
)	O
879	O
(	O
49	O
)	O
640	O
(	O
43	O
)<	O
0	O
.	O
01	O
2	O
–	O
31447	O
(	O
44	O
)	O
768	O
(	O
43	O
)	O
679	O
(	O
46	O
)	O
>	O
3302	O
(	O
9	O
)	O
142	O
(	O
8	O
)	O
160	O
(	O
11	O
)	O
Female1585	O
(	O
49	O
)	O
804	O
(	O
45	O
)	O
781	O
(	O
53	O
)<	O
0	O
.	O
01Preterm	O
birth175	O
(	O
5	O
)	O
95	O
(	O
5	O
)	O
80	O
(	O
5	O
)	O
0	O
.	O
96Small	O
for	O
gestational	O
age343	O
(	O
10	O
)	O
198	O
(	O
11	O
)	O
145	O
(	O
10	O
)	O
0	O
.	O
26Low	O
birth	O
weight195	O
(	O
6	O
)	O
99	O
(	O
6	O
)	O
96	O
(	O
6	O
)	O
0	O
.	O
28	O
X2test	O
.	O

Oka	O
[	O
134	O
]	O
recommended	O
that	O
vitamin	O
A	O
-	O
deficient	O
levels	O
not	O
fall	O
below	O
30	O
IU	O
/	O
dL	O
to	O
enhance	O
MS	O
and	O
maintain	O
health	O
.	O

The	O
infant	O
reported	O
here	O
was	O
managed	O
as	O
a	O
case	O
of	O
acute	O
laryngotracheobronchitis	O
initially	O
as	O
there	O
was	O
no	O
evidence	O
of	O
rickets	O
and	O
the	O
diagnosis	O
of	O
hypocalcemia	O
was	O
made	O
only	O
after	O
he	O
had	O
convulsions	O
.	O

Genetic	O
influences	B
on	O
EAH	O
(	O
49	O
,	O
65	O
)	O
and	O
other	O
eating	O
behaviors	O
such	O
as	O
emotional	O
eating	O
(	O
66	O
)	O
are	O
supported	O
by	O
findings	O
that	O
the	O
behavior	O
is	O
more	O
common	O
when	O
1	O
or	O
both	O
parents	O
are	O
overweight	O
,	O
even	O
after	O
certain	O
environmental	O
factors	B
(	O
eg	O
,	O
parental	O
eating	O
habits	O
)	O
have	O
been	O
controlled	O
for	O
.	O

Phase	O
1	O
data	O
are	O
collected	O
at	O
<	O
18	O
weeks	O
’	O
gestation	O
(	O
as	O
confirmed	O
by	O
obstetric	O
ultrasound	O
).	O

In	O
the	O
strata	O
,	O
each	O
eligible	O
pregnant	O
woman	O
was	O
assigned	O
in	O
the	O
control	O
or	O
the	O
vitamin	O
D	O
groups	O
using	O
block	O
randomization	O
strategy	O
.	O

Background	O
Recent	O
estimates	O
indicate	O
that	O
250	O
million	O
children	O
in	O
low	O
-	O
and	O
middle	O
income	O
countries	O
are	O
at	O
risk	O
of	O
not	O
reaching	O
their	O
developmental	O
potential	O
[	O
1	O
].	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
examination	O
of	O
the	O
relation	B
between	O
plasma	O
glucose	O
concentrations	O
,	O
GDM	O
risk	O
and	O
sleep	O
parameters	O
(	O
i	O
.	O
e	O
.,	O
snoring	O
and	O
habitual	O
sleep	O
duration	O
)	O
during	O
pregnancy	O
.	O

Normal	O
Weight	O
Mothers	O
In	O
initial	O
,	O
unadjusted	O
analyses	O
,	O
few	O
significant	O
correlations	B
were	O
found	O
between	O
prenatal	O
behaviors	O
and	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
and	O
6	O
months	O
in	O
the	O
offspring	O
of	O
normal	O
weight	O
mothers	O
.	O

Due	O
to	O
heterogeneity	O
in	O
methodology	O
and	O
measured	O
outcomes	O
,	O
a	O
qualitative	O
comparison	O
of	O
study	O
findings	O
was	O
conducted	O
.	O

Male	O
adult	O
offspring	O
(	O
n	O
=	O
8	O
)	O
were	O
compared	O
to	O
control	O
male	O
(	O
n	O
=	O
8	O
).	O

In	O
addition	O
,	O
treating	O
the	O
infant	O
with	O
DDAVP	O
besides	O
intravenous	O
fluids	O
may	O
also	O
be	O
beneficial	O
.	O

Furthermore	O
,	O
the	O
median	O
age	O
of	O
miners	O
with	O
lung	O
cancer	O
was	O
44	O
years	O
,	O
compared	O
with	O
63	O
years	O
for	O
nonminers	O
with	O
other	O
cancers	O
.	O
18Decades	O
after	O
their	O
exposure	O
ended	O
,	O
standardized	O
mortality	O
ratios	O
and	O
relative	O
risks	O
for	O
lung	O
cancer	O
and	O
other	O
respiratory	O
problems	O
were	O
still	O
nearly	O
four	O
times	O
higher	O
in	O
Navajo	O
miners	O
than	O
in	O
nonminers	O
.	O
19	O
Community	O
Exposure	O
to	O
Uranium	O
Getting	O
the	O
ore	O
out	O
of	O
the	O
ground	O
was	O
only	O
the	O
first	O
step	O
in	O
a	O
long	O
process	O
.	O

For	O
62	O
.	O
0	O
%	O
of	O
them	O
the	O
multivitamin	O
contained	O
vitamin	O
D	O
.	O
In	O
the	O
first	O
and	O
third	O
trimester	O
of	O
pregnancy	O
the	O
percentage	O
of	O
women	O
taking	O
a	O
multivitamin	O
containing	O
vitamin	O
D	O
was	O
52	O
.	O
6	O
%	O
and	O
72	O
.	O
3	O
%	O
respectively	O
.	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
using	O
the	O
PITA	O
algorithm	O
.	O

These	O
values	O
were	O
changed	O
by	O
intervention	O
to	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%,	O
respectively	O
.	O

With	O
a	O
larger	O
sample	O
,	O
it	O
would	O
be	O
possible	O
to	O
extend	O
our	O
calculations	O
to	O
estimate	O
the	O
cost	O
per	O
death	O
averted	O
with	O
a	O
reduction	O
of	O
the	O
prevalence	O
of	O
severe	O
anemia	O
in	O
pregnant	O
women	O
.	O

Finally	O
,	O
lambda	O
stat	O
was	O
used	O
to	O
compare	O
correlation	O
coefficients	O
of	O
variables	O
in	O
the	O
two	O
groups	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Cole	O
et	O
al	O
,	O
30for	O
instance	O
,	O
concluded	O
that	O
ponderal	O
index	O
was	O
not	O
appropriate	O
for	O
measuring	O
intrauterine	O
malnutrition	O
.	O

Our	O
systematic	O
review	O
identified	O
one	O
randomised	O
placebo	O
controlled	O
trial3relating	B
pneumonia	O
or	O
lower	O
respiratory	O
infections	O
to	O
vitamin	O
D	O
deficiency	O
supplementation	O
in	O
young	O
children	O
.	O

In	O
total	O
,	O
28	O
individual	O
liver	O
mRNA	O
samples	O
were	O
analyzed	O
in	O
duplicate	O
per	O
stage	O
.	O

Thus	O
,	O
for	O
practical	O
purposes	O
,	O
the	O
early	O
pregnancy	O
window	O
was	O
set	O
at	O
<	O
18	O
weeks	O
’	O
gestation	O
.	O

Among	O
other	O
findings	O
,	O
Grandjean	O
’	O
s	O
team	O
linked	B
postnatal	O
exposure	O
to	O
a	O
group	O
of	O
chemicals	O
called	O
perfluoroalkyl	O
substances	O
(	O
PFASs	O
)	O
with	O
lower	O
immune	O
response	O
to	O
tetanus	O
and	O
diphtheria	O
vaccinations	O
in	O
Faroese	O
children	O
.	O
20PFASs	O
are	O
widely	O
used	O
chemicals	O
that	O
build	O
up	O
in	O
the	O
bodies	O
of	O
humans	O
and	O
other	O
animals	O
.	O

Therefore	O
,	O
an	O
average	O
daily	O
dose	O
of	O
4	O
–	O
6	O
mg	O
of	O
iron	O
is	O
required	O
in	O
the	O
second	O
and	O
third	O
trimesters	O
of	O
pregnancy	O
[	O
14	O
].	O

At	O
some	O
time	O
in	O
their	O
life	O
,	O
these	O
children	O
laid	O
down	O
less	O
cortical	O
bone	O
than	O
normal	O
children	O
,	O
a	O
finding	O
consistent	O
with	O
undetected	O
and	O
untreated	O
childhood	O
or	O
even	O
intrauterine	O
vitamin	O
D	O
deficiency	O
.	O

Methods	O
Study	O
population	O
Women	O
aged	O
30	O
-	O
49	O
years	O
,	O
residing	O
in	O
the	O
Uppsala	O
Health	O
Care	O
Region	O
in	O
Sweden	O
during	O
1991	O
and	O
1992	O
,	O
form	O
the	O
source	O
population	O
for	O
this	O
study	O
.	O

After	O
the	O
woman	O
gave	O
birth	O
and	O
began	O
to	O
breastfeed	O
,	O
Biskind	O
noted	O
that	O
her	O
symptoms	O
,	O
which	O
included	O
vomiting	O
,	O
abdominal	O
pain	O
,	O
hyper	O
-	O
irritability	O
,	O
and	O
muscle	O
weakness	O
,	O
began	O
to	O
dissipate	O
.	O

Significantly	O
more	O
children	O
in	O
the	O
S	O
-	O
ECC	O
group	O
were	O
bottle	O
-	O
fed	O
compared	O
to	O
controls	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
bottle	O
-	O
fed	O
to	O
a	O
later	O
age	O
(	O
19	O
.	O
7	O
±	O
8	O
.	O
7	O
months	O
vs	O
.	O
16	O
.	O
4	O
±	O
7	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
02	O
).	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
alterations	O
to	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
may	O
act	O
as	O
a	O
marker	O
for	O
key	O
changes	O
to	O
the	O
extent	O
of	O
methylation	O
at	O
loci	O
targeted	O
by	O
important	O
transcription	O
factors	O
for	O
normal	O
development	O
and	O
placenta	O
processes	O
necessary	O
for	O
appropriate	O
growth	O
.	O

Furthermore	O
,	O
the	O
propensity	O
score	O
analyses	O
minimized	O
biases	O
introduced	O
by	O
differences	O
in	O
baseline	O
characteristics	O
between	O
unvaccinated	O
and	O
vaccinated	O
pregnant	O
women	O
by	O
accounting	O
for	O
the	O
probability	O
of	O
vaccination	O
based	O
on	O
these	O
characteristics	O
[	O
43	O
].	O

A	O
factor	O
loading	O
criteria	O
of	O
0	O
.	O
4	O
was	O
used	O
to	O
determine	O
whether	O
to	O
retain	O
individual	O
items	O
in	O
a	O
single	O
principal	O
factor	O
.	O

Podocin	O
provides	O
the	O
structural	O
organization	O
of	O
the	O
slit	O
diaphragm	O
and	O
the	O
regulation	O
of	O
filtration	O
function	O
and	O
seems	O
to	O
be	O
involved	B
in	O
the	O
alteration	O
of	O
the	O
glomerular	O
basement	O
membrane	O
[	O
35	O
].	O

Bioinformatics	O
was	O
employed	O
as	O
secondary	O
analyses	O
.	O

Notably	O
,	O
q	O
-	O
values	O
between	O
ontogenetic	O
stages	O
within	O
diet	O
were	O
remarkable	O
lower	O
(	O
q	O
≤	O
0	O
.	O
05	O
)	O
than	O
between	O
diets	O
within	O
stage	O
(	O
q	O
≤	O
0	O
.	O
25	O
).	O

In	O
the	O
homozygous	O
group	O
for	O
Tth111	O
I	O
polymorphism	O
,	O
mothers	O
with	O
negative	O
attitudes	O
towards	O
the	O
pregnancy	O
gave	O
birth	O
to	O
infants	O
with	O
significantly	O
lower	O
birth	O
weights	O
compared	O
to	O
women	O
with	O
positive	O
/	O
neutral	O
attitudes	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
6	O
month	O
infant	O
neurodevelopmental	O
outcomes	O
by	O
treatment	O
group	O
,	O
assessed	O
by	O
the	O
Ages	O
and	O
Stages	O
QuestionnaireOutcomeLifestyle	O
advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
care	O
(	O
N	O
=	O
1065	O
)	O
Unadjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Unadjusted	O
P	O
-	O
valueAdjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Adjusted	O
P	O
-	O
valueCommunication	O
domain51	O
.	O
30	O
(	O
9	O
.	O
03	O
)	O
50	O
.	O
95	O
(	O
9	O
.	O
63	O
)	O
0	O
.	O
35	O
(−	O
0	O
.	O
68	O
,	O
1	O
.	O
38	O
)	O
0	O
.	O
5010	O
.	O
36	O
(−	O
0	O
.	O
67	O
,	O
1	O
.	O
38	O
)	O
0	O
.	O
493Gross	O
motor	O
domain53	O
.	O
35	O
(	O
10	O
.	O
05	O
)	O
52	O
.	O
74	O
(	O
10	O
.	O
84	O
)	O
0	O
.	O
61	O
(−	O
0	O
.	O
54	O
,	O
1	O
.	O
75	O
)	O
0	O
.	O
2970	O
.	O
55	O
(−	O
0	O
.	O
59	O
,	O
1	O
.	O
69	O
)	O
0	O
.	O
344Fine	O
motor	O
domain52	O
.	O
25	O
(	O
10	O
.	O
52	O
)	O
51	O
.	O
20	O
(	O
10	O
.	O
74	O
)	O
1	O
.	O
05	O
(−	O
0	O
.	O
11	O
,	O
2	O
.	O
21	O
)	O
0	O
.	O
0751	O
.	O
00	O
(−	O
0	O
.	O
13	O
,	O
2	O
.	O
14	O
)	O
0	O
.	O
082Problem	O
solving	O
domain53	O
.	O
60	O
(	O
9	O
.	O
55	O
)	O
52	O
.	O
86	O
(	O
9	O
.	O
15	O
)	O
0	O
.	O
74	O
(−	O
0	O
.	O
29	O
,	O
1	O
.	O
76	O
)	O
0	O
.	O
1580	O
.	O
72	O
(−	O
0	O
.	O
31	O
,	O
1	O
.	O
74	O
)	O
0	O
.	O
170Social	O
domain51	O
.	O
71	O
(	O
9	O
.	O
52	O
)	O
50	O
.	O
95	O
(	O
9	O
.	O
74	O
)	O
0	O
.	O
77	O
(−	O
0	O
.	O
34	O
,	O
1	O
.	O
87	O
)	O
0	O
.	O
1730	O
.	O
69	O
(−	O
0	O
.	O
41	O
,	O
1	O
.	O
79	O
)	O
0	O
.	O
218Total	O
score262	O
.	O
47	O
(	O
34	O
.	O
92	O
)	O
258	O
.	O
72	O
(	O
36	O
.	O
54	O
)	O
3	O
.	O
75	O
(−	O
0	O
.	O
13	O
,	O
7	O
.	O
63	O
)	O
0	O
.	O
0583	O
.	O
53	O
(−	O
0	O
.	O
33	O
,	O
7	O
.	O
40	O
)	O
0	O
.	O
073More	O
than	O
1	O
score	O
below	O
cut	O
-	O
off	O
*	O
49	O
(	O
4	O
.	O
58	O
)	O
69	O
(	O
6	O
.	O
51	O
)	O
0	O
.	O
70	O
(	O
0	O
.	O
44	O
,	O
1	O
.	O
12	O
)	O
0	O
.	O
1370	O
.	O
69	O
(	O
0	O
.	O
43	O
,	O
1	O
.	O
11	O
)	O
0	O
.	O
126	O
Values	O
are	O
mean	O
and	O
standard	O
deviation	O
(	O
or	O
number	O
and	O
percentage	O
),	O
and	O
treatment	O
effects	O
are	O
differences	O
in	O
means	O
(	O
or	O
relative	O
risks	O
)	O
and	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
.	O

The	O
risk	O
was	O
also	O
lower	O
for	O
women	O
with	O
a	O
high	O
intake	O
of	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
PUFA	O
compared	O
to	O
women	O
with	O
a	O
lower	O
intake	O
of	O
these	O
fatty	O
acids	O
.	O

However	O
,	O
these	O
studies	O
have	O
been	O
limited	O
by	O
the	O
relatively	O
low	O
rates	O
of	O
assessment	O
[	O
18	O
–	O
20	O
].	O

proposed	O
that	O
permanent	O
changes	O
in	O
autonomic	O
tone	O
could	O
result	O
in	O
neurological	O
changes	O
in	O
the	O
fetus	O
,	O
especially	O
after	O
two	O
or	O
more	O
weeks	O
of	O
high	O
dose	O
β	O
2	O
adrenergic	O
receptor	O
agonist	O
exposure	O
.	O

In	O
addition	O
,	O
vitamin	O
C	O
may	O
help	O
to	O
regulate	O
adipogenesis	O
.	O

Visible	O
skeletal	O
malformations	O
in	O
Skm1	O
(	O
B	O
)	O
mice	O
and	O
Skm2	O
(	O
C	O
)	O
mice	O
.	O

We	O
collected	O
information	O
about	O
sleep	O
duration	O
and	O
snoring	O
during	O
early	O
pregnancy	O
.	O

(	O
2005	O
).	O

Maternal	O
handwashing	O
with	O
soap	O
may	O
prevent	O
neonatal	O
sepsis	O
.	O

On	O
the	O
other	O
hand	O
,	O
there	O
were	O
consistent	B
positive	O
correlations	B
between	O
the	O
HRV	O
parameters	O
and	O
birth	O
weight	O
(	O
RMSSD	O
:	O
P	O
=	O
0	O
.	O
001	O
;	O
PNN50	O
:	O
P	O
=	O
0	O
.	O
001	O
;	O
HF	O
:	O
P	O
=	O
0	O
.	O
002	O
).	O

This	O
behavior	O
included	O
social	O
behavior	O
deficits	O
,	O
increased	O
repetitive	O
behaviors	O
,	O
and	O
deficits	O
in	O
communication	O
.	O

The	O
intake	O
of	O
individual	O
seafood	O
items	O
was	O
grouped	O
into	O
four	O
categories	O
(	O
none	O
,	O
1	O
-	O
3	O
times	O
per	O
month	O
,	O
1	O
time	O
per	O
week	O
and	O
2	O
times	O
per	O
week	O
or	O
more	O
).	O

The	O
individual	O
scores	O
for	O
the	O
3	O
patterns	O
show	O
the	O
values	O
estimated	O
for	O
each	O
individual	O
based	O
on	O
their	O
consumption	O
of	O
foods	O
and	O
the	O
factor	O
loadings	O
of	O
the	O
foods	O
.	O

The	O
Shapiro	O
-	O
Wilk	O
and	O
Levene	O
tests	O
were	O
used	O
to	O
assess	O
normality	O
and	O
homogeneity	O
of	O
variance	O
of	O
data	O
,	O
respectively	O
.	O

The	O
fattening	O
period	O
can	O
be	O
divided	O
into	O
early	O
and	O
late	O
periods	O
,	O
during	O
which	O
the	O
concentrate	O
is	O
mainly	O
fed	O
with	O
a	O
small	O
portion	O
of	O
roughage	O
.	O

A	O
recent	O
study	O
showed	O
that	O
for	O
each	O
hour	O
of	O
television	O
watched	O
,	O
children	O
consumed	O
an	O
extra	O
167	O
kcal	O
/	O
d	O
(	O
89	O
).	O

Source	O
:	O
Countdown	O
to	O
2015	O
(	O
Requejo	O
et	O
al	O
.,	O
2013	O
)	O
[	O
29	O
].	O

However	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
podocin	O
expression	O
between	O
the	O
F2	O
-	O
VitD	O
-	O
and	O
the	O
F2	O
-	O
SC	O
offspring	O
.	O

Additionally	O
,	O
both	O
CC	O
and	O
RC	O
males	O
exhibited	O
an	O
increase	O
in	O
body	O
weight	O
compared	O
to	O
the	O
respective	O
CC	O
(	O
postnatal	O
week	O
7	O
on	O
)	O
and	O
RC	O
(	O
postnatal	O
week	O
6	O
on	O
)	O
females	O
in	O
a	O
time	O
period	O
that	O
comprise	O
most	O
weeks	O
of	O
the	O
adolescence	O
and	O
adulthood	O
(	O
Figure2C	O
).	O

Propensity	O
Score	O
Models	O
adjusted	O
for	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
Fe	O
and	O
vitamin	O
B12	O
consumption	O
during	O
pregnancy	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
calcium	O
consumption	O
during	O
pregnancy	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
parturitions	O
,	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
).	O

Similarly	O
,	O
left	O
-	O
handedness	O
has	O
been	O
linked	B
to	O
congenital	O
adrenal	O
hyperplasia	O
,	O
a	O
condition	O
characterized	O
by	O
high	O
in	O
utero	O
levels	O
of	O
androgeizing	O
hormones	O
[	O
197	O
].	O

Then	O
,	O
we	O
observed	O
the	O
series	O
of	O
slices	O
apart	O
from	O
this	O
mean	O
size	O
to	O
avoid	O
overestimation	O
caused	O
by	O
counting	O
the	O
same	O
glomerulus	O
twice	O
.	O

to	O
expand	O
the	O
delivery	O
of	O
services	O
in	O
selected	O
districts	O
of	O
some	O
of	O
the	O
states	O
of	O
the	O
country	O
)	O
(	O
1	O
).	O

Vitamin	O
D	O
Vitamin	O
D	O
is	O
a	O
fat	O
-	O
soluble	O
prohormone	O
which	O
operates	O
via	O
a	O
nuclear	O
receptor	O
[	O
145	O
].	O

In	O
term	O
placentas	O
,	O
there	O
was	O
a	O
significant	O
correlation	B
between	O
GR	O
β	O
and	O
GR	O
γ	O
(	O
r	O
=	O
0	O
.	O
580	O
,	O
P	O
=	O
0	O
.	O
038	O
)	O
and	O
with	O
GR	O
-	O
P	O
(	O
r	O
=	O
0	O
.	O
980	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

Interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
),	O
predominantly	O
known	O
as	O
a	O
pro	O
-	O
inflammatory	O
cytokine	O
,	O
is	O
secreted	O
by	O
skeletal	O
muscle	O
(	O
Pal	O
et	O
al	O
.,	O
2014	O
),	O
helper	O
T	O
cells	O
,	O
as	O
well	O
as	O
by	O
WAT	O
and	O
BAT	O
(	O
Mohamed	O
-	O
Ali	O
et	O
al	O
.,	O
1997	O
;	O
Cannon	O
et	O
al	O
.,	O
1998	O
).	O

The	O
rapid	O
acting	O
analogs	O
lispro	O
and	O
aspart	O
are	O
considered	O
safe	O
,	O
but	O
the	O
safety	O
of	O
the	O
long	O
-	O
acting	O
analogs	O
are	O
yet	O
to	O
be	O
determined	O
.	O

All	O
these	O
costs	O
could	O
be	O
identified	O
from	O
financial	O
records	O
.	O

Do	O
these	O
mechanism	O
(	O
s	O
)	O
function	O
in	O
humans	O
?	O

Cox	O
proportional	O
hazards	O
mixed	O
models	O
will	O
be	O
used	O
for	O
mortality	O
outcomes	O
&	O
will	O
include	O
groundwater	O
iron	O
level	O
as	O
an	O
interaction	O
term	O
in	O
the	O
mortality	O
model	O
.	O

Significantly	O
more	O
children	O
with	O
S	O
-	O
ECC	O
had	O
a	O
first	O
visit	O
to	O
the	O
dentist	O
for	O
a	O
dental	O
problem	O
(	O
e	O
.	O
g	O
.	O

Castration	O
Castration	O
of	O
bulls	O
generally	O
increases	O
IMF	O
content	O
in	O
several	O
cattle	O
breeds	O
,	O
although	O
it	O
reduces	O
growth	O
rate	O
[	O
40	O
].	O

To	O
counteract	O
the	O
growing	O
incidence	O
of	O
obesity	O
,	O
interventions	O
must	O
adopt	O
an	O
approach	O
that	O
grasps	O
the	O
interplay	O
of	O
economic	O
,	O
social	O
,	O
behavioral	O
,	O
biomedical	O
,	O
and	O
environmental	O
influences	B
.	O

There	O
are	O
also	O
high	O
preterm	O
birth	O
rates	O
in	O
many	O
high	O
-	O
income	O
countries	O
,	O
including	O
the	O
United	O
States	O
.	O

FGF21	O
deficiency	O
in	O
mice	O
was	O
shown	O
to	O
result	O
in	O
impaired	O
ability	O
to	O
adapt	O
to	O
long	O
-	O
term	O
cold	O
exposure	O
with	O
diminished	O
“	O
browning	O
”	O
of	O
WAT	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

Using	O
RNA	O
FISH	O
,	O
GAS5	O
localized	O
primarily	O
in	O
syncytiotrophoblasts	O
(	O
Figure	O
2	O
(	O
c	O
)).	O

Results	O
We	O
report	O
that	O
in	O
the	O
female	O
rat	O
,	O
pubertal	O
timing	O
and	O
subsequent	O
ovarian	O
function	O
is	O
influenced	B
by	O
the	O
animal	O
'	O
s	O
nutritional	O
status	O
in	O
utero	O
,	O
with	O
both	O
maternal	O
caloric	O
restriction	O
and	O
maternal	O
high	O
fat	O
nutrition	O
resulting	O
in	O
early	O
pubertal	O
onset	O
.	O

Earlier	O
studies	O
have	O
mostly	O
examined	O
the	O
effects	B
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
[	O
13	O
]	O
and	O
few	O
data	O
are	O
available	O
linking	B
habitual	O
diet	O
to	O
neonatal	O
anthropometric	O
measurements	O
.	O

Participants	O
were	O
also	O
required	O
to	O
have	O
a	O
working	O
cell	O
phone	O
,	O
and	O
speak	O
and	O
read	O
English	O
.	O

(	O
2006	O
)],	O
presence	O
within	O
1	O
kb	O
of	O
at	O
least	O
one	O
of	O
258	O
computationally	O
predicted	O
transcription	O
factor	O
binding	O
site	O
(	O
TFBS	O
)	O
sequences	O
obtained	O
from	O
the	O
tfbsConsSites	O
track	O
of	O
the	O
University	O
of	O
California	O
–	O
Santa	O
Cruz	O
(	O
UCSC	O
)	O
Genomes	O
Browser	O
site	O
(	O
TFBS	O
z	O
-	O
score	O
>	O
2	O
)	O
(	O
Kent	O
et	O
al	O
.	O

The	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
was	O
investigated	O
with	O
ANCOVA	O
adjusted	O
for	O
season	O
,	O
maternal	O
age	O
,	O
education	O
and	O
prepregnancy	O
BMI	O
.	O

Infancy	O
and	O
Early	O
Childhood	O
Taste	O
acquisition	O
and	O
preference	O
The	O
biological	O
substrate	O
that	O
underlies	B
the	O
taste	O
and	O
rewarding	O
properties	O
of	O
foods	O
is	O
relevant	O
because	O
the	O
best	O
predictor	B
of	O
food	O
preference	O
is	O
whether	O
a	O
child	O
likes	O
the	O
taste	O
(	O
23	O
).	O

Vitamin	O
D	O
status	O
is	O
determined	O
by	O
measuring	O
circulating	O
serum	O
levels	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D2	O
+	O
3	O
(	O
25	O
(	O
OH	O
)	O
D	O
).	O

In	O
this	O
review	O
,	O
we	O
first	O
provide	O
an	O
overview	O
of	O
muscle	O
and	O
fat	O
cell	O
growth	O
in	O
ruminants	O
.	O

For	O
instance	O
,	O
the	O
gene	O
deletion	O
of	O
the	O
2	O
-	O
AG	O
-	O
degrading	O
enzyme	O
Mgll	O
has	O
been	O
linked	B
to	O
attenuation	O
of	O
diet	O
-	O
induced	O
insulin	O
resistance	O
and	O
improvement	O
of	O
atherosclerosis	O
via	O
CB2	O
activation	O
(	O
Taschler	O
et	O
al	O
.,	O
2011	O
;	O
Vujic	O
et	O
al	O
.,	O
2016	O
).	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
with	O
no	O
PNV	O
use	O
(	O
vs	O
.	O
use	O
before	O
and	O
after	O
pregnancy	O
diagnosis	O
)	O
had	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
(	O
adjusted	O
OR	O
2	O
.	O
8	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
9	O
,	O
4	O
.	O
3	O
)	O
earlier	O
in	O
pregnancy	O
,	O
and	O
no	O
difference	O
later	O
in	O
pregnancy	O
(	O
adjusted	O
OR	O
1	O
.	O
3	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
8	O
,	O
2	O
.	O
0	O
).	O

Materials	O
and	O
methods	O
Ethics	O
statement	O
Experimental	O
procedures	O
with	O
animals	O
were	O
carried	O
out	O
following	O
with	O
the	O
recommendations	O
of	O
the	O
European	O
Communities	O
directive	O
2010	O
/	O
63	O
/	O
EU	O
and	O
Spanish	O
legislation	O
(	O
Real	O
Decreto	O
53	O
/	O
2013	O
,	O
BOE	O
34	O
/	O
11370	O
-	O
11421	O
,	O
2013	O
)	O
regulating	O
the	O
care	O
and	O
use	O
of	O
laboratory	O
animals	O
.	O

Abstract	O
:	O
SHORT	O
Higher	O
maternal	O
intake	O
of	O
sugar	O
in	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
allergy	O
and	O
allergic	O
asthma	O
in	O
the	O
offspring	O
http	O
://	O
ow	O
.	O
ly	O
/	O
zehc30bFswP	O
Introduction	O
There	O
has	O
been	O
considerable	O
interest	O
in	O
the	O
role	B
of	O
maternal	O
diet	O
in	O
pregnancy	O
in	O
the	O
aetiology	O
of	O
childhood	O
asthma	O
and	O
atopy	O
[	O
1	O
].	O

The	O
high	O
compliance	O
,	O
regular	O
follow	O
-	O
up	O
and	O
long	O
duration	O
of	O
our	O
study	O
further	O
increases	O
confidence	O
in	O
the	O
findings	O
.	O

In	O
vivo	O
and	O
in	O
vitro	O
models	O
have	O
shown	O
that	O
such	O
transfer	O
may	O
lead	O
to	O
reduced	O
neonatal	O
immunity	O
.	O

These	O
children	O
could	O
re	O
-	O
enter	O
the	O
study	O
when	O
next	O
seen	O
.	O

The	O
women	O
who	O
contacted	O
Motherisk	O
tended	B
to	O
be	O
middle	O
to	O
upper	O
middle	O
class	O
,	O
whereas	O
a	O
smaller	O
proportion	O
of	O
callers	O
came	O
from	O
the	O
lower	O
socioeconomic	O
and	O
/	O
or	O
immigrant	O
population	O
;	O
however	O
,	O
this	O
may	O
not	O
affect	B
the	O
generalisability	O
of	O
the	O
results	O
,	O
as	O
their	O
outcomes	O
may	O
be	O
confounded	O
by	O
other	O
factors	B
unrelated	O
to	O
the	O
drug	O
effect	B
.	O

Albumin	O
is	O
a	O
serum	O
protein	O
that	O
can	O
be	O
used	O
as	O
an	O
additional	O
indicator	B
of	O
overall	O
nutritional	O
status	O
and	O
malnutrition	O
[	O
34	O
].	O

The	O
exclusion	O
of	O
17	O
women	O
with	O
implausible	O
energy	O
intake	O
estimates	O
did	O
not	O
alter	O
the	O
main	O
results	O
nor	O
did	O
exclusion	O
of	O
mothers	O
with	O
diabetes	O
.	O

Adjusting	O
for	O
infant	O
feeding	O
method	O
,	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
,	O
maternal	O
fruit	O
consumption	O
was	O
associated	B
with	O
infant	O
stool	O
microbiome	O
composition	O
(	O
generalized	O
UniFrac	O
distance	O
PERMANOVA	O
,	O
p	O
=	O
0	O
.	O
028	O
;	O
Table	O
2	O
;	O
Fig	O
.	O

[	O
12	O
]	O
conducted	O
the	O
largest	O
-	O
scale	O
examination	O
of	O
vitamin	O
D	O
status	O
in	O
Thai	O
population	O
and	O
reported	O
a	O
45	O
.	O
2	O
%	O
prevalence	O
rate	O
of	O
vitamin	O
D	O
insufficiency	O
,	O
defined	O
as	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
<	O
30	O
ng	O
/	O
mL	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
a	O
5	O
.	O
7	O
%	O
prevalence	O
rate	O
of	O
vitamin	O
D	O
deficiency	O
,	O
defined	O
as	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
).	O

The	O
results	O
for	O
omega	O
-	O
3	O
fatty	O
acid	O
and	O
marine	O
fatty	O
acids	O
(	O
EPA	O
,	O
DHA	O
)	O
had	O
a	O
similar	B
pattern	B
,	O
indicating	O
a	O
reduced	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
among	O
women	O
with	O
intermediate	O
levels	O
of	O
intake	O
.	O

Statistical	O
significance	O
was	O
accepted	O
at	O
the	O
p	O
<	O
0	O
.	O
05	O
level	O
.	O

The	O
classical	O
frequency	O
low	O
frequency	O
(	O
LF	O
=	O
0	O
.	O
041	O
–	O
0	O
.	O
15	O
Hz	O
)	O
and	O
high	O
frequency	O
(	O
HF	O
=	O
0	O
.	O
15	O
–	O
0	O
.	O
40	O
Hz	O
)	O
bands	O
were	O
expressed	O
in	O
normalized	O
units	O
(	O
n	O
.	O
u	O
.).	O

However	O
,	O
factors	O
including	O
ethnicity	O
,	O
paternal	O
intelligence	O
,	O
the	O
home	O
environment	O
,	O
drug	O
use	O
,	O
dietary	O
patterns	O
,	O
supplement	O
use	O
and	O
maternal	O
responsiveness	O
were	O
not	O
always	O
measured	O
.	O

In	O
order	O
to	O
achieve	O
Millennium	O
Development	O
Goals	O
,	O
new	O
strategies	O
to	O
address	O
nutritional	O
problems	O
in	O
women	O
of	O
reproductive	O
age	O
are	O
required	O
.	O

Altogether	O
,	O
the	O
existing	O
literature	O
suggests	O
that	O
BAT	O
activation	O
is	O
not	O
only	O
involved	B
in	O
non	O
-	O
shivering	O
thermogenesis	O
,	O
but	O
also	O
in	O
the	O
regulation	O
of	O
insulin	O
-	O
mediated	O
glucose	O
disposal	O
.	O

After	O
adjusting	O
for	O
socio	O
-	O
demographic	O
factors	O
,	O
making	O
more	O
than	O
four	O
prenatal	O
consultations	O
remained	O
associated	B
with	O
the	O
use	O
of	O
multivitamin	O
supplements	O
.	O

They	O
suggest	O
that	O
VD	O
changes	O
AMH	O
production	O
patterns	B
in	O
ovarian	O
granulose	O
cells	O
and	O
alters	O
follicle	O
stimulating	O
hormone	O
(	O
FHS	O
)	O
sensitivity	O
,	O
possibly	O
playing	O
a	O
role	B
in	O
ovarian	O
follicle	O
development	O
.	O

Methods	O
The	O
data	O
form	O
part	O
of	O
the	O
Lifeways	O
Cross	O
-	O
Generation	O
Cohort	O
Study	O
,	O
established	O
in	O
2001	O
and	O
followed	O
up	O
through	O
to	O
2013	O
.	O

Using	O
the	O
Institute	O
of	O
Medicine	O
’	O
s	O
definition	O
of	O
sufficiency	O
(	O
total	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
≥	O
20	O
ng	O
/	O
mL	O
(	O
50	O
nmol	O
/	O
L	O
)	O
[	O
25	O
],	O
the	O
cohort	O
also	O
was	O
divided	O
into	O
two	O
groups	O
based	O
on	O
child	O
’	O
s	O
current	O
vitamin	O
D	O
status	O
,	O
with	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
(	O
50	O
.	O
0	O
nmol	O
/	O
L	O
)	O
defined	O
as	O
deficient	O
.	O

In	O
this	O
model	O
,	O
environmental	O
exposures	O
and	O
lifestyle	O
changes	O
that	O
occur	O
afterwards	O
play	O
a	O
mainly	O
secondary	O
role	B
to	O
the	O
programming	O
or	O
imprinting	O
that	O
occurs	O
during	O
pregnancy	O
and	O
/	O
or	O
early	O
infancy	O
[	O
14	O
,	O
15	O
].	O

Overall	O
,	O
13	O
%	O
(	O
415	O
)	O
were	O
younger	O
than	O
18	O
years	O
(	O
range	O
:	O
12	O
–	O
17	O
),	O
80	O
%	O
(	O
2620	O
)	O
were	O
between	O
18	O
and	O
34	O
years	O
,	O
and	O
7	O
%	O
(	O
233	O
)	O
were	O
35	O
years	O
and	O
older	O
(	O
range	O
:	O
35	O
–	O
45	O
;	O
Table	O
1	O
).	O

The	O
modelling	O
methods	O
have	O
been	O
widely	O
published	O
including	O
discussions	O
of	O
the	O
limitations	O
,	O
which	O
are	O
particularly	O
related	B
to	O
the	O
lack	O
of	O
coverage	O
data	O
for	O
many	O
of	O
the	O
specific	O
interventions	B
[	O
44	O
-	O
47	O
].	O

First	O
,	O
the	O
BHLM	O
model	O
did	O
not	O
account	O
for	O
interactions	B
between	O
classes	O
,	O
and	O
we	O
assumed	O
that	O
all	O
chemicals	O
within	O
a	O
class	O
share	O
a	O
similar	B
mode	O
of	O
action	O
and	O
arise	O
from	O
a	O
common	O
prior	O
distribution	O
.	O

However	O
,	O
in	O
primary	O
human	O
adipose	O
stem	O
cells	O
,	O
both	O
BMP4	O
and	O
BMP7	O
induced	O
a	O
white	O
-	O
to	O
-	O
brown	O
adipocyte	O
transdifferentiation	O
(	O
Elsen	O
et	O
al	O
.,	O
2014b	O
),	O
pointing	O
to	O
the	O
occurrence	O
of	O
different	O
effects	B
,	O
depending	O
on	O
the	O
model	O
used	O
for	O
investigation	O
.	O

Methods	O
A	O
cohort	O
of	O
1	O
,	O
290	O
women	O
was	O
interviewed	O
during	O
early	O
pregnancy	O
.	O

Follow	O
-	O
up	O
may	O
be	O
carried	O
out	O
on	O
a	O
regular	O
basis	O
with	O
ultrasound	O
techniques	O
and	O
thyroglobulin	O
assay	O
,	O
as	O
in	O
non	O
-	O
pregnant	O
women	O
.	O

On	O
the	O
other	O
hand	O
,	O
these	O
outcomes	O
also	O
were	O
twice	O
as	O
common	O
among	O
children	O
whose	O
mothers	O
worked	O
at	O
an	O
electronics	O
assembly	O
plant	O
as	O
in	O
other	O
children	O
.	O
37	O
Animal	O
studies	O
suggest	O
potential	O
reproductive	O
implications	O
of	O
exposure	O
.	O

The	O
researchers	O
found	O
that	O
the	O
more	O
vegetables	O
,	O
fruits	O
,	O
and	O
proteins	O
a	O
woman	O
ate	O
,	O
the	O
lower	O
the	O
risk	O
of	O
her	O
child	O
having	O
leukemia	O
.	O

No	O
umbilical	O
cord	O
care	O
events	O
were	O
observed	O
,	O
given	O
that	O
observations	O
were	O
conducted	O
after	O
the	O
typical	O
time	O
of	O
cord	O
separation	O
.	O

The	O
primary	O
objective	O
of	O
a	O
quantitative	O
meta	O
-	O
analysis	O
is	O
to	O
combine	O
the	O
results	O
of	O
previous	O
studies	O
examining	O
a	O
specific	O
research	O
question	O
to	O
arrive	O
at	O
a	O
summary	O
conclusion	O
about	O
a	O
body	O
of	O
research	O
.	O

Variables	O
included	O
in	O
the	O
PSM	O
model	O
that	O
could	O
explain	O
probability	O
of	O
receiving	O
vaccination	O
were	O
selected	O
a	O
priori	O
(	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
)	O
and	O
because	O
of	O
a	O
crude	O
association	O
with	O
vaccination	O
and	O
/	O
or	O
birth	O
outcomes	O
(	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
iron	O
and	O
vitamin	O
B12	O
consumption	O
during	O
pregnancy	O
,	O
albendazole	O
consumption	O
during	O
pregnancy	O
,	O
calcium	O
consumption	O
during	O
pregnancy	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
calculated	O
from	O
height	O
and	O
weight	O
measurements	O
taken	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
parturitions	O
).	O

Results	O
:	O
We	O
gathered	O
42	O
females	O
and	O
8	O
males	O
as	O
case	O
group	O
and	O
the	O
same	O
numbers	O
as	O
control	O
group	O
without	O
significant	O
age	O
difference	O
.	O

We	O
identified	O
households	O
with	O
young	O
children	O
with	O
detailed	O
maps	O
and	O
advice	O
from	O
staff	O
of	O
the	O
Agha	O
Khan	O
Trust	O
for	O
Culture	O
,	O
a	O
non	O
-	O
governmental	O
organisation	O
working	O
in	O
the	O
region	O
.	O

In	O
keeping	O
with	O
prior	O
studies	O
that	O
sought	O
to	O
assess	O
the	O
extent	O
to	O
which	O
adiposity	O
modified	O
associations	B
between	O
sleep	O
disorders	O
and	O
abnormal	O
carbohydrate	O
metabolism	O
[	O
1	O
,	O
2	O
,	O
4	O
,	O
5	O
,	O
18	O
],	O
we	O
also	O
evaluated	O
the	O
joint	O
effect	B
of	O
pre	O
-	O
pregnancy	O
overweight	O
status	O
and	O
snoring	O
on	O
GDM	O
risk	O
.	O

Euglycemia	O
is	O
maintained	O
through	O
a	O
compensatory	O
increase	O
in	O
insulin	O
secretion	O
.	O

Moreover	O
,	O
40	O
subjects	O
with	O
samples	O
from	O
two	O
subsequent	O
years	O
showed	O
a	O
highly	O
significant	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
increase	O
in	O
cathelicidin	O
concentration	O
from	O
visit	O
one	O
to	O
visit	O
two	O
.	O

Thus	O
,	O
spermatozoal	O
chromatin	O
may	O
also	O
transmit	O
unique	O
epigenetic	O
information	O
that	O
helps	O
to	O
activate	O
and	O
regulate	O
early	O
embryo	O
development	O
and	O
contribute	B
to	O
epigenetic	O
inheritance	O
across	O
multiple	O
generations	O
.	O

Epidemiological	O
data	O
were	O
obtained	O
from	O
children	O
with	O
autism	O
,	O
including	O
residential	O
history	O
of	O
the	O
mother	O
,	O
which	O
was	O
compared	O
to	O
the	O
traffic	O
-	O
related	O
air	O
pollution	O
assigned	O
to	O
each	O
location	O
using	O
measures	O
from	O
the	O
Environmental	O
Protection	O
Agency	O
'	O
s	O
Air	O
Quality	O
System	O
data	O
.	O

The	O
thermogenic	O
activity	O
of	O
BAT	O
is	O
mainly	O
controlled	O
by	O
the	O
sympathetic	O
nervous	O
system	O
.	O

In	O
both	O
models	O
,	O
some	O
variables	B
were	O
excluded	O
when	O
there	O
was	O
evidence	O
of	O
multi	O
-	O
colinearity	O
.	O

Compulsive	O
feeding	O
test	O
This	O
test	O
was	O
an	O
adaptation	O
of	O
the	O
Compulsive	O
Feeding	O
Test	O
described	O
by	O
Heyne	O
et	O
al	O
.	O

According	O
to	O
our	O
results	O
,	O
a	O
maternal	O
caloric	O
restriction	O
prior	O
to	O
mating	O
could	O
be	O
critical	O
for	O
the	O
less	O
compulsive	O
feeding	O
observed	O
in	O
female	O
offspring	O
.	O

As	O
with	O
other	O
studies	O
,	O
dietary	O
calcium	O
deficiency	O
might	O
have	O
led	O
to	O
so	O
-	O
called	O
wastage	O
of	O
body	O
stores	O
of	O
vitamin	O
D	O
in	O
both	O
groups	O
,	O
affecting	B
the	O
maintenance	O
of	O
even	O
higher	O
vitamin	O
D	O
levels	O
in	O
the	O
intervention	O
group	O
.	O

The	O
questions	O
are	O
styled	O
in	O
a	O
'	O
Do	O
you	O
ever	O
feel	O
/	O
think	O
'	O
fashion	O
in	O
order	O
to	O
study	O
continuous	O
experiences	O
during	O
life	O
-	O
time	O
.	O

Both	O
models	O
were	O
adjusted	O
for	O
infant	O
sex	O
and	O
maternal	O
age	O
,	O
BMI	O
,	O
ethnicity	O
,	O
and	O
tobacco	O
,	O
alcohol	O
and	O
prenatal	O
vitamin	O
use	O
during	O
pregnancy	O
.	O

Conclusion	O
Children	O
with	O
S	O
-	O
ECC	O
appear	O
to	O
have	O
relatively	O
poor	O
nutritional	O
health	O
compared	O
to	O
caries	O
-	O
free	O
controls	O
,	O
and	O
were	O
significantly	O
more	O
likely	O
to	O
have	O
low	O
vitamin	O
D	O
,	O
calcium	O
,	O
and	O
albumin	O
concentrations	O
and	O
elevated	O
PTH	O
levels	O
.	O

The	O
albendazole	O
for	O
helminth	O
control	O
was	O
kindly	O
donated	O
by	O
WHO	O
.	O

Epigenetic	O
changes	O
that	O
act	O
as	O
markers	O
of	O
exposure	O
and	O
/	O
or	O
predictors	B
of	O
future	O
toxicity	O
,	O
but	O
do	O
not	O
in	O
themselves	O
directly	O
induce	O
an	O
adverse	O
effect	B
,	O
may	O
also	O
be	O
useful	O
in	O
risk	O
assessment	O
and	O
intervention	O
.	O

Of	O
these	O
,	O
49	O
.	O
6	O
%	O
recommendations	O
were	O
made	O
by	O
friends	O
and	O
neighbors	O
(	O
12	O
.	O
4	O
%)	O
mother	O
or	O
sister	O
(	O
12	O
.	O
4	O
%)	O
and	O
husband	O
(	O
10	O
%).	O

Gross	O
anatomical	O
abnormalities	O
were	O
greater	O
in	O
mice	O
fathered	O
by	O
FD	O
mice	O
(	O
27	O
%	O
vs	O
.	O
3	O
%)	O
which	O
included	O
craniofacial	O
,	O
hydrocephalus	O
,	O
limb	O
,	O
and	O
muscle	O
/	O
skeletal	O
defects	O
.	O

In	O
this	O
sample	O
there	O
was	O
a	O
high	O
prevalence	O
of	O
:	O
unfavorable	O
pre	O
-	O
pregnancy	O
nutritional	O
status	O
(	O
overweight	O
or	O
obesity	O
),	O
gestational	O
weight	O
gain	O
above	O
recommendations	O
(	O
PPBMI	O
<	O
25	O
kg	O
/	O
m2is	O
associated	B
with	O
greater	O
weight	O
gain	O
compared	O
to	O
obese	O
),	O
family	O
history	O
of	O
diabetes	O
,	O
advanced	O
age	O
(	O
38	O
.	O
2	O
%)	O
and	O
low	O
levels	O
of	O
physical	O
activity	O
(	O
data	O
shown	O
in	O
Figure1	O
).	O

Implications	O
for	O
research	O
and	O
practice	O
are	O
also	O
discussed	O
.	O

Differences	O
in	O
ethnicity	O
[	O
21	O
],	O
solar	O
exposure	O
and	O
geographical	O
location	O
,	O
as	O
well	O
as	O
genetics	O
[	O
22	O
]	O
and	O
supplementation	O
[	O
23	O
–	O
25	O
],	O
are	O
known	O
to	O
affect	B
25	O
(	O
OH	O
)	O
D	O
status	O
and	O
therefore	O
influence	B
study	O
outcomes	O
.	O

Additional	O
studies	O
are	O
required	O
better	O
to	O
understand	O
women	O
’	O
s	O
attitudes	O
towards	O
using	O
supplements	O
and	O
the	O
way	O
nutritional	O
knowledge	O
is	O
delivered	O
and	O
used	O
.	O

PubMed	O
Central	O
:	O

It	O
is	O
the	O
first	O
study	O
to	O
capture	O
mothers	O
’	O
overall	O
dietary	O
patterns	B
and	O
relate	B
them	O
to	O
child	O
leukemia	O
.	O

Specifically	O
,	O
a	O
test	O
statistic	O
was	O
constructed	O
as	O
the	O
maximum	O
absolute	O
t	O
-	O
statistic	O
for	O
the	O
appropriate	O
coefficient	O
from	O
the	O
regression	O
model	O
,	O
where	O
the	O
maximum	O
was	O
computed	O
over	O
the	O
16	O
or	O
41	O
individual	O
regression	O
models	O
.	O

Between	O
-	O
group	O
and	O
within	O
-	O
group	O
comparisons	O
of	O
qualitative	O
data	O
were	O
performed	O
Chi	O
-	O
Square	O
or	O
McNemar	O
tests	O
.	O

Results	O
Approximately	O
5	O
.	O
3	O
%	O
of	O
the	O
study	O
cohort	O
developed	O
gestational	O
diabetes	O
mellitus	O
(	O
68	O
of	O
1	O
,	O
290	O
).	O

Given	O
that	O
pregnant	O
women	O
,	O
particularly	O
those	O
in	O
the	O
first	O
trimester	O
,	O
are	O
known	O
to	O
require	O
30	O
-	O
45	O
more	O
minutes	O
of	O
sleep	O
per	O
night	O
than	O
their	O
non	O
-	O
pregnant	O
counterparts	O
[	O
25	O
-	O
27	O
],	O
we	O
a	O
priori	O
defined	O
those	O
women	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
as	O
the	O
reference	O
group	O
.	O

There	O
has	O
been	O
considerable	O
research	O
interest	O
in	O
the	O
provision	O
of	O
antenatal	O
dietary	O
interventions	O
during	O
pregnancy	O
to	O
limit	O
weight	O
gain	O
and	O
improve	O
pregnancy	O
and	O
birth	O
outcomes	O
for	O
women	O
and	O
their	O
infants	O
.	O

Materials	O
and	O
Methods	O
Program	O
implementation	O
,	O
compliance	O
and	O
impact	O
assessment	O
In	O
May	O
2006	O
the	O
National	O
Institute	O
of	O
Malariology	O
,	O
Parasitology	O
and	O
Entomology	O
(	O
NIMPE	O
)	O
and	O
partners	O
introduced	O
a	O
pilot	O
program	O
consisting	O
of	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
periodic	O
de	O
-	O
worming	O
for	O
women	O
of	O
reproductive	O
age	O
in	O
Yen	O
Bai	O
province	O
.	O

Using	O
a	O
data	O
-	O
driven	O
recursively	O
partitioned	O
mixture	O
model	O
(	O
RPMM	O
),	O
these	O
CpG	O
loci	O
were	O
clustered	O
into	O
16	O
methylation	O
classes	O
based	O
on	O
like	O
methylation	O
pattern	O
obtained	O
from	O
the	O
array	O
results	O
,	O
pruning	O
the	O
model	O
after	O
four	O
splits	O
to	O
maintain	O
power	O
(	O
Houseman	O
et	O
al	O
.	O

Surprisingly	O
,	O
the	O
change	O
in	O
vitamin	O
D	O
concentration	O
(	O
baseline	O
to	O
childbirth	O
)	O
was	O
not	O
correlated	O
with	O
changes	O
in	O
depression	O
scores	O
from	O
baseline	O
to	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
or	O
to	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

The	O
adult	O
male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
exhibited	O
an	O
increase	O
in	O
body	O
weight	O
and	O
a	O
higher	O
restriction	O
in	O
total	O
caloric	O
intake	O
after	O
the	O
administration	O
of	O
AM251	O
,	O
a	O
CB1	O
receptor	O
inverse	O
agonist	O
with	O
anorexigenic	O
and	O
anti	O
-	O
obesity	O
properties	O
.	O

In	O
contrast	O
to	O
the	O
above	O
-	O
mentioned	O
studies	O
,	O
our	O
results	O
show	O
that	O
the	O
combination	O
of	O
black	O
race	O
and	O
vitamin	O
D	O
deficiency	O
was	O
associated	B
with	O
increased	O
odds	O
of	O
SGA	O
,	O
but	O
this	O
relationship	B
was	O
not	O
preserved	O
for	O
white	O
infants	O
.	O

Follow	O
-	O
up	O
of	O
a	O
smaller	O
proportion	O
of	O
child	O
participants	O
at	O
2	O
to	O
3	O
years	O
of	O
age	O
[	O
42	O
,	O
43	O
]	O
demonstrated	O
no	O
significant	O
differences	O
in	O
the	O
metabolic	O
profile	O
of	O
children	O
[	O
42	O
],	O
or	O
on	O
measures	O
of	O
growth	O
and	O
adiposity	O
[	O
43	O
].	O

Each	O
child	O
’	O
s	O
cathelicidin	O
concentration	O
also	O
was	O
compared	O
to	O
the	O
frequency	O
of	O
infections	O
each	O
child	O
had	O
diagnosed	O
within	O
the	O
last	O
year	O
,	O
and	O
to	O
the	O
age	O
of	O
the	O
child	O
.	O

The	O
protocol	O
was	O
approved	O
by	O
the	O
University	O
of	O
Toronto	O
Animal	O
Care	O
Committee	O
.	O

All	O
whole	O
body	O
DEXA	O
scans	O
were	O
done	O
by	O
the	O
same	O
technologist	O
on	O
a	O
Hologic	O
Discovery	O
A	O
densitometer	O
(	O
Bedford	O
,	O
MA	O
,	O
USA	O
).	O

The	O
lower	O
serum	O
VD	O
level	O
was	O
also	O
related	B
to	O
worse	O
sperm	O
parameters	O
[	O
52	O
].	O

Thus	O
,	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
Thai	O
people	O
is	O
generally	O
low	O
.	O

Secondary	O
analysis	O
examining	O
baseline	O
data	O
(	O
N	O
=	O
123	O
)	O
from	O
a	O
healthy	O
lifestyle	O
randomized	O
controlled	O
trial	O
conducted	O
in	O
and	O
urban	O
area	O
of	O
the	O
South	O
East	O
.	O

However	O
,	O
as	O
they	O
reached	O
adolescence	O
(	O
age	O
11	O
years	O
for	O
girls	O
,	O
16	O
for	O
boys	O
),	O
children	O
exposed	O
to	O
tobacco	O
in	O
utero	O
had	O
a	O
significantly	O
greater	O
risk	O
of	O
being	O
in	O
the	O
highest	O
10	O
%	O
of	O
BMI	O
for	O
their	O
age	O
group	O
.	O

Other	O
Allergens	O
Avoidance	O
of	O
allergens	O
(	O
pets	O
,	O
house	O
dust	O
,	O
contact	O
allergens	O
,	O
drugs	O
)	O
is	O
not	O
recommended	O
except	O
when	O
sensitization	O
has	O
already	O
been	O
diagnosed	O
.	O

No	O
individual	O
comparison	O
for	O
each	O
category	O
—	O
pooled	O
estimate	O
only	O
.	O
Fish	O
intake	O
during	O
pregnancy	O
estimated	O
via	O
semi	O
-	O
quantitative	O
FFQ	O
.	O
Peabody	O
Picture	O
Vocabulary	O
Test	O
(	O
PPVT	O
)	O
and	O
Wide	O
Range	O
Assessment	O
of	O
Visual	O
Motor	O
Abilities	O
(	O
WRAVMA	O
)	O
tested	O
at	O
~	O
38	O
months	O
age	O
of	O
child	O
and	O
analysed	O
for	O
association	O
with	O
fish	O
intake	O
.	O
FFQ	O
of	O
typical	O
diet	O
during	O
pregnancy	O
completed	O
3	O
months	O
after	O
delivery	O
and	O
fish	O
and	O
shellfish	O
/	O
squid	O
intake	O
estimated	O
.	O
Neurodevelopment	O
(	O
as	O
well	O
as	O
diet	O
and	O
physical	O
activity	O
)	O
assessed	O
when	O
child	O
was	O
4	O
years	O
of	O
age	O
using	O
the	O
McCarthy	O
Scales	O
of	O
Children	O
’	O
s	O
Abilities	O
(	O
MCSA	O
)	O
tests	O
—	O
global	O
cognitive	O
scale	O
&	O
5	O
subscales	O
(	O
perceptive	O
-	O
performance	O
,	O
memory	O
,	O
verbal	O
,	O
quantitative	O
and	O
motor	O
).	O
Fish	O
intake	O
measured	O
via	O
FFQ	O
4	O
days	O
after	O
birth	O
of	O
child	O
.	O

However	O
,	O
these	O
changes	O
with	O
slaugther	O
age	O
were	O
not	O
observed	O
in	O
double	O
-	O
muscled	O
Belgian	O
Blue	O
bulls	O
[	O
24	O
].	O

The	O
management	O
of	O
anaphylaxis	O
during	O
pregnancy	O
is	O
the	O
same	O
as	O
for	O
nonpregnant	O
patients	O
.	O

Yet	O
,	O
contrary	O
to	O
many	O
studies	O
,	O
associations	B
between	O
high	O
25	O
(	O
OH	O
)	O
D	O
and	O
GDM	O
have	O
been	O
reported	O
[	O
27	O
,	O
28	O
].	O

Another	O
key	B
factor	I
may	O
be	O
the	O
use	O
of	O
any	O
prenatal	O
,	O
prescription	O
medication	O
[	O
4	O
–	O
6	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Independent	O
effect	O
of	O
maternal	O
factors	O
on	O
birth	O
sizeaBirth	O
weight	O
(	O
SDS	O
)	O
Birth	O
length	O
(	O
SDS	O
)	O
Head	O
circumference	O
(	O
SDS	O
)	O
bPonderal	O
index	O
(	O
z	O
-	O
score	O
)	O
cMaternal	O
factors	O
np	O
value	O
p	O
value	O
p	O
value	O
p	O
valuePrepregnancy	O
BMI	O
0	O
.	O
020	O
0	O
.	O
2010	O
.	O
3640	O
.	O
719	O
Underweight19	O
−	O
0	O
.	O
49	O
±	O
0	O
.	O
17	O
−	O
0	O
.	O
36	O
±	O
0	O
.	O
19	O
−	O
0	O
.	O
34	O
±	O
0	O
.	O
22	O
−	O
0	O
.	O
12	O
±	O
0	O
.	O
23	O
Normal	O
weight494	O
−	O
0	O
.	O
30	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
14	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
01	O
±	O
0	O
.	O
05	O
Overweight117	O
−	O
0	O
.	O
13	O
±	O
0	O
.	O
07	O
−	O
0	O
.	O
12	O
±	O
0	O
.	O
08	O
−	O
0	O
.	O
04	O
±	O
0	O
.	O
090	O
.	O
08	O
±	O
0	O
.	O
09	O
Obese44	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
12	O
−	O
0	O
.	O
01	O
±	O
0	O
.	O
130	O
.	O
03	O
±	O
0	O
.	O
140	O
.	O
08	O
±	O
0	O
.	O
16Gestational	O
weight	O
gain	O
<	O
0	O
.	O
0010	O
.	O
006	O
0	O
.	O
1860	O
.	O
505	O
Inadequate164	O
−	O
0	O
.	O
43	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
37	O
±	O
0	O
.	O
07	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
07	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
08	O
Adequate261	O
−	O
0	O
.	O
28	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
20	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
11	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
02	O
±	O
0	O
.	O
06	O
Excessive242	O
−	O
0	O
.	O
12	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
09	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
060	O
.	O
07	O
±	O
0	O
.	O
07Prepregnancy	O
smoking	O
0	O
.	O
021	O
0	O
.	O
2270	O
.	O
0930	O
.	O
173	O
Yes101	O
−	O
0	O
.	O
43	O
±	O
0	O
.	O
08	O
−	O
0	O
.	O
30	O
±	O
0	O
.	O
09	O
−	O
0	O
.	O
27	O
±	O
0	O
.	O
10	O
−	O
0	O
.	O
13	O
±	O
0	O
.	O
11	O
No573	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
18	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
09	O
±	O
0	O
.	O
040	O
.	O
03	O
±	O
0	O
.	O
04Maternal	O
education0	O
.	O
9720	O
.	O
6700	O
.	O
7210	O
.	O
634	O
Higher513	O
−	O
0	O
.	O
26	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
19	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
11	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
00	O
±	O
0	O
.	O
05	O
Lower161	O
−	O
0	O
.	O
26	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
07	O
−	O
0	O
.	O
14	O
±	O
0	O
.	O
080	O
.	O
04	O
±	O
0	O
.	O
08Parity	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
0010	O
.	O
0070	O
.	O
027	O
Nullipara431	O
−	O
0	O
.	O
40	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
32	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
20	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
05	O
Secundipara185	O
−	O
0	O
.	O
03	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
06	O
−	O
0	O
.	O
03	O
±	O
0	O
.	O
070	O
.	O
18	O
±	O
0	O
.	O
07	O
Multipara580	O
.	O
04	O
±	O
0	O
.	O
100	O
.	O
22	O
±	O
0	O
.	O
110	O
.	O
17	O
±	O
0	O
.	O
12	O
−	O
0	O
.	O
07	O
±	O
0	O
.	O
13Gestational	O
diabetes	O
mellitus0	O
.	O
0630	O
.	O
5590	O
.	O
3510	O
.	O
075	O
Yes76	O
−	O
0	O
.	O
10	O
±	O
0	O
.	O
09	O
−	O
0	O
.	O
15	O
±	O
0	O
.	O
10	O
−	O
0	O
.	O
02	O
±	O
0	O
.	O
110	O
.	O
21	O
±	O
0	O
.	O
12	O
No598	O
−	O
0	O
.	O
28	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
21	O
±	O
0	O
.	O
03	O
−	O
0	O
.	O
13	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
02	O
±	O
0	O
.	O
04Pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
0	O
.	O
010	O
0	O
.	O
0950	O
.	O
3980	O
.	O
236	O
Suboptimal	O
(<	O
80	O
nmol	O
/	O
L	O
)	O
333	O
−	O
0	O
.	O
34	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
26	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
15	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
04	O
±	O
0	O
.	O
06	O
Optimal	O
(≥	O
80	O
nmol	O
/	O
L	O
)	O
341	O
−	O
0	O
.	O
19	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
15	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
09	O
±	O
0	O
.	O
050	O
.	O
05	O
±	O
0	O
.	O
06UCB	O
25	O
(	O
OH	O
)	O
D	O
concentration0	O
.	O
1490	O
.	O
486	O
0	O
.	O
003	O
0	O
.	O
234	O
Suboptimal	O
(<	O
80	O
nmol	O
/	O
L	O
)	O
369	O
−	O
0	O
.	O
22	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
18	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
02	O
±	O
0	O
.	O
050	O
.	O
05	O
±	O
0	O
.	O
05	O
Optimal	O
(≥	O
80	O
nmol	O
/	O
L	O
)	O
305	O
−	O
0	O
.	O
31	O
±	O
0	O
.	O
04	O
−	O
0	O
.	O
23	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
24	O
±	O
0	O
.	O
05	O
−	O
0	O
.	O
05	O
±	O
0	O
.	O
06	O
25	O
(	O
OH	O
)	O
D	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
,	O
UCB	O
umbilical	O
cord	O
blood	O
Values	O
are	O
adjusted	O
mean	O
±	O
SEM	O
.	O

They	O
do	O
,	O
however	O
,	O
agree	O
with	O
previously	O
published	O
studies	O
[	O
14	O
,	O
39	O
,	O
45	O
,	O
46	O
].	O

The	O
overall	O
client	O
satisfaction	O
was	O
compared	O
with	O
the	O
different	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
respondents	O
(	O
Table	O
4	O
).	O

2008	O
).	O

Thus	O
,	O
the	O
dietary	O
vitamin	O
C	O
requirement	O
for	O
beef	O
cattle	O
is	O
not	O
specified	O
in	O
the	O
NRC	O
[	O
146	O
].	O

Despite	O
unclear	O
mechanisms	O
,	O
the	O
positive	O
relationship	B
between	O
later	O
pregnancy	O
hyperglycemia	O
and	O
GDM	O
risk	O
were	O
evident	O
among	O
women	O
who	O
reported	O
short	O
/	O
long	O
sleep	O
duration	O
and	O
snoring	O
in	O
our	O
cohort	O
.	O

The	O
health	O
centres	O
are	O
run	O
by	O
senior	O
nurses	O
or	O
midwives	O
(	O
Head	O
of	O
centres	O
)	O
with	O
the	O
exception	O
of	O
Muea	O
health	O
centre	O
which	O
is	O
headed	O
by	O
a	O
medical	O
doctor	O
.	O

One	O
of	O
the	O
reasons	O
for	O
a	O
visfatin	O
effect	B
on	O
fetal	O
development	O
is	O
its	O
effect	B
on	O
sirtuins	O
(	O
SIRT	O
).	O

Height	O
The	O
estimated	O
height	O
correlations	O
at	O
each	O
age	O
and	O
across	O
generations	O
are	O
displayed	O
in	O
(	O
table	O
5	O
).	O

This	O
was	O
more	O
pronounced	O
in	O
women	O
who	O
received	O
best	O
-	O
practice	O
care	O
(	O
25	O
.	O
0	O
%	O
(	O
yes	O
)	O
vs	O
.	O
27	O
.	O
2	O
%	O
(	O
no	O
)).	O

In	O
a	O
recent	O
study	O
,	O
serum	O
levels	O
of	O
vitamin	O
D	O
,	O
steroid	O
hormones	O
,	O
SHBG	O
and	O
ovarian	O
reserve	O
markers	O
were	O
determined	O
in	O
73	O
non	O
-	O
obese	O
,	O
healthy	O
,	O
parous	O
women	O
.	O

We	O
excluded	O
stillbirths	O
,	O
those	O
who	O
declined	O
to	O
participate	O
,	O
those	O
with	O
obstetric	O
pathology	O
,	O
or	O
psychiatric	O
,	O
cognitive	O
or	O
other	O
disease	O
that	O
might	O
adversely	O
affect	B
understanding	O
of	O
the	O
study	O
objectives	O
or	O
the	O
ability	O
to	O
provide	O
accurate	O
information	O
.	O

For	O
patients	O
with	O
advanced	O
disease	O
,	O
ultrasound	O
control	O
of	O
tissue	O
growth	O
can	O
help	O
in	O
therapeutic	O
decisions	O
,	O
such	O
as	O
timing	O
of	O
surgery	O
.	O

Thus	O
,	O
preventive	O
treatment	O
with	O
iron	O
supplements	O
has	O
always	O
been	O
given	O
in	O
combination	O
with	O
folic	O
acid	O
and	O
this	O
has	O
been	O
included	O
as	O
part	O
of	O
routine	O
antenatal	O
care	O
provided	O
to	O
pregnant	O
women	O
at	O
every	O
visit	O
in	O
developing	O
countries	O
[	O
26	O
].	O

Maternal	O
dairy	O
intake	O
was	O
positively	O
associated	B
with	O
OTUs	O
classified	O
to	O
the	O
species	O
Clostridium	O
neonatale	O
and	O
C	O
.	O
butyricum	O
and	O
the	O
genus	O
Staphylococcus	O
,	O
and	O
negatively	O
related	B
to	O
OTUs	O
classified	O
to	O
the	O
Lachnospiraceae	O
family	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S2b	O
).	O

The	O
non	O
-	O
linearity	O
in	O
the	O
association	B
might	O
seemingly	O
argue	O
against	O
a	O
possible	O
causal	O
relationship	B
.	O

Most	O
government	O
drug	O
agencies	O
have	O
not	O
approved	O
their	O
use	O
in	O
pregnancy	O
,	O
and	O
major	O
specialty	O
diabetes	O
organizations	O
recommend	O
that	O
oral	O
agents	O
be	O
ceased	O
if	O
the	O
woman	O
had	O
been	O
taking	O
them	O
pre	O
-	O
pregnancy53	O
–	O
55There	O
have	O
now	O
however	O
,	O
been	O
randomized	O
trials	O
conducted	O
with	O
both	O
glyburide	O
and	O
metformin	O
which	O
have	O
not	O
demonstrated	O
short	O
term	O
harm	O
to	O
the	O
pregnancy	O
.	O

Black	O
line	O
represents	O
fitted	O
LOESS	O
curve	O
,	O
dark	O
gray	O
area	O
represents	O
1	O
standard	O
deviation	O
,	O
and	O
light	O
gray	O
area	O
represents	O
2	O
standard	O
deviations	O
.	O

In	O
view	O
of	O
hypocalcemia	O
,	O
the	O
child	O
was	O
treated	O
with	O
2	O
ml	O
/	O
kg	O
of	O
10	O
%	O
calcium	O
gluconate	O
followed	O
by	O
maintenance	O
calcium	O
,	O
following	O
which	O
the	O
stridor	O
disappeared	O
and	O
there	O
were	O
no	O
further	O
seizures	O
.	O

Several	O
studies	O
have	O
examined	O
factors	B
which	O
predict	B
failure	O
of	O
glyburide	O
to	O
achieve	O
adequate	O
glycemic	O
control	O
.	O

Targeted	O
genotyping	O
of	O
genes	O
of	O
interest	O
in	O
the	O
context	O
of	O
fatty	O
acid	O
,	O
lipid	O
and	O
micronutrient	O
metabolism	O
will	O
also	O
be	O
investigated	O
following	O
the	O
Ion	O
AmpliSeq	O
Targeted	O
Sequencing	O
approach	O
using	O
the	O
Ion	O
Chef	O
™	O
and	O
Ion	O
S5	O
™	O
Systems	O
(	O
ThermoFisher	O
).	O

An	O
important	O
limitation	O
of	O
this	O
study	O
is	O
that	O
we	O
measured	O
dietary	O
intake	O
only	O
once	O
,	O
involving	O
misclassification	O
among	O
those	O
who	O
changed	O
their	O
dietary	O
pattern	O
during	O
follow	O
-	O
up	O
.	O

Previous	O
studies	O
reported	O
that	O
unplanned	O
pregnancy	O
is	O
a	O
risk	B
factor	I
for	O
perinatal	O
depression	O
.	O

Another	O
positive	O
point	O
is	O
that	O
few	O
studies	O
have	O
collected	O
data	O
on	O
maternal	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

Preliminary	O
studies	O
of	O
interventions	B
to	O
reduce	O
rates	O
of	O
elective	O
caesarean	O
births	O
or	O
inductions	O
without	O
medical	O
indication	O
before	O
the	O
recommended	O
39	O
completed	O
weeks	O
of	O
gestation	O
suggest	O
an	O
impact	B
on	O
prevention	B
of	O
early	O
term	O
deliveries	O
in	O
some	O
high	O
-	O
and	O
middle	O
-	O
income	O
countries	O
[	O
9	O
,	O
10	O
].	O

There	O
were	O
no	O
associations	O
between	O
the	O
predictor	B
T1	O
25OHD	O
and	O
the	O
outcomes	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
(	O
Table	O
3	O
).	O

Closing	O
gaps	O
in	O
coverage	O
,	O
equity	O
and	O
quality	O
In	O
order	O
for	O
health	O
services	O
to	O
save	O
the	O
maximum	O
number	O
of	O
lives	O
,	O
coverage	O
,	O
quality	O
and	O
equity	O
need	O
to	O
be	O
high	O
;	O
thus	O
ensuring	O
high	O
coverage	O
of	O
care	O
means	O
reaching	O
every	O
woman	O
,	O
mother	O
-	O
to	O
-	O
be	O
,	O
mother	O
,	O
newborn	O
,	O
child	O
and	O
family	O
with	O
targeted	O
interventions	B
.	O

All	O
the	O
studies	O
shown	O
here	O
demonstrated	O
associations	B
among	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

The	O
range	O
between	O
therapeutic	O
and	O
toxic	O
doses	O
is	O
narrow	O
,	O
and	O
vitamin	O
D	O
toxicity	O
,	O
when	O
it	O
occurs	O
,	O
is	O
a	O
serious	O
problem	O
.	O

T1	O
25OHD	O
was	O
also	O
investigated	O
as	O
a	O
continuous	O
variable	O
as	O
there	O
were	O
few	O
cases	O
in	O
some	O
categories	O
.	O

95	O
%	O
CI	O
=	O
95	O
%	O
Confidence	O
Intervals	O
.	O

folate	O
,	O
vitamin	O
B6	O
and	O
B12	O
)	O
is	O
closely	O
linked	B
.	O
36	O
A	O
significant	O
weakness	O
of	O
the	O
study	O
arises	O
from	O
the	O
lack	O
of	O
measurement	O
of	O
gene	O
expression	O
at	O
different	O
stages	O
of	O
maturity	O
.	O

Analysis	O
conducted	O
using	O
data	O
from	O
Liu	O
et	O
al	O
.,	O
2012	O
[	O
50	O
].	O

The	O
cohort	O
of	O
the	O
mother	O
-	O
child	O
dyads	O
will	O
be	O
followed	O
up	O
from	O
recruitment	O
until	O
42	O
days	O
after	O
birth	O
.	O

The	O
primary	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
impact	B
of	O
GWG	O
,	O
maternal	O
eating	O
and	O
exercise	O
behaviors	O
,	O
and	O
psychosocial	O
factors	O
on	O
offspring	O
weight	O
status	O
.	O

Therefore	O
,	O
a	O
multiple	O
imputation	O
model	O
was	O
constructed	O
to	O
account	O
for	O
missing	O
race	O
and	O
marital	O
status	O
through	O
use	O
of	O
a	O
logit	O
function	O
with	O
parity	O
,	O
age	O
,	O
and	O
treatment	O
status	O
as	O
predictors	B
of	O
both	O
race	O
and	O
marital	O
status	O
.	O

A	O
similar	B
pattern	B
was	O
demonstrated	O
in	O
children	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
.	O

(	O
2014	O
)	O
concluded	O
that	O
modest	O
evidence	O
exist	O
for	O
a	O
positive	O
relation	B
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
birth	O
weight	O
[	O
31	O
].	O

The	O
male	O
pups	O
were	O
weaned	O
on	O
postnatal	O
day	O
21	O
and	O
housed	O
in	O
groups	O
of	O
3	O
–	O
6	O
.	O

Models	O
adjusted	O
for	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
and	O
ILI	O
for	O
mothers	O
vaccinated	O
in	O
the	O
first	O
trimester	O
;	O
education	O
level	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
delivery	O
hospital	O
,	O
sex	O
of	O
the	O
baby	O
,	O
number	O
of	O
parturitions	O
,	O
and	O
ILI	O
for	O
mothers	O
vaccinated	O
in	O
the	O
second	O
trimester	O
;	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
BMI	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
and	O
sex	O
of	O
the	O
baby	O
for	O
mothers	O
vaccinated	O
in	O
the	O
third	O
trimester	O
.	O

DNA	O
methylation	O
and	O
in	O
utero	O
exposures	O
.	O

However	O
,	O
mothers	O
with	O
optimal	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
had	O
newborns	O
with	O
smaller	O
head	O
circumference	O
than	O
those	O
with	O
suboptimal	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
=	O
0	O
.	O
003	O
),	O
which	O
was	O
further	O
confirmed	O
as	O
a	O
linear	O
association	B
(	O
P	O
=	O
0	O
.	O
024	O
).	O

The	O
LOESS	O
curve	O
for	O
the	O
MUSC	O
cohort	O
closely	O
tracks	O
the	O
LOESS	O
curve	O
for	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Mice	O
that	O
carry	O
a	O
mutation	O
in	O
Npr3	O
exhibit	O
a	O
skeletal	O
overgrowth	O
phenotype	O
,	O
resulting	O
in	O
an	O
elongated	O
body	O
and	O
kyphosis	O
.	O

BMI	O
tends	B
to	O
decrease	O
during	O
early	O
childhood	O
and	O
then	O
,	O
typically	O
between	O
the	O
ages	O
of	O
6	O
and	O
8	O
,	O
begins	O
to	O
rise	O
again	O
(	O
adiposity	O
rebound	O
).	O

Upon	O
arrival	O
at	O
RMMCH	O
on	O
the	O
booked	O
date	O
,	O
the	O
trained	O
fieldworkers	O
explain	O
the	O
informed	O
consent	O
form	O
in	O
local	O
languages	O
and	O
all	O
are	O
given	O
the	O
opportunity	O
to	O
ask	O
questions	O
.	O

A	O
strength	O
of	O
the	O
present	O
study	O
lies	O
in	O
the	O
recruitment	O
of	O
subjects	O
,	O
which	O
took	O
place	O
in	O
a	O
single	O
hospital	O
,	O
enabled	O
standardised	O
data	O
collection	O
and	O
covered	O
all	O
seasons	O
.	O

To	O
assess	O
the	O
relationship	B
between	O
each	O
maternal	O
dietary	O
factor	O
and	O
infant	O
gut	O
microbiome	O
cluster	O
membership	O
,	O
we	O
used	O
multinomial	O
logistic	O
regression	O
in	O
the	O
R	O
package	O
nnet	O
adjusting	O
all	O
models	O
for	O
the	O
same	O
covariates	O
as	O
in	O
previous	O
analyses	O
.	O

3	O
.	O

Reduction	O
of	O
energy	O
intake	O
induced	O
SIRT1	O
in	O
brain	O
(	O
21	O
).	O

Infant	O
Anthropometrics	O
Trained	O
research	O
staff	O
abstracted	O
infant	O
and	O
child	O
weight	O
and	O
length	O
from	O
obstetric	O
and	O
pediatric	O
records	O
.	O

Daily	O
use	O
of	O
iron	O
supplements	O
is	O
effective	O
when	O
administered	O
under	O
supervision	O
in	O
clinical	O
interventional	O
trials	O
,	O
but	O
is	O
less	O
so	O
in	O
public	O
health	O
programmes	O
because	O
of	O
difficulty	O
engaging	O
with	O
the	O
target	O
population	O
.	O

In	O
the	O
presence	O
of	O
adequate	O
concentrations	O
of	O
calcifediol	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
),	O
CYP27B1	O
leads	O
to	O
an	O
increase	O
synthesis	O
of	O
intracellular	O
calcitriol	O
(	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
).	O

We	O
have	O
collected	O
a	O
homogenous	O
cohort	O
of	O
Caucasian	O
mothers	O
from	O
the	O
capital	O
region	O
of	O
Finland	O
representing	O
mothers	O
without	O
regular	O
medication	O
and	O
their	O
newborns	O
who	O
were	O
born	O
at	O
term	O
with	O
normal	O
birth	O
weight	O
.	O

A	O
limitation	O
is	O
the	O
relatively	O
small	O
numbers	O
of	O
respondents	O
with	O
differential	O
response	O
rates	O
at	O
each	O
sweep	O
,	O
particularly	O
when	O
children	O
averaged	O
9	O
years	O
of	O
age	O
.	O

Only	O
those	O
who	O
had	O
completed	O
the	O
2	O
-	O
year	O
follow	O
-	O
up	O
appointment	O
had	O
serum	O
25OHD	O
measured	O
in	O
the	O
pregnancy	O
sample	O
,	O
thus	O
334	O
participants	O
were	O
included	O
.	O

Nine	O
integrated	O
public	O
health	O
centres	O
which	O
accounted	O
for	O
about	O
two	O
thirds	O
of	O
the	O
total	O
study	O
population	O
were	O
selected	O
as	O
study	O
sites	O
.	O

PubMed	O
Central	O
:	O

Infertility	O
of	O
the	O
mutagenized	O
mice	O
was	O
confirmed	O
after	O
treatment	O
and	O
mice	O
were	O
allowed	O
8	O
–	O
12	O
wk	O
to	O
recover	O
fertility	O
and	O
then	O
were	O
bred	O
to	O
129X1	O
females	O
.	O

It	O
can	O
be	O
concluded	O
that	O
women	O
with	O
low	O
socioeconomic	O
status	O
need	O
specific	O
dietary	O
intervention	O
programs	O
due	O
to	O
increase	O
in	O
nutritional	O
demands	O
during	O
pregnancy	O
.	O

Eligible	O
studies	O
included	O
those	O
of	O
healthy	O
pregnant	O
women	O
who	O
had	O
experienced	O
full	O
term	O
births	O
and	O
those	O
that	O
had	O
measured	O
fish	O
or	O
seafood	O
intake	O
and	O
assessed	O
neurodevelopmental	O
outcomes	O
in	O
offspring	O
.	O

In	O
general	O
,	O
results	O
are	O
given	O
for	O
the	O
comparisons	O
in	O
the	O
direction	O
of	O
LP	O
vs	O
.	O
AP	O
;	O
thus	O
'	O
up	O
-	O
regulation	O
'	O
or	O
'	O
increased	O
expression	O
'	O
indicates	O
higher	O
expression	O
in	O
LP	O
than	O
in	O
AP	O
.	O

Several	O
studies	O
have	O
been	O
shown	O
that	O
,	O
with	O
cutoff	O
score	O
of	O
12	O
–	O
13	O
,	O
this	O
scale	O
develops	O
into	O
more	O
indicative	O
in	O
identifying	O
real	O
depression	O
in	O
women	O
[	O
36	O
,	O
37	O
,	O
42	O
].	O

We	O
used	O
observed	O
handwashing	O
as	O
our	O
primary	O
outcome	O
of	O
interest	O
.	O

Moreover	O
,	O
it	O
should	O
be	O
noted	O
that	O
alterations	O
in	O
autonomic	O
nervous	O
function	O
are	O
associated	B
with	O
low	O
birth	O
weight	O
and	O
cardiometabolic	O
abnormalities	O
[	O
17	O
,	O
19	O
,	O
20	O
,	O
33	O
].	O

No	O
increase	O
in	O
pregnancy	O
complications	O
have	O
been	O
found	O
in	O
observational	O
studies	O
where	O
lispro	O
was	O
used	O
,	O
in	O
either	O
women	O
with	O
GDM38	O
,	O
43or	O
pre	O
-	O
existing	O
diabetes	O
.	O
38	O
–	O
43There	O
are	O
few	O
reports	O
regarding	O
the	O
use	O
of	O
aspart	O
in	O
pregnancy	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

The	O
symptoms	O
of	O
autism	O
become	O
notable	O
in	O
patient	O
in	O
the	O
first	O
three	O
years	O
of	O
life	O
and	O
may	O
necessitate	O
lifelong	O
care	O
that	O
must	O
be	O
provided	O
by	O
family	O
members	O
,	O
guardians	O
,	O
or	O
healthcare	O
professionals	O
.	O

Studies	O
focused	O
on	O
high	O
-	O
risk	O
populations	O
,	O
for	O
example	O
,	O
veiled	O
,	O
dark	O
-	O
skinned	O
or	O
obese	O
women	O
in	O
Australia	O
and	O
New	O
Zealand	O
,	O
report	O
between	O
50	O
and	O
94	O
%	O
of	O
women	O
to	O
be	O
vitamin	O
D	O
deficient	O
[	O
8	O
–	O
10	O
].	O

Preterm	O
labor	O
is	O
associated	B
with	O
high	O
mortality	O
and	O
morbidity	O
[	O
22	O
]	O
and	O
a	O
recent	O
study	O
pointed	O
towards	O
an	O
association	B
between	O
maternal	O
stress	O
and	O
complications	O
of	O
pregnancy	O
,	O
especially	O
preterm	O
birth	O
[	O
23	O
].	O

Obesity	O
is	O
correlated	B
with	O
low	O
NAD	O
+/	O
SIRT	O
pathway	O
expression	O
in	O
adipose	O
tissue	O
of	O
BMI	O
-	O
discordant	O
monozygotic	O
twins	O
(	O
22	O
).	O

Moreover	O
,	O
previously	O
noted	O
associations	B
between	O
current	O
smoking	O
and	O
age	O
at	O
menopause	O
were	O
not	O
observed	O
among	O
these	O
women	O
.	O

Seasonal	O
variations	O
in	O
the	O
number	O
of	O
pregnancies	O
have	O
already	O
been	O
noted	O
both	O
in	O
spontaneous	O
reproduction	O
and	O
in	O
IVF	O
.	O

These	O
clinically	O
relevant	O
cut	O
points	O
(	O
20	O
ng	O
/	O
mL	O
from	O
the	O
Institute	O
of	O
Medicine	O
guidelines	O
[	O
16	O
],	O
30	O
ng	O
/	O
mL	O
from	O
the	O
Endocrine	O
Society	O
Clinical	O
Practice	O
Guideline	O
[	O
17	O
],	O
and	O
40	O
ng	O
/	O
mL	O
from	O
the	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
found	O
to	O
achieve	O
maximal	O
production	O
of	O
the	O
active	O
hormone	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
[	O
13	O
])	O
are	O
similar	O
to	O
quartiles	O
based	O
on	O
the	O
distribution	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(	O
21	O
,	O
31	O
and	O
41	O
ng	O
/	O
mL	O
).	O

Logistic	O
regression	O
analysis	O
was	O
performed	O
in	O
order	O
to	O
identify	O
the	O
significant	O
predictors	O
for	O
the	O
LGA	O
outcome	O
.	O

Endocrine	O
factors	O
,	O
such	O
as	O
fibroblast	O
growth	O
factor	O
21	O
(	O
FGF21	O
)	O
and	O
bone	O
morphogenic	O
protein	O
factor	O
-	O
9	O
(	O
BMP	O
-	O
9	O
),	O
predominantly	O
produced	O
in	O
the	O
liver	O
,	O
were	O
shown	O
to	O
lead	O
to	O
activation	O
of	O
BAT	O
thermogenesis	O
,	O
as	O
well	O
as	O
to	O
“	O
browning	O
”	O
of	O
WAT	O
.	O

Methods	O
Study	O
population	O
Subjects	O
for	O
the	O
present	O
study	O
were	O
from	O
the	O
New	O
Hampshire	O
Birth	O
Cohort	O
Study	O
(	O
NHBCS	O
)	O
who	O
provided	O
infant	O
stool	O
samples	O
at	O
6	O
-	O
week	O
postpartum	O
.	O

This	O
limitation	O
has	O
to	O
be	O
considered	O
in	O
the	O
interpretation	O
of	O
the	O
data	O
and	O
further	O
research	O
will	O
be	O
addressed	O
to	O
evaluate	O
the	O
reasons	O
for	O
the	O
sex	O
-	O
dimorphic	O
alterations	O
.	O

All	O
measurements	O
are	O
done	O
twice	O
and	O
recorded	O
to	O
the	O
nearest	O
0	O
.	O
05	O
kg	O
for	O
weight	O
,	O
0	O
.	O
1	O
cm	O
for	O
MUAC	O
and	O
height	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Body	O
weight	O
(	O
g	O
)	O
and	O
caloric	O
intake	O
(	O
kcal	O
/	O
kg	O
)	O
in	O
dams	O
(	O
A	O
)	O
and	O
their	O
offspring	O
(	O
B	O
–	O
D	O
)	O
in	O
gestation	O
,	O
lactation	O
and	O
/	O
or	O
postweaning	O
periods	O
.	O

Vitamin	O
D	O
also	O
has	O
an	O
immunological	O
role	B
as	O
it	O
can	O
induce	O
the	O
production	O
of	O
antimicrobial	O
peptides	O
such	O
as	O
cathelicidin	O
and	O
certain	O
defensins	O
,	O
which	O
protect	B
us	O
from	O
oral	O
pathogens	O
[	O
22	O
,	O
24	O
].	O

wks	O
,	O
weeks	O
;	O
d	O
,	O
days	O
,	O
pp	O
,	O
postpartum	O
Maternal	O
socio	O
-	O
economics	O
and	O
-	O
demographics	O
Socio	O
-	O
economic	O
and	O
-	O
demographic	O
data	O
are	O
collected	O
at	O
phase	O
1	O
by	O
means	O
of	O
a	O
structured	O
interview	O
.	O

Lenters	O
et	O
al	O
.	O

Such	O
barriers	O
may	O
include	O
lack	O
of	O
prenatal	O
education	O
about	O
breastfeeding	O
,	O
inadequate	O
lactation	O
support	O
from	O
healthcare	O
providers	O
after	O
delivery	O
,	O
disapproval	O
from	O
spouses	O
or	O
family	O
members	O
,	O
short	O
maternity	O
leave	O
,	O
and	O
few	O
opportunities	O
to	O
pump	O
at	O
work	O
.	O

Induction	O
of	O
the	O
1α	O
-	O
hydroxylase	O
in	O
early	O
gestation	O
might	O
provide	O
a	O
mechanism	O
by	O
which	O
environmental	O
or	O
dietary	O
vitamin	O
D	O
can	O
influence	B
fetal	O
-	O
placental	O
development	O
.	O

Exposing	O
fetal	O
rats	O
to	O
high	O
levels	O
of	O
glucocorticoids	O
reduces	O
birth	O
weight	O
and	O
results	O
in	O
adults	O
with	O
high	O
blood	O
levels	O
of	O
insulin	O
and	O
glucose	O
.	O

Thyroid	O
hormone	O
deficiency	O
may	O
cause	O
severe	O
neurologic	O
disorders	O
,	O
resulting	O
from	O
defects	O
in	O
neuronal	O
cell	O
differentiation	O
and	O
migration	O
,	O
axonal	O
and	O
dendritic	O
outgrowth	O
,	O
myelin	O
formation	O
and	O
synaptogenesis7913	O
.	O

Energy	O
recommendations	O
were	O
calculated	O
according	O
to	O
the	O
Dietary	O
Reference	O
Intakes	O
.	O

Weight	O
was	O
also	O
not	O
significantly	O
different	O
between	O
groups	O
at	O
this	O
time	O
,	O
3	O
.	O
68	O
±	O
0	O
.	O
4	O
kg	O
versus	O
3	O
.	O
47	O
±	O
0	O
.	O
4	O
kg	O
for	O
Hispanic	O
and	O
Caucasians	O
respectively	O
,	O
p	O
=	O
0	O
.	O
08	O
.	O

In	O
the	O
same	O
study	O
,	O
patients	O
with	O
the	O
highest	O
concentrations	O
of	O
VD2had	O
the	O
lowest	O
glucose	O
concentration	O
in	O
follicular	O
fluid	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
[	O
61	O
].	O

Recent	O
studies	O
indicate	O
that	O
pregnant	O
women	O
lack	O
sufficient	O
knowledge	O
regarding	O
the	O
importance	O
of	O
iodine	O
and	O
LC	O
n	O
-	O
3	O
PUFAs	O
[	O
5	O
,	O
6	O
],	O
nutrients	O
that	O
are	O
present	O
in	O
fish	O
and	O
seafood	O
.	O

A	O
PET	O
/	O
CT	O
study	O
revealed	O
the	O
presence	O
of	O
BAT	O
depots	O
in	O
the	O
lower	O
neck	O
,	O
suprascapular	O
,	O
mediastinal	O
,	O
and	O
thoracic	O
paravertebral	O
regions	O
.	O

Similarly	O
,	O
a	O
growth	O
stage	O
-	O
specific	O
feeding	O
system	O
has	O
generally	O
been	O
applied	O
to	O
Korean	O
cattle	O
to	O
produce	O
highly	O
marbled	O
beef	O
.	O

While	O
there	O
are	O
no	O
firmly	O
established	O
practice	O
guidelines	O
,	O
it	O
has	O
been	O
suggested	O
that	O
before	O
28	O
weeks	O
of	O
gestation	O
,	O
aortic	O
repair	O
should	O
proceed	O
without	O
cesarean	O
section	O
and	O
after	O
32	O
weeks	O
gestation	O
,	O
emergency	O
cesarean	O
section	O
precede	O
aortic	O
repair	O
[	O
6	O
].	O

Model	O
adjusted	O
for	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
),	O
age	O
,	O
race	O
,	O
calcium	O
,	O
iron	O
,	O
and	O
folic	O
acid	O
consumption	O
during	O
pregnancy	O
,	O
education	O
level	O
,	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
and	O
sex	O
of	O
the	O
baby	O
.	O

Critics	O
of	O
these	O
genetic	O
predisposition	O
argued	O
that	O
since	O
many	O
genes	O
are	O
involved	B
in	O
the	O
etiology	O
of	O
autism	O
,	O
the	O
role	B
of	O
any	O
single	O
gene	O
polymorphism	O
in	O
causing	O
autism	O
is	O
small	O
.	O

Because	O
the	O
nucleus	O
accumbens	O
has	O
been	O
implicated	B
in	O
neuropsychiatric	O
disorders	O
,	O
in	O
the	O
current	O
study	O
we	O
examined	O
protein	O
expression	O
in	O
this	O
region	O
in	O
adult	O
rats	O
exposed	O
to	O
DVD	O
deficiency	O
Methods	O
Female	O
Sprague	O
Dawley	O
rats	O
were	O
maintained	O
on	O
a	O
vitamin	O
D	O
deficient	O
diet	O
for	O
6	O
weeks	O
,	O
mated	O
and	O
allowed	O
to	O
give	O
birth	O
,	O
after	O
which	O
a	O
diet	O
containing	O
vitamin	O
D	O
was	O
reintroduced	O
.	O

Methods	O
Study	O
design	O
and	O
subjects	O
This	O
retrospective	O
study	O
was	O
conducted	O
at	O
University	O
of	O
Cincinnati	O
Medical	O
Center	O
in	O
Cincinnati	O
,	O
OH	O
,	O
USA	O
.	O

Twelve	O
months	O
of	O
daily	O
MMN	O
supplementation	O
significantly	O
improved	O
haemoglobin	O
concentration	O
in	O
this	O
group	O
of	O
women	O
.	O

No	O
other	O
clothing	O
or	O
lifestyle	O
habits	O
affecting	O
sunlight	O
exposure	O
were	O
observed	O
by	O
the	O
study	O
staff	O
as	O
related	O
to	O
ethnicity	O
.	O

Consistent	O
with	O
the	O
Flnb	O
knockout	O
mice	O
,	O
the	O
Skm2	O
phenotype	O
resembles	O
that	O
seen	O
in	O
human	O
vertebral	O
malformation	O
syndromes	O
involving	O
this	O
gene	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
:	O
Flowchart	O
of	O
design	O
and	O
protocol	O
of	O
the	O
study	O
.	O

These	O
subjects	O
had	O
cathelicidin	O
values	O
of	O
737	O
.	O
5	O
,	O
2000	O
.	O
4	O
,	O
and	O
3368	O
.	O
6	O
ng	O
/	O
mL	O
,	O
while	O
the	O
next	O
highest	O
value	O
was	O
195	O
.	O
6	O
ng	O
/	O
mL	O
.	O

Key	O
messages	O
The	O
use	O
of	O
SGAs	O
in	O
polytherapy	O
in	O
pregnant	O
women	O
with	O
mental	O
health	O
disorders	O
is	O
presently	O
a	O
common	O
practice	O
and	O
is	O
associated	B
with	O
adverse	O
pregnancy	O
outcomes	O
for	O
both	O
the	O
mother	O
and	O
the	O
child	O
.	O

The	O
largest	O
increase	O
in	O
the	O
OCP	O
class	O
was	O
seen	O
with	O
a	O
10	O
-	O
fold	O
increase	O
in	O
HCH	O
exposure	O
(	O
5	O
g	O
),	O
while	O
the	O
largest	O
birth	O
weight	O
decrease	O
was	O
seen	O
in	O
response	O
to	O
a	O
10	O
-	O
fold	O
increase	O
in	O
Nonachlor	O
exposure	O
(	O
10	O
g	O
).	O

1	O
pregnant	O
woman	O
from	O
2ndtrimester	O
.	O

[	O
24	O
]	O
included	O
supplement	O
usage	O
as	O
a	O
confounder	O
.	O

In	O
a	O
study	O
by	O
Hovsepian	O
et	O
al	O
.,	O
in	O
men	O
and	O
women	O
with	O
average	O
age	O
of	O
41	O
.	O
4	O
years	O
in	O
Isfahan	O
,	O
45	O
%	O
of	O
men	O
and	O
52	O
.	O
4	O
%	O
of	O
women	O
had	O
vitamin	O
D	O
concentrations	O
lower	O
than	O
20	O
ng	O
/	O
mL	O
([	O
52	O
]).	O

For	O
care	O
of	O
preterm	O
babies	O
,	O
the	O
emphasis	O
is	O
on	O
rapidly	O
scaling	O
up	O
implementations	O
,	O
so	O
that	O
the	O
maximum	O
number	O
of	O
preterm	O
babies	O
and	O
their	O
mothers	O
benefit	O
.	O

The	O
gene	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
Cnr1	O
and	O
Cnr2	O
was	O
increased	O
in	O
RC	O
male	O
hypothalamus	O
,	O
but	O
a	O
down	O
-	O
expression	O
of	O
most	O
eCBs	O
-	O
metabolizing	O
enzymes	O
(	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
Mgll	O
)	O
and	O
several	O
key	O
regulators	O
of	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1b	O
,	O
Acox1	O
),	O
mitochondrial	O
respiration	O
(	O
Cox4i1	O
),	O
and	O
lipid	O
flux	O
(	O
Ppar	O
γ	O
)	O
was	O
found	O
in	O
their	O
PAT	O
.	O

Introduction	O
WHO	O
estimates	O
suggest	O
that	O
globally	O
up	O
to	O
500	O
million	O
women	O
of	O
reproductive	O
age	O
suffer	O
from	O
anaemia	O
.	O

Each	O
data	O
collector	O
will	O
need	O
to	O
log	O
into	O
the	O
system	O
using	O
a	O
pre	O
-	O
assigned	O
unique	O
user	O
ID	O
and	O
password	O
.	O

The	O
multivitamin	O
supplementations	O
contained	O
200	O
–	O
400	O
IU	O
of	O
vitamin	O
D	O
.	O
Sample	O
size	O
and	O
statistical	O
analysis	O
We	O
could	O
not	O
find	O
a	O
similar	O
study	O
to	O
use	O
its	O
means	O
for	O
determining	O
the	O
sample	O
size	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
determinants	B
of	O
season	O
-	O
corrected	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
include	O
origin	O
,	O
sun	O
-	O
exposure	O
and	O
dietary	O
as	O
well	O
as	O
supplementary	O
vitamin	O
D	O
intake	O
[	O
18	O
].	O

Considering	O
that	O
exposure	O
to	O
SGA	O
monotherapy	O
was	O
not	O
associated	O
with	O
birth	O
defects	O
in	O
our	O
cohort	O
and	O
that	O
the	O
majority	O
of	O
pregnant	O
women	O
with	O
psychiatric	O
disorders	O
are	O
on	O
psychotropic	O
drug	O
polytherapy	O
,	O
research	O
on	O
the	O
reproductive	O
safety	O
of	O
these	O
medications	O
should	O
reflect	B
this	O
reality	O
.	O

However	O
,	O
we	O
should	O
not	O
discard	O
a	O
predictive	B
marker	O
of	O
impaired	O
fetal	O
nutrition	O
in	O
those	O
cases	O
with	O
absence	O
of	O
low	O
birth	O
weight	O
.	O

At	O
present	O
a	O
supplementation	O
program	O
is	O
the	O
most	O
feasible	O
method	O
for	O
addressing	O
iron	O
and	O
folate	O
deficiencies	O
in	O
Viet	O
Nam	O
.	O

The	O
day	O
of	O
birth	O
was	O
defined	O
as	O
postnatal	O
day	O
0	O
(	O
PND	O
0	O
).	O

(	O
2014a	O
)*/†	O
Pandey	O
et	O
al	O
.	O

So	O
a	O
perceived	O
problem	O
with	O
supply	O
can	O
quickly	O
become	O
a	O
real	O
problem	O
once	O
a	O
mother	O
introduces	O
formula	O
and	O
the	O
frequency	O
of	O
breastfeeding	O
declines	O
,	O
especially	O
if	O
formula	O
is	O
offered	O
while	O
a	O
mother	O
is	O
still	O
trying	O
to	O
establish	O
her	O
milk	O
supply	O
.	O
8	O
To	O
complicate	O
matters	O
,	O
a	O
number	O
of	O
key	O
socioeconomic	O
,	O
cultural	O
,	O
and	O
clinical	O
factors	B
also	O
can	O
prevent	B
some	O
women	O
from	O
breastfeeding	O
as	O
long	O
as	O
they	O
would	O
like	O
.	O

In	O
the	O
phthalates	O
and	O
BPA	O
class	O
,	O
there	O
was	O
a	O
9	O
g	O
birth	O
weight	O
increase	O
in	O
response	O
to	O
a	O
10	O
-	O
fold	O
increase	O
exposure	O
to	O
MEOHP	O
,	O
and	O
a	O
10	O
-	O
fold	O
increase	O
in	O
MEHP	O
exposure	O
was	O
associated	B
with	O
a	O
7	O
g	O
decrease	O
in	O
birth	O
weight	O
.	O

For	O
example	O
,	O
beef	O
with	O
higher	O
IMF	O
produces	O
higher	O
sensory	O
traits	O
,	O
including	O
tenderness	O
,	O
juiciness	O
,	O
flavor	O
,	O
and	O
overall	O
acceptability	O
in	O
Korean	O
cattle	O
[	O
2	O
]	O
and	O
in	O
USA	O
beef	O
samples	O
[	O
3	O
].	O

3	O
.	O
4	O
.	O

While	O
there	O
is	O
interest	O
in	O
the	O
role	B
of	O
vitamin	O
D	O
in	O
the	O
prevention	B
of	O
multiple	O
sclerosis	O
,	O
following	O
epidemiological	O
studies	O
demonstrating	O
an	O
association	B
between	O
vitamin	O
D	O
supplementation	O
and	O
reduced	O
prevalence	O
of	O
the	O
disease	O
,	O
future	O
research	O
,	O
including	O
randomized	O
controlled	O
trials	O
in	O
pregnant	O
or	O
nonpregnant	O
individuals	O
,	O
is	O
awaited	O
to	O
confirm	O
or	O
refute	O
such	O
benefit	O
.	O

In	O
the	O
present	O
study	O
,	O
adiposity	O
was	O
not	O
the	O
focus	O
.	O

Of	O
all	O
pregnancies	O
,	O
1	O
–	O
14	O
%	O
are	O
affected	B
by	O
GDM	O
[	O
9	O
],	O
and	O
globally	O
GDM	O
prevalence	O
has	O
been	O
increasing	O
in	B
line	I
with	I
increasing	O
obesity	O
[	O
10	O
].	O

All	O
models	O
were	O
adjusted	O
for	O
infant	O
sex	O
and	O
maternal	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
before	O
pregnancy	O
,	O
ethnicity	O
(	O
non	O
-	O
Caucasian	O
/	O
Caucasian	O
),	O
and	O
alcohol	O
,	O
tobacco	O
,	O
and	O
prenatal	O
vitamin	O
use	O
during	O
pregnancy	O
(	O
all	O
yes	O
/	O
no	O
).	O

[	O
12	O
]	O
Vitamin	O
D	O
deficiency	O
can	O
result	O
in	O
lower	O
bone	O
mineral	O
density	O
and	O
an	O
increased	O
risk	O
of	O
bone	O
loss	O
(	O
osteoporosis	O
)	O
or	O
bone	O
fracture	O
because	O
a	O
lack	O
of	O
vitamin	O
D	O
alters	O
mineral	O
metabolism	O
in	O
the	O
body	O
.	O

It	O
is	O
noteworthy	O
that	O
there	O
are	O
few	O
studies	O
assessing	O
the	O
birth	O
anthropometric	O
measurements	O
along	O
the	O
maternal	O
dietary	O
patterns	O
[	O
16	O
].	O

Research	O
indicates	O
that	O
adequate	O
vitamin	O
D	O
intake	O
in	O
pregnancy	O
is	O
optimal	O
for	O
maternal	O
,	O
fetal	O
and	O
child	O
health	O
.	O

The	O
inter	O
-	O
assay	O
coefficient	O
of	O
variation	O
is	O
6	O
%	O
at	O
40	O
nmol	O
/	O
L	O
for	O
both	O
25OHD3and	O
25OHD2	O
.	O

Average	O
hours	O
of	O
sunlight	O
per	O
day	O
in	O
Adelaide	O
from	O
September	O
2005	O
to	O
September	O
2008	O
were	O
obtained	O
from	O
the	O
Australian	O
Government	O
Bureau	O
of	O
Meteorology	O
and	O
compared	O
against	O
serum	O
vitamin	O
D	O
measured	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
(	O
Fig	O
.	O

The	O
GM	O
of	O
phthalate	O
and	O
BPA	O
concentrations	O
ranged	O
from	O
2	O
.	O
4	O
ng	O
/	O
ml	O
(	O
MCPP	O
)	O
to	O
41	O
.	O
3	O
ng	O
/	O
ml	O
(	O
MECPP	O
).	O

Compliance	O
with	O
study	O
medication	O
was	O
assessed	O
by	O
asking	O
participants	O
to	O
bring	O
any	O
remaining	O
study	O
medication	O
to	O
each	O
assessment	O
.	O

Prenatal	O
diet	O
influences	B
the	O
risk	O
of	O
infant	O
and	O
child	O
allergy	O
.	O

(	O
2016	O
)*	O
Chemicals	O
Bisphenol	O
A	O
(	O
BPA	O
)	O
In	O
utero	O
ChildhoodBehavioral	O
abnormalitiesDNA	O
methylationKundakovic	O
et	O
al	O
.	O

Subgroup	O
analyses	O
revealed	O
some	O
potentially	O
key	O
findings	O
.	O

PubMed	O
Central	O
:	O

However	O
,	O
women	O
attending	O
for	O
their	O
subsequent	O
pregnancies	O
and	O
those	O
at	O
their	O
third	O
or	O
more	O
visits	O
were	O
more	O
tolerant	O
of	O
the	O
services	O
provided	O
at	O
the	O
health	O
centres	O
.	O

In	O
particular	O
,	O
a	O
7	O
.	O
5	O
-	O
fold	O
OR	O
(	O
95	O
%	O
CI	O
=	O
1	O
.	O
3	O
–	O
44	O
.	O
9	O
)	O
for	O
low	O
grade	O
astrocytoma	O
has	O
been	O
observed	O
for	O
neonatal	O
urinary	O
tract	O
infections	O
[	O
141	O
].	O

It	O
has	O
long	O
been	O
known	O
that	O
African	O
Americans	O
are	O
two	O
to	O
three	O
times	O
more	O
prone	O
to	O
myomas	O
than	O
European	O
Americans	O
.	O

We	O
fitted	O
generalized	O
linear	O
models	O
,	O
using	O
a	O
log	O
-	O
link	O
function	O
,	O
to	O
derive	O
relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CIs	O
)	O
[	O
29	O
,	O
30	O
]	O
of	O
the	O
associations	O
between	O
sleep	O
duration	O
and	O
snoring	O
variables	O
with	O
glucose	O
intolerance	O
and	O
GDM	O
risk	O
.	O

Conversely	O
,	O
the	O
two	O
studies	O
by	O
Oken	O
et	O
al	O
.	O

Our	O
results	O
suggested	O
that	O
impaired	O
cardiac	O
autonomic	O
modulation	O
characterized	O
by	O
a	O
reduction	O
in	O
the	O
parasympathetic	O
activity	O
occurs	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

These	O
findings	O
support	O
the	O
inverse	O
association	B
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
risk	O
found	O
in	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

It	O
is	O
well	O
known	O
that	O
lower	O
HRV	O
parameters	O
are	O
associated	B
with	O
increased	O
mortality	O
due	O
to	O
heart	O
failure	O
,	O
coronary	O
heart	O
disease	O
and	O
ischemic	O
cardiomyopathy	O
during	O
adulthood	O
[	O
40	O
].	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
high	O
renin	O
and	O
AT1r	O
expressions	O
observed	O
in	O
the	O
present	O
study	O
.	O

Fieldworkers	O
allocated	O
children	O
to	O
randomisation	O
groups	O
during	O
recruitment	O
and	O
gave	O
vitamin	O
D	O
or	O
placebo	O
.	O

Mitotic	O
cyclins	O
interact	O
with	O
Polo	O
-	O
like	O
kinases	O
(	O
PLK	O
),	O
an	O
evolutionary	O
conserved	O
family	O
of	O
essential	O
cell	O
cycle	O
regulators	O
,	O
which	O
are	O
required	O
at	O
several	O
key	O
points	O
within	O
mitosis	O
,	O
including	O
entry	O
into	O
and	O
exit	O
from	O
mitosis	O
[	O
23	O
,	O
24	O
].	O

Absolute	O
risk	O
reduction	O
(	O
ARR	O
)	O
and	O
number	O
needed	O
to	O
treat	O
(	O
NNT	O
)	O
were	O
also	O
calculated	O
.	O

By	O
clustering	O
,	O
we	O
hoped	O
to	O
uncover	O
biologically	O
meaningful	O
groups	O
of	O
CpG	O
loci	O
,	O
with	O
similar	O
methylation	O
patterns	O
,	O
which	O
may	O
share	O
biological	O
characteristics	O
such	O
as	O
comparable	O
functionality	O
in	O
certain	O
developmental	O
pathways	O
or	O
location	O
in	O
similar	O
genomic	O
regions	O
.	O

The	O
medical	O
management	O
of	O
gestational	O
diabetes	O
is	O
still	O
evolving	O
,	O
and	O
recent	O
randomized	O
controlled	O
trials	O
have	O
added	O
considerably	O
to	O
our	O
knowledge	O
in	O
this	O
area	O
.	O

To	O
assess	O
the	O
potential	O
problem	O
of	O
multicollinearity	O
we	O
used	O
Pearsons	O
correlation	O
coefficient	O
or	O
Cramers	O
V	O
(	O
for	O
paired	O
categorical	O
variables	O
).	O

A	O
separate	O
study	O
from	O
Western	O
Australia	O
concluded	O
that	O
autistic	O
children	O
generally	O
had	O
parents	O
who	O
were	O
older	O
and	O
had	O
greater	O
frequencies	O
of	O
threatened	O
abortions	O
,	O
epidural	O
anesthesia	O
,	O
labor	O
induction	O
,	O
and	O
labor	O
duration	O
of	O
less	O
than	O
1	O
hour	O
.	O

E1	O
–	O
education	O
:	O
>	O
12	O
years	O
;	O
E2	O
–	O
9	O
–	O
12	O
years	O
;	O
reference	O
category	O
-	O
≤	O
8	O
years	O
.	O

In	O
addition	O
,	O
the	O
prevalence	O
of	O
GDM	O
was	O
in	O
accordance	O
with	O
the	O
national	O
statistics	O
[	O
12	O
].	O

PubMed	O
Central	O
:	O

Hematoxylin	O
and	O
eosin	O
stain	O
,	O
same	O
magnification	O
in	O
all	O
pictures	O
.	O

Early	O
diagnosis	O
rather	O
than	O
more	O
extensive	O
surgery	O
may	O
improve	O
survival	O
and	O
reduce	O
recurrences	O
,	O
mostly	O
in	O
the	O
MEN	O
IIB	O
form	O
of	O
MTC	O
,	O
which	O
is	O
highly	O
aggressive	O
.	O

She	O
will	O
also	O
counsel	O
the	O
mother	O
about	O
the	O
benefits	O
of	O
IFA	O
supplements	O
in	O
pregnancy	O
.	O

Similar	O
analyses	O
were	O
conducted	O
using	O
logistic	O
regression	O
to	O
examine	O
impact	O
on	O
odds	O
of	O
macrosomia	O
.	O

This	O
study	O
suggested	O
that	O
changes	O
in	O
MS	O
with	O
slaughter	O
age	O
vary	O
among	O
farms	O
.	O

The	O
vitamin	O
D	O
was	O
added	O
separately	O
only	O
to	O
the	O
SC	O
diet	O
,	O
and	O
the	O
vitamin	O
mixture	O
added	O
to	O
both	O
the	O
SC	O
and	O
VitD	O
-	O
diets	O
did	O
not	O
contain	O
vitamin	O
D	O
.	O
Table	O
1shows	O
the	O
nutritional	O
components	O
in	O
each	O
diet	O
,	O
including	O
the	O
dietary	O
composition	O
of	O
vitamin	O
D	O
.	O
The	O
recommended	O
minimum	O
dietary	O
requirement	O
of	O
pregnant	O
mice	O
for	O
vitamin	O
D	O
,	O
according	O
to	O
the	O
AIN93G	O
,	O
is	O
1	O
,	O
000	O
.	O
0	O
IU	O
/	O
kg	O
of	O
diet	O
.	O

For	O
obese	O
women	O
,	O
a	O
30	O
%–	O
33	O
%	O
calorie	O
restriction	O
to	O
approximately	O
25	O
kcal	O
/	O
kg	O
actual	O
weight	O
per	O
day	O
is	O
recommended	O
.	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
MelbourneTraining	O
of	O
trainers	O
amortized	O
over	O
5	O
years	O
:	O
USD85	O
.	O
67	O
/	O
year	O
;	O
training	O
of	O
local	O
health	O
staff	O
USD10	O
/	O
person	O
,	O
2000	O
staff	O
,	O
amortized	O
over	O
5	O
years	O
.	O

PubMed	O
Central	O
:	O

The	O
primary	O
form	O
of	O
vitamin	O
D	O
,	O
colecalciferol	O
(	O
vitamin	O
D3	O
),	O
is	O
available	O
from	O
two	O
sources	O
:	O
skin	O
exposure	O
to	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
)	O
in	O
sunlight	O
and	O
diet	O
.	O

If	O
the	O
vitamin	O
D	O
theory	O
is	O
true	O
,	O
autism	O
should	O
be	O
more	O
common	O
in	O
richer	O
well	O
-	O
educated	O
mothers	O
,	O
who	O
are	O
more	O
likely	O
than	O
other	O
mothers	O
to	O
practice	O
sun	O
avoidance	O
and	O
use	O
sunblock	O
(	O
1	O
,	O
2	O
).	O

Stata	O
V	O
.	O
14	O
(	O
StataCorp	O
.	O

Although	O
the	O
evidence	O
from	O
mobile	O
phone	O
studies	O
is	O
less	O
conclusive	O
in	O
these	O
areas	O
,	O
preliminary	O
research	O
has	O
shown	O
promise	O
in	O
delivering	O
healthy	O
eating	O
and	O
active	O
living	O
(	O
HEAL	O
)	O
interventions	B
.	O

The	O
first	O
section	O
comprises	O
10	O
chapters	O
on	O
various	O
aspects	O
of	O
nutrition	O
such	O
as	O
nutrition	O
adequacy	O
to	O
dietary	O
supplements	O
.	O

Type	O
2	O
iodothyronine	O
deiodinase	O
(	O
D2	O
),	O
responsible	O
for	O
the	O
transformation	O
of	O
thyroxine	O
(	O
T4	O
)	O
to	O
triiodothyronine	O
(	O
T3	O
),	O
is	O
also	O
inducing	O
UCP1	O
expression	O
locally	O
,	O
in	O
BAT	O
(	O
de	O
Jesus	O
et	O
al	O
.,	O
2001	O
).	O

Additionally	O
,	O
the	O
diagnosis	O
of	O
GDM	O
indicates	O
that	O
the	O
mother	O
has	O
a	O
predisposition	O
to	O
diabetes	O
.	O

Three	O
factors	O
were	O
retained	O
,	O
based	O
on	O
the	O
screen	O
plot	O
,	O
an	O
eigenvalue	O
of	O
more	O
than	O
1	O
.	O
9	O
,	O
and	O
the	O
interpretability	O
of	O
the	O
derived	O
factors	O
and	O
of	O
the	O
earlier	O
literature	O
.	O

CMH	O
was	O
responsible	O
for	O
the	O
questions	O
on	O
positive	O
psychotic	O
-	O
like	O
symptom	O
,	O
funding	O
and	O
the	O
initial	O
idea	O
in	O
collaboration	O
with	O
MH	O
.	O

As	O
reviewed	O
previously	O
,	O
prenatal	O
maternal	O
stress	O
has	O
been	O
shown	O
to	O
have	O
long	O
-	O
term	O
effects	B
on	O
the	O
psychological	O
as	O
well	O
as	O
behavioral	O
development	O
of	O
the	O
offspring	O
[	O
15	O
,	O
16	O
].	O

and	O
Peet	O
&	O
Horrobin	O
suggest	O
that	O
there	O
might	O
be	O
such	O
a	O
therapeutic	O
window	O
for	O
DHA	O
and	O
EPA	O
regarding	O
their	O
protective	B
role	B
for	O
schizophrenia	O
or	O
depression	O
[	O
39	O
-	O
41	O
].	O

Thus	O
,	O
all	O
the	O
machinery	O
involved	B
in	O
these	O
pathways	O
,	O
including	O
DNA	O
and	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
,	O
are	O
epigenetically	O
important	O
.	O

Discussion	O
The	O
text4baby	O
program	O
is	O
significant	O
in	O
that	O
it	O
represents	O
one	O
of	O
the	O
largest	O
worldwide	O
mHealth	O
programs	O
to	O
date	O
,	O
with	O
more	O
than	O
800	O
,	O
000	O
enrollees	O
from	O
inception	O
in	O
February	O
2010	O
through	O
November	O
2014	O
[	O
40	O
].	O

Weitz	O
et	O
al	O
.	O

Data	O
were	O
analyzed	O
using	O
the	O
PROC	O
MIXED	O
,	O
including	O
effects	O
of	O
diet	O
,	O
sex	O
,	O
mother	O
,	O
birth	O
weight	O
and	O
interaction	O
between	O
diet	O
and	O
sex	O
(	O
SAS	O
version	O
9	O
.	O
1	O
;	O
SAS	O
Institute	O
,	O
Cary	O
,	O
NC	O
).	O

The	O
serum	O
level	O
of	O
25	O
-	O
OH	O
Vitamin	O
D2	O
in	O
the	O
intervention	O
group	O
was	O
11	O
.	O
61	O
±	O
6	O
.	O
71	O
(	O
6	O
.	O
06	O
–	O
24	O
.	O
71	O
)	O
nmol	O
/	O
L	O
,	O
however	O
,	O
the	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
level	O
in	O
the	O
fourteen	O
cases	O
in	O
the	O
control	O
group	O
was	O
too	O
low	O
to	O
be	O
detected	O
with	O
the	O
current	O
technology	O
(	O
Table	O
2	O
).	O

Diagnosis	O
of	O
Allergy	O
During	O
Pregnancy	O
The	O
diagnosis	O
of	O
allergy	O
in	O
pregnant	O
women	O
should	O
focus	O
on	O
a	O
detailed	O
medical	O
history	O
and	O
symptom	O
analysis	O
.	O

Cranial	O
ultrasound	O
was	O
done	O
following	O
the	O
seizures	O
and	O
was	O
reported	O
as	O
normal	O
.	O

Prevalence	O
of	O
postpartum	O
depression	O
varies	O
throughout	O
the	O
world	O
;	O
however	O
researchers	O
have	O
used	O
different	O
scales	O
and	O
cut	O
off	O
points	O
to	O
describe	O
this	O
psychological	O
disorder	O
.	O

Other	O
hypotheses	O
postulate	O
mechanisms	O
such	O
as	O
poor	O
placental	O
blood	O
supply	O
because	O
of	O
nicotine	O
-	O
induced	O
vasoconstriction	O
,	O
poor	O
maternal	O
nutrition	O
,	O
and	O
fetal	O
exposure	O
to	O
carbon	O
monoxide	O
.	O

This	O
is	O
supported	O
by	O
the	O
recent	O
finding	O
from	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
examining	O
the	O
effects	B
of	O
a	O
single	O
annual	O
megadose	O
of	O
vitamin	O
D3	O
(	O
500	O
,	O
000	O
IU	O
,	O
equivalent	O
to	O
approximately	O
1370	O
IU	O
/	O
d	O
)	O
on	O
fall	O
and	O
fracture	O
outcomes	O
in	O
community	O
-	O
dwelling	O
elderly	O
women	O
with	O
a	O
history	O
of	O
fall	O
or	O
fracture	O
.	O

However	O
,	O
such	O
management	O
may	O
lead	B
to	I
an	O
increased	O
risk	O
of	O
adverse	O
pregnancy	O
outcomes	O
.	O

Maternal	O
and	O
newborn	O
data	O
Maternal	O
data	O
were	O
obtained	O
from	O
a	O
self	O
-	O
administered	O
baseline	O
questionnaire	O
,	O
filled	O
in	O
after	O
delivery	O
,	O
and	O
from	O
medical	O
records	O
.	O

Gestational	O
exposure	O
to	O
endocrine	O
disrupting	O
chemicals	O
in	O
relation	B
to	O
infant	O
birth	O
weight	O
:	O
a	O
Bayesian	O
analysis	O
of	O
the	O
HOME	O
Study	O
Abstract	O
Background	O
Pregnant	O
women	O
are	O
exposed	O
to	O
a	O
mixture	O
of	O
endocrine	O
disrupting	O
chemicals	O
(	O
EDCs	O
).	O

As	O
a	O
result	O
,	O
the	O
genetic	O
etiology	O
of	O
many	O
congenital	O
vertebral	O
malformation	O
syndromes	O
remains	O
unknown	O
.	O

The	O
4	O
-	O
carbon	O
ring	O
backbone	O
of	O
this	O
molecule	O
makes	O
it	O
more	O
of	O
a	O
steroid	O
hormone	O
than	O
a	O
vitamin	O
.	O

According	O
to	O
USDA	O
nutrition	O
data	O
,	O
the	O
main	O
food	O
sources	O
of	O
Vitamin	O
D	O
are	O
cheese	O
(	O
7	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
egg	O
yolk	O
(	O
5	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
canned	O
sardine	O
(	O
4	O
.	O
8	O
μg	O
/	O
100	O
g	O
),	O
butter	O
(	O
1	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
and	O
animal	O
organs	O
and	O
meat	O
products	O
(	O
less	O
than	O
1	O
%)	O
[	O
5	O
].	O

Transgenic	O
mice	O
that	O
overexpress	O
the	O
brain	O
NP	O
or	O
C	O
-	O
type	O
NP	O
ligand	O
exhibit	O
elongated	O
bones	O
and	O
skeletal	O
overgrowth	O
(	O
Suda	O
et	O
al	O
.	O

Additionally	O
,	O
more	O
women	O
using	O
metformin	O
indicated	O
that	O
their	O
treatment	O
was	O
acceptable	O
compared	O
to	O
those	O
on	O
insulin	O
.	O

In	O
order	O
to	O
assess	O
the	O
effectiveness	B
of	O
MMN	O
supplementation	O
in	O
anaemia	O
prevention	B
in	O
rural	O
Gambian	O
women	O
,	O
we	O
analysed	O
a	O
sub	O
-	O
sample	O
of	O
participants	O
enrolled	O
as	O
part	O
of	O
a	O
large	O
MMN	O
,	O
placebo	O
-	O
controlled	O
supplementation	O
trial	O
.	O

Therefore	O
,	O
during	O
pregnancy	O
,	O
thyroxin	O
and	O
ferrous	O
sulphate	O
doses	O
should	O
be	O
spaced	O
by	O
at	O
least	O
4	O
hours	O
.	O

Studies	O
by	O
other	O
groups	O
have	O
reported	O
abnormal	O
expression	O
of	O
1α	O
-	O
hydroxylase	O
,	O
a	O
vitamin	O
D	O
—	O
activating	O
enzyme	O
in	O
preeclamptic	O
pregnancies	O
,	O
revealing	O
a	O
potential	O
role	B
for	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
as	O
a	O
regulator	B
of	O
placentation	O
.	O

Dietary	O
intake	O
of	O
omega	O
-	O
3	O
,	O
omega	O
-	O
6	O
fatty	O
acids	O
,	O
vitamin	O
D	O
and	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
The	O
relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
by	O
the	O
level	O
of	O
fatty	O
acids	O
intake	O
is	O
shown	O
in	O
Table3	O
.	O

While	O
this	O
large	O
body	O
of	O
work	O
also	O
provides	O
some	O
comprehensive	O
evidence	O
for	O
,	O
and	O
specific	O
mechanisms	O
of	O
,	O
epigenetic	O
toxicity	O
,	O
it	O
was	O
considered	O
outside	O
the	O
scope	O
of	O
this	O
review	O
.	O

PTB	O
rates	O
were	O
calculated	O
for	O
the	O
overall	O
population	O
as	O
well	O
as	O
among	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
of	O
<	O
20	O
ng	O
/	O
mL	O
,	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
,	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
and	O
≥	O
40	O
ng	O
/	O
mL	O
closest	O
to	O
delivery	O
.	O

These	O
ratio	O
changes	O
will	O
ultimately	O
lead	B
to	I
an	O
augmented	O
response	O
towards	O
glucocorticoids	O
with	O
potential	O
detrimental	O
effects	B
for	O
the	O
mother	O
and	O
the	O
fetus	O
.	O

Statistical	O
analytical	O
methods	O
We	O
compared	O
the	O
frequency	O
distribution	O
of	O
sociodemographic	O
,	O
lifestyle	O
,	O
behavioral	O
and	O
medical	O
history	O
characteristics	O
of	O
participants	O
according	O
to	O
GDM	O
diagnosis	O
status	O
.	O

Moreover	O
,	O
another	O
study	O
,	O
18showed	O
that	O
a	O
single	O
dose	O
of	O
200	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
in	O
the	O
healthy	O
youths	O
was	O
associated	B
with	O
a	O
peak	O
in	O
vitamin	O
D	O
concentration	O
after	O
two	O
weeks	O
of	O
treatment	O
,	O
but	O
lower	O
than	O
that	O
of	O
our	O
study	O
at	O
three	O
months	O
after	O
treatment	O
.	O

Associations	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
Among	O
all	O
682	O
women	O
,	O
the	O
common	O
allele	O
(	O
T	O
)	O
of	O
rs12785878	O
(	O
DHCR7	O
)	O
was	O
associated	B
with	O
greater	O
baseline	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
Table	O
2	O
).	O

Environmental	O
insults	O
in	O
utero	O
may	O
lead	O
to	O
changes	O
in	O
epigenetic	O
mechanisms	O
potentially	O
affecting	B
fetal	O
development	O
.	O

©	O
BSIP	O
/	O
UIG	O
/	O
Getty	O
Images	O
She	O
found	O
that	O
measures	O
of	O
glucose	O
intolerance	O
predicted	B
delayed	O
lactogenesis	O
in	O
a	O
group	O
of	O
primiparous	O
Sacramento	O
-	O
area	O
mothers	O
.	O
10In	O
a	O
small	O
group	O
of	O
Cincinnati	O
mothers	O
,	O
she	O
showed	O
that	O
women	O
with	O
weaker	O
insulin	O
response	O
tended	B
to	O
start	O
lactating	O
later	O
than	O
those	O
with	O
good	O
insulin	O
response	O
,	O
with	O
the	O
onset	O
of	O
lactogenesis	O
ranging	O
from	O
10	O
to	O
121	O
hours	O
postpartum	O
.	O
32When	O
Nommsen	O
-	O
Rivers	O
looked	O
at	O
insulin	O
-	O
sensitive	O
genes	O
in	O
the	O
human	O
mammary	O
gland	O
,	O
she	O
found	O
a	O
potential	O
biomarker	B
linking	B
insulin	O
resistance	O
and	O
difficulty	O
lactating	O
.	O
33	O
She	O
then	O
compared	O
milk	O
production	O
over	O
a	O
24	O
-	O
hour	O
period	O
in	O
mothers	O
with	O
evidence	O
of	O
insulin	O
resistance	O
versus	O
mothers	O
without	O
.	O

The	O
reproductive	O
safety	O
of	O
antipsychotic	O
medications	O
should	O
be	O
studied	O
using	O
a	O
prospective	O
design	O
and	O
a	O
powerful	O
sample	O
size	O
and	O
in	O
the	O
reality	O
of	O
polytherapy	O
,	O
associated	B
comorbidities	O
and	O
environmental	O
and	O
genetic	O
confounders	O
.	O

[	O
8	O
]	O
The	O
active	O
form	O
of	O
vitamin	O
D	O
(	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
,	O
1	O
,	O
25	O
[	O
OH	O
]	O
2D3	O
)	O
has	O
well	O
-	O
established	O
effects	B
on	O
bone	O
metabolism	O
and	O
mineral	O
homeostasis	O
.	O

Above	O
-	O
average	O
nutritional	O
knowledge	O
was	O
independently	O
associated	B
with	O
the	O
use	O
of	O
folic	O
acid	O
(	O
aOR	O
,	O
4	O
.	O
7	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
6	O
-	O
13	O
.	O
8	O
),	O
iron	O
(	O
aOR	O
,	O
2	O
.	O
6	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
5	O
.	O
7	O
)	O
and	O
multivitamins	O
(	O
aOR	O
,	O
2	O
.	O
8	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
6	O
.	O
8	O
).	O

While	O
the	O
exact	O
mechanism	O
by	O
which	O
PFAS	O
impact	B
birth	O
weight	O
is	O
unknown	O
,	O
several	O
theories	O
have	O
been	O
proposed	O
.	O

The	O
heightened	O
preference	O
for	O
sweet	O
taste	O
,	O
which	O
is	O
evident	O
within	O
hours	O
after	O
birth	O
and	O
persists	O
until	O
adolescence	O
(	O
27	O
,	O
28	O
)	O
most	O
likely	O
evolved	O
because	O
sweet	O
-	O
tasting	O
foods	O
are	O
high	O
in	O
energy	O
.	O

The	O
RNA	O
-	O
Seq	O
transcriptome	O
and	O
KEGG	O
pathway	O
analyses	O
of	O
differentially	O
expressed	O
genes	O
showed	O
that	O
pathways	O
for	O
PPAR	O
signaling	O
,	O
regulation	O
of	O
the	O
actin	O
cytoskeleton	O
,	O
biosynthesis	O
of	O
unsaturated	O
fatty	O
acids	O
(	O
FA	O
),	O
and	O
Wnt	O
signaling	O
changed	O
in	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
group	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
,	O
whereas	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
30	O
%	O
starch	O
diet	O
group	O
showed	O
changes	O
in	O
insulin	O
signaling	O
and	O
mTOR	O
signaling	O
pathways	O
.	O

Therefore	O
,	O
recommendations	O
regarding	O
the	O
optimal	O
times	O
to	O
interrupt	O
pathogen	O
transmission	O
,	O
while	O
preserving	O
the	O
transfer	O
of	O
healthy	O
microbiota	O
to	O
neonates	O
,	O
should	O
be	O
articulated	O
based	O
on	O
an	O
increased	O
understanding	O
of	O
the	O
mechanisms	O
of	O
transmission	O
of	O
pathogenic	O
and	O
commensal	O
organisms	O
from	O
mothers	O
to	O
neonates	O
.	O

The	O
chance	O
of	O
becoming	O
obese	O
during	O
a	O
given	O
period	O
increased	O
with	O
development	O
of	O
obesity	O
in	O
a	O
friend	O
(	O
57	O
%	O
increase	O
),	O
a	O
sibling	O
(	O
40	O
%	O
increase	O
),	O
or	O
a	O
spouse	O
(	O
37	O
%	O
increase	O
).	O

The	O
remaining	O
four	O
studies	O
did	O
not	O
correct	O
for	O
either	O
paternal	O
IQ	O
or	O
home	O
environment	O
.	O

Pubertal	O
onset	O
and	O
adult	O
ovarian	O
function	O
is	O
dependent	B
on	O
maternal	O
nutritional	O
background	O
Pubertal	O
onset	O
in	O
control	O
offspring	O
Pubertal	O
age	O
of	O
offspring	O
born	O
to	O
control	O
dams	O
was	O
similar	O
to	O
that	O
reported	O
previously	O
[	O
38	O
].	O

Of	O
note	O
,	O
most	O
of	O
the	O
children	O
in	O
this	O
study	O
were	O
not	O
vitamin	O
D	O
deficient	O
and	O
the	O
vitamin	O
D	O
ranges	O
were	O
relatively	O
narrow	O
.	O

Similarly	B
,	O
the	O
activation	O
of	O
TEs	O
would	O
be	O
deleterious	O
for	O
the	O
embryonic	O
genome	O
and	O
so	O
the	O
continued	O
silencing	O
of	O
such	O
loci	O
through	O
early	O
embryogenesis	O
is	O
essential	O
for	O
genome	O
stability	O
and	O
subsequent	O
normal	O
development	O
.	O

Among	O
the	O
essential	O
regulators	O
of	O
kidney	O
development	O
are	O
components	O
of	O
the	O
renin	O
-	O
angiotensin	O
system	O
(	O
RAS	O
),	O
podocin	O
(	O
a	O
critical	O
component	O
of	O
the	O
glomerular	O
slit	O
diaphragm	O
)	O
and	O
the	O
Wilms	O
'	O
tumor	O
suppressor	O
gene	O
WT1	O
[	O
12	O
].	O

Two	O
mothers	O
(	O
1	O
Hispanic	O
,	O
1	O
Caucasian	O
)	O
reported	O
covering	O
their	O
face	O
and	O
body	O
due	O
to	O
their	O
religious	O
beliefs	O
.	O

Early	O
childhood	O
and	O
adolescence	O
are	O
also	O
periods	O
of	O
significant	O
growth	O
and	O
development	O
,	O
so	O
it	O
is	O
easy	O
to	O
envisage	O
how	O
environmentally	O
induced	O
epigenetic	O
changes	O
during	O
these	O
stages	O
could	O
have	O
detrimental	O
effects	B
on	O
future	O
health	O
and	O
fertility	O
.	O

Public	O
health	O
interventions	O
have	O
included	O
reducing	O
maternal	O
disease	O
,	O
prenatal	O
care	O
of	O
mothers	O
,	O
reduction	O
of	O
exposure	O
to	O
teratogens	O
(	O
agent	O
that	O
can	O
disturb	O
the	O
development	O
of	O
an	O
embryo	O
or	O
fetus	O
),	O
and	O
nutritional	O
interventions	O
[	O
2	O
].	O

For	O
an	O
excellent	O
discussion	O
of	O
the	O
obstetric	O
management	O
of	O
GDM	O
,	O
I	O
will	O
refer	O
the	O
reader	O
to	O
the	O
review	O
by	O
Conway	O
.	O
24	O
Diabetes	O
education	O
,	O
self	O
-	O
monitoring	O
of	O
blood	O
glucose	O
,	O
dietary	O
therapy	O
,	O
and	O
exercise	O
Self	O
-	O
care	O
is	O
an	O
important	O
component	O
of	O
the	O
management	O
of	O
GDM	O
.	O

Our	O
objectives	O
were	O
to	O
study	O
the	O
associations	B
between	O
vitamin	O
D	O
status	O
in	O
both	O
early	O
and	O
late	O
pregnancy	O
,	O
as	O
well	O
as	O
change	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
with	O
neonatal	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

Dietary	O
data	O
was	O
collected	O
using	O
a	O
validated	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

Environmentally	O
induced	O
epigenetic	O
changes	O
during	O
the	O
vital	O
first	O
developmental	O
re	O
-	O
programing	O
and	O
programing	O
event	O
could	O
result	O
in	O
incorrect	O
erasure	O
and	O
/	O
or	O
re	O
-	O
establishment	O
of	O
the	O
embryo	O
epigenome	O
.	O

Maternal	O
consumption	O
of	O
a	O
HF	O
diet	O
resulted	O
in	O
adult	O
offspring	O
progesterone	O
concentrations	O
that	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
offspring	O
born	O
to	O
Cont	O
dams	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Figure	O
4B	O
),	O
although	O
in	O
MHF	O
offspring	O
these	O
differences	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O

[	O
6	O
]	O
Low	O
dietary	O
calcium	O
intake	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
associated	B
with	O
deleterious	O
effects	B
on	O
bone	O
mineral	O
homeostasis	O
.	O

However	O
,	O
substitution	O
of	O
equivalent	O
amount	O
of	O
energy	O
from	O
grazed	O
pasture	O
with	O
high	O
-	O
energy	O
grain	O
-	O
based	O
feed	O
has	O
not	O
increased	O
IMF	O
contents	O
.	O

For	O
girls	O
,	O
change	O
in	O
height	O
at	O
age	O
5	O
–	O
0	O
was	O
correlated	B
with	O
the	O
height	O
of	O
the	O
mother	O
,	O
p	O
<	O
0	O
.	O
0001	O
,	O
and	O
father	O
,	O
p	O
=	O
0	O
.	O
0003	O
.	O

[	O
5	O
]	O
The	O
increasing	O
prevalence	O
of	O
disorders	O
linked	B
to	O
vitamin	O
D	O
deficiency	O
is	O
reflected	B
in	O
the	O
several	O
hundred	O
children	O
with	O
rickets	O
treated	O
each	O
year	O
.	O

Average	O
level	O
of	O
influenza	O
activity	O
corresponds	O
to	O
years	O
2011	O
–	O
2013	O
(	O
Nicaragua	O
,	O
national	O
influenza	O
surveillance	O
data	O
,	O
Severe	O
Acute	O
Respiratory	O
Infections	O
network	O
,	O
SARInet	O
,	O
PAHO	O
).	O

Although	O
the	O
measurement	O
scales	O
specific	O
for	O
the	O
PNA	O
syndrome	O
are	O
not	O
available	O
,	O
numerous	O
studies	O
have	O
found	O
that	O
use	O
of	O
SSRI	O
late	O
in	O
pregnancy	O
is	O
associated	B
with	O
an	O
increased	O
risk	O
of	O
infants	O
developing	O
this	O
clinical	O
presentation	O
,	O
4445which	O
is	O
also	O
labelled	O
as	O
Prenatal	O
Antidepressant	O
Exposure	O
Syndrome	O
.	O
46The	O
three	O
remaining	O
neonates	O
in	O
our	O
cohort	O
who	O
displayed	O
PNA	O
symptoms	O
were	O
prenatally	O
exposed	O
to	O
an	O
SGA	O
but	O
not	O
to	O
an	O
SSRI	O
.	O

Examination	O
of	O
the	O
skeletal	O
abnormalities	O
To	O
further	O
characterize	O
the	O
skeletal	O
abnormalities	O
,	O
we	O
performed	O
radiography	O
on	O
wild	O
-	O
type	O
and	O
mutant	O
mice	O
aged	O
6	O
wk	O
.	O

These	O
spots	O
were	O
matched	O
,	O
normalized	O
and	O
quantified	O
.	O

Chest	O
and	O
soft	O
tissue	O
neck	O
X	O
-	O
ray	O
were	O
normal	O
.	O

Much	O
like	O
anticonvulsants	O
and	O
other	O
drug	O
exposures	O
,	O
the	O
use	O
of	O
SSRIs	O
in	O
pregnant	O
women	O
and	O
its	O
association	B
to	O
autism	O
have	O
been	O
explored	O
.	O

It	O
is	O
said	O
that	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
above	O
75	O
nmol	O
/	O
L	O
(	O
30	O
ng	O
/	O
mL	O
)	O
are	O
“	O
not	O
consistently	O
associated	B
with	O
increased	O
benefit	O
”.	O

p	O
<	O
0	O
.	O
05	O
was	O
considered	O
as	O
statistically	O
significant	O
.	O

Depending	O
on	O
the	O
offspring	O
'	O
s	O
nutritional	O
history	O
during	O
the	O
prenatal	O
and	O
lactational	O
periods	O
,	O
subsequent	O
nutrition	O
and	O
body	O
weight	O
gain	O
did	O
not	O
further	O
influence	O
offspring	O
reproductive	O
tempo	O
,	O
which	O
was	O
dominated	O
by	O
the	O
effect	B
of	O
prenatal	O
nutrition	O
.	O

Thus	O
,	O
there	O
are	O
reasons	O
to	O
believe	O
that	O
the	O
dimension	O
of	O
positive	O
symptoms	O
is	O
an	O
independent	B
dimension	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
University	O
of	O
Cincinnati	O
and	O
Cincinnati	O
Children	O
'	O
s	O
Hospital	O
Medical	O
Center	O
Institutional	O
Review	O
Boards	O
.	O

While	O
,	O
the	O
mean	O
depression	O
scores	O
were	O
significantly	O
lower	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
the	O
control	O
one	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
p	O
>	O
0	O
.	O
001	O
)	O
(	O
Table	O
3	O
).	O

For	O
patients	O
who	O
were	O
already	O
on	O
immunotherapy	O
before	O
the	O
pregnancy	O
,	O
maintenance	O
treatment	O
may	O
be	O
continued	O
safely	O
during	O
pregnancy	O
.	O

In	O
obese	O
mothers	O
,	O
we	O
found	O
that	O
higher	O
intake	O
of	O
sweets	O
early	O
in	O
pregnancy	O
was	O
related	B
to	O
higher	O
offspring	O
weight	O
status	O
at	O
birth	O
and	O
6	O
months	O
.	O

The	O
colored	O
dots	O
indicate	O
the	O
degree	O
of	O
average	O
CpG	O
class	O
methylation	O
,	O
as	O
indicated	O
by	O
the	O
key	O
.	O

Scenario	O
1	O
:	O
"	O
Business	O
as	O
usual	O
"	O
Should	O
governments	O
and	O
the	O
global	O
community	O
take	O
no	O
further	O
direct	O
action	O
to	O
address	O
deaths	O
due	O
to	O
preterm	O
birth	O
,	O
mortality	O
will	O
decline	O
by	O
24	O
%	O
by	O
2025	O
according	O
to	O
an	O
analysis	O
of	O
regional	O
trends	B
over	O
the	O
past	O
decade	O
and	O
forward	O
projection	O
(	O
or	O
16	O
%,	O
if	O
the	O
projection	O
is	O
based	O
on	O
forecasted	O
GNI	O
change	O
)	O
(	O
Figure4	O
).	O

Furthermore	O
,	O
we	O
found	O
that	O
mean	O
AluYb8	O
levels	O
differed	O
significantly	O
by	O
maternal	O
tobacco	O
use	O
during	O
pregnancy	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
whereas	O
mean	O
LINE	O
-	O
1	O
levels	O
significantly	O
differed	O
only	O
by	O
maternal	O
alcohol	O
use	O
during	O
pregnancy	O
(	O
p	O
=	O
0	O
.	O
02	O
;	O
Table	O
2	O
).	O

In	O
marked	O
contrast	O
,	O
the	O
Kenyan	O
study	O
by	O
Ouma	O
and	O
collaborators	O
[	O
24	O
]	O
and	O
that	O
in	O
Nigeria	O
by	O
Dairo	O
and	O
Owoyokun	O
[	O
25	O
]	O
found	O
that	O
only	O
10	O
.	O
4	O
%	O
and	O
up	O
to	O
89	O
.	O
6	O
%	O
of	O
pregnant	O
women	O
were	O
informed	O
of	O
pregnancy	O
danger	O
signs	O
respectively	O
.	O

Measurement	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
Blood	O
was	O
collected	O
after	O
overnight	O
fasting	O
and	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
(	O
Molecular	O
weight	O
412	O
.	O
66	O
)	O
and	O
D3	O
(	O
Molecular	O
weight	O
400	O
.	O
63	O
)	O
levels	O
were	O
measured	O
by	O
using	O
LC	O
-	O
MS	O
/	O
MS	O
(	O
Waters	O
UPLC	O
,	O
AB	O
Sciex	O
4000QTRP	O
),	O
and	O
then	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
was	O
calculated	O
.	O

The	O
NCCLS	O
is	O
a	O
population	O
-	O
based	O
case	O
–	O
control	O
study	O
of	O
risk	O
factors	O
for	O
child	O
leukemia	O
,	O
including	O
maternal	O
diet	O
.	O

Besides	O
,	O
depression	O
scores	O
were	O
evaluated	O
four	O
times	O
:	O
at	O
26	O
–	O
28	O
and	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
and	O
finally	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
.	O

Selecting	O
a	O
sire	O
is	O
important	O
for	O
high	O
-	O
quality	O
beef	O
production	O
;	O
animals	O
with	O
high	O
genetic	O
potential	O
will	O
generally	O
exhibit	O
higher	O
MS	O
at	O
slaughter	O
age	O
,	O
whereas	O
animals	O
with	O
low	O
genetic	O
potential	O
will	O
give	O
low	O
MS	O
[	O
50	O
].	O

Food	O
Intake	O
,	O
Weight	O
Gain	O
and	O
Oral	O
Glucose	O
Tolerance	O
Test	O
Figure	O
1boutlines	O
the	O
study	O
protocol	O
.	O

4	O
.	O

Only	O
4	O
%	O
of	O
women	O
treated	O
with	O
glyburide	O
achieved	O
inadequate	O
control	O
and	O
required	O
a	O
switch	O
to	O
insulin	O
.	O

Improved	O
metrics	O
are	O
critical	O
for	O
both	O
burden	O
and	O
tracking	O
programmatic	O
change	O
.	O

Their	O
studies	O
suggest	O
that	O
the	O
abnormal	O
growth	O
in	O
children	O
with	O
autism	O
spectrum	O
disorders	O
may	O
be	O
related	B
to	O
the	O
causal	O
factors	O
that	O
also	O
increase	O
the	O
risk	O
for	O
ASD	O
,	O
as	O
it	O
was	O
found	O
that	O
children	O
with	O
ASD	O
had	O
proportionally	O
smaller	O
head	O
circumference	O
compared	O
to	O
height	O
during	O
their	O
first	O
year	O
of	O
life	O
,	O
which	O
was	O
absent	O
in	O
premature	O
/	O
low	O
birth	O
weight	O
children	O
with	O
ASD	O
.	O

Follow	O
-	O
up	O
schedule	O
Each	O
infant	O
was	O
assessed	O
by	O
a	O
research	O
assistant	O
,	O
blinded	O
to	O
the	O
allocated	O
treatment	O
group	O
.	O

The	O
doses	O
for	O
adults	O
and	O
elderly	O
people	O
of	O
proper	O
body	O
weight	O
,	O
and	O
pregnant	O
and	O
lactating	O
women	O
should	O
not	O
exceed	O
4000	O
IU	O
daily	O
,	O
and	O
the	O
supplementation	O
dosage	O
recommended	O
for	O
pregnant	O
women	O
in	O
winter	O
and	O
less	O
sunny	O
countries	O
is	O
1500	O
–	O
4000	O
IU	O
per	O
day	O
(	O
37	O
.	O
5	O
–	O
50	O
.	O
0	O
μg	O
/	O
day	O
)	O
[	O
10	O
,	O
66	O
,	O
70	O
].	O

The	O
possible	O
reasons	O
for	O
the	O
higher	O
uptake	O
of	O
the	O
weekly	O
supplements	O
are	O
many	O
.	O

Among	O
women	O
with	O
BMI	O
<	O
25	O
kg	O
/	O
m2	O
,	O
lack	O
of	O
PNV	O
use	O
was	O
associated	B
with	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
during	O
the	O
first	O
trimester	O
(	O
seasonally	O
adjusted	O
OR	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
9	O
,	O
4	O
.	O
8	O
),	O
but	O
not	O
at	O
the	O
later	O
time	O
point	O
(	O
OR	O
1	O
.	O
4	O
,	O
95	O
%	O
CI	O
0	O
.	O
9	O
,	O
2	O
.	O
3	O
).	O

A	O
developmental	O
perspective	O
considers	O
family	O
,	O
school	O
,	O
and	O
community	O
context	O
.	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
.	O

Previous	O
studies	O
demonstrated	O
short	O
-	O
term	O
effects	B
on	O
KAB	O
among	O
participants	O
,	O
including	O
the	O
initial	O
outcomes	O
of	O
the	O
Madigan	O
study	O
[	O
23	O
,	O
26	O
].	O

Accordingly	O
,	O
another	O
study	O
showed	O
that	O
fish	O
consumption	O
decreased	O
eczema	O
[	O
80	O
].	O

Among	O
the	O
71	O
infants	O
who	O
underwent	O
infant	O
lung	O
function	O
testing	O
,	O
bacterial	O
cultures	O
from	O
nasopharyngeal	O
specimens	O
were	O
taken	O
from	O
66	O
infants	O
,	O
with	O
a	O
positive	O
culture	O
rate	O
of	O
68	O
.	O
2	O
%	O
(	O
45	O
/	O
66	O
).	O

If	O
nodal	O
involvement	O
is	O
confirmed	O
,	O
total	O
thyroidectomy	O
and	O
modified	O
radical	O
neck	O
dissection	O
are	O
indicated	O
.	O

Groundwater	O
iron	O
levels	O
will	O
be	O
measured	O
in	O
all	O
study	O
households	O
using	O
a	O
validated	O
test	O
kit	O
.	O

Previtamin	O
D3is	O
then	O
rapidly	O
converted	O
by	O
a	O
heat	O
dependent	O
process	O
to	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
5	O
,	O
6	O
.	O

Between	O
28	O
and	O
32	O
weeks	O
,	O
the	O
risks	O
and	O
benefits	O
of	O
early	O
delivery	O
should	O
be	O
considered	O
.	O

Whereas	O
future	O
observational	O
epidemiological	O
studies	O
and	O
genetic	O
and	O
molecular	O
investigations	O
will	O
be	O
useful	O
to	O
strengthen	O
and	O
refine	O
the	O
hypothesis	O
,	O
it	O
might	O
be	O
necessary	O
to	O
do	O
a	O
large	O
randomized	O
trial	O
to	O
establish	O
the	O
safety	O
and	O
efficacy	O
needed	O
to	O
promote	O
large	O
-	O
scale	O
vitamin	O
D	O
supplementation	O
.	O

Therefore	O
,	O
the	O
adverse	O
effects	B
of	O
vitamin	O
D	O
restriction	O
during	O
kidney	O
development	O
need	O
further	O
exploration	O
.	O

One	O
hundred	O
children	O
aged	O
5	O
and	O
14	O
years	O
had	O
anthropometric	O
parameters	O
,	O
body	O
composition	O
and	O
blood	O
pressure	O
levels	O
determined	O
.	O

Using	O
data	O
from	O
a	O
U	O
.	O
S	O
.	O
national	O
study	O
on	O
the	O
health	O
effects	O
of	O
prenatal	O
diethylstilbestrol	O
exposure	O
,	O
a	O
team	O
of	O
researchers	O
reported	O
in	O
the	O
11	O
January	O
2008	O
advance	O
access	O
edition	O
of	O
the	O
American	O
Journal	O
of	O
Epidemiology	O
that	O
study	O
participants	O
who	O
had	O
never	O
smoked	O
cigarettes	O
but	O
had	O
been	O
prenatally	O
exposed	O
to	O
maternal	O
cigarette	O
smoke	O
experienced	O
earlier	O
-	O
onset	O
menopause	O
.	O

Antibiotic	O
Resistance	O
Seen	O
in	O
Arctic	O
Wildfowl	O
Swedish	O
researchers	O
reported	O
in	O
the	O
January	O
2008	O
issue	O
of	O
Emerging	O
Infectious	O
Diseases	O
that	O
birds	O
living	O
in	O
three	O
different	O
geographic	O
regions	O
of	O
the	O
Arctic	O
tundra	O
carry	O
E	O
.	O
coli	O
bacteria	O
resistant	O
to	O
multiple	O
types	O
of	O
antibiotics	O
.	O

We	O
will	O
exclude	O
five	O
Upazilas	O
from	O
Kishoreganj	O
,	O
six	O
Upazilas	O
from	O
Netrokona	O
and	O
two	O
Upazilas	O
from	O
Sherpur	O
because	O
of	O
insufficient	O
BRAC	O
Program	O
Officer	O
(	O
PO	O
)	O
coverage	O
.	O

Furthermore	O
,	O
regarding	O
the	O
role	B
of	O
allergies	O
and	O
immunity	O
,	O
there	O
is	O
no	O
clear	O
trend	O
toward	O
a	O
decreasing	O
risk	O
for	O
glioma	O
with	O
younger	O
ages	O
at	O
onset	O
of	O
the	O
allergic	O
condition	O
[	O
121	O
].	O

However	O
,	O
until	O
these	O
results	O
,	O
no	O
behavioral	O
effects	O
had	O
been	O
observed	O
.	O

It	O
closely	O
resembles	O
other	O
benign	O
lesions	O
such	O
as	O
PG	O
.	O

We	O
computed	O
the	O
relative	O
abundance	O
for	O
each	O
OTU	O
by	O
dividing	O
the	O
read	O
count	O
in	O
each	O
cell	O
by	O
the	O
total	O
number	O
of	O
reads	O
in	O
the	O
sample	O
and	O
filtered	O
out	O
OTUs	O
with	O
zero	O
or	O
near	O
-	O
zero	O
variance	O
using	O
the	O
caret	O
package	O
in	O
R	O
.	O
This	O
results	O
in	O
624	O
OTUs	O
.	O

The	O
husband	O
has	O
been	O
shown	O
to	O
play	O
a	O
significant	O
role	B
in	O
determining	O
the	O
choice	O
of	O
ANC	O
site	O
by	O
the	O
woman	O
in	O
a	O
Nigerian	O
[	O
19	O
]	O
and	O
Ugandan	O
study	O
[	O
20	O
]	O
where	O
they	O
accounted	O
for	O
43	O
%	O
and	O
32	O
%	O
of	O
all	O
recommendations	O
respectively	O
.	O

We	O
combined	O
EPA	O
,	O
DHA	O
and	O
DPA	O
to	O
estimate	O
the	O
total	O
intake	O
of	O
marine	O
fatty	O
acids	O
.	O

PA01	O
.	O
78	O
.	O

On	O
the	O
other	O
hand	O
,	O
resting	O
HR	O
values	O
were	O
positive	O
correlated	B
with	O
BMI	O
(	O
r	O
=	O
0	O
.	O
300	O
,	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
blood	O
pressure	O
levels	O
(	O
SBP	O
:	O
r	O
=	O
0	O
.	O
382	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
DBP	O
:	O
r	O
=	O
0	O
.	O
317	O
,	O
P	O
=	O
0	O
.	O
001	O
).	O

In	O
order	O
to	O
assess	O
confounding	O
arising	O
from	O
other	O
dimensions	O
of	O
diet	O
,	O
we	O
additionally	O
adjusted	O
separately	O
for	O
maternal	O
intake	O
of	O
vitamin	O
E	O
,	O
zinc	O
,	O
selenium	O
,	O
n	O
-	O
3	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFAs	O
),	O
n	O
-	O
6	O
PUFAs	O
,	O
and	O
total	O
fruits	O
and	O
vegetables	O
in	O
pregnancy	O
[	O
1	O
,	O
29	O
–	O
31	O
].	O

The	O
findings	O
from	O
the	O
Bangladesh	O
study	O
did	O
however	O
provide	O
additional	O
support	O
for	O
the	O
use	O
of	O
combinations	O
of	O
micronutrients	O
in	O
preference	O
to	O
iron	O
alone	O
,	O
as	O
the	O
prevalence	O
of	O
other	O
nutrient	O
deficiencies	O
including	O
folic	O
acid	O
,	O
riboflavin	O
and	O
vitamin	O
B12	O
,	O
A	O
and	O
C	O
were	O
also	O
decreased	O
in	O
addition	O
to	O
improved	O
values	O
for	O
haematological	O
parameters	O
(	O
Ahmed	O
et	O
al	O
2005	O
).	O

Caption	O
(	O
FIG	O
)	O
The	O
western	O
sandpiper	O
,	O
one	O
of	O
the	O
Arctic	O
species	O
studied	O
UK	O
Organic	O
Certifier	O
Says	O
No	O
to	O
Nanomaterials	O
The	O
Soil	O
Association	O
,	O
a	O
nonprofit	O
UK	O
organization	O
that	O
certifies	O
the	O
majority	O
of	O
that	O
nation	O
’	O
s	O
organic	O
products	O
,	O
announced	O
in	O
January	O
2008	O
it	O
will	O
no	O
longer	O
allow	O
man	O
-	O
made	O
nanomaterials	O
(	O
materials	O
with	O
a	O
mean	O
size	O
of	O
less	O
than	O
200	O
nm	O
)	O
to	O
be	O
used	O
in	O
goods	O
carrying	O
its	O
certification	O
label	O
.	O

LASSO	O
and	O
Elastic	O
Net	O
regression	O
coefficients	O
were	O
larger	O
in	O
size	O
but	O
with	O
less	O
precise	O
95	O
%	O
intervals	O
compared	O
to	O
BHLM	O
.	O

Approximately	O
three	O
-	O
quarters	O
of	O
the	O
women	O
were	O
immigrants	O
(	O
75	O
%),	O
primarily	O
from	O
Mexico	O
and	O
Honduras	O
.	O

Diagnosis	O
of	O
allergy	O
during	O
pregnancy	O
should	O
mainly	O
consist	O
of	O
the	O
patient	O
'	O
s	O
history	O
and	O
in	O
vitro	O
testing	O
.	O

Previous	O
clinical	O
trials	O
,	O
in	O
which	O
vitamin	O
D	O
supplementations	O
were	O
consumed	O
during	O
pregnancy	O
[	O
18	O
,	O
58	O
],	O
have	O
not	O
evaluated	O
the	O
antenatal	O
and	O
postnatal	O
depression	O
disorders	O
.	O

These	O
modifications	O
alter	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
(	O
such	O
as	O
transcription	O
factors	O
and	O
RNA	O
polymerases	O
)	O
so	O
that	O
it	O
is	O
the	O
overall	O
combined	O
effect	O
of	O
the	O
histone	O
code	O
that	O
determines	O
an	O
active	O
or	O
repressive	O
chromatin	O
structure	O
and	O
thus	O
regulates	O
gene	O
expression	O
.	O

Body	O
circumference	O
and	O
skin	O
-	O
fold	O
thickness	O
measures	O
also	O
did	O
not	O
differ	O
significantly	O
between	O
infants	O
born	O
to	O
women	O
who	O
received	O
the	O
antenatal	O
intervention	O
,	O
and	O
those	O
who	O
received	O
standard	O
care	O
.	O

One	O
recent	O
study	O
suggests	O
that	O
both	O
the	O
microbial	O
and	O
fatty	O
acid	O
composition	O
of	O
breast	O
milk	O
may	O
differ	O
by	O
delivery	O
mode	O
[	O
18	O
],	O
so	O
the	O
differential	O
effect	O
of	O
maternal	O
dairy	O
intake	O
by	O
delivery	O
mode	O
on	O
the	O
infant	O
gut	O
microbiome	O
may	O
be	O
attributable	O
to	O
the	O
differences	O
in	O
breast	O
milk	O
microbiota	O
or	O
lipids	O
in	O
relation	B
to	O
maternal	O
diet	O
by	O
delivery	O
mode	O
.	O

Placental	O
Tissue	O
Placental	O
tissues	O
were	O
obtained	O
from	O
women	O
delivering	O
at	O
term	O
(>	O
37	O
weeks	O
of	O
gestation	O
)	O
and	O
preterm	O
(<	O
37	O
weeks	O
of	O
gestation	O
)	O
(	O
total	O
n	O
=	O
23	O
).	O

The	O
region	O
of	O
the	O
mutation	O
was	O
localized	O
to	O
a	O
22	O
.	O
6	O
Mb	O
interval	O
on	O
chromosome	O
15	O
(	O
Figure	O
2B	O
,	O
left	O
panel	O
)	O
containing	O
180	O
known	O
genes	O
.	O

To	O
confirm	O
the	O
presence	O
of	O
the	O
Bcl	O
I	O
polymorphism	O
,	O
17	O
μ	O
L	O
of	O
the	O
PCR	O
product	O
was	O
digested	O
with	O
2	O
μ	O
L	O
of	O
10x	O
Restriction	O
Endonuclease	O
Buffer	O
and	O
15	O
U	O
of	O
the	O
restriction	O
enzyme	O
Bcl	O
I	O
(	O
New	O
England	O
Biolabs	O
,	O
UK	O
)	O
for	O
1	O
.	O
5	O
hr	O
at	O
50	O
°	O
C	O
.	O

In	O
contrast	O
to	O
calorie	O
restricted	O
offspring	O
,	O
these	O
pups	O
regained	O
their	O
weight	O
and	O
by	O
day	O
12	O
(	O
MHF	O
)	O
or	O
day	O
14	O
(	O
PLHF	O
)	O
surpassed	O
controls	O
in	O
both	O
weight	O
and	O
rate	O
of	O
weight	O
gain	O
,	O
reflective	B
of	O
a	O
significantly	O
altered	O
growth	O
trajectory	O
(	O
Figure	O
1D	O
).	O

It	O
is	O
worth	O
mentioning	O
that	O
their	O
tools	O
for	O
determining	O
depression	O
were	O
different	O
than	O
ours	O
.	O

A	O
subgroup	O
of	O
infants	O
from	O
the	O
MIG	O
Study	O
are	O
currently	O
being	O
followed	O
up	O
.	O
72It	O
may	O
be	O
circumspect	O
to	O
await	O
the	O
findings	O
from	O
this	O
follow	O
-	O
up	O
study	O
before	O
metformin	O
can	O
be	O
considered	O
safe	O
for	O
the	O
routine	O
treatment	O
of	O
GDM	O
.	O

It	O
should	O
be	O
emphasized	O
that	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
included	O
a	O
fairly	O
homogeneous	O
cohort	O
of	O
Mediterranean	O
patients	O
from	O
Crete	O
.	O

An	O
increased	O
daily	O
dose	O
of	O
120	O
mg	O
of	O
iron	O
is	O
further	O
suggested	O
if	O
the	O
duration	O
of	O
supplementation	O
in	O
pregnant	O
nonanaemic	O
women	O
is	O
shorter	O
or	O
where	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
in	O
women	O
is	O
high	O
or	O
in	O
settings	O
where	O
pregnant	O
women	O
are	O
generally	O
anaemic	O
[	O
27	O
].	O

In	O
contrast	O
,	O
the	O
RC	O
males	O
presented	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Napepld	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
whereas	O
RC	O
females	O
showed	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Faah	O
,	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Napepld	O
in	O
PAT	O
,	O
compared	O
to	O
those	O
of	O
their	O
respective	O
CC	O
offspring	O
(	O
Figures4B	O
,	O
C	O
).	O

Management	O
of	O
these	O
patients	O
and	O
providing	O
evidencebased	O
advice	O
are	O
obviously	O
extremely	O
difficult	O
tasks	O
.	O

Wagner	O
et	O
al	O
.	O

All	O
participants	O
were	O
analyzed	O
in	O
the	O
group	O
to	O
which	O
they	O
were	O
originally	O
randomized	O
.	O

Additionally	O
,	O
LINE1	O
,	O
AluYb8	O
,	O
and	O
specific	O
array	O
-	O
based	O
methylation	O
loci	O
often	O
interrogate	O
different	O
genetic	O
regions	O
;	O
therefore	O
,	O
their	O
methylation	O
may	O
have	O
a	O
differential	O
genomic	O
impact	B
.	O

Morton	O
et	O
al	O
16indicate	O
that	O
population	O
strategies	O
aimed	O
at	O
optimising	O
size	O
at	O
birth	O
require	O
intergenerational	O
considerations	O
for	O
social	O
as	O
well	O
as	O
biological	O
reasons	O
.	O

We	O
also	O
examined	O
GWG	O
as	O
an	O
independent	O
predictor	O
and	O
potential	O
mediator	O
of	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
weight	O
outcomes	O
(	O
Table	O
4	O
).	O

The	O
challenge	O
of	O
intervening	O
in	O
the	O
obesity	O
epidemic	O
becomes	O
even	O
more	O
daunting	O
with	O
the	O
realization	O
that	O
,	O
in	O
children	O
and	O
adolescents	O
,	O
these	O
influences	B
must	O
be	O
considered	O
separately	O
at	O
each	O
stage	O
of	O
development	O
.	O

It	O
synchronizes	O
growth	O
and	O
fertility	O
with	O
periods	O
of	O
either	O
adequate	O
or	O
inadequate	O
food	O
availability	O
[	O
45	O
];	O
post	O
-	O
weaning	O
treatment	O
with	O
leptin	O
accelerates	O
puberty	O
in	O
rodents	O
[	O
46	O
],[	O
47	O
],	O
and	O
leptin	O
in	O
the	O
rat	O
neonate	O
affects	B
hypothalamic	O
maturation	O
[	O
48	O
].	O

A	O
relatively	O
low	O
proportion	O
of	O
women	O
in	O
our	O
study	O
used	O
iron	O
supplements	O
(	O
45	O
.	O
3	O
%),	O
although	O
these	O
are	O
provided	O
free	O
of	O
charge	O
to	O
women	O
after	O
the	O
16thweek	O
of	O
pregnancy	O
.	O

Regarding	O
to	O
the	O
relationship	B
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
lung	O
function	O
in	O
adults	O
,	O
the	O
HUNT	O
study	O
revealed	O
that	O
low	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
was	O
not	O
associated	O
with	O
airway	O
obstruction	O
in	O
most	O
asthma	O
adults	O
with	O
the	O
exception	O
of	O
males	O
with	O
asthma	O
but	O
without	O
allergic	O
rhinitis	O
[	O
36	O
].	O

This	O
simple	O
,	O
inexpensive	O
and	O
safe	O
treatment	O
may	O
prevent	O
the	O
need	O
to	O
use	O
more	O
invasive	O
therapy	O
.	O

While	O
the	O
urban	O
/	O
rural	O
gradient	O
in	O
rickets	O
is	O
well	O
known	O
and	O
was	O
one	O
of	O
the	O
keys	O
to	O
discovering	O
that	O
sunlight	O
prevented	B
rickets	O
,	O
less	O
well	O
known	O
is	O
a	O
meta	O
-	O
analysis	O
showing	O
a	O
twofold	O
urban	O
/	O
rural	O
gradient	O
for	O
autism	O
(	O
18	O
).	O

Maternal	O
diet	O
effect	O
;	O
p	O
<	O
0	O
.	O
001	O
;	O
postnatal	O
diet	O
effect	O
;	O
p	O
<	O
0	O
.	O
001	O
.	O

A	O
final	O
advantage	O
of	O
Bayesian	O
modeling	O
is	O
that	O
posterior	O
distributions	O
of	O
the	O
regression	O
coefficients	O
are	O
shrunk	O
towards	O
pooled	O
mean	O
μβ	O
,	O
reducing	O
the	O
Type	O
I	O
error	O
(	O
false	O
positives	O
)	O
rate	O
when	O
the	O
interval	O
estimates	O
are	O
used	O
for	O
frequentist	O
hypothesis	O
testing	O
.	O

However	O
,	O
such	O
associations	O
were	O
not	O
seen	O
with	O
healthy	O
and	O
traditional	O
dietary	O
pattern	O
.	O

In	O
general	O
,	O
histone	O
acetylation	O
and	O
demethylation	O
are	O
associated	O
with	O
active	O
chromatin	O
(	O
euchromatin	O
),	O
while	O
histone	O
deacteylation	O
and	O
methylation	O
are	O
associated	O
with	O
repressive	O
chromatin	O
(	O
heterochromatin	O
).	O

of	O
filtered	O
probe	O
-	O
setsNo	O
.	O

Our	O
correlation	B
estimates	O
of	O
0	O
.	O
15	O
of	O
the	O
child	O
at	O
age	O
0	O
with	O
the	O
mother	O
rising	O
to	O
0	O
.	O
25	O
at	O
age	O
9	O
and	O
averaging	O
at	O
0	O
.	O
25	O
in	O
adulthood	O
is	O
consistent	O
with	O
this	O
with	O
the	O
caveat	O
that	O
no	O
change	O
was	O
seen	O
between	O
age	O
0	O
and	O
5	O
.	O

[	O
18	O
],	O
the	O
phthalate	O
MEOHP	O
.	O

Exclusion	O
criteria	O
were	O
avoiding	O
of	O
follow	O
-	O
up	O
during	O
the	O
study	O
and	O
current	O
-	O
smoker	O
women	O
.	O

The	O
examples	O
of	O
Sri	O
Lanka	O
and	O
Turkey	O
(	O
see	O
Figure5	O
)	O
present	O
examples	O
of	O
significant	O
reduction	O
in	O
mortality	O
,	O
halving	O
deaths	O
in	O
10	O
years	O
linked	B
to	O
scale	O
up	O
of	O
intensive	O
care	O
.	O

Compared	O
to	O
women	O
who	O
were	O
recruited	O
at	O
the	O
Adelaide	O
site	O
,	O
women	O
recruited	O
in	O
Auckland	O
were	O
older	O
,	O
had	O
a	O
lower	O
BMI	O
,	O
less	O
likely	O
to	O
smoke	O
or	O
drink	O
alcohol	O
during	O
pregnancy	O
and	O
more	O
likely	O
to	O
eat	O
fruit	O
and	O
undertake	O
recreational	O
walks	O
.	O

Eligible	O
women	O
initiated	O
prenatal	O
care	O
before	O
20	O
weeks	O
gestation	O
,	O
were	O
18	O
years	O
of	O
age	O
or	O
older	O
,	O
could	O
speak	O
and	O
read	O
English	O
,	O
and	O
planned	O
to	O
carry	O
the	O
pregnancy	O
to	O
term	O
and	O
to	O
deliver	O
at	O
either	O
hospital	O
.	O

The	O
effectiveness	O
of	O
the	O
distribution	O
system	O
and	O
women	O
'	O
s	O
compliance	O
were	O
assessed	O
by	O
an	O
independent	O
Non	O
-	O
Government	O
Organization	O
at	O
10	O
weeks	O
and	O
18	O
and	O
36	O
months	O
post	O
-	O
implementation	O
.	O

However	O
,	O
it	O
is	O
argued	O
that	O
cost	O
benefit	O
of	O
intravenous	O
iron	O
prophylaxis	O
may	O
be	O
large	O
taking	O
into	O
consideration	O
the	O
opportunity	O
costs	O
of	O
erythropoiesis	O
-	O
stimulating	O
agents	O
,	O
blood	O
transfusions	O
,	O
and	O
hospitalization	O
[	O
25	O
].	O

Of	O
those	O
who	O
delivered	O
preterm	O
,	O
10	O
delivered	O
before	O
gestational	O
week	O
31	O
and	O
thus	O
before	O
the	O
T3	O
blood	O
sample	O
could	O
be	O
drawn	O
.	O

The	O
cut	O
-	O
off	O
points	O
used	O
to	O
define	O
vitamin	O
D	O
insufficiency	O
and	O
deficiency	O
are	O
not	O
well	O
established	O
and	O
remain	O
controversial	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Between	O
groups	O
comparisons	O
of	O
depression	O
scores	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrationsVariablesmean	O
±	O
sdDepression	O
score	O
,	O
N	O
(%)	O
Vitamin	O
D	O
groupControl	O
group	O
P	O
-	O
valueVitamin	O
D	O
groupControl	O
group	O
<	O
99	O
–	O
13	O
>	O
13	O
<	O
99	O
–	O
13	O
>	O
13	O
P	O
-	O
value	O
*	O
Depression	O
score	O
at	O
baseline8	O
.	O
44	O
±	O
3	O
.	O
898	O
.	O
64	O
±	O
3	O
.	O
810	O
.	O
74737	O
(	O
49	O
.	O
3	O
)	O
38	O
(	O
50	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
33	O
(	O
42	O
.	O
3	O
)	O
45	O
(	O
57	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
383Depression	O
score	O
at	O
38	O
–	O
40w	O
gestation6	O
.	O
17	O
±	O
3	O
.	O
477	O
.	O
77	O
±	O
3	O
.	O
920	O
.	O
0149	O
(	O
72	O
.	O
1	O
)	O
18	O
(	O
26	O
.	O
5	O
)	O
1	O
(	O
1	O
.	O
5	O
)	O
37	O
(	O
50	O
.	O
7	O
)	O
30	O
(	O
41	O
.	O
1	O
)	O
6	O
(	O
8	O
.	O
2	O
)	O
0	O
.	O
024Depression	O
score	O
at	O
post	O
partum	O
(	O
4w	O
)	O
4	O
.	O
59	O
±	O
3	O
.	O
297	O
.	O
36	O
±	O
4	O
.	O
27	O
<	O
0	O
.	O
00158	O
(	O
90	O
.	O
6	O
)	O
6	O
(	O
9	O
.	O
4	O
)	O
0	O
(	O
0	O
)	O
43	O
(	O
59	O
.	O
7	O
)	O
23	O
(	O
31	O
.	O
9	O
)	O
6	O
(	O
8	O
.	O
3	O
)<	O
0	O
.	O
001Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
19	O
±	O
3	O
.	O
767	O
.	O
18	O
±	O
3	O
.	O
99	O
<	O
0	O
.	O
00157	O
(	O
89	O
.	O
1	O
)	O
7	O
(	O
10	O
.	O
9	O
)	O
0	O
(	O
0	O
)	O
46	O
(	O
63	O
.	O
9	O
)	O
22	O
(	O
30	O
.	O
6	O
)	O
4	O
(	O
5	O
.	O
6	O
)	O
0	O
.	O
001Categorized	O
25	O
(	O
OH	O
)	O
D	O
,	O
N	O
(%)<	O
2020	O
–	O
29	O
≥	O
30	O
<	O
2020	O
–	O
29	O
≥	O
30	O
P	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
12	O
.	O
84	O
±	O
7	O
.	O
9111	O
.	O
89	O
±	O
6	O
.	O
400	O
.	O
63a65	O
(	O
86	O
.	O
7	O
)	O
7	O
(	O
9	O
.	O
3	O
)	O
3	O
(	O
4	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
8	O
(	O
10	O
.	O
3	O
)	O
1	O
(	O
1	O
.	O
3	O
)	O
0	O
.	O
6125	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
17	O
.	O
46	O
±	O
10	O
.	O
0912	O
.	O
07	O
±	O
5	O
.	O
980	O
.	O
001a41	O
(	O
66	O
.	O
1	O
)	O
15	O
(	O
24	O
.	O
2	O
)	O
6	O
(	O
9	O
.	O
7	O
)	O
58	O
(	O
85	O
.	O
3	O
)	O
10	O
(	O
14	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
006	O
*	O
Fisher	O
’	O
s	O
Exact	O
Test	O
aMann	O
-	O
Whitney	O
U	O
test	O
The	O
mean	O
depression	O
score	O
of	O
184	O
participants	O
was	O
9	O
.	O
20	O
±	O
4	O
.	O
44	O
at	O
baseline	O
.	O

Anderson	O
Cancer	O
Center	O
are	O
currently	O
conducting	O
clinical	O
trials	O
in	O
Shanghai	O
on	O
a	O
cancer	O
therapy	O
that	O
uses	O
the	O
venom	O
of	O
the	O
Asiatic	O
toad	O
(	O
Bufo	O
gargarizans	O
).	O

Also	O
,	O
postpregnancy	O
dietary	O
habits	O
and	O
choices	O
may	O
be	O
different	O
compared	O
with	O
prepregnancy	O
.	O

Moreover	O
,	O
due	O
to	O
the	O
similarity	O
in	O
metabolism	O
,	O
physiology	O
,	O
anatomy	O
and	O
genome	O
the	O
study	O
is	O
also	O
a	O
beneficial	O
model	O
for	O
nutritional	O
programming	O
in	O
humans	O
[	O
13	O
,	O
14	O
].	O

In	O
final	O
,	O
multiple	O
regression	O
analyses	O
that	O
included	O
adjustments	O
for	O
confounding	O
variables	O
,	O
the	O
strongest	O
predictor	O
of	O
higher	O
WFA	O
z	O
score	O
at	O
birth	O
was	O
greater	O
consumption	O
of	O
soft	O
drinks	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
16	O
;	O
P	O
=	O
0	O
.	O
04	O
;	O
Table	O
4	O
).	O

Like	O
females	O
,	O
male	O
low	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
and	O
high	O
(>	O
125	O
nmol	O
/	O
L	O
)	O
vitamin	O
D	O
serum	O
concentrations	O
decrease	O
not	O
only	O
spermatozoa	O
count	O
but	O
also	O
their	O
progressive	O
movement	O
as	O
well	O
as	O
increasing	O
morphology	O
abnormalities	O
.	O

In	O
addition	O
,	O
smoking	O
is	O
a	O
cause	O
of	O
reflux	O
and	O
should	O
be	O
avoided	O
.	O

The	O
presence	O
of	O
somatostatin	O
receptors	O
provides	O
the	O
basis	O
for	O
treatment	O
with	O
longacting	O
analogues	O
of	O
somatostatin	O
or	O
with	O
Y	O
-	O
octreotide	O
(	O
DOTATOC	O
)	O
in	O
some	O
patients	O
.	O

Second	O
,	O
the	O
model	O
also	O
excluded	O
non	O
-	O
linear	O
relationships	O
,	O
including	O
potential	O
threshold	O
effects	B
that	O
could	O
yield	O
important	O
information	O
about	O
the	O
relationships	B
between	O
EDC	O
exposure	O
and	O
birth	O
weight	O
.	O

To	O
account	O
for	O
clustering	O
of	O
behavior	O
at	O
the	O
individual	O
level	O
(	O
i	O
.	O
e	O
.,	O
an	O
individual	O
is	O
more	O
likely	O
to	O
behave	O
like	O
herself	O
than	O
she	O
is	O
to	O
behave	O
like	O
others	O
),	O
we	O
introduced	O
a	O
design	O
effect	O
of	O
2	O
,	O
increasing	O
the	O
sample	O
size	O
up	O
to	O
160	O
in	O
each	O
arm	O
.	O

Whilst	O
this	O
study	O
is	O
inadequately	O
powered	O
to	O
demonstrate	O
safety	O
of	O
acarbose	O
,	O
it	O
is	O
not	O
absorbed	O
from	O
the	O
gut	O
,	O
and	O
therefore	O
would	O
be	O
unlikely	O
to	O
affect	B
the	O
fetus	O
.	O

Ninety	O
-	O
seven	O
percent	O
(	O
3172	O
)	O
reported	O
having	O
at	O
least	O
one	O
antenatal	O
visit	O
during	O
pregnancy	O
,	O
78	O
%	O
(	O
2549	O
)	O
reported	O
four	O
or	O
more	O
antenatal	O
visits	O
,	O
and	O
91	O
%	O
(	O
2984	O
)	O
reported	O
having	O
at	O
least	O
one	O
dose	O
of	O
tetanus	O
vaccine	O
;	O
all	O
of	O
these	O
antenatal	O
care	O
indicators	O
were	O
significantly	O
more	O
common	O
among	O
vaccinated	O
compared	O
to	O
unvaccinated	O
women	O
.	O

When	O
Grandjean	O
and	O
his	O
team	O
dug	O
a	O
little	O
deeper	O
,	O
they	O
saw	O
that	O
women	O
with	O
the	O
highest	O
PFAS	O
levels	O
in	O
their	O
blood	O
tended	B
to	O
spend	O
less	O
time	O
breastfeeding	O
their	O
babies	O
.	O
22	O
In	O
the	O
study	O
,	O
led	O
by	O
Timmermann	O
—	O
who	O
at	O
the	O
time	O
was	O
pursuing	O
her	O
PhD	O
under	O
Grandjean	O
’	O
s	O
supervision	O
—	O
the	O
researchers	O
estimated	O
the	O
average	O
duration	O
of	O
total	O
breastfeeding	O
(	O
i	O
.	O
e	O
.,	O
with	O
or	O
without	O
any	O
other	O
sources	O
of	O
nutrition	O
)	O
in	O
association	B
with	O
serum	O
levels	O
of	O
two	O
PFASs	O
,	O
perfluorooctane	O
sulfonic	O
acid	O
(	O
PFOS	O
)	O
and	O
perfluorooctanoic	O
acid	O
(	O
PFOA	O
).	O

We	O
assessed	O
glucose	O
intolerance	O
by	O
analyzing	O
results	O
of	O
the	O
1	O
-	O
hour	O
oral	O
glucose	O
screening	O
test	O
results	O
.	O

The	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
exhibited	O
higher	O
plasma	O
levels	O
of	O
LDL	O
and	O
glucose	O
as	O
well	O
as	O
a	O
reduction	O
in	O
chocolate	O
and	O
caloric	O
intake	O
at	O
post	O
-	O
weaning	O
periods	O
in	O
the	O
feeding	O
tests	O
.	O

Treatment	O
of	O
reflux	O
during	O
pregnancy	O
should	O
focus	O
on	O
nonpharmacological	O
measures	O
,	O
such	O
as	O
avoiding	O
large	O
meals	O
shortly	O
before	O
bedtime	O
,	O
sleeping	O
with	O
the	O
upper	O
body	O
elevated	O
,	O
and	O
avoiding	O
extensive	O
consumption	O
of	O
coffee	O
,	O
sweets	O
,	O
and	O
fatty	O
foods	O
.	O

All	O
the	O
AWCs	O
are	O
manned	O
by	O
members	O
from	O
the	O
ICDS	O
team	O
-	O
consisting	O
of	O
Anganwadi	O
helpers	O
,	O
Anganwadi	O
workers	O
,	O
Supervisors	O
,	O
Child	O
Development	O
Project	O
Officers	O
(	O
CDPOs	O
)	O
and	O
District	O
Program	O
Officers	O
(	O
1	O
,	O
4	O
).	O

It	O
is	O
also	O
needed	O
for	O
bone	O
growth	O
and	O
bone	O
remodeling	O
by	O
osteoblasts	O
.	O

b	O
Predicted	O
probability	O
plot	O
of	O
infant	O
stool	O
cluster	O
membership	O
by	O
maternal	O
fruit	O
intake	O
during	O
pregnancy	O
from	O
multinomial	O
logistic	O
regression	O
models	O
adjusted	O
for	O
infant	O
feeding	O
method	O
,	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
.	O

[	O
18	O
]	O
This	O
recommendation	O
may	O
be	O
controversial	O
because	O
very	O
high	O
doses	O
of	O
vitamin	O
D	O
have	O
long	O
been	O
believed	O
to	O
cause	O
birth	O
defects	O
.	O

The	O
lowest	O
odds	O
of	O
SGA	O
and	O
LBW	O
are	O
found	O
among	O
women	O
with	O
the	O
largest	O
increments	O
in	O
25OHD	O
(≥	O
30	O
nmol	O
/	O
L	O
).	O

HIV	O
status	O
was	O
not	O
assessed	O
during	O
this	O
study	O
but	O
national	O
sentinel	O
data	O
from	O
antenatal	O
clinics	O
indicates	O
a	O
HIV	O
prevalence	O
of	O
around	O
1	O
%	O
(	O
Schim	O
van	O
der	O
Loeff	O
et	O
al	O
2003	O
).	O

Additionally	O
,	O
classes	O
7	O
,	O
11	O
,	O
and	O
12	O
were	O
marginally	O
positively	O
associated	B
with	O
AluYb8	O
methylation	O
levels	O
,	O
with	O
CpGs	O
exhibiting	O
low	O
to	O
intermediate	O
methylation	O
.	O

There	O
is	O
evidence	O
that	O
angiotensin	O
II	O
inhibits	O
parasympathetic	O
modulation	O
[	O
51	O
].	O

Interestingly	O
,	O
adjustment	O
for	O
GWG	O
attenuated	O
but	O
generally	O
did	O
not	O
completely	O
remove	O
the	O
impact	B
of	O
dietary	O
variables	O
on	O
offspring	O
weight	O
,	O
particularly	O
at	O
6	O
months	O
.	O

2	O
.	O
2	O
.	O

Hypocalcemia	O
is	O
common	O
in	O
preterm	O
infants	O
,	O
infants	O
born	O
to	O
gestational	O
diabetic	O
mothers	O
and	O
infants	O
on	O
cow	O
'	O
s	O
milk	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

Infant	O
lung	O
function	O
testing	O
Measurements	O
were	O
taken	O
of	O
healthy	O
infants	O
who	O
had	O
had	O
no	O
respiratory	O
tract	O
infection	O
for	O
at	O
least	O
3	O
weeks	O
.	O

Review	O
of	O
Literature	O
Several	O
recent	O
studies	O
have	O
explored	O
season	O
of	O
birth	O
as	O
a	O
risk	O
factor	O
for	O
adult	O
glioma	O
,	O
but	O
results	O
have	O
been	O
mixed	O
(	O
Table	O
1	O
).	O

A	O
comment	O
to	O
the	O
authors	O
(	O
20	O
)	O
detailed	O
the	O
evidence	O
that	O
antiepileptic	O
drugs	O
are	O
one	O
of	O
the	O
few	O
classes	O
of	O
drugs	O
that	O
consistently	O
and	O
significantly	O
interfere	B
with	O
vitamin	O
D	O
metabolism	O
,	O
lowering	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

In	O
this	O
software	O
,	O
the	O
artifacts	O
were	O
corrected	O
with	O
a	O
moderated	O
filter	O
,	O
and	O
the	O
time	O
-	O
domain	O
components	O
were	O
calculated	O
.	O

The	O
MiG	O
Study	O
randomized	O
751	O
women	O
with	O
GDM	O
to	O
treatment	O
with	O
insulin	O
or	O
metformin	O
.	O
72The	O
women	O
in	O
the	O
metformin	O
arm	O
were	O
treated	O
with	O
supplemental	O
insulin	O
if	O
the	O
maximal	O
dose	O
of	O
metformin	O
,	O
2500	O
mg	O
daily	O
,	O
failed	O
to	O
meet	O
the	O
glucose	O
targets	O
.	O

Many	O
of	O
the	O
dopaminergic	O
cells	O
in	O
this	O
region	O
also	O
express	O
neuropeptides	O
such	O
as	O
bradykinan	O
,	O
neurotensin	O
and	O
substance	O
P	O
.	O
The	O
protein	O
with	O
the	O
greatest	O
fold	O
change	O
in	O
this	O
study	O
was	O
thimet	O
oligopeptidase	O
(	O
down	O
-	O
regulated	O
1	O
.	O
67	O
),	O
which	O
is	O
involved	B
in	O
the	O
degradation	O
of	O
these	O
small	O
proteins	O
[	O
37	O
].	O

We	O
suggest	O
further	O
clinical	O
trial	O
in	O
pregnant	O
mothers	O
who	O
are	O
at	O
risk	O
for	O
postnatal	O
depression	O
.	O

Assuming	O
a	O
crude	O
birth	O
rate	O
of	O
23	O
per	O
1000	O
people	O
,	O
10	O
%	O
loss	O
of	O
pregnancies	O
before	O
birth	O
and	O
15	O
%	O
loss	O
to	O
follow	O
up	O
each	O
cluster	O
will	O
yield	O
300	O
births	O
over	O
15	O
months	O
,	O
and	O
this	O
will	O
be	O
sufficient	O
to	O
reach	O
the	O
desired	O
sample	O
size	O
.	O

In	O
contrast	O
,	O
the	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
did	O
not	O
show	O
changes	O
in	O
body	O
weight	O
and	O
adiposity	O
,	O
but	O
exhibited	O
higher	O
levels	O
of	O
LDL	O
and	O
glucose	O
in	O
plasma	O
,	O
and	O
a	O
reduction	O
in	O
chocolate	O
preference	O
at	O
adolescence	O
and	O
total	O
caloric	O
intake	O
at	O
adulthood	O
.	O

2001	O
).	O

Analyses	O
were	O
performed	O
by	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
,	O
Mass	O
spectrometer	O
API	O
4000	O
)	O
by	O
the	O
clinical	O
chemistry	O
laboratory	O
in	O
Region	O
Skåne	O
,	O
Sweden	O
,	O
certified	O
by	O
the	O
Vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
[	O
15	O
].	O

Also	O
,	O
we	O
included	O
50	O
healthy	O
populations	O
randomly	O
from	O
Alzahra	O
hospital	O
’	O
s	O
staff	O
that	O
were	O
matched	O
on	O
sex	O
,	O
age	O
and	O
living	O
style	O
situation	O
to	O
case	O
group	O
as	O
control	O
one	O
.	O

Concordance	O
of	O
mothers	O
’	O
personal	O
weight	O
gain	O
target	O
with	O
clinical	O
recommendations	O
varied	O
by	O
mothers	O
’	O
pre	O
-	O
pregnancy	O
weight	O
status	O
[	O
χ	O
(	O
4	O
)	O
2	O
=	O
9	O
.	O
781	O
,	O
p	O
=	O
0	O
.	O
044	O
].	O

Despite	O
this	O
fact	O
,	O
the	O
overall	O
direction	O
of	O
results	O
was	O
consistent	O
with	O
previous	O
text4baby	O
studies	O
and	O
additionally	O
we	O
found	O
a	O
behavioral	O
effect	B
.	O

In	O
adipose	O
tissue	O
,	O
it	O
appears	O
that	O
PPARγ	O
transcriptionally	O
controls	O
FGF21	O
,	O
which	O
then	O
acts	O
as	O
an	O
autocrine	O
or	O
paracrine	O
way	O
to	O
increase	O
PPARγ	O
transcriptional	O
activity	O
in	O
a	O
feed	O
-	O
forward	O
loop	O
system	O
(	O
Wang	O
et	O
al	O
.,	O
2008	O
;	O
Dutchak	O
et	O
al	O
.,	O
2012	O
).	O

This	O
supplement	O
should	O
include	O
400	O
μ	O
g	O
of	O
folic	O
acid	O
or	O
lower	O
doses	O
,	O
if	O
this	O
amount	O
is	O
not	O
available	O
[	O
7	O
].	O

For	O
binary	O
outcomes	O
,	O
relative	O
risks	O
with	O
95	O
%	O
CI	O
were	O
estimated	O
using	O
log	O
binomial	O
regression	O
.	O

Important	O
research	O
themes	O
can	O
be	O
summarised	O
across	O
the	O
research	O
pipeline	O
of	O
description	O
,	O
discovery	O
,	O
development	O
and	O
delivery	O
science	O
,	O
showing	O
the	O
dual	O
agenda	O
of	O
preventing	O
preterm	O
birth	O
and	O
addressing	O
the	O
care	O
and	O
survival	O
gap	O
for	O
babies	O
born	O
preterm	O
(	O
Table1	O
)	O
[	O
30	O
].	O

Our	O
findings	O
suggest	O
that	O
women	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
have	O
altered	O
glucose	O
metabolism	O
in	O
later	O
gestation	O
,	O
but	O
the	O
evidence	O
is	O
not	O
consistent	O
for	O
insulin	O
resistance	O
.	O

For	O
example	O
,	O
certain	O
metals	O
and	O
environmental	O
chemicals	O
can	O
directly	O
bind	O
and	O
alter	O
the	O
activity	O
of	O
DNMTs	O
,	O
TETs	O
and	O
histone	O
modifiers	O
(	O
Chervona	O
&	O
Costa2012	O
;	O
Hou	O
et	O
al	O
.	O
2012	O
;	O
Wang	O
&	O
Wang2013	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

Mice	O
with	O
a	O
mutation	O
in	O
Npr3	O
,	O
or	O
Npr3	O
knockout	O
mice	O
,	O
all	O
exhibit	O
the	O
same	O
skeletal	O
-	O
overgrowth	O
phenotype	O
,	O
resulting	O
in	O
an	O
elongated	O
body	O
and	O
thoracic	O
kyphosis	O
(	O
Jaubert	O
et	O
al	O
.	O

A	O
thumbprint	O
was	O
requested	O
from	O
women	O
who	O
were	O
unable	O
to	O
write	O
.	O

Introduction	O
There	O
were	O
15	O
million	O
preterm	O
births	O
(	O
PTB	O
)	O
(<	O
37	O
weeks	O
)	O
worldwide	O
and	O
more	O
than	O
1	O
million	O
infant	O
deaths	O
from	O
PTB	O
complications	O
in	O
2010	O
[	O
1	O
].	O

Briefly	O
,	O
we	O
conducted	O
a	O
multicentre	O
randomised	O
trial	O
involving	O
women	O
with	O
a	O
singleton	O
pregnancy	O
,	O
between	O
10	O
+	O
0and	O
20	O
+	O
0weeks	O
’	O
gestation	O
,	O
and	O
body	O
mass	O
index	O
≥	O
25	O
.	O
0	O
kg	O
/	O
m2	O
,	O
who	O
were	O
randomised	O
to	O
either	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
(	O
Lifestyle	O
Advice	O
Group	O
)	O
or	O
standard	O
antenatal	O
care	O
(	O
Standard	O
Care	O
Group	O
)	O
[	O
22	O
].	O

We	O
identified	O
additive	O
and	O
modifiable	O
maternal	O
risk	B
factors	I
that	O
would	O
benefit	O
most	O
from	O
risk	O
reduction	O
and	O
targeted	O
vitamin	O
D	O
supplementation	O
.	O

Data	O
regarding	O
the	O
long	O
-	O
acting	O
insulin	O
analogs	O
are	O
less	O
clear	O
than	O
for	O
rapid	O
-	O
acting	O
analogs	O
.	O

A	O
pooled	O
analysis	O
of	O
data	O
from	O
Indonesian	O
Demographic	O
and	O
Health	O
Surveys	O
,	O
which	O
included	O
40	O
,	O
576	O
singleton	O
live	O
-	O
born	O
infants	O
,	O
found	O
mothers	O
using	O
any	O
IFA	O
supplements	O
during	O
pregnancy	O
significantly	O
reduced	O
the	O
risk	O
of	O
early	O
neonatal	O
death	O
of	O
their	O
newborns	O
after	O
adjustment	O
for	O
potential	O
confounders	O
[	O
10	O
].	O

This	O
system	O
will	O
allow	O
the	O
field	O
supervisors	O
to	O
monitor	O
the	O
performance	O
of	O
individual	O
data	O
collectors	O
.	O

Collectively	O
,	O
the	O
findings	O
from	O
this	O
pilot	O
study	O
provides	O
evidence	O
consistent	O
with	O
the	O
notion	O
that	O
glucose	O
homeostasis	O
in	O
pregnancy	O
is	O
sensitive	O
to	O
maternal	O
habitual	O
short	O
sleep	O
duration	O
and	O
snoring	O
during	O
pregnancy	O
.	O

Weight	O
at	O
puberty	O
Offspring	O
that	O
were	O
exposed	O
to	O
altered	O
maternal	O
nutrition	O
(	O
either	O
maternal	O
undernutrition	O
or	O
high	O
fat	O
diet	O
)	O
all	O
showed	O
significantly	O
lower	O
body	O
weights	O
at	O
pubertal	O
onset	O
compared	O
to	O
Cont	O
offspring	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Table	O
1	O
).	O

In	O
women	O
belonging	O
to	O
the	O
high	O
level	O
symptoms	O
group	O
,	O
the	O
RRs	O
with	O
increasing	O
quartiles	O
of	O
omega	O
-	O
6	O
intake	O
were	O
:	O
0	O
.	O
67	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
55	O
-	O
0	O
.	O
82	O
),	O
0	O
.	O
66	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
54	O
-	O
0	O
.	O
81	O
),	O
0	O
.	O
78	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
64	O
-	O
0	O
.	O
97	O
).	O

Female	O
rats	O
were	O
maintained	O
on	O
the	O
same	O
diet	O
paradigm	O
as	O
in	O
the	O
pregestational	O
period	O
up	O
to	O
the	O
gestational	O
day	O
20	O
(	O
GD	O
20	O
).	O

Not	O
only	O
is	O
it	O
unlikely	O
that	O
a	O
human	O
would	O
receive	O
this	O
,	O
or	O
any	O
,	O
environmental	O
exposure	O
via	O
the	O
same	O
route	O
of	O
administration	O
,	O
but	O
also	O
the	O
way	O
in	O
which	O
an	O
exposure	O
is	O
administered	O
determines	O
its	O
overall	O
effect	B
.	O

For	O
example	O
,	O
the	O
maternal	O
aMED	O
score	O
was	O
consistently	O
positively	O
and	O
negatively	O
associated	B
with	O
the	O
Enterobacteriaceae	O
family	O
,	O
and	O
additionally	O
negatively	O
associated	B
with	O
the	O
species	O
Escherichia	O
coli	O
,	O
in	O
both	O
delivery	O
mode	O
strata	O
.	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
with	O
an	O
online	O
miRNA	O
prediction	O
tool	O
[	O
4	O
].	O

This	O
group	O
also	O
received	O
routine	O
prenatal	O
care	O
.	O

Children	O
presenting	O
at	O
the	O
study	O
hospital	O
with	O
signs	O
of	O
pneumonia	O
had	O
their	O
diagnosis	O
confirmed	O
radiographically	O
.	O

A	O
recent	O
international	O
expert	O
consultation	O
organized	O
by	O
WHO	O
went	O
further	O
and	O
recommended	O
weekly	O
supplementation	O
with	O
iron	O
and	O
folic	O
acid	O
for	O
all	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
in	O
areas	O
where	O
anaemia	O
prevalence	O
is	O
greater	O
than	O
20	O
%[	O
8	O
].	O

The	O
masked	O
radiographs	O
were	O
read	O
by	O
two	O
independent	O
paediatric	O
radiologists	O
(	O
based	O
at	O
the	O
Acute	O
Respiratory	O
Infections	O
Unit	O
of	O
the	O
Pakistan	O
Institute	O
of	O
Medical	O
Sciences	O
),	O
experienced	O
in	O
reading	O
paediatric	O
chest	O
radiographs	O
from	O
WHO	O
vaccine	O
trials	O
,	O
with	O
WHO	O
proformas	O
for	O
standardised	O
interpretation	O
of	O
paediatric	O
chest	O
radiographs	O
for	O
the	O
diagnosis	O
of	O
pneumonia	O
.	O
17In	O
case	O
of	O
disagreement	O
,	O
radiographs	O
were	O
read	O
by	O
a	O
third	O
independent	O
radiologist	O
and	O
most	O
decisions	O
were	O
accepted	O
.	O

Uncomplicated	O
pregnancies	O
were	O
defined	O
as	O
those	O
without	O
any	O
pregnancy	O
disorder	O
who	O
delivered	O
an	O
appropriate	O
weight	O
for	O
gestational	O
age	O
infant	O
at	O
term	O
(≥	O
37	O
weeks	O
gestation	O
)	O
[	O
31	O
].	O

We	O
used	O
block	O
randomization	O
,	O
using	O
blocks	O
of	O
4	O
,	O
to	O
randomize	O
participants	O
to	O
either	O
the	O
intervention	O
or	O
control	O
arm	O
.	O

The	O
positive	O
association	B
remained	O
,	O
though	O
was	O
attenuated	O
somewhat	O
,	O
after	O
further	O
adjustment	O
for	O
maternal	O
pre	O
-	O
pregnancy	O
BMI	O
(	O
RR	O
=	O
4	O
.	O
18	O
;	O
95	O
%	O
CI	O
0	O
.	O
94	O
-	O
18	O
.	O
60	O
).	O

Female	O
rat	O
pups	O
born	O
to	O
and	O
suckled	O
by	O
fat	O
-	O
fed	O
mothers	O
have	O
high	O
blood	O
pressure	O
,	O
even	O
after	O
being	O
placed	O
on	O
a	O
balanced	O
diet	O
after	O
weaning	O
.	O

Using	O
a	O
job	O
exposure	O
matrix	O
,	O
which	O
can	O
differ	O
from	O
exposure	O
measurement	O
,	O
Birks	O
et	O
al	O
.	O

Thus	O
,	O
identifying	O
optimal	O
mHealth	O
dosages	O
could	O
have	O
potential	O
major	O
benefits	O
for	O
future	O
programs	O
in	O
terms	O
of	O
cost	O
effectiveness	B
and	O
outcomes	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
,	O
and	O
**	O
p	O
<	O
0	O
.	O
01	O
comparing	O
“	O
High	O
cord	O
25	O
(	O
OH	O
)	O
D	O
”	O
group	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Demographic	O
data	O
,	O
family	O
and	O
environmental	O
data	O
,	O
outcomes	O
,	O
and	O
infant	O
lung	O
function	O
in	O
groups	O
with	O
different	O
25	O
(	O
OH	O
)	O
D	O
status	O
of	O
maternal	O
serum	O
.	O
Low	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
36	O
)	O
High	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
35	O
)	O
Demographic	O
data	O
Gestational	O
age	O
(	O
weeks	O
)	O
38	O
.	O
4	O
±	O
1	O
.	O
238	O
.	O
8	O
±	O
1	O
.	O
3Male	O
(%)	O
5049Nature	O
delivery	O
(%)	O
6662Birth	O
BW	O
(	O
kg	O
)	O
3	O
.	O
1	O
±	O
0	O
.	O
33	O
.	O
2	O
±	O
0	O
.	O
4Birth	O
BL	O
(	O
cm	O
)	O
50	O
.	O
6	O
±	O
2	O
.	O
150	O
.	O
4	O
±	O
2	O
.	O
5BW	O
(	O
kg	O
)	O
8	O
.	O
3	O
±	O
1	O
.	O
18	O
.	O
1	O
±	O
1	O
.	O
0BL	O
(	O
cm	O
)	O
69	O
.	O
0	O
±	O
2	O
.	O
868	O
.	O
6	O
±	O
3	O
.	O
3	O
%	O
of	O
fall	O
/	O
winter	O
birth38	O
.	O
951	O
.	O
4	O
Family	O
and	O
environmental	O
data	O
Asthma	O
,	O
mother2	O
.	O
88	O
.	O
6Asthma	O
,	O
father2	O
.	O
80AR	O
mother22	O
.	O
231	O
.	O
4AR	O
,	O
father30	O
.	O
631	O
.	O
4AD	O
,	O
mother13	O
.	O
98	O
.	O
6AD	O
,	O
father02	O
.	O
8Daycare	O
attendance	O
(%)	O
11	O
.	O
114	O
.	O
3Maternal	O
smoke	O
in	O
pregnancy	O
(%)	O
8	O
.	O
32	O
.	O
8Postnatal	O
smoke	O
Exposure	O
(%)	O
41	O
.	O
637	O
.	O
1	O
Outcomes	O
NP	O
colonization	O
rate	O
(%)	O
69	O
.	O
766	O
.	O
7Ever	O
RTI	O
till	O
6	O
months	O
(%)	O
25	O
.	O
022	O
.	O
8Eczema	O
at	O
6	O
months	O
(%)	O
1720Ever	O
wheeze	O
at	O
6	O
months	O
(%)	O
2523	O
Infant	O
lung	O
function	O
%	O
of	O
Tpef	O
/	O
Te	O
<	O
0	O
.	O
2259Z	O
score	O
of	O
Rrs	O
-	O
0	O
.	O
04	O
±	O
0	O
.	O
33	O
-	O
0	O
.	O
04	O
±	O
0	O
.	O
39Z	O
score	O
of	O
Crs	O
-	O
0	O
.	O
03	O
±	O
1	O
.	O
13	O
-	O
0	O
.	O
39	O
±	O
1	O
.	O
08Z	O
score	O
of	O
VmaxFRC0	O
.	O
07	O
±	O
1	O
.	O
01	O
-	O
0	O
.	O
24	O
±	O
1	O
.	O
09	O
BW	O
,	O
body	O
weight	O
;	O
BL	O
,	O
body	O
length	O
;	O
AR	O
,	O
allergic	O
rhinitis	O
;	O
AD	O
,	O
atopic	O
dermatitis	O
;	O
NP	O
,	O
nasopharyngeal	O
cavity	O
;	O
RTI	O
,	O
respiratory	O
tract	O
infection	O
,	O
Tpef	O
/	O
Te	O
,	O
ratio	O
of	O
time	O
to	O
peak	O
expiratory	O
flow	O
to	O
total	O
expiratory	O
time	O
;	O
Rrs	O
,	O
resistance	O
of	O
respiratory	O
system	O
;	O
Crs	O
,	O
compliance	O
of	O
respiratory	O
system	O
;	O
VmaxFRC	O
,	O
maximal	O
expiratory	O
flow	O
at	O
functional	O
residual	O
capacity	O
.	O

There	O
are	O
no	O
current	O
studies	O
that	O
can	O
give	O
real	O
good	O
answers	O
to	O
the	O
question	O
if	O
dietary	O
deficiency	O
interacts	B
with	O
genetic	O
vulnerability	O
for	O
schizophrenia	O
.	O

Pregnancy	O
itself	O
may	O
also	O
affect	B
the	O
course	O
of	O
asthma	O
and	O
related	B
diseases	O
.	O

Thus	O
,	O
while	O
it	O
is	O
important	O
to	O
fully	O
characterize	O
the	O
hazard	O
,	O
further	O
studies	O
at	O
doses	O
and	O
routes	O
of	O
administration	O
similar	O
to	O
those	O
found	O
in	O
humans	O
are	O
necessary	O
for	O
determining	O
relevance	O
to	O
public	O
health	O
.	O

Nutrition	O
during	O
pregnancy	O
is	O
an	O
important	O
factor	O
associated	B
with	O
both	O
maternal	O
and	O
infant	O
health	O
outcomes	O
[	O
80	O
].	O

The	O
use	O
of	O
opium	O
,	O
bread	O
and	O
tea	O
could	O
not	O
be	O
assessed	O
in	O
the	O
retrospective	O
framework	O
.	O

Introduction	O
Psychiatric	O
disorders	O
are	O
among	O
the	O
most	O
common	O
pathologies	O
affecting	B
women	O
of	O
childbearing	O
age	O
.	O

Demand	O
for	O
family	O
planning	O
satisfied	O
and	O
antenatal	O
care	O
coverage	O
,	O
even	O
though	O
feasible	O
through	O
primary	O
care	O
services	O
,	O
still	O
leave	O
out	O
many	O
women	O
,	O
especially	O
the	O
poorest	O
.	O

The	O
intra	O
-	O
and	O
inter	O
-	O
assay	O
coefficients	O
of	O
variation	O
were	O
4	O
.	O
2	O
%,	O
and	O
9	O
%	O
respectively	O
.	O

According	O
to	O
the	O
extent	O
of	O
the	O
disease	O
,	O
hemithyroidectomy	O
or	O
radical	O
thyroidectomy	O
is	O
performed	O
.	O

Postnatal	O
data	O
collection	O
time	O
points	O
are	O
at	O
infant	O
postnatal	O
age	O
of	O
6	O
weeks	O
(	O
phase	O
5	O
);	O
24	O
weeks	O
(	O
phase	O
6	O
);	O
6	O
weeks	O
post	O
measles	O
immunisation	O
(±	O
3	O
days	O
)	O
(	O
phase	O
7	O
)	O
or	O
30	O
weeks	O
(+	O
30	O
days	O
)	O
if	O
measles	O
immunization	O
was	O
not	O
given	O
between	O
24	O
and	O
28	O
weeks	O
;	O
and	O
52	O
weeks	O
(+	O
30	O
days	O
)	O
(	O
phase	O
8	O
).	O

Black	O
mothers	O
on	O
Medicaid	O
who	O
were	O
obese	O
and	O
did	O
not	O
take	O
prenatal	O
vitamins	O
had	O
the	O
highest	O
probability	O
of	O
having	O
an	O
infant	O
with	O
vitamin	O
D	O
deficiency	O
.	O

In	O
addition	O
to	O
an	O
unadjusted	O
model	O
,	O
which	O
strictly	O
looked	O
at	O
the	O
effect	O
of	O
the	O
intervention	O
on	O
those	O
who	O
completed	O
baseline	O
and	O
at	O
least	O
1	O
follow	O
-	O
up	O
interview	O
(	O
n	O
=	O
459	O
),	O
a	O
second	O
adjusted	O
model	O
included	O
several	O
maternal	O
covariates	O
:	O
age	O
quintile	O
,	O
parity	O
,	O
marital	O
status	O
,	O
and	O
race	O
.	O

To	O
address	O
this	O
gap	O
in	O
the	O
literature	O
,	O
the	O
aim	O
of	O
this	O
follow	O
-	O
up	O
study	O
was	O
to	O
determine	O
if	O
maternal	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
and	O
/	O
or	O
a	O
child	O
’	O
s	O
current	O
vitamin	O
D	O
status	O
affect	B
the	O
circulating	O
concentration	O
of	O
cathelicidin	O
in	O
healthy	O
children	O
years	O
after	O
delivery	O
.	O

The	O
expression	O
and	O
activity	O
of	O
1	O
-	O
α	O
-	O
hydroxylase	O
(	O
CYP27B1	O
)	O
was	O
evaluated	O
in	O
in	O
vitro	O
experiments	O
on	O
decidua	O
cell	O
cultures	O
collected	O
in	O
the	O
1st	O
and	O
3rd	O
trimesters	O
[	O
15	O
].	O

2005	O
).	O

However	O
,	O
longitudinal	O
studies	O
focussed	O
on	O
diet	O
-	O
dependent	O
alterations	O
of	O
cell	O
cycle	O
regulators	O
are	O
scarce	O
.	O

Children	O
were	O
classified	O
as	O
overweight	O
(+	O
1	O
SDS	O
)	O
or	O
obese	O
(+	O
2	O
SDS	O
)	O
according	O
to	O
BMI	O
-	O
for	O
-	O
age	O
following	O
the	O
cut	O
-	O
off	O
parameters	O
of	O
the	O
WHO	O
growth	O
standards	O
[	O
23	O
].	O

MH	O
processed	O
all	O
food	O
diaries	O
and	O
calculated	O
intake	O
of	O
energy	O
and	O
nutrients	O
,	O
prepared	O
a	O
database	O
with	O
all	O
variables	O
as	O
well	O
as	O
performed	O
the	O
data	O
analyses	O
,	O
in	O
collaboration	O
with	O
MOl	O
who	O
supervised	O
the	O
statistical	O
analyses	O
.	O

Several	O
maternal	O
nutritional	O
factors	O
have	O
been	O
investigated	O
in	O
relation	B
to	O
adverse	O
pregnancy	O
outcomes	O
,	O
as	O
well	O
as	O
offspring	O
health	O
and	O
development	O
[	O
7	O
–	O
9	O
].	O

Methods	O
Male	O
offspring	O
of	O
dams	O
fed	O
HV	O
diet	O
during	O
pregnancy	O
weaned	O
to	O
RV	O
,	O
HV	O
or	O
HFol	O
diets	O
were	O
compared	O
to	O
those	O
born	O
to	O
RV	O
dams	O
and	O
weaned	O
to	O
RV	O
diet	O
for	O
29	O
weeks	O
.	O

Evidence	O
that	O
treatment	O
of	O
gestational	O
diabetes	O
improves	O
pregnancy	O
outcomes	O
The	O
strongest	O
evidence	O
that	O
treatment	O
of	O
GDM	O
is	O
of	O
benefit	O
comes	O
from	O
the	O
Australian	O
Carbohydrate	O
Intolerance	O
Study	O
(	O
ACHOIS	O
)	O
in	O
Pregnant	O
Women	O
.	O
82In	O
this	O
randomized	O
controlled	O
trial	O
,	O
1000	O
women	O
fulfilling	O
the	O
1985	O
WHO	O
criteria	O
for	O
“	O
gestational	O
glucose	O
intolerance	O
”	O
were	O
recruited	O
.	O

It	O
is	O
worth	O
noting	O
that	O
some	O
genomic	O
regions	O
escape	O
this	O
first	O
global	O
‘	O
reset	O
’,	O
including	O
imprinted	O
control	O
regions	O
(	O
ICRs	O
)	O
and	O
the	O
most	O
active	O
TEs	O
.	O

Pearson	O
’	O
s	O
correlation	O
and	O
multiple	O
linear	O
regression	O
analyses	O
were	O
performed	O
to	O
verify	O
the	O
relationship	O
between	O
HRV	O
parameters	O
and	O
independent	O
factors	O
.	O

Serum	O
visfatin	O
levels	O
were	O
measured	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
with	O
human	O
visfatin	O
(	O
ZellBio	O
GmbH	O
,	O
Germany	O
;	O
Ulm	O
kit	O
,	O
Cat	O
No	O
:	O
ZB	O
-	O
3408	O
-	O
H9648	O
).	O

Moreover	O
,	O
we	O
used	O
international	O
standards	O
to	O
define	O
the	O
variable	O
small	O
for	O
gestational	O
age	O
[	O
36	O
]	O
and	O
validated	O
it	O
with	O
a	O
World	O
Health	O
Organization	O
calculator	O
to	O
estimate	O
SGA	O
[	O
56	O
];	O
results	O
were	O
consistent	O
for	O
both	O
(	O
data	O
not	O
shown	O
).	O

Defective	O
Spermatogenesis	O
:	O
Martin	O
et	O
al	O
.	O

The	O
risk	O
of	O
high	O
level	O
symptoms	O
was	O
53	O
%	O
(	O
95	O
%	O
CI	O
,	O
30	O
-	O
69	O
%)	O
lower	O
among	O
women	O
who	O
ate	O
fish	O
3	O
-	O
4	O
times	O
per	O
week	O
compared	O
to	O
women	O
who	O
never	O
ate	O
fish	O
.	O

Background	O
Vitamin	O
D	O
status	O
and	O
season	O
are	O
intrinsically	O
linked	B
;	O
upon	O
exposure	O
to	O
natural	O
ultraviolet	O
solar	O
radiation	O
,	O
endogenous	O
skin	O
production	O
of	O
vitamin	O
D	O
occurs	O
.	O

Weaning	O
age	O
Weaning	O
age	O
is	O
known	O
to	O
affect	B
IMF	O
deposition	O
and	O
MS	O
in	O
beef	O
.	O

The	O
coordination	O
of	O
several	O
factors	O
affects	B
IMF	O
deposition	O
.	O

Risk	O
Factors	O
Related	O
To	O
Season	O
of	O
Birth	O
The	O
underlying	O
rationale	O
for	O
the	O
occurrence	O
of	O
a	O
glioma	O
decades	O
after	O
a	O
seasonal	O
exposure	O
remains	O
elusive	O
.	O

We	O
found	O
a	O
significant	O
correlation	B
(	O
at	O
the	O
0	O
.	O
01	O
level	O
,	O
two	O
-	O
tailed	O
)	O
between	O
maternal	O
pre	O
-	O
pregnancy	O
weight	O
and	O
neonatal	O
birth	O
weight	O
.	O

On	O
average	O
,	O
Australian	O
women	O
are	O
consuming	O
33	O
g	O
of	O
fish	O
per	O
day	O
and	O
pregnant	O
women	O
an	O
average	O
of	O
28	O
g	O
of	O
fish	O
per	O
day	O
,	O
below	O
Food	O
Standards	O
Australia	O
New	O
Zealand	O
(	O
FSANZ	O
)	O
recommended	O
intakes	O
[	O
8	O
].	O

The	O
animal	O
studies	O
performed	O
by	O
Roullet	O
have	O
been	O
used	O
as	O
a	O
model	O
to	O
ameliorate	O
and	O
improve	O
upon	O
studies	O
that	O
focus	O
on	O
the	O
association	B
between	O
the	O
risk	O
of	O
autism	O
and	O
the	O
maternal	O
need	O
for	O
anticonvulsants	O
[	O
5	O
].	O

For	O
example	O
,	O
epigenetic	O
changes	O
have	O
the	O
potential	O
to	O
provide	O
(	O
1	O
)	O
more	O
sensitive	O
/	O
earlier	O
end	O
points	O
of	O
toxicity	O
within	O
existing	O
regulatory	O
test	O
guidelines	O
(	O
TGs	O
),	O
(	O
2	O
)	O
novel	O
markers	O
of	O
exposure	O
/	O
predictors	B
of	O
future	O
toxicity	O
for	O
the	O
development	O
of	O
in	O
vitro	O
chemical	O
screening	O
assays	O
and	O
(	O
3	O
)	O
novel	O
end	O
points	O
of	O
toxicities	O
for	O
which	O
we	O
are	O
currently	O
rarely	O
able	O
to	O
conduct	O
definitive	O
regulatory	O
testing	O
due	O
to	O
animal	O
welfare	O
,	O
cost	O
and	O
time	O
considerations	O
(	O
such	O
as	O
non	O
-	O
genotoxic	O
carcinogens	O
,	O
multigenerational	O
toxicity	O
and	O
chronic	O
low	O
-	O
dose	O
exposures	O
that	O
impact	B
health	O
in	O
later	O
life	O
).	O

1	O
Comparison	O
of	O
Vitamin	O
D	O
deficiency	O
rate	O
of	O
different	O
seasons	O
between	O
the	O
two	O
groups	O
.	O

Depending	O
of	O
the	O
size	O
of	O
the	O
fold	O
changes	O
,	O
we	O
planned	O
to	O
use	O
western	O
blot	O
and	O
/	O
or	O
bioinformatics	O
as	O
secondary	O
analyses	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
systematically	O
investigated	O
confounders	O
between	O
groups	O
,	O
and	O
adjusted	O
for	O
those	O
when	O
applicable	O
.	O

In	O
vitro	O
oestrogens	O
have	O
been	O
shown	O
to	O
down	O
-	O
regulate	O
the	O
NIS	O
(	O
sodium	O
iodide	O
symporter	O
)	O
gene	O
and	O
promote	O
the	O
production	O
of	O
thyroglobulin	O
(	O
HTG	O
),	O
increasing	O
HTG	O
-	O
gene	O
expression	O
via	O
oestrogen	O
receptors	O
present	O
in	O
thyroid	O
tissue	O
,	O
without	O
stimulating	O
rapid	O
cell	O
proliferation145	O
.	O

No	O
studies	O
adjusted	O
for	O
maternal	O
responsiveness	O
which	O
has	O
been	O
shown	O
to	O
be	O
related	B
to	O
developmental	O
outcomes	O
independent	O
of	O
sociodemographic	O
factors	O
[	O
28	O
].	O

A	O
recent	O
study	O
,	O
21has	O
indicated	O
that	O
administrating	O
a	O
high	O
dose	O
of	O
vitamin	O
D	O
every	O
two	O
months	O
was	O
an	O
easy	O
and	O
comfortable	O
treatment	O
.	O

The	O
EPA	O
has	O
mapped	O
521	O
abandoned	O
uranium	O
mines	O
on	O
the	O
reservation	O
,	O
ranging	O
from	O
small	O
holes	O
dug	O
by	O
a	O
single	O
prospector	O
into	O
the	O
side	O
of	O
a	O
mesa	O
to	O
large	O
commercial	O
mining	O
operations	O
.	O
1The	O
Navajo	O
people	O
did	O
not	O
have	O
a	O
word	O
for	O
“	O
radioactivity	O
”	O
when	O
mining	O
outfits	O
looking	O
for	O
vanadium2and	O
uranium3began	O
moving	O
onto	O
their	O
land	O
in	O
the	O
1940s	O
,	O
and	O
they	O
did	O
not	O
understand	O
that	O
radiation	O
could	O
be	O
dangerous	O
.	O

When	O
using	O
cut	O
-	O
off	O
point	O
of	O
>	O
13	O
,	O
susceptibility	O
to	O
prenatal	O
depression	O
decreases	O
to	O
8	O
.	O
2	O
%.	O

Therefore	O
,	O
pregnancy	O
in	O
thyroid	O
cancer	O
patients	O
is	O
not	O
unusual	O
,	O
and	O
about	O
10	O
%	O
of	O
thyroid	O
cancers	O
occurring	O
during	O
reproductive	O
years	O
are	O
diagnosed	O
during	O
pregnancy	O
or	O
in	O
the	O
early	O
post	O
-	O
partum	O
period	O
.	O

These	O
figures	O
were	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%	O
for	O
the	O
IG	O
and	O
CG	O
,	O
respectively	O
after	O
the	O
intervention	O
.	O

For	O
instance	O
,	O
women	O
with	O
asthma	O
or	O
allergic	O
diseases	O
require	O
drug	O
therapy	O
during	O
pregnancy	O
to	O
prevent	O
symptoms	O
severe	O
enough	O
to	O
be	O
life	O
threatening	O
to	O
the	O
mother	O
or	O
the	O
fetus	O
(	O
eg	O
,	O
severe	O
acute	O
asthma	O
that	O
can	O
result	O
in	O
hypoxia	O
).	O

Statistical	O
theory	O
demonstrates	O
that	O
the	O
estimators	O
have	O
smaller	O
mean	O
squared	O
error	O
than	O
ordinary	O
least	O
squares	O
estimators	O
[	O
51	O
].	O

By	O
means	O
of	O
succeeding	O
direct	O
and	O
indirect	O
interactions	O
of	O
downstream	O
target	O
genes	O
,	O
mRNA	O
expression	O
regarding	O
metabolic	O
,	O
behavioural	O
,	O
cardiovascular	O
and	O
immune	O
functions	O
is	O
modulated	O
.	O

Lastly	O
,	O
the	O
generalizability	O
of	O
our	O
study	O
may	O
be	O
limited	O
,	O
as	O
our	O
cohort	O
was	O
primarily	O
comprised	O
of	O
Non	O
-	O
Hispanic	O
White	O
and	O
well	O
-	O
educated	O
women	O
.	O

The	O
current	O
lack	O
of	O
evidence	O
of	O
benefit	O
for	O
women	O
at	O
lower	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
points	O
to	O
the	O
need	O
for	O
further	O
research	O
into	O
vitamin	O
D	O
supplementation	O
in	O
pregnant	O
women	O
with	O
clinical	O
neonatal	O
and	O
infant	O
end	O
-	O
points	O
under	O
scrutiny	O
.	O

of	O
regulated	O
probe	O
-	O
sets	O
private	O
to	O
LP	O
offspringNo	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Comparison	O
of	O
socio	O
-	O
demographic	O
characteristics	O
with	O
respondent	O
'	O
s	O
knowledge	O
about	O
when	O
to	O
start	O
ANC	O
visits	O
and	O
the	O
number	O
of	O
visitsSocio	O
-	O
demographic	O
characteristicFisher	O
'	O
s	O
exact	O
test	O
(	O
N	O
=	O
385	O
)	O
=	O
x	O
p	O
-	O
valueWhen	O
to	O
start	O
ANCMarital	O
status2	O
.	O
220	O
.	O
55Age	O
group16	O
.	O
560	O
.	O
09Pregnancy	O
number10	O
.	O
230	O
.	O
46Number	O
of	O
visit8	O
.	O
130	O
.	O
039	O
+	O
Educational	O
level7	O
.	O
690	O
.	O
27How	O
many	O
visits	O
to	O
attendMarital	O
status7	O
.	O
80	O
.	O
049	O
+	O
Age	O
group36	O
.	O
040	O
.	O
000	O
+	O
Pregnancy	O
number18	O
.	O
970	O
.	O
000	O
+	O
Number	O
of	O
visit1	O
.	O
0750	O
.	O
81Educational	O
level11	O
.	O
320	O
.	O
065	O
statistically	O
significant	O
Primigravida	O
,	O
younger	O
and	O
single	O
women	O
were	O
less	O
likely	O
to	O
know	O
how	O
many	O
ANC	O
visits	O
they	O
were	O
expected	O
to	O
attend	O
during	O
their	O
gestational	O
period	O
when	O
compared	O
to	O
older	O
and	O
multiparous	O
womenPTable	O
2	O
).	O

Expanding	O
on	O
this	O
,	O
a	O
matched	O
case	O
control	O
studies	O
of	O
children	O
in	O
Stockholm	O
county	O
showed	O
a	O
correlation	B
between	O
low	O
growth	O
for	O
gestation	O
age	O
and	O
preterm	O
birth	O
with	O
ASD	O
combined	O
with	O
intellectual	O
disabilities	O
.	O

(	O
2010	O
)¶/†	O
Under	O
-	O
nutritionMouseOral	O
(	O
diet	O
)	O
(↓	O
folate	O
and	O
choline	O
)	O
Early	O
adulthoodLater	O
adulthoodHepatic	O
abnormalitiesmiRNAsTryndyak	O
et	O
al	O
.	O

Even	O
in	O
the	O
last	O
published	O
guidelines	O
the	O
treatment	O
of	O
vitamin	O
D	O
deficient	O
women	O
is	O
not	O
specifically	O
discussed	O
[	O
24	O
].	O

“	O
But	O
what	O
we	O
will	O
end	O
up	O
with	O
is	O
that	O
we	O
now	O
will	O
be	O
able	O
to	O
study	O
three	O
successive	O
generations	O
of	O
Navajos	O
that	O
have	O
been	O
exposed	O
.”	O
Although	O
the	O
literature	O
on	O
chronic	O
low	O
-	O
level	O
uranium	O
exposure	O
is	O
still	O
quite	O
small	O
,	O
by	O
2003	O
researchers	O
knew	O
that	O
the	O
dangers	O
these	O
exposures	O
posed	O
were	O
due	O
not	O
to	O
uranium	O
’	O
s	O
radioactivity	O
but	O
to	O
its	O
chemical	O
toxicity	O
.	O
24Both	O
animal25and	O
human26studies	O
have	O
found	O
uranium	O
to	O
be	O
primarily	O
toxic	O
to	O
the	O
kidneys	O
.	O

Information	O
about	O
the	O
quantity	O
of	O
vitamin	O
D	O
within	O
supplements	O
was	O
not	O
collected	O
.	O

This	O
was	O
the	O
first	O
study	O
to	O
show	O
phenotypic	O
and	O
epigenetic	O
changes	O
in	O
generations	O
not	O
directly	O
exposed	O
to	O
the	O
original	O
stimulus	O
.	O

It	O
was	O
translated	O
to	O
Persian	O
and	O
was	O
used	O
in	O
the	O
study	O
by	O
Mazhari	O
and	O
Nakhaee	O
,	O
with	O
a	O
validity	O
and	O
reliability	O
of	O
0	O
.	O
76	O
and	O
0	O
.	O
83	O
,	O
respectively	O
[	O
42	O
].	O

Utrera	O
and	O
Van	O
Vleck	O
[	O
41	O
]	O
presented	O
estimates	O
of	O
heritability	O
for	O
cattle	O
carcass	O
traits	O
in	O
72	O
studies	O
(	O
1962	O
through	O
2004	O
).	O

Vitamin	O
D	O
deficiency	O
is	O
a	O
widespread	O
global	O
problem	O
,	O
which	O
even	O
can	O
observe	O
in	O
the	O
countries	O
which	O
get	O
enough	O
sunlight	O
[	O
49	O
,	O
51	O
].	O

Although	O
infectious	O
and	O
inflammatory	O
processes	O
contribute	B
to	O
a	O
high	O
proportion	O
of	O
early	O
spontaneous	O
preterm	O
births	O
[	O
35	O
],	O
antibiotic	O
treatment	O
of	O
reproductive	O
tract	O
infections	O
,	O
especially	O
bacterial	O
vaginosis	O
and	O
other	O
remote	O
site	O
infections	O
,	O
has	O
generally	O
failed	O
to	O
reduce	O
preterm	O
risk	O
[	O
36	O
].	O

For	O
each	O
subject	O
,	O
41	O
corresponding	O
aggregate	O
methylation	O
values	O
were	O
obtained	O
by	O
averaging	O
together	O
average	O
β	O
-	O
values	O
from	O
all	O
CpGs	O
within	O
the	O
class	O
.	O

However	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
in	O
the	O
female	O
rat	O
,	O
sex	O
steroids	O
regulate	O
both	O
the	O
expression	O
and	O
function	O
of	O
the	O
endogenous	O
cannabinoid	O
system	O
,	O
so	O
a	O
potential	O
explanation	O
will	O
also	O
involve	O
the	O
impact	B
of	O
malnutrition	O
on	O
this	O
important	O
modulatory	O
system	O
,	O
as	O
it	O
was	O
described	O
previously	O
(	O
Bonnin	O
et	O
al	O
.,	O
1993	O
;	O
Rodríguez	O
de	O
Fonseca	O
et	O
al	O
.,	O
1994	O
).	O

The	O
role	B
of	O
maternal	O
disease	O
cannot	O
be	O
ignored	O
as	O
antiphospholipid	O
syndrome	O
and	O
perinatal	O
inflammation	O
may	O
have	O
important	O
roles	B
in	O
the	O
eventual	O
development	O
of	O
autism	O
.	O

It	O
is	O
necessary	O
to	O
increase	O
exogenous	O
Vitamin	O
D	O
intake	O
in	O
this	O
population	O
especially	O
in	O
fall	O
and	O
winter	O
,	O
when	O
there	O
is	O
an	O
increase	O
of	O
Vitamin	O
D	O
deficiency	O
in	O
Beijing	O
area	O
.	O

The	O
required	O
dosage	O
of	O
insulin	O
usually	O
increases	O
gradually	O
over	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
.	O

As	O
a	O
further	O
preventive	O
measure	O
,	O
the	O
early	O
introduction	O
of	O
solid	O
food	O
(	O
ie	O
,	O
baby	O
food	O
from	O
jars	O
and	O
table	O
food	O
)	O
into	O
the	O
infant	O
'	O
s	O
diet	O
has	O
to	O
be	O
revisited	O
.	O

Three	O
studies	O
[	O
19	O
,	O
21	O
,	O
24	O
]	O
reported	O
on	O
the	O
frequency	O
of	O
consumption	O
without	O
specifying	O
the	O
weight	O
of	O
fish	O
servings	O
while	O
the	O
remaining	O
studies	O
made	O
assumptions	O
based	O
on	O
standard	O
serving	O
sizes	O
,	O
as	O
to	O
the	O
quantity	O
of	O
fish	O
consumed	O
at	O
each	O
occasion	O
.	O

This	O
supplement	O
identifies	O
risks	O
for	O
preterm	O
birth	O
and	O
the	O
solutions	O
needed	O
to	O
reduce	O
those	O
risks	O
across	O
the	O
RMNCH	O
continuum	O
;	O
yet	O
for	O
many	O
of	O
these	O
risks	O
,	O
we	O
do	O
not	O
have	O
effective	B
solutions	O
.	O

It	O
was	O
determined	O
that	O
both	O
maternal	O
race	O
and	O
marital	O
status	O
(	O
both	O
missing	O
for	O
215	O
/	O
943	O
,	O
22	O
.	O
7	O
%	O
of	O
baseline	O
participants	O
)	O
were	O
potentially	O
variables	O
that	O
were	O
differentially	O
missing	O
for	O
women	O
of	O
certain	O
racial	O
and	O
marital	O
statuses	O
.	O

[	O
57	O
].	O

They	O
opined	O
that	O
sufficient	O
attention	O
should	O
be	O
paid	O
to	O
adolescent	O
girls	O
and	O
women	O
of	O
reproductive	O
age	O
long	O
before	O
pregnancy	O
and	O
suggested	O
intermittent	O
low	O
-	O
dose	O
iron	O
supplements	O
and	O
in	O
some	O
cases	O
,	O
combined	O
with	O
necessary	O
micronutrients	O
[	O
36	O
,	O
37	O
].	O

In	O
general	O
,	O
patients	O
with	O
severe	O
asthma	O
are	O
more	O
likely	O
to	O
experience	O
worsening	O
of	O
their	O
disease	O
during	O
pregnancy	O
.	O

Accordingly	O
,	O
we	O
conducted	O
sensitivity	O
analyses	O
without	O
controlling	O
for	O
GA	O
(	O
Table3	O
)	O
and	O
stratified	O
the	O
BHLM	O
results	O
by	O
sex	O
(	O
Additional	O
file1	O
:	O
Tables	O
S1	O
and	O
S2	O
).	O

The	O
exclusion	O
criteria	O
are	O
:	O
1	O
).	O

However	O
,	O
an	O
Australian	O
study	O
showed	O
that	O
both	O
women	O
and	O
providers	O
thought	O
the	O
time	O
for	O
antenatal	O
classes	O
was	O
too	O
small	O
to	O
incorporate	O
all	O
they	O
had	O
to	O
learn	O
with	O
some	O
women	O
complaining	O
of	O
having	O
received	O
too	O
much	O
information	O
[	O
29	O
].	O

[	O
17	O
]	O
Rojroongwasonkul	O
et	O
al	O
.	O

A	O
secondary	O
aim	O
is	O
to	O
prevent	O
excessive	O
maternal	O
weight	O
gain	O
,	O
particularly	O
in	O
women	O
who	O
are	O
overweight	O
or	O
have	O
gained	O
excess	O
weight	O
in	O
pregnancy	O
.	O

All	O
RNA	O
samples	O
were	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
downstream	O
analysis	O
was	O
performed	O
.	O

Data	O
from	O
the	O
feeding	O
response	O
to	O
AM251	O
were	O
analyzed	O
by	O
two	O
-	O
way	O
ANOVA	O
with	O
treatment	O
and	O
diet	O
as	O
factors	O
.	O

As	O
a	O
result	O
,	O
GRs	O
cannot	O
bind	O
to	O
their	O
DNA	O
GRE	O
and	O
subsequently	O
their	O
function	O
is	O
compromised	O
[	O
8	O
].	O

There	O
was	O
no	O
effect	O
of	O
the	O
gestational	O
or	O
pup	O
diets	O
on	O
hypothalamic	O
expression	O
of	O
other	O
genes	O
.	O

White	O
perirenal	O
and	O
perigonadal	O
fat	O
were	O
completely	O
dissected	O
out	O
,	O
weighed	O
,	O
frozen	O
,	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
until	O
RT	O
-	O
qPCR	O
analyses	O
.	O

Effects	B
of	O
nutritional	O
restriction	O
from	O
early	O
gestation	O
to	O
parturition	O
and	O
/	O
or	O
throughout	O
lactation	O
on	O
offspring	O
growth	O
and	O
production	O
characteristics	O
to	O
30	O
mo	O
of	O
age	O
and	O
health	O
and	O
reproductive	O
performance	O
of	O
cows	O
were	O
studied	O
in	O
large	O
maternal	O
grazing	O
systems	O
with	O
offspring	O
of	O
Hereford	O
cows	O
mated	O
to	O
Piedmontese	O
or	O
Wagyu	O
sires	O
[	O
33	O
].	O

The	O
obtained	O
factors	O
are	O
linear	O
combinations	O
of	O
the	O
included	O
variables	O
,	O
explaining	O
as	O
much	O
variation	O
in	O
the	O
original	O
variables	O
as	O
possible	O
.	O

Receiving	O
advice	O
did	O
not	O
vary	O
by	O
pre	O
-	O
pregnancy	O
BMI	O
[	O
χ	O
(	O
2	O
)	O
2	O
=	O
0	O
.	O
421	O
,	O
p	O
=	O
0	O
.	O
810	O
].	O

Thus	O
,	O
significant	O
correlation	B
between	O
lower	O
HRV	O
parameters	O
and	O
low	O
birth	O
weight	O
found	O
in	O
healthy	O
children	O
may	O
have	O
adverse	O
prognostic	O
effects	B
and	O
serve	O
as	O
an	O
early	O
sign	O
of	O
cardiometabolic	O
diseases	O
.	O

The	O
IG	O
received	O
an	O
IM	O
injection	O
of	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
,	O
whereas	O
CG	O
did	O
not	O
.	O

Following	O
the	O
first	O
hydroxylation	O
in	O
the	O
liver	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
is	O
produced	O
.	O

Most	O
of	O
them	O
recommended	O
an	O
improvement	O
in	O
the	O
nurses	O
’	O
skills	O
.	O

Phase	O
2	O
data	O
are	O
collected	O
at	O
22	O
weeks	O
’	O
gestation	O
(	O
window	O
±	O
12	O
days	O
)	O
when	O
anomaly	O
ultrasounds	O
are	O
typically	O
scheduled	O
.	O

The	O
mean	O
BW	O
was	O
3008	O
g	O
(	O
Range	O
:	O
1400	O
to	O
4590	O
;	O
SD	O
=	O
605	O
g	O
)	O
with	O
birth	O
length	O
47	O
.	O
1	O
cm	O
(	O
Range	O
:	O
39	O
.	O
0	O
–	O
53	O
.	O
0	O
;	O
SD	O
=	O
3	O
.	O
28	O
cm	O
).	O

Surprisingly	O
,	O
high	O
maternal	O
seafood	O
consumption	O
,	O
of	O
the	O
type	O
known	O
to	O
be	O
contaminated	O
with	O
mercury	O
,	O
has	O
been	O
associated	B
with	O
fewer	O
–	O
not	O
more	O
–	O
autistic	O
markers	B
in	O
the	O
offspring	O
(	O
17	O
).	O

Skm1	O
mice	O
in	O
the	O
lateral	O
position	O
showing	O
kyphosis	O
(	O
C	O
)	O
and	O
in	O
the	O
supine	O
position	O
showing	O
elongated	O
body	O
(	O
D	O
).	O

It	O
is	O
the	O
precursor	O
to	O
form	O
25	O
-	O
hydroxyvitamin	O
D3	O
[	O
25	O
(	O
OH	O
)	O
D3	O
],	O
a	O
prehormone	O
,	O
which	O
is	O
ultimately	O
converted	O
to	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
],	O
one	O
of	O
the	O
most	O
potent	O
steroid	O
hormones	O
known	O
.	O

Advisory	O
committee	O
To	O
facilitate	O
the	O
overall	O
implementation	O
process	O
and	O
to	O
engage	O
policymakers	O
and	O
other	O
key	O
decision	O
makers	O
,	O
we	O
will	O
establish	O
a	O
national	O
project	O
advisory	O
committee	O
consisting	O
of	O
Ministry	O
of	O
Health	O
and	O
Family	O
Welfare	O
staff	O
,	O
staff	O
,	O
representatives	O
from	O
UNICEF	O
,	O
WHO	O
,	O
the	O
Obstetric	O
and	O
Gynaecological	O
,	O
the	O
Perinatal	O
,	O
and	O
the	O
Nutrition	O
Societies	O
of	O
Bangladesh	O
.	O

Of	O
the	O
original	O
cohort	O
of	O
mothers	O
participating	O
in	O
this	O
vitamin	O
D	O
supplementation	O
trial	O
,	O
55	O
%	O
of	O
the	O
children	O
were	O
available	O
for	O
follow	O
-	O
up	O
,	O
and	O
of	O
those	O
,	O
68	O
%	O
of	O
those	O
who	O
came	O
for	O
follow	O
-	O
up	O
(	O
38	O
%	O
of	O
the	O
original	O
cohort	O
)	O
were	O
able	O
to	O
have	O
a	O
blood	O
sample	O
obtained	O
at	O
the	O
time	O
of	O
the	O
visit	O
.	O

General	O
Practice	O
Physical	O
Activity	O
Questionnaire	O
(	O
GPPAQ	O
)	O
was	O
used	O
to	O
assess	O
the	O
physical	O
activity	O
of	O
participants	O
[	O
22	O
].	O

Therefore	O
,	O
breastmilk	O
,	O
a	O
normally	O
poor	O
source	O
of	O
vitamin	O
D	O
,	O
11becomes	O
even	O
more	O
deficient	O
.	O

country16	O
(	O
13	O
.	O
0	O
)	O
African	O
country3	O
(	O
2	O
.	O
4	O
)	O
Other	O
country2	O
(	O
1	O
.	O
6	O
)	O
Highest	O
education	O
level	O
Eighth	O
grade	O
or	O
below26	O
(	O
21	O
.	O
1	O
)	O
Some	O
HS	O
,	O
no	O
diploma51	O
(	O
41	O
.	O
5	O
)	O
HS	O
diploma	O
/	O
GED28	O
(	O
22	O
.	O
7	O
)	O
Some	O
college	O
,	O
vocational	O
/	O
technical	O
degree13	O
(	O
10	O
.	O
6	O
)	O
Bachelor	O
’	O
s	O
degree	O
or	O
higher5	O
(	O
4	O
.	O
1	O
)	O
Language	O
of	O
preference	O
English29	O
(	O
23	O
.	O
6	O
)	O
Spanish85	O
(	O
69	O
.	O
1	O
)	O
English	O
and	O
Spanish9	O
(	O
7	O
.	O
3	O
)	O
WIC	O
No48	O
(	O
39	O
.	O
3	O
)	O
Yes74	O
(	O
60	O
.	O
7	O
)	O
Expecting	O
Twins	O
No121	O
(	O
98	O
.	O
4	O
)	O
Yes2	O
(	O
1	O
.	O
6	O
)	O
Previous	O
pregnancies	O
042	O
(	O
34	O
.	O
1	O
)	O
134	O
(	O
27	O
.	O
6	O
)	O
224	O
(	O
19	O
.	O
5	O
)	O
316	O
(	O
13	O
.	O
0	O
)	O
44	O
(	O
3	O
.	O
3	O
)	O
52	O
(	O
1	O
.	O
6	O
)	O
60	O
(	O
0	O
)	O
71	O
(	O
0	O
.	O
8	O
)	O
Smoked	O
after	O
pregnancy	O
was	O
confirmed	O
No110	O
(	O
90	O
.	O
2	O
)	O
Yes12	O
(	O
9	O
.	O
8	O
)	O
Consumed	O
alcohol	O
after	O
pregnancy	O
was	O
confirmed	O
No111	O
(	O
91	O
.	O
0	O
)	O
Yes11	O
(	O
9	O
)	O
Taking	O
prenatal	O
vitamins	O
No9	O
(	O
7	O
.	O
3	O
)	O
Yes114	O
(	O
92	O
.	O
7	O
)	O
Currently	O
employed	O
No	O
,	O
by	O
choice17	O
(	O
13	O
.	O
9	O
)	O
No	O
,	O
not	O
by	O
choice56	O
(	O
45	O
.	O
9	O
)	O
Yes	O
,	O
but	O
with	O
an	O
irregular	O
schedule10	O
(	O
8	O
.	O
2	O
)	O
Yes	O
,	O
part	O
time18	O
(	O
14	O
.	O
8	O
)	O
Yes	O
,	O
full	O
time21	O
(	O
17	O
.	O
2	O
)	O
Provider	O
Advice	O
on	O
Gestational	O
Weight	O
Gain	O
Although	O
all	O
of	O
the	O
women	O
had	O
at	O
least	O
one	O
prenatal	O
appointment	O
before	O
completing	O
the	O
baseline	O
survey	O
,	O
only	O
24	O
%	O
reported	O
that	O
their	O
healthcare	O
provider	O
told	O
them	O
how	O
much	O
weight	O
to	O
gain	O
during	O
their	O
pregnancy	O
.	O

Blood	O
pressure	O
is	O
measured	O
at	O
each	O
prenatal	O
visit	O
(	O
phases	O
1	O
to	O
3	O
)	O
as	O
well	O
as	O
postnatally	O
(	O
phases	O
5	O
,	O
6	O
and	O
8	O
)	O
according	O
to	O
international	O
guidelines	O
[	O
46	O
]	O
using	O
calibrated	O
equipment	O
.	O

In	O
Romania	O
,	O
almost	O
all	O
women	O
are	O
hospitalised	O
for	O
at	O
least	O
3	O
days	O
post	O
-	O
partum	O
during	O
which	O
time	O
the	O
newborn	O
is	O
immunised	O
against	O
tuberculosis	O
and	O
hepatitis	O
B	O
;	O
it	O
is	O
very	O
uncommon	O
to	O
leave	O
the	O
hospital	O
earlier	O
.	O

Labor	O
induction	O
and	O
augmentation	O
appear	O
to	O
be	O
an	O
area	O
of	O
association	B
.	O

The	O
treatment	O
also	O
enhanced	O
UCP1	O
protein	O
levels	O
in	O
BAT	O
,	O
via	O
stimulation	O
of	O
the	O
sympathetic	O
nervous	O
system	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

The	O
observation	O
that	O
early	O
registration	O
with	O
a	O
physician	O
in	O
pregnancy	O
was	O
associated	B
with	O
folic	O
acid	O
intake	O
could	O
indicate	O
the	O
recognised	O
importance	O
of	O
early	O
prenatal	O
care	O
.	O

However	O
,	O
the	O
age	O
of	O
the	O
mother	O
needs	O
to	O
be	O
taken	O
into	O
consideration	O
,	O
as	O
artificial	O
insemination	O
among	O
older	O
mothers	O
has	O
been	O
studied	O
to	O
lead	O
to	O
more	O
complications	O
.	O

All	O
12	O
%	O
of	O
the	O
instrumental	O
deliveries	O
were	O
observed	O
in	O
the	O
polytherapy	O
subgroup	O
.	O

CC	O
and	O
RC	O
females	O
showed	O
a	O
lower	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
than	O
those	O
of	O
the	O
respective	O
CC	O
and	O
RC	O
males	O
.	O

Throughout	O
in	O
utero	O
development	O
,	O
the	O
placenta	O
,	O
through	O
the	O
production	O
of	O
various	O
enzymes	O
and	O
hormones	O
,	O
plays	O
an	O
important	O
role	B
in	O
controlling	O
growth	O
and	O
development	O
through	O
the	O
transfer	O
of	O
nutrients	O
and	O
waste	O
and	O
in	O
protecting	O
the	O
fetus	O
from	O
many	O
xenobiotic	O
insults	O
(	O
Robins	O
et	O
al	O
.	O

The	O
glycosylated	O
hemoglobin	O
A1C	O
(	O
HBA1C	O
),	O
serum	O
25	O
-	O
OH	O
-	O
D	O
,	O
parathyroid	O
hormone	O
(	O
PTH	O
),	O
serum	O
calcium	O
and	O
phosphorus	O
were	O
measured	O
.	O

The	O
analysis	O
will	O
follow	O
the	O
intention	O
to	O
treat	O
principle	O
.	O

Briefly	O
,	O
normal	O
beat	O
to	O
beat	O
intervals	O
(	O
RR	O
)	O
were	O
transferred	O
from	O
Polar	O
S810i	O
to	O
Precision	O
Performance	O
Software	O
by	O
an	O
infrared	O
interface	O
device	O
.	O

In	O
addition	O
,	O
antibodies	O
can	O
be	O
transferred	O
to	O
the	O
child	O
via	O
placenta	O
(	O
IgG	O
,	O
IgA	O
)	O
or	O
breast	O
milk	O
(	O
IgA	O
,	O
IgG	O
,	O
IgM	O
,	O
IgE	O
),[	O
61	O
,	O
62	O
]	O
and	O
even	O
a	O
transamniotic	O
transfer	O
of	O
intact	O
maternal	O
IgE	O
into	O
the	O
amniotic	O
fluid	O
can	O
occur	O
[	O
63	O
].	O

Interventions	O
:	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
from	O
14	O
weeks	O
of	O
gestation	O
until	O
delivery	O
.	O

Therefore	O
,	O
increased	O
glucose	O
availability	O
is	O
important	O
for	O
providing	O
glycerol	O
for	O
IMF	O
deposition	O
in	O
ruminants	O
[	O
69	O
],	O
similar	O
to	O
monogastric	O
animals	O
such	O
as	O
pigs	O
.	O

We	O
evaluated	O
the	O
relationship	B
between	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
and	O
BMC	O
and	O
BMD	O
at	O
one	O
week	O
of	O
age	O
.	O

Adaptive	O
versus	O
adverse	O
epigenetic	O
change	O
Epigenetic	O
change	O
offers	O
a	O
much	O
more	O
versatile	O
,	O
reversible	O
and	O
rapid	O
way	O
for	O
adapting	O
to	O
changes	O
in	O
our	O
environment	O
compared	O
with	O
genetic	O
mutation	O
.	O

Probably	O
the	O
most	O
familiar	O
technique	O
in	O
estimating	O
heritability	O
is	O
parent	O
–	O
offspring	O
regression	O
in	O
which	O
,	O
for	O
example	O
,	O
a	O
trait	O
'	O
s	O
heritability	O
can	O
be	O
estimated	O
as	O
the	O
slope	O
of	O
the	O
regression	O
of	O
offspring	O
phenotype	O
on	O
mid	O
-	O
parent	O
phenotype	O
.	O

The	O
authors	O
suggested	O
that	O
feeding	O
concentrate	O
plus	O
roughage	O
or	O
starch	O
after	O
early	O
weaning	O
at	O
a	O
young	O
age	O
could	O
alter	O
adipogenic	O
and	O
lipogenic	O
potential	O
in	O
loin	O
meat	O
.	O

The	O
study	O
had	O
significant	O
selection	O
and	O
recall	O
biases	O
.	O

We	O
examined	O
impact	B
of	O
intensive	O
handwashing	O
promotion	O
on	O
handwashing	O
behavior	O
of	O
mothers	O
of	O
neonates	O
.	O

Maternal	O
nutrient	O
restriction	O
during	O
pregnancy	O
and	O
/	O
or	O
lactation	O
significantly	O
advanced	O
pubertal	O
age	O
in	O
female	O
offspring	O
to	O
a	O
similar	B
degree	O
(	O
p	O
<	O
0	O
.	O
01	O
,	O
figure	O
2A	O
;	O
Table	O
1	O
).	O

While	O
the	O
microbiome	O
-	O
wide	O
significance	O
of	O
maternal	O
dietary	O
factors	O
after	O
adjusting	O
p	O
values	O
using	O
the	O
false	O
discovery	O
rate	O
(	O
FDR	O
)	O
method	O
was	O
not	O
observed	O
,	O
OTUs	O
with	O
the	O
same	O
taxonomic	O
assignment	O
tended	O
to	O
appear	O
together	O
in	O
the	O
most	O
significant	O
results	O
,	O
supporting	O
a	O
true	O
association	B
of	O
maternal	O
dietary	O
factors	O
and	O
infant	O
gut	O
microbiota	O
.	O

We	O
believe	O
that	O
this	O
study	O
provides	O
a	O
clearer	O
understanding	O
of	O
the	O
effect	B
of	O
perinatal	O
vitamin	O
D	O
levels	O
on	O
respiratory	O
function	O
and	O
respiratory	O
outcome	O
in	O
infancy	O
.	O

In	O
another	O
study	O
conducted	O
in	O
rural	O
pocket	O
of	O
Varanasi	O
to	O
evaluate	O
the	O
impact	B
of	O
ICDS	O
on	O
maternal	O
nutrition	O
and	O
birth	O
weight	O
,	O
it	O
was	O
concluded	O
that	O
undernourished	O
antenatal	O
women	O
are	O
definitely	O
benefitted	O
by	O
late	O
pregnancy	O
nutrition	O
supplement	O
(	O
7	O
).	O

Accelerating	O
evidence	O
-	O
based	O
action	O
for	O
prevention	B
and	O
care	O
Addressing	O
the	O
burden	O
of	O
preterm	O
birth	O
has	O
a	O
dual	O
track	O
--	O
prevention	B
and	O
care	O
(	O
Figure1	O
).	O

Many	O
series	O
have	O
reported	O
reduced	O
rates	O
of	O
tumour	O
recurrence	O
both	O
in	O
PTC	O
and	O
in	O
FTC	O
.	O

Using	O
model	O
organisms	O
and	O
using	O
a	O
phenotype	O
-	O
driven	O
approach	O
to	O
identify	O
causal	O
genes	O
underlying	B
spinal	O
deformities	O
can	O
overcome	O
some	O
of	O
the	O
limitations	O
to	O
studying	O
the	O
genetic	O
basis	O
of	O
these	O
syndromes	O
.	O

Genes	O
influence	B
many	O
aspects	O
of	O
eating	O
behavior	O
,	O
including	O
taste	O
sensitivity	O
(	O
55	O
),	O
food	O
preference	O
(	O
56	O
),	O
intake	O
of	O
specific	O
foods	O
(	O
57	O
),	O
meal	O
patterns	O
(	O
58	O
),	O
energy	O
density	O
(	O
59	O
),	O
macronutrient	O
intake	O
(	O
60	O
,	O
61	O
),	O
and	O
meal	O
(	O
61	O
-	O
63	O
)	O
and	O
daily	O
energy	O
intake	O
(	O
61	O
).	O

In	O
brief	O
,	O
800	O
secundigravida	O
women	O
,	O
who	O
had	O
previously	O
delivered	O
a	O
macrosomic	O
infant	O
(>	O
4000	O
g	O
),	O
were	O
randomised	O
to	O
receive	O
either	O
low	O
glycaemic	O
index	O
dietary	O
advice	O
or	O
usual	O
care	O
(	O
no	O
dietary	O
advice	O
)	O
[	O
34	O
].	O

Cold	O
stress	O
causes	O
white	O
fat	O
depot	O
lipolysis	O
in	O
rats	O
[	O
102	O
].	O

Traditionally	O
,	O
and	O
in	O
may	O
regions	O
of	O
the	O
world	O
today	O
,	O
seasonal	O
availability	O
of	O
food	O
determines	O
dietary	O
intakes	O
.	O

Maternal	O
BMI	O
and	O
Offspring	O
Weight	O
Parameters	O
At	O
birth	O
,	O
WFA	O
z	O
-	O
scores	O
were	O
significantly	O
higher	O
for	O
offspring	O
of	O
overweight	O
/	O
obese	O
compared	O
with	O
normal	O
weight	O
mothers	O
(	O
0	O
.	O
42	O
±	O
0	O
.	O
92	O
versus	O
0	O
.	O
21	O
±	O
0	O
.	O
76	O
,	O
resp	O
.	O

Table3details	O
actions	O
for	O
the	O
seven	O
constituencies	O
and	O
Figures9	O
,	O
10	O
,	O
11	O
,	O
12	O
,	O
13	O
,	O
14provide	O
examples	O
of	O
action	O
.	O

PubMed	O
Central	O
:	O

However	O
,	O
studies	O
in	O
women	O
from	O
Australia	O
and	O
New	O
Zealand	O
are	O
less	O
consistent	O
.	O

Eligible	O
women	O
were	O
contacted	O
to	O
arrange	O
a	O
follow	O
-	O
up	O
assessment	O
of	O
their	O
child	O
,	O
either	O
at	O
the	O
hospital	O
of	O
their	O
birth	O
,	O
or	O
if	O
more	O
convenient	O
,	O
for	O
a	O
research	O
assistant	O
to	O
visit	O
their	O
home	O
.	O

Plasma	O
concentrations	O
of	O
insulin	O
were	O
determined	O
by	O
the	O
Human	O
Endocrine	O
Panel	O
.	O

These	O
women	O
received	O
a	O
standard	O
antenatal	O
preparation	O
of	O
60mg	O
elemental	O
iron	O
and	O
250μg	O
of	O
folic	O
acid	O
daily	O
.	O

(	O
2009	O
)*	O
2	O
,	O
3	O
,	O
7	O
,	O
8	O
-	O
tetrachloro	O
-	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
TCDD	O
)	O
Mouse	O
RatInjection	O
(	O
ip	O
)	O
(	O
50	O
µg	O
/	O
kg	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
1	O
µg	O
/	O
kg	O
/	O
d	O
)	O
In	O
utero	O
Early	O
adulthood	O
In	O
utero	O
Neonatal	O
Adolescence	O
/	O
early	O
adulthood	O
Adulthood	O
F0	O
-	O
F1generations	O
↓	O
gonado	O
-	O
tropins	O
and	O
gonadal	O
steroid	O
-	O
genesis	O
Mammary	O
and	O
hepatic	O
abnormalitiesHistone	O
modification	O
DNA	O
methylation	O
Epigenetic	O
machinery	O
miRNAsPapoutsis	O
et	O
al	O
.	O

Another	O
study	O
found	O
that	O
smoking	O
during	O
the	O
12	O
months	O
before	O
birth	O
of	O
a	O
child	O
was	O
associated	B
with	O
adolescent	O
overweight	O
(	O
21	O
).	O

Furthermore	O
,	O
there	O
are	O
new	O
therapeutic	O
approaches	O
under	O
validation	O
for	O
advanced	O
or	O
recurrent	O
disease46	O
-	O
48	O
.	O

Implementation	O
research	O
and	O
program	O
evaluation	O
evaluates	O
how	O
best	O
to	O
achieve	O
wide	O
scale	O
coverage	O
of	O
interventions	O
,	O
including	O
prevention	O
particularly	O
family	O
planning	O
and	O
such	O
as	O
care	O
of	O
women	O
with	O
infectious	O
diseases	O
such	O
as	O
malaria	O
,	O
HIV	O
and	O
STIs	O
;	O
improved	O
nutrition	O
;	O
smoking	O
cessation	O
;	O
and	O
reducing	O
maternal	O
workload	O
.	O

Women	O
under	O
the	O
age	O
of	O
35	O
using	O
fertility	O
therapies	O
such	O
as	O
ovulation	O
inducing	O
drugs	O
and	O
artificial	O
insemination	O
did	O
not	O
increase	O
the	O
risk	O
for	O
having	O
a	O
child	O
with	O
autism	O
,	O
while	O
researchers	O
suggest	O
that	O
the	O
rise	O
in	O
fertility	O
treatments	O
in	O
older	O
women	O
above	O
35	O
may	O
increase	O
the	O
risk	O
of	O
having	O
a	O
child	O
with	O
autism	O
for	O
those	O
using	O
artificial	O
insemination	O
and	O
/	O
or	O
ovulation	O
inducing	O
drugs	O
.	O

SNPs	O
in	O
GC	O
have	O
also	O
been	O
associated	B
with	O
the	O
binding	O
affinities	O
of	O
25	O
(	O
OH	O
)	O
D	O
to	O
VDP	O
(	O
24	O
),	O
although	O
the	O
effect	B
of	O
rs2282679	O
on	O
binding	O
affinity	O
has	O
not	O
been	O
established	O
.	O

Waist	O
and	O
hip	O
circumferences	O
were	O
measured	O
using	O
inextensible	O
tape	O
.	O

We	O
did	O
not	O
observe	O
an	O
overall	O
association	O
between	O
any	O
attribute	O
-	O
defined	O
gene	O
-	O
associated	O
class	O
methylation	O
and	O
LINE	O
-	O
1	O
methylation	O
levels	O
.	O

Significantly	O
more	O
children	O
with	O
S	O
-	O
ECC	O
had	O
suboptimal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
compared	O
to	O
their	O
caries	O
-	O
free	O
peers	O
(	O
p	O
=	O
0	O
.	O
006	O
)	O
(	O
Table	O
2	O
).	O

Vasopressinase	O
is	O
metabolized	O
in	O
the	O
liver	O
,	O
which	O
may	O
explain	O
higher	O
concentrations	O
of	O
the	O
enzyme	O
in	O
patients	O
with	O
fatty	O
liver	O
,	O
hepatitis	O
and	O
preeclampsia	O
as	O
discussed	O
by	O
Barbey	O
et	O
al	O
.	O

These	O
confounders	O
included	O
women	O
'	O
s	O
age	O
and	O
BMI	O
and	O
were	O
not	O
explained	O
by	O
gestational	O
age	O
.	O

Women	O
will	O
not	O
receive	O
any	O
additional	O
information	O
or	O
counselling	O
other	O
than	O
usual	O
standard	O
care	O
provided	O
by	O
the	O
existing	O
BRAC	O
structure	O
.	O

Age	O
had	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
18	O
and	O
39	O
,	O
respectively	O
.	O

Similarly	O
,	O
seasonal	O
occurrence	O
has	O
been	O
observed	O
for	O
chicken	O
pox	O
,	O
measles	O
,	O
influenza	O
and	O
many	O
other	O
common	O
childhood	O
infectious	O
diseases	O
[	O
7	O
,	O
142	O
].	O

In	O
previous	O
work	O
and	O
a	O
scoping	O
study	O
,	O
we	O
found	O
that	O
most	O
of	O
the	O
research	O
carried	O
out	O
in	O
relation	B
to	O
impaired	O
spermatogenesis	O
had	O
investigated	O
time	O
trends	O
rather	O
than	O
association	B
with	O
specific	O
risk	O
factors	O
(	O
Martin	O
et	O
al	O
.	O

Epidemiological	O
data	O
suggest	O
that	O
seasonality	O
in	O
sunlight	O
and	O
vitamin	O
D	O
are	O
related	B
to	O
mortality	O
and	O
infection	O
rates	O
[	O
18	O
].	O

Thus	O
,	O
there	O
is	O
a	O
lack	O
of	O
published	O
information	O
regarding	O
the	O
efficacy	B
of	O
perinatal	O
handwashing	O
promotion	O
interventions	O
on	O
maternal	O
handwashing	O
behavior	O
in	O
the	O
neonatal	O
period	O
and	O
on	O
neonatal	O
mortality	O
.	O

Secondary	O
outcomes	O
included	O
the	O
total	O
number	O
of	O
times	O
mothers	O
were	O
observed	O
washing	O
hands	O
with	O
soap	O
during	O
3	O
-	O
hour	O
observations	O
;	O
the	O
maintenance	O
of	O
soap	O
and	O
water	O
for	O
handwashing	O
anywhere	O
in	O
the	O
home	O
and	O
specifically	O
where	O
newborns	O
rest	O
for	O
most	O
of	O
the	O
day	O
;	O
handwashing	O
with	O
soap	O
by	O
other	O
household	O
members	O
at	O
times	O
of	O
possible	O
pathogen	O
transmission	O
;	O
and	O
the	O
number	O
of	O
events	O
observed	O
among	O
household	O
members	O
other	O
than	O
the	O
mother	O
washing	O
hands	O
with	O
soap	O
during	O
the	O
3	O
-	O
hour	O
observations	O
.	O

In	O
supplemental	O
multivariate	O
analyses	O
,	O
we	O
adjusted	O
for	O
baseline	O
differences	O
between	O
study	O
arms	O
.	O

Thus	O
,	O
the	O
dietary	O
energy	O
source	O
may	O
differentially	O
influence	B
marbling	O
and	O
IMF	O
deposition	O
,	O
depending	O
on	O
the	O
feeding	O
period	O
.	O

Both	O
,	O
the	O
EpiTect	O
Methyl	O
II	O
Signature	O
and	O
EpiTect	O
Methyl	O
II	O
Complete	O
PCR	O
Arrays	O
(	O
Qiagen	O
)	O
will	O
be	O
considered	O
.	O

Due	O
to	O
this	O
heterogeneity	O
a	O
qualitative	O
rather	O
than	O
quantitative	O
approach	O
was	O
deemed	O
appropriate	O
for	O
comparison	O
and	O
presentation	O
of	O
findings	O
.	O

per	O
quintile	O
effect	O
).	O

Gene	O
rs12800438	O
is	O
correlated	B
with	O
higher	O
serum	O
25	O
[	O
OH	O
]	O
D	O
levels	O
,	O
and	O
gene	O
rs6058017	O
-	O
with	O
lighter	O
skin	O
pigmentation	O
[	O
35	O
].	O

Although	O
poor	O
lung	O
function	O
performance	O
and	O
an	O
increased	O
risk	O
of	O
respiratory	O
tract	O
infection	O
were	O
related	B
to	O
relatively	O
low	O
cord	O
serum	O
vitamin	O
D	O
levels	O
,	O
further	O
extrapolating	O
the	O
effects	B
of	O
vitamin	O
D	O
on	O
the	O
respiratory	O
function	O
of	O
the	O
general	O
infant	O
population	O
might	O
still	O
be	O
difficult	O
.	O

Nonetheless	O
the	O
woman	O
should	O
be	O
advised	O
regarding	O
appropriate	O
hypoglycemia	O
prevention	O
and	O
management	O
measures	O
.	O

Therefore	O
,	O
we	O
constructed	O
additional	O
models	O
that	O
simultaneously	O
adjusted	O
for	O
pre	O
-	O
pregnancy	O
BMI	O
.	O

One	O
trial	O
in	O
schoolchildren28	O
(	O
measuring	O
influenza	O
A	O
antigen	O
from	O
swabs	O
)	O
found	O
a	O
statistically	O
significant	O
reduced	O
incidence	O
in	O
the	O
intervention	O
group	O
(	O
RR	O
0	O
·	O
58	O
,	O
95	O
%	O
CI	O
0	O
·	O
34	O
–	O
0	O
·	O
99	O
).	O

Moreover	O
,	O
CC	O
and	O
RC	O
adult	O
females	O
displayed	O
higher	O
caloric	O
intake	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adult	O
males	O
(	O
day	O
1	O
,	O
2	O
,	O
and	O
4	O
;	O
Figure3D	O
).	O

The	O
inclusion	O
criteria	O
were	O
:	O
being	O
18	O
years	O
or	O
older	O
,	O
healthy	O
women	O
means	O
;	O
any	O
one	O
with	O
no	O
history	O
of	O
mental	O
illness	O
and	O
internal	O
diseases	O
such	O
as	O
hyper	O
/	O
hypothyroidism	O
,	O
parathyroid	O
,	O
renal	O
,	O
diabetes	O
and	O
heart	O
diseases	O
,	O
no	O
addiction	O
to	O
any	O
kind	O
of	O
narcotic	O
drugs	O
,	O
living	O
with	O
a	O
husband	O
,	O
a	O
singleton	O
live	O
fetus	O
,	O
without	O
any	O
pregnancy	O
complications	O
such	O
as	O
preeclampsia	O
,	O
gestational	O
diabetes	O
,	O
ruptured	O
membranes	O
and	O
suspicion	O
of	O
preterm	O
birth	O
,	O
no	O
previous	O
cesarean	O
sections	O
,	O
gestational	O
age	O
of	O
26	O
–	O
28	O
weeks	O
based	O
on	O
ultrasound	O
results	O
,	O
and	O
the	O
EPDS	O
baseline	O
scores	O
of	O
0	O
to	O
13	O
.	O

We	O
are	O
describing	O
a	O
unique	O
case	O
of	O
gestational	O
diabetes	O
insipidus	O
in	O
a	O
patient	O
with	O
HELLP	O
syndrome	O
.	O

However	O
,	O
cord	O
serum	O
levels	O
ranged	O
widely	O
from	O
10	O
.	O
95	O
to	O
34	O
.	O
4	O
ng	O
/	O
mL	O
[	O
7	O
,	O
11	O
–	O
13	O
,	O
30	O
].	O

However	O
,	O
of	O
the	O
128	O
respondents	O
who	O
indicated	O
zero	O
drinks	O
per	O
day	O
,	O
only	O
51	O
(	O
40	O
%)	O
of	O
them	O
were	O
in	O
the	O
control	O
group	O
and	O
77	O
(	O
60	O
%)	O
in	O
text4baby	O
.	O

Further	O
,	O
it	O
would	O
be	O
of	O
interest	O
to	O
study	O
if	O
dietary	O
aspects	O
are	O
associated	B
with	O
separable	O
latent	O
dimensions	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
and	O
if	O
the	O
associations	B
are	O
valid	O
for	O
men	O
and	O
for	O
other	O
age	O
groups	O
.	O

Birth	O
weight	O
percentile	O
was	O
calculated	O
using	O
the	O
Fenton	O
growth	O
chart	O
from	O
gestational	O
age	O
and	O
birth	O
weight	O
in	O
grams	O
(	O
Fenton	O
2003	O
),	O
allowing	O
us	O
to	O
account	O
for	O
gestational	O
age	O
in	O
our	O
birth	O
weight	O
metric	O
and	O
to	O
create	O
a	O
normalized	O
distribution	O
for	O
birth	O
weight	O
through	O
birth	O
weight	O
percentile	O
.	O

The	O
mean	O
serum	O
calcifediol	O
concentration	O
was	O
consistently	O
and	O
significantly	O
higher	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
in	O
the	O
placebo	O
group	O
at	O
1	O
week	O
,	O
4	O
weeks	O
,	O
and	O
3	O
months	O
after	O
administration	O
of	O
the	O
first	O
dose	O
of	O
vitamin	O
D	O
during	O
the	O
winter	O
and	O
at	O
2	O
weeks	O
'	O
post	O
administration	O
of	O
dose	O
3	O
(	O
spring	O
;	O
figure	O
3	O
).	O

Nowadays	O
,	O
we	O
know	O
that	O
brain	O
cells	O
such	O
as	O
microglia	O
and	O
astrocytes	O
,	O
can	O
secrete	O
cytokines	O
.	O

There	O
was	O
no	O
significant	O
relationship	O
between	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
BMC	O
or	O
BMD	O
in	O
the	O
first	O
week	O
of	O
life	O
(	O
n	O
=	O
49	O
)	O
or	O
after	O
3	O
months	O
of	O
vitamin	O
D	O
supplementation	O
.	O

Part	O
1	O
:	O
Specific	O
Allergic	O
Diseases	O
in	O
Pregnancy	O
Epidemiology	O
:	O
Prevalence	O
of	O
Asthma	O
and	O
Allergy	O
in	O
Pregnant	O
Women	O
Allergic	O
sensitization	O
to	O
common	O
allergens	O
can	O
be	O
detected	O
in	O
approximately	O
25	O
%	O
to	O
35	O
%	O
of	O
the	O
general	O
population	O
in	O
industrialized	O
countries	O
[	O
7	O
].	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
metabolic	O
enzymes	O
regulating	O
de	O
novo	O
lipogenesis	O
(	O
Acaca	O
,	O
Fasn	O
,	O
Scd1	O
)	O
and	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1a	O
,	O
Cpt1b	O
,	O
Acox1	O
),	O
and	O
key	O
regulators	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
(	O
Chrebp	O
,	O
Srebp1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
Hmgcr	O
)	O
and	O
mitochondrial	O
respiration	O
(	O
Ucp1	O
,	O
Cox4i1	O
)	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure5	O
).	O

In	O
this	O
article	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
mutations	O
affecting	B
skeletal	O
morphology	O
,	O
skeletal	O
morphology	O
1	O
(	O
skm1	O
)	O
and	O
skeletal	O
morphology	O
2	O
(	O
Skm2	O
),	O
in	O
a	O
recessive	O
ENU	O
mutagenesis	O
screen	O
for	O
infectious	O
disease	O
susceptibility	O
.	O

Understanding	O
the	O
extent	O
to	O
which	O
hand	O
hygiene	O
behavior	O
of	O
mothers	O
and	O
other	O
caregivers	O
needs	O
to	O
improve	O
at	O
other	O
times	O
of	O
potential	O
pathogen	O
transmission	O
would	O
support	O
the	O
development	O
of	O
feasible	O
guidance	O
on	O
handwashing	O
to	O
reduce	O
neonatal	O
infections	O
.	O

We	O
decided	O
not	O
to	O
include	O
dietary	O
Vitamin	O
D	O
estimates	O
in	O
the	O
final	O
multivariate	O
models	O
as	O
fish	O
is	O
a	O
rich	O
source	O
of	O
vitamin	O
D	O
and	O
could	O
account	O
for	O
some	O
of	O
the	O
effect	B
of	O
fish	O
on	O
our	O
outcome	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaneous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
categorised	O
based	O
on	O
standardised	O
quartiles	O
and	O
clinical	O
definitions	O
of	O
vitamin	O
D	O
statusPregnancy	O
ComplicationsAll	O
womenAny	O
ComplicationPEGHGDMsPTBSGA	O
n	O
(%)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*(	O
95	O
%	O
CI	O
)	O
Standardised	O
Quartiles	O
**	O
Low711	O
(	O
25	O
)	O
328	O
(	O
46	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
07	O
)	O
46	O
(	O
6	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
66	O
,	O
1	O
.	O
57	O
))	O
57	O
(	O
8	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
42	O
)	O
28	O
(	O
4	O
)	O
0	O
.	O
79	O
(	O
0	O
.	O
47	O
,	O
1	O
.	O
30	O
)	O
36	O
(	O
5	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
29	O
)	O
84	O
(	O
12	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
75	O
,	O
1	O
.	O
39	O
)	O
Low	O
-	O
Moderate755	O
(	O
27	O
)	O
318	O
(	O
42	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
90	O
,	O
1	O
.	O
12	O
)	O
42	O
(	O
6	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
64	O
)	O
65	O
(	O
9	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
74	O
,	O
1	O
.	O
52	O
)	O
25	O
(	O
3	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
39	O
,	O
1	O
.	O
16	O
)	O
33	O
(	O
4	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
56	O
,	O
1	O
.	O
3572	O
(	O
10	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
73	O
,	O
1	O
.	O
32	O
)	O
Moderate	O
-	O
High702	O
(	O
25	O
)	O
309	O
(	O
44	O
)	O
1	O
.	O
0	O
†	O
37	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
50	O
(	O
7	O
)	O
1	O
.	O
0	O
†	O
28	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
39	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
81	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
High630	O
(	O
23	O
)	O
258	O
(	O
41	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
82	O
,	O
1	O
.	O
06	O
)†	O
35	O
(	O
6	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
78	O
,	O
1	O
.	O
96	O
)	O
40	O
(	O
6	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
58	O
,	O
1	O
.	O
30	O
)	O
10	O
(	O
2	O
)	O
0	O
.	O
47	O
(	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
)	O
30	O
(	O
5	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
25	O
)	O
60	O
(	O
10	O
)	O
0	O
.	O
80	O
(	O
0	O
.	O
57	O
,	O
1	O
.	O
11	O
)	O
Vitamin	O
D	O
Status	O
<	O
25	O
nmol	O
/	O
L99	O
(	O
4	O
)	O
51	O
(	O
52	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
)	O
8	O
(	O
8	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
03	O
))	O
6	O
(	O
6	O
)	O
0	O
.	O
70	O
(	O
0	O
.	O
32	O
,	O
1	O
.	O
52	O
)	O
5	O
(	O
5	O
)	O
0	O
.	O
98	O
(	O
0	O
.	O
38	O
,	O
2	O
.	O
52	O
)	O
7	O
(	O
7	O
)	O
1	O
.	O
44	O
(	O
0	O
.	O
68	O
,	O
3	O
.	O
04	O
)	O
13	O
(	O
13	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
66	O
,	O
2	O
.	O
01	O
)	O
25	O
-	O
50	O
nmol	O
/	O
L673	O
(	O
24	O
)	O
301	O
(	O
45	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
83	O
,	O
1	O
.	O
03	O
)	O
45	O
(	O
7	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
80	O
,	O
1	O
.	O
75	O
)	O
59	O
(	O
9	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
71	O
,	O
1	O
.	O
34	O
)	O
26	O
(	O
4	O
)	O
0	O
.	O
89	O
(	O
0	O
.	O
54	O
,	O
1	O
.	O
47	O
)	O
29	O
(	O
4	O
)	O
0	O
.	O
75	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
16	O
)	O
74	O
(	O
11	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
69	O
,	O
1	O
.	O
24	O
)	O
>	O
50	O
-	O
75	O
nmol	O
/	O
L928	O
(	O
33	O
)	O
428	O
(	O
46	O
)	O
1	O
.	O
0	O
†	O
48	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
80	O
(	O
9	O
)	O
1	O
.	O
0	O
†	O
35	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
52	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
107	O
(	O
12	O
)	O
1	O
.	O
0	O
†	O
>	O
75	O
nmol	O
/	O
L1098	O
(	O
39	O
)	O
435	O
(	O
40	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
86	O
,	O
1	O
.	O
04	O
)	O
60	O
(	O
5	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
87	O
,	O
1	O
.	O
87	O
)	O
67	O
(	O
6	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
12	O
)†	O
26	O
(	O
2	O
)	O
0	O
.	O
78	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
28	O
)	O
51	O
(	O
5	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
59	O
,	O
1	O
.	O
26	O
)	O
104	O
(	O
9	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
67	O
,	O
1	O
.	O
12	O
)	O
*	O
Relative	O
risks	O
compared	O
to	O
all	O
women	O
were	O
adjusted	O
for	O
age	O
,	O
maternal	O
body	O
mass	O
index	O
,	O
ethnicity	O
(	O
non	O
Caucasian	O
vs	O
.	O
Caucasian	O
),	O
smoking	O
status	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
no	O
vs	O
.	O
yes	O
),	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
(	O
no	O
vs	O
yes	O
),	O
recreational	O
walking	O
(	O
1	O
-	O
3	O
×/	O
week	O
and	O
≥	O
4	O
×/	O
week	O
vs	O
.	O
never	O
)	O
and	O
recruitment	O
site	O
(	O
Auckland	O
vs	O
.	O
Adelaide	O
)	O
**	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
standardised	O
for	O
month	O
that	O
serum	O
was	O
sampled	O
based	O
as	O
previously	O
described	O
[	O
34	O
]	O
†	O
Reference	O
category	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
,	O
pregnancy	O
outcome	O
and	O
fetal	O
sex	O
As	O
there	O
is	O
evidence	O
to	O
suggest	O
that	O
vitamin	O
D	O
metabolism	O
within	O
the	O
placenta	O
may	O
differ	O
with	O
respect	O
to	O
fetal	O
sex	O
[	O
35	O
]	O
thus	O
,	O
we	O
assessed	O
the	O
effect	B
of	O
“	O
standardised	O
”	O
vitamin	O
D	O
status	O
on	O
pregnancy	O
outcome	O
stratified	O
by	O
fetal	O
sex	O
(	O
Table	O
3	O
).	O

Any	O
medication	O
and	O
supplementation	O
use	O
is	O
also	O
recorded	O
daily	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g005	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Photomicrographs	O
of	O
the	O
developing	O
kidneys	O
of	O
offspring	O
at	O
birth	O
.	O

Children	O
with	O
S	O
-	O
ECC	O
were	O
found	O
to	O
have	O
significantly	O
lower	O
albumin	O
levels	O
than	O
caries	O
-	O
free	O
controls	O
.	O

[	O
40	O
]	O
shows	O
that	O
assisted	O
reproductive	O
therapy	O
and	O
a	O
history	O
of	O
infertility	O
do	O
not	O
increase	O
the	O
risk	O
for	O
autism	O
spectrum	O
disorders	O
.	O

Nonetheless	O
,	O
folic	O
acid	O
supplementation	O
might	O
address	O
other	O
forms	O
of	O
anaemia	O
,	O
and	O
the	O
advice	O
might	O
also	O
increase	O
the	O
likelihood	O
of	O
folic	O
acid	O
use	O
before	O
and	O
during	O
future	O
pregnancies	O
.	O

Vitamin	O
D	O
is	O
primarily	O
synthesized	O
in	O
the	O
skin	O
and	O
is	O
partly	O
derived	O
from	O
dietary	O
sources	O
[	O
4	O
].	O

Currently	O
,	O
there	O
are	O
no	O
routine	O
data	O
available	O
for	O
many	O
of	O
the	O
interventions	B
for	O
preterm	O
birth	O
prevention	B
and	O
care	O
.	O

Park	O
et	O
al	O
[	O
15	O
]	O
studied	O
Korean	O
infants	O
at	O
2	O
to	O
5	O
months	O
of	O
age	O
and	O
found	O
no	O
relationship	O
between	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
BMC	O
assessed	O
by	O
DXA	O
even	O
though	O
many	O
of	O
the	O
infants	O
had	O
very	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

Furthermore	O
,	O
women	O
were	O
asked	O
a	O
validated	O
,	O
single	O
-	O
item	O
question	O
on	O
food	O
insufficiency	O
–“	O
How	O
many	O
days	O
in	O
the	O
past	O
week	O
have	O
you	O
gone	O
hungry	O
?	O

After	O
degranulation	O
,	O
mast	O
cells	O
lose	O
membrane	O
area	O
,	O
become	O
activated	O
,	O
and	O
start	O
a	O
de	O
novo	O
synthesis	O
of	O
prostaglandins	O
and	O
leukotrienes	O
from	O
membrane	O
arachidonic	O
acid	O
[	O
4	O
,	O
5	O
].	O

Although	O
SSRIs	O
are	O
not	O
contraindicated	O
for	O
use	O
during	O
pregnancy	O
,	O
the	O
effects	B
should	O
be	O
examined	O
more	O
carefully	O
[	O
66	O
].	O

This	O
was	O
covered	O
under	O
a	O
data	O
use	O
agreement	O
(	O
DUA	O
)	O
between	O
the	O
Department	O
of	O
Defense	O
,	O
National	O
Healthy	O
Mothers	O
,	O
Healthy	O
Babies	O
(	O
HMHB	O
)	O
Coalition	O
,	O
Voxiva	O
,	O
and	O
The	O
George	O
Washington	O
University	O
.	O

An	O
increase	O
of	O
'	O
mTOR	O
signaling	O
'	O
within	O
developmental	O
period	O
II	O
was	O
observed	O
in	O
AP	O
offspring	O
,	O
but	O
not	O
in	O
the	O
LP	O
group	O
.	O

Standard	O
case	O
definitions	O
of	O
the	O
types	O
and	O
causes	O
of	O
preterm	O
birth	O
are	O
being	O
developed	O
[	O
31	O
,	O
32	O
]	O
and	O
will	O
be	O
critical	O
to	O
accelerating	O
discovery	O
and	O
making	O
comparisons	O
across	O
studies	O
from	O
basic	O
science	O
to	O
clinical	O
trials	O
and	O
program	O
evaluation	O
.	O

First	O
trimester	O
BMI	O
was	O
used	O
as	O
a	O
proxy	B
for	O
prepregnancy	O
BMI	O
for	O
both	O
first	O
and	O
third	O
trimester	O
pregnant	O
women	O
.	O

We	O
employed	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
to	O
reflect	O
both	O
the	O
maternal	O
vitamin	O
D	O
status	O
at	O
the	O
end	O
of	O
pregnancy	O
and	O
the	O
newborn	O
’	O
s	O
vitamin	O
D	O
status	O
at	O
birth	O
[	O
1	O
].	O

To	O
estimate	O
the	O
association	O
between	O
exposure	O
to	O
extended	O
winter	O
and	O
the	O
transformed	O
metabolic	O
markers	O
,	O
the	O
reverse	O
transformation	O
of	O
the	O
B	O
values	O
from	O
regression	O
models	O
were	O
computed	O
.	O

However	O
,	O
the	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
with	O
the	O
highest	O
burden	O
of	O
preterm	O
births	O
also	O
carry	O
the	O
greatest	O
burden	O
of	O
higher	O
-	O
risk	O
conditions	O
for	O
preterm	O
birth	O
that	O
are	O
preventable	O
or	O
treatable	O
.	O

We	O
conducted	O
a	O
pilot	O
study	O
in	O
four	O
BRAC	O
village	O
fieldworker	O
areas	O
,	O
two	O
with	O
intervention	O
and	O
two	O
comparison	O
areas	O
,	O
to	O
test	O
the	O
feasibility	O
of	O
our	O
intervention	O
.	O

Prophylaxis	O
iron	O
supplement	O
and	O
food	O
fortification	O
with	O
iron	O
have	O
the	O
prospects	O
of	O
improving	O
maternal	O
and	O
child	O
health	O
,	O
except	O
for	O
the	O
identified	O
constraints	O
.	O

The	O
special	O
nuclear	O
receptors	O
for	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
and	O
also	O
essential	O
enzymes	O
for	O
hydroxylation	O
of	O
vitamin	O
D	O
are	O
found	O
in	O
the	O
central	O
nervous	O
system	O
.	O

A	O
research	O
pipeline	O
to	O
address	O
preterm	O
birth	O
Greater	O
investment	O
in	O
research	O
and	O
,	O
in	O
particular	O
,	O
into	O
discovery	O
of	O
the	O
many	O
complex	O
and	O
interrelated	B
factors	B
causing	O
preterm	O
birth	O
is	O
needed	O
to	O
strengthen	O
prevention	B
and	O
offers	O
a	O
potential	O
over	O
the	O
longer	O
term	O
for	O
significant	O
reductions	O
in	O
mortality	O
,	O
childhood	O
disability	O
and	O
healthcare	O
expenditure	O
.	O

observed	O
significantly	O
higher	O
HbA1cin	O
the	O
UK	O
among	O
female	O
patients	O
with	O
type	O
2	O
diabetes	O
in	O
the	O
months	O
February	O
,	O
March	O
and	O
June	O
,	O
and	O
suggested	O
that	O
poorer	O
diet	O
and	O
reduced	O
physical	O
activity	O
associated	O
with	O
Christmas	O
and	O
Easter	O
celebrations	O
may	O
be	O
involved	B
[	O
20	O
].	O

If	O
the	O
delivery	O
is	O
induced	O
or	O
caesarean	O
section	O
conducted	O
,	O
the	O
reason	O
for	O
this	O
intervention	O
is	O
obtained	O
.	O

The	O
cohort	O
,	O
consisting	O
of	O
46	O
.	O
6	O
%	O
females	O
and	O
53	O
.	O
4	O
%	O
males	O
,	O
included	O
41	O
Blacks	O
,	O
38	O
Whites	O
,	O
and	O
54	O
Hispanics	O
.	O

Vitamin	O
D	O
is	O
present	O
in	O
a	O
small	O
number	O
of	O
foods	O
,	O
although	O
,	O
for	O
an	O
average	O
person	O
food	O
will	O
only	O
supply	O
about	O
10	O
%	O
of	O
the	O
amount	O
needed	O
.	O

These	O
authors	O
estimate	O
that	O
the	O
productivity	O
gains	O
for	O
an	O
individual	O
removed	O
from	O
anaemia	O
are	O
5	O
%	O
in	O
manual	O
occupations	O
(	O
70	O
%	O
of	O
employment	O
in	O
a	O
country	O
such	O
as	O
Viet	O
Nam	O
),	O
and	O
17	O
%	O
in	O
heavy	O
manual	O
occupations	O
(	O
which	O
form	O
12	O
.	O
7	O
%	O
of	O
employment	O
in	O
manual	O
occupations	O
in	O
Viet	O
Nam	O
:	O
the	O
share	O
of	O
agriculture	O
in	O
GDP	O
is	O
22	O
.	O
1	O
%)[	O
16	O
].	O

(	O
2012	O
)*	O
Jiang	O
et	O
al	O
.	O

In	O
addition	O
,	O
maternal	O
25D	O
(	O
OH	O
)	O
level	O
≥	O
15	O
.	O
0	O
ng	O
/	O
ml	O
was	O
described	O
as	O
“	O
high	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
”	O
and	O
<	O
15	O
.	O
0	O
ng	O
/	O
ml	O
as	O
“	O
low	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
.”	O
A	O
significant	O
difference	O
in	O
the	O
Rrs	O
was	O
found	O
between	O
the	O
high	O
and	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
groups	O
(	O
3	O
.	O
8	O
±	O
0	O
.	O
8	O
vs	O
.	O
4	O
.	O
4	O
±	O
1	O
.	O
0	O
kPa	O
*	O
s	O
/	O
L	O
,	O
p	O
<	O
0	O
.	O
01	O
).	O

Therefore	O
,	O
these	O
three	O
subjects	O
were	O
included	O
in	O
the	O
analysis	O
.	O

Relatively	O
few	O
women	O
worldwide	O
meet	O
the	O
World	O
Health	O
Organization	O
’	O
s	O
recommendation	O
that	O
infants	O
breastfeed	O
exclusively	O
for	O
the	O
first	O
6	O
months	O
of	O
life	O
,	O
with	O
continued	O
breastfeeding	O
combined	O
with	O
appropriate	O
foods	O
thereafter	O
for	O
2	O
years	O
or	O
more1	O
—	O
even	O
those	O
who	O
intend	O
to	O
do	O
so	O
at	O
the	O
outset	O
.	O

“	O
We	O
started	O
to	O
look	O
at	O
breastfeeding	O
as	O
a	O
confounding	O
factor	B
in	O
our	O
studies	O
primarily	O
because	O
it	O
is	O
known	O
to	O
be	O
beneficial	O
to	O
child	O
health	O
,”	O
he	O
says	O
.	O

CC	O
females	O
exhibited	O
an	O
increased	O
caloric	O
intake	O
than	O
CC	O
males	O
from	O
the	O
13th	O
postnatal	O
week	O
(	O
adulthood	O
)	O
onward	O
,	O
meanwhile	O
RC	O
females	O
showed	O
a	O
higher	O
caloric	O
intake	O
than	O
RC	O
males	O
from	O
the	O
7th	O
postnatal	O
week	O
(	O
adolescence	O
)	O
to	O
adulthood	O
(	O
Figure2D	O
).	O

Spearman	O
Rank	O
correlation	O
test	O
showed	O
a	O
negative	O
significant	O
relationship	B
between	O
second	O
trimester	O
visfatin	O
level	O
and	O
birth	O
height	O
(	O
p	O
=	O
0	O
.	O
015	O
,	O
r	O
=-	O
0	O
.	O
523	O
)	O
in	O
group	O
B	O
(	O
Table	O
2	O
).	O

2	O
.	O

We	O
examined	O
GWG	O
as	O
an	O
independent	O
predictor	O
and	O
potential	O
mediator	O
of	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
offspring	O
weight	O
outcomes	O
(	O
Table	O
3	O
).	O

Only	O
three	O
TFBS	O
genes	O
were	O
overrepresented	O
among	O
loci	O
whose	O
methylation	O
was	O
associated	B
with	O
LINE	O
-	O
1	O
methylation	O
:	O
MEF2	O
,	O
TBX1	O
,	O
and	O
POU2F1	O
.	O

This	O
can	O
improve	B
after	O
dental	O
surgery	O
under	O
GA	O
[	O
3	O
,	O
9	O
].	O

We	O
conducted	O
the	O
key	O
informant	O
interviews	O
to	O
understand	O
the	O
community	O
norms	O
around	O
IFA	O
supplementation	O
,	O
and	O
challenges	O
and	O
successes	O
of	O
the	O
existing	O
programme	O
.	O

These	O
data	O
were	O
processed	O
in	O
a	O
specific	O
previous	O
routine	O
designed	O
in	O
MatLab	O
(	O
Math	O
Works	O
,	O
6	O
.	O
0	O
version	O
,	O
USA	O
)	O
for	O
the	O
automatic	O
selection	O
of	O
5	O
minutes	O
RR	O
with	O
the	O
smallest	O
variance	O
[	O
29	O
].	O

However	O
,	O
comparing	O
to	O
our	O
study	O
,	O
the	O
median	O
level	O
of	O
cord	O
25	O
(	O
OH	O
)	O
D	O
of	O
COPSAC2000was	O
relatively	O
high	O
(	O
19	O
ng	O
/	O
ml	O
).	O

The	O
search	O
generated	O
27	O
related	O
articles	O
in	O
the	O
following	O
categories	O
:	O
prevalence	O
—	O
2	O
,	O
treatments	O
—	O
8	O
,	O
reviews	O
—	O
6	O
,	O
interventions	O
/	O
trials	O
—	O
6	O
,	O
dosage	O
—	O
1	O
,	O
and	O
technical	O
reports	O
—	O
4	O
.	O

Verburg	O
et	O
al	O
.	O

Previous	O
studies	O
have	O
suggested	O
that	O
perinatal	O
depression	O
is	O
more	O
frequent	O
and	O
serious	O
in	O
primiparous	O
women	O
than	O
multiparous	O
women	O
[	O
75	O
,	O
76	O
].	O

There	O
are	O
also	O
several	O
evidences	O
regarding	O
the	O
association	B
between	O
the	O
impaired	O
growth	O
indices	O
at	O
birth	O
and	O
increased	O
risk	O
of	O
developing	O
some	O
chronic	O
disorders	O
such	O
as	O
obesity	O
,	O
diabetes	O
[	O
5	O
],	O
cardiovascular	O
diseases	O
[	O
5	O
],	O
endothelial	O
dysfunction	O
[	O
6	O
],	O
nonalcoholic	O
fatty	O
liver	O
disease	O
[	O
7	O
],	O
and	O
chronic	O
kidney	O
disease	O
[	O
8	O
].	O

These	O
analyses	O
used	O
data	O
from	O
UN	O
demographic	O
projections	O
of	O
births	O
[	O
49	O
]	O
and	O
the	O
Child	O
Health	O
Epidemiology	O
Reference	O
Group	O
/	O
World	O
Health	O
Organization	O
neonatal	O
cause	O
of	O
death	O
time	O
series	O
,	O
2000	O
to	O
2010	O
[	O
50	O
].	O

Infants	O
with	O
lower	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(<	O
13	O
.	O
7	O
ng	O
/	O
ml	O
)	O
had	O
higher	O
resistance	O
of	O
respiratory	O
system	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
a	O
higher	O
risk	O
of	O
a	O
respiratory	O
tract	O
infection	O
before	O
the	O
age	O
of	O
6	O
months	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

However	O
,	O
after	O
adjusting	O
for	O
factors	O
shown	O
to	O
be	O
associated	B
with	O
vitamin	O
D	O
status	O
including	O
BMI	O
and	O
recreational	O
walking	O
,	O
serum	O
25	O
(	O
OH	O
)	O
D	O
remained	O
significantly	O
lower	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
suggesting	O
the	O
influence	B
of	O
other	O
factors	O
not	O
measured	O
as	O
part	O
of	O
SCOPE	O
for	O
example	O
,	O
hours	O
spent	O
outside	O
in	O
the	O
sun	O
.	O

However	O
,	O
such	O
drugs	O
are	O
not	O
environmental	O
factors	O
and	O
so	O
were	O
not	O
considered	O
any	O
further	O
.	O

Women	O
of	O
high	O
educational	O
level	O
were	O
the	O
most	O
interested	O
in	O
the	O
health	O
talk	O
recommendation	O
(	O
76	O
%	O
of	O
all	O
recommendations	O
were	O
made	O
by	O
this	O
class	O
of	O
respondents	O
),	O
arguing	O
that	O
the	O
“	O
lectures	O
”	O
should	O
be	O
more	O
detailed	O
than	O
what	O
they	O
were	O
at	O
the	O
moment	O
.	O

A	O
putative	O
decrease	O
in	O
hypothalamic	O
sensitivity	O
to	O
leptin	O
may	O
result	O
in	O
an	O
inability	O
to	O
detect	O
satiety	O
despite	O
the	O
fat	O
stores	O
,	O
which	O
finally	O
develop	O
to	O
obesity	O
(	O
Sasaki	O
,	O
2015	O
).	O

The	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
study	O
cohort	O
(	O
overall	O
and	O
by	O
GDM	O
status	O
),	O
are	O
presented	O
in	O
Table1	O
.	O

It	O
was	O
remarkably	O
observed	O
that	O
preparation	O
for	O
hibernation	O
was	O
characterized	O
by	O
striking	O
increases	O
in	O
body	O
weight	O
and	O
in	O
fat	O
mass	O
.	O

There	O
is	O
probably	O
no	O
specific	O
etiologic	O
agent	O
acting	O
in	O
isolation	O
that	O
completely	O
explains	O
a	O
season	O
of	O
birth	O
association	B
with	O
adult	O
glioma	O
risk	O
.	O

Previous	O
studies	O
on	O
pregnant	O
Australian	O
and	O
New	O
Zealand	O
women	O
have	O
reported	O
that	O
while	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
was	O
significantly	O
lower	O
in	O
women	O
with	O
PE	O
,	O
sPTB	O
,	O
GDM	O
and	O
those	O
who	O
delivered	O
a	O
small	O
-	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
infant	O
,	O
no	O
association	O
between	O
vitamin	O
D	O
deficiency	O
and	O
these	O
pregnancy	O
complications	O
was	O
found	O
after	O
adjusting	O
for	O
covariates	O
[	O
18	O
–	O
20	O
].	O

We	O
found	O
that	O
birth	O
weight	O
percentile	O
levels	O
increased	O
by	O
about	O
10	O
and	O
15	O
points	O
,	O
respectively	O
,	O
with	O
a	O
10	O
%	O
increase	O
in	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
levels	O
,	O
suggesting	O
a	O
strong	O
association	B
of	O
repetitive	O
element	O
methylation	O
markers	O
with	O
fetal	O
growth	O
.	O

3	O
.	O
2	O
.	O

Guidelines	O
could	O
be	O
developed	O
for	O
improved	O
molecular	O
(	O
in	O
vivo	O
,	O
in	O
vitro	O
and	O
epidemiological	O
)	O
and	O
bioinformatic	O
study	O
designs	O
that	O
incorporate	O
suitable	O
new	O
technologies	O
(	O
such	O
as	O
omics	O
platforms	O
)	O
and	O
appropriate	O
inhibitors	O
/	O
treatments	O
/	O
cessations	O
(	O
for	O
exposure	O
/	O
change	O
/	O
effect	O
validation	O
)	O
to	O
definitively	O
identify	O
detailed	O
epigenetic	O
mechanisms	O
that	O
link	B
,	O
or	O
act	O
as	O
markers	O
of	O
,	O
environmental	O
exposures	O
and	O
adverse	O
health	O
outcomes	O
.	O

Their	O
mean	O
depression	O
score	O
changed	O
to	O
8	O
.	O
54	O
±	O
3	O
.	O
84	O
.	O

Given	O
that	O
the	O
association	B
between	O
early	O
gestation	O
through	O
extended	O
winter	O
and	O
insulin	O
resistance	O
is	O
independent	B
of	O
serum	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
,	O
our	O
novel	O
findings	O
imply	O
that	O
seasonal	O
variation	O
in	O
insulin	O
resistance	O
may	O
not	O
be	O
fully	O
explained	O
by	O
differences	O
in	O
vitamin	O
D	O
status	O
.	O

A	O
diet	O
higher	O
in	O
n	O
-	O
6	O
PUFAs	O
--	O
as	O
present	O
,	O
for	O
example	O
,	O
in	O
margarine	O
and	O
vegetable	O
oils	O
--	O
seems	O
to	O
be	O
more	O
likely	O
to	O
induce	O
eczema	O
than	O
n	O
-	O
3	O
PUFAs	O
,	O
which	O
are	O
for	O
instance	O
found	O
in	O
fish	O
[	O
79	O
].	O

Note	O
:	O
Eight	O
selected	O
Commission	O
on	O
Information	O
and	O
Accountability	O
for	O
Women	O
'	O
s	O
and	O
Children	O
'	O
s	O
Health	O
indicators	O
,	O
showing	O
median	O
for	O
Countdown	O
priority	O
countries	O
.	O

In	O
this	O
study	O
,	O
the	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
in	O
the	O
cord	O
serum	O
(	O
13	O
.	O
8	O
ng	O
/	O
mL	O
)	O
was	O
comparable	O
with	O
other	O
reports	O
,	O
but	O
a	O
lower	O
mean	O
level	O
in	O
the	O
maternal	O
serum	O
(	O
15	O
.	O
0	O
ng	O
/	O
mL	O
)	O
was	O
observed	O
.	O

This	O
susceptibility	O
is	O
mainly	O
because	O
decision	O
making	O
,	O
critical	O
thinking	O
,	O
and	O
abstract	O
thinking	O
are	O
underdeveloped	O
in	O
childhood	O
.	O

Changes	O
in	O
BMI	O
with	O
age	O
In	O
an	O
analysis	O
of	O
change	O
from	O
birth	O
to	O
5	O
years	O
,	O
the	O
weight	O
difference	O
of	O
the	O
child	O
was	O
calculated	O
(	O
age	O
5	O
–	O
0	O
)	O
and	O
regressed	O
on	O
the	O
other	O
family	O
members	O
’	O
weight	O
.	O

When	O
the	O
“	O
deficient	O
”	O
threshold	O
(<	O
35	O
nmol	O
/	O
L	O
)	O
was	O
applied	O
,	O
this	O
relationship	B
failed	O
to	O
reach	O
significance	O
(	O
p	O
=	O
0	O
.	O
12	O
(	O
Fisher	O
’	O
s	O
Exact	O
Test	O
),	O
OR	O
=	O
2	O
.	O
7	O
).	O

In	O
the	O
preterm	O
group	O
,	O
the	O
dynamics	O
of	O
GR	O
splicing	O
were	O
altered	O
,	O
since	O
GR	O
α	O
correlated	B
with	O
GR	O
-	O
P	O
(	O
r	O
=	O
0	O
.	O
710	O
,	O
P	O
=	O
0	O
.	O
021	O
)	O
and	O
GR	O
β	O
correlated	B
with	O
GAS5	O
(	O
r	O
=	O
0	O
.	O
792	O
,	O
P	O
=	O
0	O
.	O
011	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
4	O
Skeletal	O
abnormalities	O
in	O
skeletal	O
morphology	O
mutant	O
(	O
Skm	O
)	O
mice	O
.	O

There	O
are	O
numerous	O
studies	O
which	O
have	O
shown	O
that	O
vitamin	O
D	O
deficiency	O
is	O
associated	B
with	O
adverse	O
pregnancy	O
outcomes	O
(	O
Most	O
recent	O
:	O
[	O
14	O
–	O
17	O
]),	O
particularly	O
in	O
populations	O
that	O
reside	O
at	O
higher	O
latitudes	O
.	O

Participants	O
were	O
categorized	O
by	O
quintiles	O
of	O
dietary	O
pattern	O
scores	O
.	O

Significantly	O
lower	O
serum	O
testosterone	O
concentration	O
is	O
associated	B
with	O
lower	O
BMD	O
measured	O
densitometrically	O
in	O
the	O
lumbar	O
spine	O
and	O
iliac	O
bone	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Ninety	O
-	O
three	O
per	O
cent	O
of	O
the	O
exposed	O
neonates	O
that	O
presented	O
with	O
PNA	O
symptoms	O
were	O
born	O
to	O
mothers	O
receiving	O
psychotropic	O
polytherapy	O
,	O
and	O
53	O
%	O
of	O
these	O
neonates	O
were	O
prenatally	O
exposed	O
to	O
a	O
selective	O
serotonin	O
reuptake	O
inhibitor	O
(	O
SSRI	O
).	O

The	O
risk	O
was	O
four	O
-	O
fold	O
higher	O
in	O
women	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
below	O
37	O
.	O
5	O
nmol	O
/	O
L	O
(	O
15ng	O
/	O
mL	O
)	O
controlling	O
for	O
multiple	O
confounding	O
factors	O
.	O

The	O
lines	O
represent	O
the	O
weighted	O
regression	O
with	O
its	O
95	O
%	O
confidence	O
interval	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIG	O
2	O
Scatter	O
plots	O
showing	O
the	O
correlation	O
between	O
birth	O
weight	O
with	O
parameters	O
of	O
the	O
time	O
domain	O
:	O
(	O
A	O
)	O
RMSSD	O
and	O
(	O
B	O
)	O
PNN50	O
.	O

The	O
exposed	O
neonates	O
were	O
more	O
likely	O
to	O
be	O
born	O
premature	O
,	O
were	O
admitted	O
more	O
often	O
to	O
the	O
neonatal	O
intensive	O
care	O
unit	O
,	O
presented	O
with	O
poor	O
neonatal	O
adaptation	O
signs	O
and	O
had	O
higher	O
rates	O
of	O
congenital	O
malformations	O
.	O

There	O
are	O
different	O
forms	O
of	O
preventive	O
treatment	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
.	O

Such	O
findings	O
,	O
both	O
positive	O
and	O
negative	O
,	O
have	O
been	O
incorporated	O
into	O
UK	O
governmental	O
advice	O
and	O
recommendations	O
(	O
Boyd	O
et	O
al	O
.	O
2013	O
).	O

Lack	O
of	O
engagement	O
may	O
be	O
a	O
consequence	O
of	O
insufficient	O
involvement	O
of	O
policy	O
makers	O
,	O
issues	O
regarding	O
distribution	O
and	O
costs	O
and	O
difficulties	O
in	O
training	O
the	O
educators	O
,	O
or	O
the	O
beliefs	O
and	O
cultural	O
practices	O
of	O
the	O
target	O
population	O
and	O
the	O
characteristics	O
and	O
side	O
effects	B
of	O
supplements	O
[	O
11	O
,	O
14	O
].	O

The	O
sample	O
size	O
necessary	O
to	O
define	O
a	O
twofold	O
increase	O
of	O
malformation	O
rates	O
of	O
1	O
–	O
3	O
%	O
above	O
the	O
baseline	O
was	O
insufficient	O
.	O

We	O
used	O
vsearch	O
[	O
34	O
]	O
to	O
remove	O
chimeras	O
both	O
de	O
novo	O
and	O
in	O
comparison	O
to	O
the	O
RDP	O
classifier	O
training	O
reference	O
.	O

There	O
are	O
two	O
major	O
forms	O
of	O
active	O
Vitamin	O
D	O
,	O
Vitamin	O
D2	O
(	O
ergocalciferol	O
)	O
and	O
Vitamin	O
D3	O
(	O
cholecalciferol	O
).	O

Health	O
staff	O
interviews	O
and	O
participating	O
women	O
surveys	O
were	O
conducted	O
in	O
2006	O
and	O
2009	O
.	O

No	O
other	O
significant	O
associations	O
between	O
birth	O
outcomes	O
and	O
vaccination	O
by	O
trimester	O
were	O
noted	O
.	O

